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Cardiac arrhythmias arise from a variety of structural and electrical substrates and range 
in clinical presentation from asymptomatic to severely disabling or life threatening. 
Existing techniques for the characterisation of arrhythmia substrates include surface 
electrocardiography and intracardiac mapping together with ultrasound, computed 
tomography and magnetic resonance imaging. In this thesis I study a spectrum of 
arrhythmia characterisation techniques to improve the understanding of complex 
arrhythmia mechanisms. The role of surface electrocardiography and intra-cardiac 
contact mapping together with cardiac magnetic resonance imaging are studied in a 
variety of atrial and ventricular arrhythmias as well as in an animal model of atrial 
ablation. Arrhythmia characterisation techniques result in large quantities of data that are 
frequently considered in combination with other modalities and visualised within the 3- 
dimensional nature of cardiac structures. Since no techniques are currently available to 
display multiple parameters without loss of fidelity of either parameter, I developed a 
new system for data representation. Termed Dot Mapping, this system allows two or more 
datasets to be concurrently displayed by using separate visual entities (colour and dots) 
for each. The function, development and feasibility of the system are studied. In summary, 
this thesis explores and develops a number of techniques for assessing arrhythmia 
substrates, including surface electrocardiography, intra-cardiac mapping and cardiac 
magnetic resonance imaging. New (and existing) data thus created are displayed using a 
new data representation technique designed to optimise the co-display of multiple related 
modalities. 
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Thesis Outline 
Cardiac arrhythmias arise from a variety of structural and electrical substrates and range 
in clinical presentation from asymptomatic to severely disabling or life threatening. 
Existing techniques for the characterisation of arrhythmia substrates include surface 
electrocardiography and intracardiac mapping together with ultrasound, computed 
tomography and magnetic resonance imaging. In this thesis I study a spectrum of 
arrhythmia characterisation techniques to improve understanding of complex arrhythmia 
mechanisms before developing a new technique for the representation (display) of these 
arrhythmia substrates. 
The role of surface electrocardiography in risk-stratifying the early repolarization 
phenotype is covered first (Chapter 2). Although sudden cardiac death arising from 
idiopathic ventricular fibrillation has been associated with early repolarization, the 
finding of early repolarization on the ECG of an otherwise-well individual is of uncertain 
significance. The early repolarization phenotype is itself similar to the ECG appearances 
of hypothermia. Therefore I studied whether therapeutic hypothermia could augment the 
ECG appearances substantially differentially in a group of idiopathic ventricular 
fibrillation survivors compared to a control group consisting of coronary artery disease-
related ventricular fibrillation survivors.  
Chapters 3 and 4 focus on the role of intra-cardiac mapping in characterising atrial 
arrhythmia substrates. Local activation mapping is performed by recording the timing of 
a local electrogram compared to a fixed (usually intracardiac) reference electrogram. The 
use of local activation time mapping in atrial tachycardias allows arrhythmia mechanism 
diagnosis and appropriate targeting of ablation therapy, but the optimal mapping density 
for local activation mapping is not currently known. In Chapter 3 this optimal sampling 
density is explored, using both simulated and clinical data. The impacts of chamber 
geometry complexity and activation pattern complexity on the optimal sampling density 
are characterised. 
Intra-cardiac mapping has also been used to characterise local electrical properties in 
various arrhythmia states, frequently in order to guide ablation. However, to date, 
procedural success rates in paroxysmal atrial fibrillation have been variable. I 
hypothesised that varying degrees of electrical remodelling may therefore be 
demonstrable within a clinically homogeneous population of paroxysmal atrial 
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fibrillation patients. Chapter 4 develops techniques to characterise regional atrial 
electrophysiology whilst using supporting evidence from simulation experiments to 
provide a detailed characterisation of these patients. 
In addition to electrical remodelling, structural remodelling has also been identified in 
atrial fibrillation, and in Chapter 5 the comparison between cardiac magnetic resonance 
and local electrophysiology is made. Together these modalities provide a tool for 
characterising the atrial fibrillation substrate which could in the future be used to guide 
treatment strategies. 
In the final chapter of this section (Chapter 6), several arrhythmia characterisation 
modalities are combined to assess ablation lesion formation in a porcine model. The 
creation of effective ablation lesions is crucial to the success of ablation procedures, but 
ineffective ablation lesions can also themselves become arrhythmogenic by for example 
altering local conductivities and providing substrate for re-entry. This chapter uses 
intracardiac mapping, imaging and histological assessment to examine the impact of 
catheter-myocardium contact force on the creation of linear ablation lesions. 
Finally, arrhythmia characterisation techniques result in large quantities of data that are 
frequently considered in combination with other modalities and visualised within the 3-
dimensional nature of cardiac structures. Since no techniques are currently available to 
display multiple parameters without loss of fidelity of either parameter, Chapter 7 
develops a new system for data representation. Termed Dot Mapping, this system allows 
two or more datasets to be concurrently displayed by using separate visual entities (colour 
and dots) for each. The function, development and feasibility of the system are studied. 
In summary, this thesis explores and develops a number of techniques for assessing 
arrhythmia substrates, including surface electrocardiography, intra-cardiac mapping and 
cardiac magnetic resonance imaging. New (and existing) data thus created are displayed 



















In this section I will firstly outline the electrophysiological basis of arrhythmias before 
describing the key techniques used for in vivo arrhythmia characterisation. I will then 
highlight some of the clinical contexts in which these techniques are applied and in doing 
so identify the first aims of this thesis. Finally, I will review the technologies used for 
clinical representation of arrhythmia substrates, identifying scope for further work. Aims 
are therefore split into two categories: arrhythmia characterisation (prefixed ‘C’) and 
arrhythmia representation (prefixed ‘R’). 
1.1 Cardiac Electrophysiology 
Molecular Basis of Cardiac Electrophysiology 
Ionic Equilibrium and Transmembrane Potential 
The lipid bilayer forming the cardiomyocyte cell membrane is impermeable to water-
soluble ions. Ion channels spanning the cell membrane allow for the passive movement 
of ions, driven by electrostatic and chemical gradients. These gradients may oppose each 
other, such that there exists a point where the forces are exactly opposite. In this situation 
there is no net movement of the ion across the cell membrane and the ion is said to be in 
equilibrium. Due to the existence of a chemical gradient in addition to an electrical 
gradient, at ionic equilibrium there will be a net accumulation of charge on one side of 
the membrane. This equilibrium potential for a specific ion is termed the Nernst potential 
(!"#$). The transmembrane potential (!%) at ionic equilibrium is found by calculating a 
weighted average of the !"#$ of all the ions for which the membrane is permeable. The 
weighting for a particular ion is calculated as the ratio of the conductance of the 
membrane for that ion to the total membrane conductance.                
In addition to passive movement, cardiomyocytes maintain an excess of negative ions 
inside the cell membrane, resulting in polarisation of the cell membrane and a negative 
transmembrane potential (!%). The cell membrane demonstrates both a capacitance and 
a resistance. The small transmembrane potential results in accumulation of oppositely 
charged ions on the intracellular and extracellular aspects of the cell membrane, and since 
the membrane is thin, the resulting electrical potential gradient is extremely high. Whilst 
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this membrane capacitance is fixed, the membrane resistance varies depending on the 
conductance of membrane ion channels. For a particular ion, membrane conductance is 
termed &"#$. Since conductance is simply the inverse of resistance, and given Ohm’s law 
(! = (×*), then the current generated by a particular ion is given by the following 
relationship: 
 ("#$ = &"#$× !% − !"#$  Equation	1-1	
A net inward current (generated by influx of positively charged ions (e.g. Na+ or Ca2+) or 
efflux of negatively charged ions (e.g. Cl-)) results in depolarization of the transmembrane 
potential whilst an outward current (generated typically by efflux of positively charged 
K+ ions) results in hyperpolarisation of the transmembrane potential. The transmembrane 
potential (!%) hence depends on membrane conductances for Na+, K+, Ca2+ and Cl- ions, 
which are determined by the activity of specific ion channels, transporters and exchangers. 
Cardiac Action Potential 
The cardiac action potential is an ‘all-or-nothing’ response characterised by dramatic 
changes in membrane conductances and transmembrane potential that is triggered by an 
abrupt change in !%  usually as a result of an electric current from an adjacent cell. 
Activation of adjacent cardiomyocytes is triggered by changes in capacitive currents. In 
contrast to ionic currents (generated by movement of ions across the cell membrane), 
capacitive currents arise from an accumulation of electrons at the extracellular aspect of 
the cell membrane as the depolarization wave approaches. The electrons reduce the 
extracellular positive charge and the intracellular negative charge correspondingly falls. 
The net effect of these capacitive currents is to increase !% towards zero. Once the !% 
passes a threshold of around -65mV, Na+ channels in the cell membrane open resulting 
in a rapid influx of positively charged ions and a cascade of subsequent ion channel events 






effective	 refractory	period;	RRP,	 relative	 refractory	period;	 FRP,	 functional	 refractory	period.	Adapted	
from	(1).		
The cardiac action potential is divided into five phases, numbered 0-4, and beginning 
with the resting membrane potential (Phase 4). During Phase 4, resting membrane 
potential is dependent on passive movement of Na+, K+, Ca2+ and Cl- ions. Since the 
resting membrane is highly permeable to K+ ions (owing to the presence of the inwardly 
rectifying K+ channels (Kir)), the resting membrane potential is clamped close to the 
Nernst potential for K+, i.e. !% is close to !,. The Na+-K+ adenosine triphosphatase pump 
(Na+-K+ pump) also contributes to resting !% , by facilitating the energy-dependent 
movement of Na+ and K+ against their chemical gradients. The net effect of these channels 
is to maintain the resting transmembrane potential around -85mV. Following initial 
depolarisation of the cell membrane above the threshold potential, Phase 0 of the action 
potential is triggered. In atrial and ventricular myocytes as well as His-Purkinje fibres, 
Phase 0 is characterised by a rapid upstroke dependent on fast inward Na+ currents, 
termed the ‘fast response action potential’. In contrast, sinus node and atrioventricular 
node cells have action potentials characterised by a slow upstroke dependent on L-type 
voltage-gated Ca2+ currents. Following the depolarisation phase of the action potential, 
three repolarisation phases occur: early repolarisation (Phase 1), plateau phase (Phase 2) 







potential near to 0mV and is mediated primarily by the transient outward K+ current (Ito) 
with further contributions from the Na+-Ca2+ exchanger. During the plateau phase (Phase 
2), Ca2+ ions enter the cell through L-type Ca2+ channels (ICaL), but this depolarizing 
inward current is balanced by repolarizing outward potassium currents (ultra-rapidly 
(IKur), rapidly (IKr) and slowly (IKs) activating delayed outward rectifying currents). 
Overall, therefore, there is no net movement of charge during Phase 2. The duration of 
Phase 2 varies between types of cardiomyocytes, with atrial and His-Purkinje cells 
characterised by the shortest and longest Phase 2 durations, respectively. Finally, Phase 
3 is the final rapid repolarization, restoring !% back to the resting membrane potential. 
Time-dependent inactivation of ICaL together with delayed outward rectifying currents 
(IKr and IKs) and inwardly rectifying K+ currents (IK1 and IKAch) are responsible for final 
repolarization. 
Excitability 
An action potential is triggered when a charge applied to the cardiomyocyte results in a 
reduction of the transmembrane potential (!%) above the threshold value for excitation. 
The charge required for excitation defines the excitability of the cell. When excitability 
is reduced, a greater external charge is required to trigger the action potential. During 
Phase 0, excitability is reduced by increased (i.e. less negative) !% as more Na+ channels 
become progressively inactivated as the !% rises above -70mV to -50mV (when all the 
Na+ channels are inactivated). In contrast, towards the end of Phase 3 of the action 
potential, sufficient Na+ channels are available to trigger rapid depolarization, and !% is 
relatively close to the threshold potential, resulting in supernormal excitability. A number 
of states, including Na+ channel blockade with class I antiarrhythmic drugs and 
myocardial ischemia reduce cardiomyocyte excitability. 
Refractoriness 
Refractoriness refers to the period following excitation during which the cardiomyocytes 
remain unexcitable. Further excitation requires the transmembrane potential to recover 
toward the resting membrane potential. Refractoriness is thus related to, but generally 
slightly shorter than, the action potential duration. A phenomenon termed post-
repolarisation refractoriness (PRR) is however described whereby myocardial tissue 
remains non-excitable even after the transmembrane potential has returned to the resting 
membrane potential. PRR typically occurs in cells depending on the ICaL current for 
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excitation (over and above INa) and has been documented in sinoatrial/atrioventricular 
nodal cells (2, 3), in the post-ischaemic state (4, 5) and in atrial tissue preparations (6). 
Since the recovery of Ca2+ channels from inactivation may continue into phase 4 of the 
action potential, recovery of excitability in these myocytes may require a time interval 
that is longer than the action potential duration. Although physiological states promoting 
PRR have been described, for example hypoxia, acidosis and hyperkalaemia, the 
underlying cellular mechanisms of PRR are currently debated (7). Regardless of the 
relative contribution of APD and/or PRR to overall refractoriness, refractoriness itself is 
a crucial determinant of arrhythmogenesis since it dictates the maximal frequency of 
activation. 
A number of terminologies have been applied to describe refractory periods in terms of 
cellular activation and the action potential (see Figure 1-1). During Phase 0, 1 and 2 of 
the action potential, no stimulus regardless of size can elicit a further action potential: this 
period is termed the absolute refractory period (ARP). The effective refractory period 
(ERP) refers to the ARP plus the early portion of Phase 3 when non-propagated cellular 
depolarisation can be triggered. During the ERP, an applied stimulus will not result in 
propagation of the depolarization wave. The relative refractory period (RRP) refers to a 
period during Phase 3 when cellular activation may be triggered by a larger-than-normal 
stimulus. During the RRP, further cellular activation is inhibited but not impossible. A 
stimulus applied during the RRP will result in a lower amplitude action potential with 
less rapid Phase 0, and at a tissue scale propagation is also inhibited resulting in a 
reduction in conduction velocity. ERP, RRP and additionally the functional refractory 










Cardiac excitation relies on the propagation of an action potential from one 
cardiomyocyte to the next (termed a regenerative action potential). Conduction velocity 
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refers to the speed of depolarisation across the myocardium and depends on both active 
and passive cell membrane properties (i.e. ion channel conductances and action potential 
formation) as well as tissue-scale properties (cellular coupling and geometry). During 
conduction, adjacent cardiomyocytes exist in a source-sink relationship. Initially, an 
excited cardiomyocyte acts as a (capacitive) current source for adjacent non-excited 
cell(s) (sink). Gradually the transmembrane potential of the non-excited cell(s) rises 
above the threshold potential, at which point an action potential is triggered and the non-
excited (sink) cell becomes an excited (source) cell acting as a source for the next non-
excited cell. A number of resistances act against current propagation from source to sink, 
including intracellular resistance (within the cell), intercellular resistance (relating to gap 
junctions) and extracellular resistance provided by the interstitial fluid. The mathematical 
relationship between these resistances (i.e. conductances) is well described (see 
Continuous Propagation Models, p. 44). 
Given the dependence of conduction on the generation of a capacitive current, it follows 
that conduction velocity is dependent on both the action potential amplitude and the rate 
of change of transmembrane potential (i.e. the steepness of Phase 0 of the action potential). 
Conduction velocity therefore depends upon the factors influencing INa, which (as 
discussed above) include the resting membrane potential !% at the time of stimulation, 
the availability of Na+ channels and the electrochemical gradient of Na+. These 
observations explain both the rapid conduction seen in His-Purkinje tissue (with a high 
concentration of Na+ channels) and the conduction delay seen in nodal tissue (with a very 
slow ICaL-dependent Phase 0). 
Electrophysiological Mechanisms of Cardiac Arrhythmias 
At a cellular level, arrhythmia may occur due to automaticity (spontaneous impulse 
generation), triggered activity (arising from after-depolarisations) and re-entry (perpetual 
activation of the origin site by the returning original depolarisation wave). Clinical 
characterisation of arrhythmia mechanisms depends on the ability to record cardiac 
activation in vivo, but relating clinical arrhythmias to underlying cellular mechanisms is 
challenging. Automaticity, triggered activity and re-entry are considered further below. 
Automaticity 
Automaticity is a normal property of cells within the sinus node, atrioventricular node 
and His-Purkinje system. Arrhythmias may arise from enhanced normal automaticity as 
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well as abnormal automaticity occurring in atrial or ventricular myocytes. Normal 
automaticity in pacemaker regions depends at least in part on the action of If (the funny 
current) (8). If is an inward current carried in the If channel with mixed permeability to 
both Na+ and K+. It activates during repolarisation when !%  falls to -50mV and 
completely activates at -100mV, leading to a depolarisation that triggers Ca2+ influx 
resulting in triggering of the action potential. Whilst atrial and ventricular myocytes do 
also have an If, the range of activation is significantly more negative than the resting 
transmembrane potential (e.g. -120 to -170mV), and hence abnormal automaticity 
occurring in these cells is not If-dependent (9). However, automaticity can be seen in these 
cells when the resting membrane potential is abnormally high (e.g. depolarization to -70 
to -30mV vs. -85mV). A variety of candidate mechanisms for abnormal automaticity have 
been identified including a dependence on the delayed rectifier IK current and intracellular 
sarcoplasmic calcium release causing activation of inward Ca2+ currents. Clinically, 
automatic arrhythmias often initiate with acceleration (‘warm-up’) and terminate after 
deceleration (‘warm-down’). They are susceptible to suppression by overdrive pacing, 
which is usually followed by gradual re-acceleration of the tachycardia. 
Triggered Activity 
Triggered activity refers to excitation occurring due to afterdepolarisations consequent to 
a preceding impulse (10, 11). Afterdepolarisations may occur just before (phase 2), during 
(phase 3) or after (phase 4) repolarisation. Afterdepolarisations are referred to as early 
(EAD) when they occur during repolarisation phases 2 or 3 and delayed (DAD) when 
they occur after repolarisation in phase 4. When an EAD/DAD reaches membrane 
threshold potential a further action potential is triggered, which may in turn result in a 
sustained arrhythmia for example by initiating abnormal automaticity, subsequent 
triggered activity or re-entry (12). Both EADs (13) and DADs (14) have been described 
in pulmonary venous myocardial sheaths, although their exact relationship to the 
pathogenesis human atrial fibrillation remains uncertain (15). 
EADs are caused by any imbalance in the net repolarising current during phase 2 and 
phase 3 of the action potential. During phase 2, inward currents carried through 
incompletely inactivated Na+ channels (16) and the slow inward Ca2+ current (17) are 
offset by outward currents carried by rapidly activating IKr and slowly activating IKs 
delayed rectifier currents (18). There is a slight net excess of outward currents, which 
shifts membrane potential gradually in a negative direction, until such time as phase 3 
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and complete repolarisation occur. Any imbalance of these currents that results in a region 
of net inward current can prevent repolarisation (19) and potentially lead to an EAD. A 
number of states may pre-dispose to EAD occurrence including hypoxia, elevated pCO2 
and elevated catecholamines, as well as exposure drugs such as sotalol and procainamide 
which prolong the repolarisation phase of the action potential (12). There is also a 
relationship between heart rate and EADs. As heart rate increases, shorter APD is 
associated with lower amplitude EADs, likely due to augmentation of the delayed rectifier 
potassium current (20). Similarly, at slower heart rates, prolongation of APD reflects a 
decrease in the net outward current and an increase in the likelihood of EAD formation 
and bradycardia-induced arrhythmias (21). 
DADs are membrane potential oscillations occurring after completion of repolarization 
and are caused by alterations of sarcoplasmic calcium handling (22) resulting in increased 
intracellular calcium concentration. In the presence of elevated [Ca2+] reuptake of Ca2+ 
by the sarcoplasmic reticulum may be incomplete by the end of the action potential and 
there may be further release of Ca2+ from the sarcoplasmic reticulum (23). In turn the 
increased level of cytoplasmic calcium may lead to altered sarcolemmal conductance and 
an inward movement of charge carried by sodium ions creating an overall transient 
inward current causing the DAD (24, 25). The consequences of elevated cytosolic 
calcium are clearly demonstrated during digitalis toxicity where inhibition of the Na+-K+ 
pump causes elevation of the intracellular sodium concentration which in turn activates 
the Na+-Ca2+ exchange mechanism causing a rise in intracellular calcium and frequent 
ventricular ectopy (26). Elevated catecholamines have also been associated with DADs 
in both the atrium (27) and ventricle (28). As for EADs, heart rate is also a key 
determinant of DADs, although the opposite relationship is seen with more rapid 
stimulation being associated with higher amplitude DADs that are more likely to reach 
threshold for triggered activity (29).  
Clinically, arrhythmias due to triggered activity show a variable response to overdrive 
pacing. If pacing is fast enough for a long enough duration, then the rate of triggered 
activity slows and may stop. However, if the pacing rate is only slightly faster than 
tachycardia, then it can cause overdrive acceleration of the tachycardia.	
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Re-entry and the Excitable Gap 
In sinus rhythm (and during focal tachycardias), the activation wave expires following 
complete activation of the myocardium, since the period of excitation is significantly 
shorter than the refractoriness of the tissue. In contrast, during re-entry the depolarisation 
wave re-enters tissue that it has previously depolarised at a time when local repolarisation 
has already occurred. In doing so, repeated depolarisations of the original tissue can occur 
in a process of self-perpetuation. Re-entry can only occur when certain conditions are 
met: 1) unidirectional block is required for initiation; and 2) the circuit activation time 
must be longer than the refractory period of the tissue (30). Unidirectional block can occur 
if there is anatomical asymmetry of the conduction tissue, or if there is functional 
asymmetry in excitability (31). The second condition implies that there must be an 
excitable gap – i.e. that the circuit is long enough such that tissue at the trailing edge of 
the wave front has time to become excitable before return of the leading edge of the next 
wave front. The concept of the excitable gap depends on the wavelength of the re-entrant 
circuit. Wavelength is defined as the product of conduction velocity and effective 
refractory period and determines the distance travelled by the depolarisation wave relative 
to the refractory period of the tissue. Hence, increased conduction velocity or 
refractoriness both increase wavelength, reduce the excitable gap and ultimately require 
a greater re-entrant path length to support re-entry. 
1.2 Arrhythmia Substrate Characterisation Techniques 
Surface Electrocardiography 
From the beginning of the 19th century a number of key discoveries paved the way for the 
development of modern surface electrocardiography (ECG), one of the most ubiquitous 
investigations in modern cardiology. That the beating heart is associated with an electric 
current was first demonstrated using the ‘rheoscopic frog’. In this experiment the cut 
nerve of a frog’s leg connected to the epicardial surface of the ventricle would cause 
twitching of the frog’s leg in time with the heart beat (32). These early findings were later 
confirmed using the astatic galvanometer (33) and, following the invention of more 
sensitive galvanometers, transmembrane potentials (i.e. action potentials) were shown to 
accompany muscular contraction (34). Eventually, in 1887, the first human 
electrocardiogram was recorded at St Mary’s Medical School (35) using the capillary 
electrometer (see Figure 1-2). This device consisted of a column of mercury within a glass 
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tube. The technique was subsequently refined allowing identification of atrial and 
ventricular components of the waveform together with the first measurements of 





Several innovations in the first half of the 20th century then followed, progressing toward 
the standard 12-lead ECG still in use today. Use of a refined capillary electrometer 
allowed demonstration of 5 deflections in the electrocardiogram, and mathematical 
correction for inertia and friction in the capillary system resulted in the familiar ‘PQRST’ 
waveforms (37) (Figure 1-3). Subsequently, the string galvanometer was invented, which 
was a highly sensitive device not requiring mathematical correction of the acquired 
waveform (38). The string galvanometer propelled electrocardiography from research to 
clinical practice, using three leads connected to the left arm, right arm and left leg 
arranged in bipolar configuration. It was not until 1928 that non-mechanical amplification 






Whilst the early electrocardiogram in the coronal plane was useful for detecting 
arrhythmias, including atrial fibrillation (delirium cordis, (40)) and myocardial infarction 
(41), the 3-lead configuration in use resulted in ‘silent’ areas of the heart (42). This 
observation led to the invention of the ‘central terminal’ created by joining the three limb 
leads together via 5kΩ resistors in order to create a single ground terminal (43). A roving 
electrode could then be used to record unipolar surface electrograms (termed V) anywhere 
on the body in reference to the central terminal. Eventually, combined American Heart 
Association / Cardiac Society of Great Britain guidelines were published recommending 
the V1-V6 chest lead positions that are still in use today (44). 
 
Figure	1-4.	Wilson's	Central	Terminal		
To	create	a	 central	 terminal,	or	ground,	each	of	 the	 limb	 leads	 (right	hand,	 left	hand	and	 left	 foot)	 is	
connected	together	via	5kΩ	resistors.	Reproduced	from	(43).	
One final innovation in the creation of the 12 lead ECG came with the development of 
the augmented limb leads. The standard 3-lead ECG provided leads in 60° intervals in the 
frontal plane. In order to provide a more detailed coverage (e.g. 30°) in the coronal plane, 
unipolar limb leads (VL, VR, VF) were created (43). Owing to the low amplitude signal 
found in VL, VR and VF a method was derived to amplify (‘augment’) their signal, 
resulting in the now-familiar leads termed a-VL, a-VR and a-VF (45). The eventual 
configuration of the standard limb leads, augmented limb leads and chest leads, as defined 
by the American Heart Association (46) is shown in Figure 1-5. Although this system 
remains in use today, the position of the chest leads does limit the diagnostic yield of the 
surface ECG. Indeed, adaptations to the standard positions have been suggested in order 
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to improve this including the addition of a right sided precordial lead in right ventricular 
infarction (47) and the use of posterior leads (V8 and V9) in posterior ventricular 
infarction (48). As an extension, ECG systems recording tens or hundreds of leads 
(termed body surface potential mapping) have been studied in a wide range of cardiac 





Whilst the surface ECG can reveal important information about the arrhythmia (e.g. rate, 
A-V relationship) and is frequently in itself diagnostic, determining the specific 
underlying mechanism and/or cardiac activation pattern requires more advanced 
techniques. These include intracardiac contact and non-contact mapping and body surface 
potential mapping. These techniques are addressed in the following sections. 
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Intracardiac Contact Mapping 
Intracardiac mapping catheters are used to record electrograms from cardiac structures, 
with the resulting electrograms being compared to other intracardiac and surface 
recordings. The catheters may be positioned once at the start of the procedure and then 
remain stationary (e.g. in the case of CS or HRA catheters), or may be roving catheters 
recording electrograms from multiple sites as required (e.g. in the case of the 
mapping/ablation catheter). Electrograms may be recorded from intracardiac catheters in 
unipolar or bipolar configuration (50). In the case of unipolar recordings, the electrogram 
is recorded as the potential difference between an intra-cardiac electrode and an 
indifferent reference electrode, for example Wilson's central terminal (WCT). In the case 
of bipolar recordings, the potential difference is recorded between two closely spaced 
intracardiac electrodes. Since far-field and signal noise is present on both recording 
channels in a bipolar recording, bipolar recordings frequently have substantially higher 
signal-to-noise ratio than unipolar recordings. Nevertheless, identification of local 
activation time using unipolar recordings is very accurate owing to the close relationship 
between the steepest negative gradient of the unipolar signal and the onset of phase 0 of 
the local action potential (51). Furthermore unipolar signals give information about the 
direction of activation, with positive deflections occurring as the depolarisation wave 
approaches, and negative deflections occurring as the depolarisation wave travels away 
from the recording electrode. In contrast, assigning local activation time to bipolar 
recordings is more error prone, especially in the context of complex fractionated signals, 
and bipolar recordings give less information about the direction of activation.  
Activation Mapping 
Since activation mapping is performed during tachycardia, a stable, inducible tachycardia 
is a prerequisite for activation mapping. Bipolar recordings are generally used for 
activation mapping due to their improved signal to noise ratio and rejection of far field 
signal components. A sampling frequency of 1000Hz and a band pass filter of 30-250Hz 
are typically used for activation mapping of atrial arrhythmias, in order to highlight signal 
components most representative of local activation (50). Catheter positions are 
traditionally assessed with fluoroscopy, although electroanatomic mapping systems 
permit minimisation or even elimination of radiation exposure during mapping (see 
below). Local activation is taken as the time from the reference electrogram to a fixed 
characteristic (e.g. electrogram peak or onset) of the electrogram of the most distal bipole 
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of the mapping catheter. By considering the timing of local electrograms recorded with 
the mapping catheter to a fixed reference (e.g. atrial appendage electrogram for atrial 
tachycardias or QRS onset for ventricular tachycardias) it is possible to deduce the 
mechanism of tachycardia.  




and	 RV	 apex	 electrograms.	 Right	 –	 schematic	 representation	 of	 a	 re-entrant	 tachycardia	 with	
corresponding	surface	ECG,	mapping	catheter	and	RV	apex	electrograms.	Notice	the	diastolic	potential	
on	Map	recorded	from	the	critical	isthmus.	Reproduced	from	(1).	
In the case of a focal tachycardia, the goal is to locate the earliest activity within the 
chamber of interest. The following general sequence is typically employed. 1) Analysis 
of the surface ECG provides an initial estimate of the location of the tachycardia. 2) 
Analysis of activation sequences on a limited number of static intracardiac catheters (e.g. 
placed at the high right atrium, bundle of His, coronary sinus or right ventricular apex) 
refines the initial estimate to identify the region of interest. 3) A mapping catheter is 
manoeuvred into position and used to ‘explore’ the region of interest, searching for the 
site of earliest activation. Unipolar signals may then be used to confirm the exact site of 
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origin of the focal tachycardia, with a ‘QS’ morphology signifying that activation spreads 
away centrifugally from the catheter location. 
In the case of macro-re-entrant tachycardias, the goal is to locate the critical isthmus of 
the tachycardia (see Figure 1-6). The critical isthmus is identified as the site with 
continuous diastolic activity, or with an isolated mid-diastolic potential. Identification of 
the critical isthmus is challenging due to a number of factors. ‘Bystander’ pathways (false 
isthmus) may complicate mapping but have no relevance to the tachycardia mechanism 
whilst sites of late activation may appear to display diastolic potentials. In order to 
determine whether an isthmus is true or false it is necessary to identify whether the 
diastolic potential represents a site required for maintenance of the tachycardia (52). A 
fixed relationship between the diastolic potential and the subsequent tachycardia beat 
during cycle length changes (spontaneously or due to pacing) is consistent with, but does 
not prove, that the diastolic potential represents the location of the critical isthmus. 
Further manoeuvres (e.g. entrainment, see below) are necessary to finally confirm the 
correct site has been identified. 
Aside from assessing timing of local depolarisation (and therefore the tachycardia 
mechanism), analysis of the bipolar electrogram morphology can yield valuable 
information about local activation and/or underlying atrial substrate. Normal activation 
shows a simple electrogram with single peaks. Double potentials may be seen at any lines 
of block, including the crista terminalis in the normal atrium (53), due to previous ablation 
(54) or at sites of previous incisions (55). Fractionated potentials may be seen at sites of 
localised re-entry, but also at sites of atrial fibrosis or discontinuous conduction. 
Entrainment Mapping 
Entrainment mapping is a technique used to detect the presence (and circuit) of re-entry 
(56). During tachycardia, pacing distant to the tachycardia circuit may result in one of 
three outcomes. 1) The paced beat may reach the tachycardia circuit when the circuit is 
still refractory and have no effect on the tachycardia. 2) The paced beat may reach the 
tachycardia circuit early enough in the refractory period that it blocks in the orthodromic 
direction but still collides antidromically with the last beat of tachycardia, resulting in 
termination of the tachycardia. 3) The paced beat may reach the tachycardia circuit during 
the ‘excitable gap’, propagate in the antegrade direction and collide with the previous 
tachycardia cycle in the retrograde direction. Where this ‘resetting’ of the tachycardia 
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occurs reproducibly the tachycardia is said to be entrained (57). Note should be made that 
the degree of advancement of the tachycardia depends both on stimulus prematurity and 
conduction slowing in response to prematurity within the tachycardia circuit. In order to 
prove the presence of re-entry, four entrainment criteria have been identified (Table 1-2). 
Recently, a fifth criterion has been proposed that can assist with identification of single 
or double loop re-entry (58). Demonstration of any one criterion is sufficient to prove the 














Following cessation of the overdrive pacing train, the post-pacing interval (PPI) can be 
measured, as the time from the last pacing stimulus to the next non-paced recorded 
electrogram at the pacing site. In order for PPI measurements to be valid, entrainment of 
the tachycardia must first be demonstrated. When the pacing site lies on the tachycardia 
circuit, the time from the final paced stimulus to the return electrogram will be equal to 
the tachycardia cycle length (TCL). As the pacing site moves progressively farther from 
the circuit the PPI prolongs, since the final paced stimulus must travel to the circuit, 
around the circuit and back to the recording site. Hence the PPI is equal to the TCL plus 
the conduction time from the pacing site to the tachycardia circuit and back to the pacing 
site. Entrainment mapping is typically used to examine whether candidate regions 
identified from activation mapping are indeed part of the tachycardia circuit. 
Intracardiac Non-contact Mapping 
As an alternative to contact mapping, which records single bipolar electrograms or limited 
numbers of electrograms individually, the ESI non-contact mapping system (St Jude 
Medical, St Paul, MN) provides a tool to record many thousands of extrapolated 
electrograms simultaneously. Its major advantage is that it can document activation 
timing from large regions of a cardiac chamber from a single beat. This can be particularly 
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useful when the tachycardia may not be sufficiently sustained to allow conventional 
mapping to be performed. The non-contact mapping system consists of a balloon multi-
electrode array with 64 electrodes, a reference electrode located on the shaft of the 
catheter in the blood pool and a processing station. The multi-electrode array is positioned 
within the chamber of interest and the balloon inflated such that the 64 electrodes all 
record far-field signals. Prior to inflation a geometric model of the endocardial surface of 
the chamber is created (see Anatomical Representation, p.58). Given the known quantities 
of the shape of the balloon, the shape of the chamber and the potential field across the 
balloon, the system then computes the potential field across the surface of the chamber 
(using the Laplace equation). This is an inverse problem solved using the boundary 
element method. In doing so it becomes possible to estimate the unipolar electrograms 
found at a large number (e.g. 3000) of sites on the endocardial surface and, just as for 
contact mapping with unipolar signals, activation time can then be assigned as the steepest 
negative gradient of the calculated unipolar electrograms. Thus an estimated local 
activation time map can be created from a single beat, which is particularly useful for 
non-sustained, or haemodynamically unstable ventricular arrhythmias (60, 61). Non-
contact mapping has also been applied in the atrium where simultaneous electrical 
recordings across the whole chamber can permit the assessment of the spatiotemporal 
characteristics of AF (62, 63). 
Despite these advantages, non-contact mapping does suffer from a number of limitations. 
Since the calculation of virtual unipolar electrograms depends on the geometrical 
relationship between the balloon and cardiac chamber, any inaccuracies in the chamber 
geometry (including changes in volume loading or contraction pattern during 
tachycardia) can adversely affect the accuracy of the virtual electrograms. Furthermore, 
increased distance between the balloon and the chamber wall also reduce the accuracy of 
mapping, limiting the use of non-contact mapping in large chambers. Finally, the 
presence of the balloon in small chambers (e.g. the left atrium) can hinder manipulation 
of the mapping catheter around the inflated balloon.  
Electrocardiographic Imaging 
The solution to the inverse Laplace equation has also been applied to body surface 
potential mapping using three dimensional cross sectional imaging (usually computed 
tomography) to determine the geometrical relationship between the body surface and 
epicardial surface of the heart. Recovery of epicardial potentials from body surface 
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potentials in this way (the so-called inverse problem of electrophysiology) is an ill-posed 
problem 1  sensitive to noise and requiring regularization 2  of the solution. Two 
mathematical processes are involved in the calculation of epicardial potentials. 
Discretization3 of Laplace’s equation in the volume between body surface and epicardial 
surface is achieved using the boundary element method allowing the transfer matrix 
relating epicardial potentials to body surface potentials to be determined. Inverse 
solutions such as Tikhonov regularization or the generalized minimal residual method are 
then required to solve the inverse of this problem and compute epicardial potentials from 
the transfer matrix and body surface potentials (64–66). More recently these techniques 
have been applied in humans (67, 68) resulting in production of a commercially available 
system for electrocardiographic imaging (ECGI). The process of combining body surface 
potential recordings with three-dimensional heart-torso geometry to reconstruct an 
epicardial electroanatomic map is outlined in Figure 1-7. 
ECGI is a promising clinical tool for non-invasive risk stratification, arrhythmia diagnosis, 
intervention planning and evaluation as well as a research tool for studying mechanisms 
and properties of arrhythmias. ECGI has been validated in ventricular arrhythmias using 
comparisons with intra-operative multi-electrode mapping (68) and comparisons with 
known right ventricular (RV) and left ventricular (LV) pacing sites (69). ECGI has been 
validated in atrial arrhythmias using comparisons with intracardiac contact mapping (70, 
71), and known sites of left atrial (LA) pacing (72). ECGI has also been employed for 
substrate assessment in atrial fibrillation, including identification of zones of low voltage 
(73). Atrial activation patterns in AF have been assessed using ECGI, finding most 
commonly multiple wavelets and focal sources with rotors found more rarely (72). 
Another study was able to identify rotors in all patients studied with AF (74). Since ECGI 
has been shown to have a resolution of ~6mm for both ventricular and atrial activation 
(68, 72), the true ability of ECGI to detect rotor activation in AF (especially in the 
presence of wave break) remains uncertain. 
                                               
1 An 'ill-posed' problem (in the sense of Hadamard (360)) is one in which the solution is not unique, or the solution 
does not vary continuously with the input data.  
2 'Regularization' refers to a group of mathematical techniques that impose constraints on input data in order to force 
uniqueness in the solution (i.e. converting an ill-posed problem to a well-posed problem). 
3 'Discretization' is the process of transferring a continuous function (e.g. the relationship between body surface and 





obtained	 from	 transverse	 CT	 images.	 Processing	 software	 (see	 text)	 solves	 the	 inverse	 problem	 to	
calculate	 epicardial	 potentials	 from	 surface	 potentials	 and	 the	 heart-torso	 geometrical	 relationship.	
Adapted	from	(71).		
Cardiovascular Magnetic Resonance 
Cardiovascular Magnetic Resonance (CMR) is a non-invasive technique that has evolved 
over the past decade to allow comprehensive assessment of cardiac anatomy and function. 
Late enhancement CMR with gadolinium-based contrast agents has greatly improved the 
imaging of ventricular (75) and atrial (76–78) myocardial tissue composition and fibrosis. 
Such non-invasive identification of physical tissue characteristics offers the possibility of 
non-invasive characterisation of tissue electrical properties and ultimately arrhythmia 
mechanisms. 
Physical Basis of CMR Tissue Characterisation 
T1 and T2 Relaxation Times 
In CMR the pixel signal intensity is based on the relaxation of protons in a static magnetic 
field (typically 1.5 or 3 Tesla) characterized by 2 distinct magnetic resonance relaxation 
parameters: 1) the T1 or spin-lattice relaxation time and 2) the T2 or spin-spin relaxation 
time. The T1 relaxation time is the time constant defining the rate of recovery of 














relaxation time is the time constant defining the loss of magnetization (and therefore 
signal) in the transverse (xy) plane following radiofrequency excitation.  
Since the magnetic resonance characteristics of protons depends on their immediate 
molecular environment the T1 and T2 relaxation times vary between tissue types (e.g. fat, 
myocardium or blood) and also within the same tissue depending on its pathological state 
(e.g. inflammation, oedema or fibrosis). These inherent differences can be exploited by 
specific CMR sequences in order to reveal the molecular environment within the tissue 
and are further enhanced by the use of gadolinium-based contrast agents. 
Late Gadolinium Enhanced CMR 
Late gadolinium enhanced (LGE) imaging uses a T1-dependent inversion recovery technique 
to exploit the significant shortening of T1 relaxation times by gadolinium contrast agents. The 
pixel signal intensity is therefore dependent upon the local temporal gadolinium 
concentration. Gadolinium is a small rare-earth metal element that is prepared as a chelate 
and injected intravenously from where it can enter the interstitial space in the myocardium. 
In normal myocardium, the interstitial space is minimal, but it is expanded in certain 
pathological states (e.g. fibrosis, inflammation, infarction or infiltration) so that sufficient 
gadolinium to be detected may be present. Furthermore, gadolinium washes out of tissue 
capillary beds within minutes, but takes 10-30 minutes to wash out from the interstitial space. 
By imaging within this window using an inversion time where normal myocardium has a net 
magnetization vector of zero (and therefore appears black or 'nulled') the difference with 
normal myocardium (from which gadolinium has washed out) can be exploited (79, 80). 
Imaging Ventricular Fibrosis with LGE 
The first clinical application of myocardial LGE was in acute and chronic myocardial 
infarction imaging (81–83) with animal studies showing a close correlation between areas of 
LGE in the ventricle and areas of scar on histology (84). During the chronic phase of 
infarction, when dense fibrotic scar replaces infarcted myocardium, LGE accurately and 
reproducibly determines infarct size (85). Subsequently the assessment of myocardial fibrosis 
by LGE in non-ischaemic cardiomyopathies has been assessed. Different patterns of LGE 
have been demonstrated according to the underlying aetiology, and LGE CMR now forms an 
important part of the assessment in new-onset myocardial dysfunction (86–88). 
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Imaging Atrial Fibrosis with LGE 
Atrial wall imaging with LGE poses a greater challenge since the wall of the LA is several 
times thinner than the left ventricular myocardium and therefore greater spatial resolution is 
required. Over the past few years, technological developments and novel imaging sequences 
have made LA LGE CMR possible although with significant remaining limitations. A recent 
series of studies has suggested that LA LGE both before and after catheter ablation can help 
predict the chance of recurrence of AF by identifying the extent of pre-existing fibrosis and 
post-ablation scar (77, 78, 89–91). It is proposed that this may allow a more individualized 
approach to AF ablation. 
Atrial LGE Imaging Protocols 
Sequences for LA LGE imaging vary between centres, particularly depending on the MRI 
scanner manufacturer and the magnetic field strength. In general, they involve a series of 
planning scans, an anatomical scan for LA and PV segmentation and a 3D inversion recovery 
(IR) LGE sequence 20-25 minutes following the injection of a gadolinium-based contrast 
agent. In our institution, scans are performed in a 1.5T Philips Achieva MR scanner (Philips 
Medical Systems, Best, The Netherlands) using a 32 channel surface coil (Invivo, Orlando, 
Florida, USA). The 3D LGE sequence is a respiratory-navigated, ECG-triggered IR turbo 
field echo (TFE) acquisition, with a pixel resolution of 1.3 x 1.3 x 4 mm3, reconstructed to 2 
mm slice thickness (typical repetition time (TR) and TE are 6.2 ms and 3.0 ms respectively). 
The IR delay time is determined from a Look-Locker sequence to achieve partial suppression 
of both ventricular myocardium and blood. The scan is acquired in a four-chamber orientation, 
typically with 30-40 slices to allow for complete coverage of the LA. 
3D reconstruction of atrial CMR requires segmentation of the LA and PVs as well as the 
more challenging segmentation of the LGE information. Such image processing is necessary 
for the integration of late enhancement data with functional and electrical data but is also met 
with significant challenges (76, 78, 92). Whilst there is good image contrast between healthy 
and enhanced myocardium in the ventricle, this is not so for the atrium where the wall is 
much thinner and image contrast is lower. Additionally atrial LGE is susceptible to image 
artefacts (motion and partial volume effect) as the wall may only be a few pixels wide. The 
method used here (adapted from (92)) first involves registration of the 2D information from 
the LGE scan and the anatomical scan. Automated segmentation of the LA 3D anatomy from 
the anatomical scan is then performed. A maximum intensity projection (MIP) is used, 
whereby the maximum signal intensity within ±3mm of the 3D surface is selected as the LGE 
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signal intensity for that point on the shell. Signal intensities are displayed as a number of 
standard deviations from the mean intensity of the atrial blood pool, or as a ratio of the atrial 
wall to atrial blood pool signal intensities. 
Predicting Ablation Success with CMR 
Ablation for persistent AF is notable for lower initial and repeat success rates and increased 
recurrence rates (93). Electrical and structural remodelling of the atrium (see above) is one 
limiting factor in the success of ablation for persistent AF (94). In some hands it has been 
shown possible to measure the quantity of left atrial fibrosis (classified as mild (<15%), 
moderate (15-35%) and severe (>35%) LGE) with CMR and demonstrate increased 6-month 
recurrence rates with increasing LGE intensity (78). This work has led to the development of 
the Utah classification system: Utah I (<5% enhancement), Utah II (5-20% enhancement), 
Utah III (21-35% enhancement) and Utah IV (>35% enhancement) (90, 91), again showing 
that the extent of pre-existing LGE is predictive of AF recurrence. The authors suggest a more 
extensive ablation strategy is appropriate in those with more enhancement and that in Utah 
IV, ablation is unlikely to be successful. Despite these findings, other cohorts fail to show 
pre-ablation LGE in any patients (76) casting doubt over the current resolution of CMR to 
detect atrial fibrosis. 
Computational Modelling 
With advances in computer technology electro-anatomically accurate computer models 
of the atria (integrating information from the molecular to organ scale) have established 
computational electrophysiology as a technique able to provide unique insights into 
pathophysiological processes affecting the human heart. 
Multiple Scales of Computational Electrophysiology 
Computational electrophysiology is usually applied with a 'bottom-up' approach spanning 















In this section atrial cell models, propagation models (tissue level) and geometry and 
structural models (organ level) will be considered. 
Atrial Cell Models 
The atrial cell membrane consists of a dielectric lipid bilayer and acts as a capacitor. The 
electric charge per unit area of the membrane -% is given by the product of the membrane 
potential .% and the membrane capacitance per unit area /% (Equation 1-2). 
 -% = /%.% Equation	1-2	
The total ionic current ("#$ per unit area is responsible for variations in .% according to 
Equation 1-3 and Equation 1-4, where 0 represents all dynamic variables of the cell and 
the function & describes the dynamics of those variables: 
 /% 1.%12 = −("#$ .%, 0 + (52"%(7) Equation	1-3	
 1017 = &(.%, 0) Equation	1-4	
An external current (52"% is used to trigger an action potential. All cell models conform 
to this prototype, but differ in their specification of the variables (0), their dynamics (&) 
and their effects of the membrane potential (("#$). In turn, ("#$ is defined as the sum of a 
number of ion channel, pump and ion-exchanger currents. 
A number of atrial cell models have been published, relying heavily on the mathematical 
formulation introduced by Hodgkin and Huxley for neuronal cells (95). A simple 
implementation of this cell model is given below: 
function [data] = hodghux(Vo, dt, dep, delay) 
% HODGHUX Solves the Hodgkin-Huxley cell model. 
% 
% Usage: 
%   data = hodghux(Vo, dt, dep, delay) 
% 
% Where: 
%   Vo - is the resting membrane value (eg 0mV) 
%   dt - is the time interval to compute the model (eg 0.01ms) 
%   dep - is the depolarising voltage to be applied 
%   delay is the time to the extrastim - set at <0 for no extrastim. 
% 
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% HODGHUX creates a Hodgkin Huxley model. 
%   Variable definitions: 
%   Vo - initial membrane potential 
%   gK - potassium ion conductance 
%   gNa - sodium ion conductance 
%   gL - leakage ion conductance 
%   VK - potassium ion potential difference 
%   VNa - sodium ion potential difference 
%   VL - leakage ion potential difference 
%   Cm - membrane capacitance 
% 
%   Derived variable definitions: 
%   m, n , h - voltange/time dependent gating variables 
%   alphaM, alphaN, alphaH, betaM, betaN, betaH - rate constants 
% 
% Author: Steven Williams (2012) 
% Modifications - 
% 
% Info on Code Testing: 
% --------------------------------------------------------------- 







% ---------- Initialise output variable ---------- % 
data = NaN(10000,1); 
  
% ---------- Constans Initialisation begins ---------- % 
gK = 36; 
gNa = 120; 
gL = 0.3; 
VK = -12; 
VNa = 115; 
VL =  10.6; 
Cm = 1; 
  
% ---------- Function Definitions ---------- % 
% Calculate rate constant values 
    function [output] = alphaMCalc(volt) 
        output = 0.1 * ((25 - volt) / ( exp((25-volt)/10)-1)); 
    end 
    function [output] = betaMCalc(volt) 
        output = 4 * (exp(-volt/18)); 
    end 
    function [output] = alphaHCalc(volt) 
        output = 0.07 * (exp(-volt/20)); 
    end 
    function [output] = betaHCalc(volt) 
        output = 1 / (exp((30-volt)/10)+1); 
    end 
    function [output] = alphaNCalc(volt) 
        output = 0.01 * ((10-volt)/(exp((10-volt)/10)-1)); 
    end 
    function [output] = betaNCalc(volt) 
        output = 0.125 * (exp(-volt/80)); 
    end 
  
% Calculate dvdt 
    function [output] = dvdtCalc(volt) 
        output = Cm -((gK * (n^4) * (volt - VK)) + (gNa * (m^3) * h * (volt-VNa)) + (gL * 
(volt - VL))); 
    end 
  
% Calcuate rate of change of rate constants 
    function [output] = dmdtCalc() 
        output = (alphaM * (1 - m)) - (betaM * m); 
    end 
    function [output] = dndtCalc() 
        output = (alphaN * (1 - n)) - (betaN * n); 
    end 
    function [output] = dhdtCalc() 
        output = (alphaH * (1 - h)) - (betaH * h); 
    end 
  
% Calculate values of m, n and h 
    function [output] = mCalc() 
        output = alphaM / (alphaM + betaM); 
    end 
    function [output] = nCalc() 
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        output = alphaN / (alphaN + betaN); 
    end 
    function [output] = hCalc() 
        output = alphaH / (alphaH + betaH); 
    end 
  
% Calculate initial rate constant values 
alphaM = alphaMCalc(Vo); 
betaM = betaMCalc(Vo); 
alphaN = alphaNCalc(Vo); 
betaN = betaNCalc(Vo); 
alphaH = alphaHCalc(Vo); 
betaH = betaHCalc(Vo); 
  
% Calculate the steady stage values of m, n , h 
m = mCalc(); 
n = nCalc(); 
h = hCalc(); 
  
% Calculate dvdt 
dvdt = dvdtCalc(Vo); 
  
% Calculate rate of change of m, n, h 
dmdt = dmdtCalc(); 
dndt = dndtCalc(); 
dhdt = dhdtCalc(); 
  
V = Vo + dep; 
  
for i = 1:10000 
    % Calculate new rate constants with the new membrane voltage 
    alphaM = alphaMCalc(V); 
    betaM = betaMCalc(V); 
    alphaN = alphaNCalc(V); 
    betaN = betaNCalc(V); 
    alphaH = alphaHCalc(V); 
    betaH = betaHCalc(V); 
     
    % Calculate rate of change of m, n, h 
    dmdt = dmdtCalc(); 
    dndt = dndtCalc(); 
    dhdt = dhdtCalc(); 
     
    % Calcuate the new values of m, n and h 
    m = m + dmdt * dt; 
    n = n + dndt * dt; 
    h = h + dhdt * dt; 
     
    % Calculate the new value for dvdt 
    dvdt = dvdtCalc(V); 
     
    % Calculate and save the new value for V 
    if i == delay 
        V = V + dvdt * dt + 100; 
    else 
        V = V + dvdt * dt; 
    end 




In recent years the availability of increasing experimental detail has led to the refinement 
of these models. The first such models described the action potential (AP) in terms of 
transmembrane ion channels with little focus on intracellular calcium dynamics (96, 97). 
These models could provide good representations of the morphological changes seen in 
the AP in AF by, for example, reducing the transient outward current ((2#), ultrarapid 
delayed rectifier current ((9:;) and L-type calcium current ((<=,>) by experimentally-
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measured amounts (98). Notably however, the rate-dependent behaviour of these models 
is dissimilar, largely due to differences in intracellular calcium handling (99). 
Subsequent refinements of these models have: 1) improved the potassium current 
description to better represent repolarisation and rate-dependence of the transient outward 
potassium current ((2), (9:; and the AP duration (100); and 2) improved the description 
of subcellular calcium dynamics to account for a delay between peripheral and central 
sarcoplasmic reticulum calcium release (101). Noting the presence of an extensive t-
tubular network in atrial myocytes and remodelling of this network in AF allows accurate 
representation of AP and calcium dynamics in human atrial myocytes in sinus rhythm 
and AF states (102). 
Continuous Propagation Models 
To formulate continuous models describing current movement in cardiac tissue, the tissue 
is considered as three separate domains (the intracellular medium, extracellular medium 
and cell membranes) occupying the same physical space (Ω%@# ). The intracellular 
potential A", the cell state 0 and the extracellular potential AB become fields A"(C), 0(C) 
and AB(C) defined on Ω%@#. The transmembrane potential .% is given by: 
 .% = A" − AB Equation	1-5	
Assuming the intracellular medium is continuous, the current flows are described by a 
continuity equation expressing the conservation of electric charge: 
 
DE"D7 + ∇ ∙ H" = (5;I," Equation	1-6	
where E" is the charge density, H" is the current density in the intracellular medium and (5;I," is a current source term. A similar expression can be written for the extracellular 
medium. The charge density, current density and current source are given by Equation 
1-7, Equation 1-8 and Equation 1-9, respectively: 
 E" = /%.%JK Equation	1-7	
 H" = −L"∇A" Equation	1-8	
 (5;I," = −("#$JK Equation	1-9	
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where, JK  is the area of membrane per unit volume and L"  is the conductivity tensor. 
Combining Equation 1-6, Equation 1-7, Equation 1-8 and Equation 1-9 and rearranging 
leads to: 
 /% D.%D7 = JKMN∇ ∙ L"∇A" − ("#$ Equation	1-10	
Similarly, charges in the extracellular medium form the other side of the capacitor such 
that EB + E" = 0, (5;I,B + (5;I," = 0 and HB = −LB∇AB leading to: 
 −/% D.%D7 = JKMN∇ ∙ LB∇AB + ("#$ Equation	1-11	
The complete system, known as the bidomain equations, is usually written as: 
 JKMN∇ ∙ L"∇A" = /% D.%D7 + ("#$ Equation	1-12	
 ∇ ∙ (L"∇A" + LB∇AB) = 0 Equation	1-13	
If the anisotropy ratios are equal the bidomain equations can be decoupled and Equation 
1-10 and Equation 1-11 combined to give the monodomain equation: 
 /% D.%D7 = JKMN∇ ∙ P∇.% − ("#$ Equation	1-14	
In the following chapters, the bidomain and monodomain equations were solved using 
the Cardiac Arrhythmia Research Package (103). 
1.3 Clinical Contexts 
Normal Heart Ventricular Arrhythmias 
The assessment of patients presenting with ventricular arrhythmias (premature ventricular 
complexes (PVCs), monomorphic ventricular tachycardia VT, polymorphic VT (PMVT), 
ventricular fibrillation (VF)) includes 12-lead ECG, 2-dimensional echocardiogram, non-
invasive tests of functional ischemia, coronary angiography and cardiovascular magnetic 
resonance imaging. In the absence of demonstrable structural heart disease, the majority 
of ventricular arrhythmias have an excellent prognosis, but a minority of patients are 
susceptible to life-threatening arrhythmias. Arrhythmia substrate characterisation in these 
two groups is considered separately below. 
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Non-Life-Threatening 
Non-life-threatening ventricular arrhythmias may still cause significant symptoms and/or 
tachycardia-related cardiomyopathy.  Tachycardia-related cardiomyopathy can result in 
a significant reduction in ejection fraction although the precise ectopy burden at which 
this occurs is quite variable between patients: >30,000 ectopic beats (104), >17,000 
ectopic beats (105), >16% ectopic beats (106), >20% ectopic beats (107), and >24% 
ectopic beats (108). However, even once a pre-defined ectopic beat threshold is reached, 
tachycardia-related cardiomyopathy is still rare (104, 106). Although non-life-threatening 
ventricular arrhythmias may originate from any location in the heart, including the mitral 
annulus, tricuspid annulus and papillary muscles, the two most common forms are 
outflow tract and idiopathic left ventricular tachycardia. 
Life-Threatening 
A number of genetic syndromes leading to abnormal ion channel function are associated 
with ventricular arrhythmias and sudden cardiac death. ECG phenotypes, but not family 
history, have been used for risk stratification (109). Although secondary prevention with 
implantable cardioverter-defibrillators is mandated, primary prevention should be based 
on risk stratification and the availability of medical therapy (see below). 
Long QT Syndrome 
The hallmark of the long QT syndromes is prolongation of the QT interval (QTc >440ms 
in males and >460ms in females) with or without T-wave abnormalities. Prolongation of 
repolarisation owing to decreased outward potassium currents or increased inward 
sodium currents during phase 2 of the action potential results in a predisposition to early 
afterdepolarisations and torsade de pointes VT (see Triggered Activity, p. 25). A number 
of genes have been identified with LQT1 (KCNQ1, α subunit of IKs), LQT2 (KCNH2, α 
subunit of IKr) and LQT3 (SCN5A, α subunit of INa) accounting for >90% of genotyped 
long QT syndrome cases (110). Clinical triggers vary between the long QT syndrome 
phenotypes, with LQT1 being associated with physical exertion, LQT2 with auditory 
stimulation or emotional stress and LQT3 with arrhythmias during rest or sleep. The ECG 
shows broad-based T-waves in LQT1, notched T-waves in LQT2 and long ST segments 
in LQT3 although there is considerable overlap. Characterisation of the arrhythmia 
substrate in long QT syndromes involves clinical scoring (111), exercise testing, 
epinephrine challenge and genetic testing. 
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Brugada Syndrome 
The Brugada syndrome with its characteristic ECG manifestations of coved precordial 
ST-segment elevation and complete or incomplete right bundle branch block may present 
with syncope or cardiac arrest (112, 113). Substrate characterisation in the Brugada 
syndrome involves both rest ECG and provocation studies with sodium channel blocking 
agents (e.g. ajmaline, flecainide or procainamide) as well as long-term ECG monitoring. 
Genetic mutations in SCN5A (BrS1) lead to loss of function of sodium channels and 
clinical overlap with the LQT3 phenotype (114, 115). Risk stratification involves 
considering the presence of spontaneous Brugada ECG pattern and syncope, and notably 
family history does not predict risk of syncope and/or sudden cardiac death events (116). 
Catecholaminergic PMVT 
Catecholaminergic PMVT is characterised by polymorphic or bidirectional VT and 
presents clinically with exertional syncope and sudden cardiac death. Mutations of the 
cardiac ryanodine receptor (RyR2, autosomal dominant inheritance) and the calsequestrin 
2 gene (CASQ2, autosomal recessive inheritance) have been identified. Both of these 
genes encode proteins important in calcium handling with mutations leading to excess 
intracellular calcium and delayed afterdepolarisations (see Triggered Activity, p. 25). 
Whilst the resting ECG is normal, exercise induces bidirectional VT preceded by 
increasing frequency of premature ventricular complexes when the sinus rate reaches 120 
to 130 beats per minute.  
Idiopathic Ventricular Fibrillation 
Idiopathic ventricular fibrillation is defined as the presence of ventricular fibrillation in 
the absence of structural heart disease or an identifiable genetic syndrome. It may present 
with episodes of ventricular fibrillation (VF) or polymorphic ventricular tachycardia 
(PMVT) associated with syncope or sudden cardiac death. VF and PMVT are triggered 
by premature ventricular complexes which can typically be mapped to the distal Purkinje 
system or right ventricular outflow tract (117). 
The early repolarisation ECG pattern (QRS-ST junction (“J-point”) elevation 0.1mV in 
inferolateral leads) has been associated with idiopathic VF (118). Analysis of the ST 
segment has been suggested to help differentiate benign from malignant J-point elevation, 
with a horizontal/descending ST segment, but not ascending ST segment, being 
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associated with risk of sudden cardiac death (119). However, the early repolarisation 
phenotype occurs frequently in the normal population without determining future 
syncopal or sudden cardiac death events (120). In contrast to the other normal heart 
arrhythmias described above, risk stratification in patients with the early repolarisation 
phenotype is less well described. This leads to the following aim: 
C1 Examine the role of the surface ECG, augmented by therapeutic hypothermia, in 
characterising the arrhythmia substrate in idiopathic ventricular fibrillation. 
Atrial Tachycardia 
Atrial tachycardias are classified as either focal or macro-re-entrant (121). Additionally a 
third mechanistic group termed localised re-entry has been described, most frequently 
described after catheter ablation for persistent AF (122). 
Diagnosis of Atrial Tachycardia 
Where a clinical diagnosis is sought to guide ablation, intra-cardiac contact mapping (see 
Intracardiac Contact Mapping, p. 31) is usually required. Even given the logical approach 
to intra-cardiac mapping described above, mapping can frequently be a challenging and 
time consuming process. The optimal sampling density for atrial tachycardias is not 
known. This leads to the following aim: 
C2 Determine the optimal point sampling density for intracardiac contact mapping in the 
diagnosis of tachycardia mechanism in a variety of atrial tachycardias. 
Focal Atrial Tachycardia 
Focal atrial tachycardias may account for up to 15% of all supraventricular arrhythmias 
(123). They are characterised by a single site of origin with centrifugal electrical 
activation spreading away from that site. Typical sites of origin include the crista 
terminalis, tricuspid annulus, coronary sinus os, superior vena cava and RA appendage. 
The underlying mechanism may be abnormal automaticity, triggered activity or micro-
re-entry (see above). Focal ATs show gradual rates of onset and termination. Focal atrial 
tachycardias are most often seen in the absence of structural heart disease (124). 
The surface ECG may be diagnostic in focal AT. P waves are separated by an isoelectric 
interval consistent in all ECG leads where it is not obscured by a rapid ventricular 
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response rate. Assuming normal atrial conduction, algorithms have been proposed to 
localise the source from the surface ECG (125). A positive P-wave in lead V1 suggests a 
left atrial origin, whilst a negative P-wave in lead V1 suggest a right atrial origin (126). 
In the presence of surgical scars or ablation lesions, localisation of the focal origin from 
the surface ECG is less reliable. 
Pharmacotherapy has traditionally been the first line treatment for focal AT, using rate-
limiting drugs such as cardio-selective beta-blockers and non-dihydropyridine calcium 
channel antagonists or Class Ic (e.g. flecainide or propafenone) or Class III (e.g. sotalol 
or amiodarone) antiarrhythmic agents for tachycardia management. Owing to poor 
efficacy and side effects of pharmacological treatment, catheter ablation is now first line 
therapy for recurrent/incessant tachycardia or tachycardia-induced cardiomyopathy (127). 
Ablation has an acute success rate of 85-90% (128), complications (including recurrence) 
are rare, and good recovery of LV function is seen in the case of tachycardia induced 
cardiomyopathy (129). 
Macro-re-entrant Atrial Tachycardia (Including Atrial Flutter) 
Macro-re-entrant atrial tachycardias are characterised by continuous activation of a large 
circuit around a central obstacle. The obstacle may be anatomic (e.g. pulmonary veins, 
mitral or tricuspid annulus, surgical or spontaneous scar) or functional (e.g. crista 
terminalis). Macro-re-entrant atrial tachycardias include cavotricuspid isthmus (CTI) 
dependent atrial flutter (both typical and reverse typical) and non-CTI dependent macro-
re-entry. Typically, macro-re-entrant tachycardias show a sudden onset and termination. 
CTI dependent atrial flutter occurs around a circuit bounded anteriorly by the tricuspid 
annulus and posteriorly by the crista terminalis and Eustachian ridge (130). Activation is 
counter clockwise (typical atrial flutter) in the majority of cases resulting in inferior to 
superior septal activation and superior to inferior lateral wall activation, whilst 10% see 
the opposite direction of activation (reverse typical atrial flutter) (131). The CTI itself 
provides a critical isthmus for the circuit and therefore an ablation target (132, 133). 
Associations of CTI dependent flutter include ischaemic heart disease, valvular heart 
disease, cardiomyopathy, any cause of increased RA pressure, age and male sex (134). 
Approximately one third of patients with CTI dependent flutter will later develop AF 
(135). 
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Non-CTI dependent macro-re-entry tachycardias include mitral isthmus-dependent 
macro-re-entry, roof-dependent macro-re-entry and scar-related macro-re-entry. 
Additionally, macro-re-entry may occur around areas of spontaneous fibrosis in the LA 
or RA (136). Substrates for scar-related macro-re-entry include surgical scars, suture lines 
or prosthetic patches following correction of congenital heart disease as well as scars 
arising from surgical or catheter ablation of AF. With more extensive LA ablation for 
persistent AF, up to 50% of cases may subsequently develop a macro-re-entrant atrial 
tachycardia (137). Since gaps in ablation lines result in conduction slowing, and an 
increased likelihood of developing post ablation atrial tachycardia, an important goal is 
to ensure that the ablation energy delivered forms effective, contiguous and transmural 
lesions. This leads to the following aim for this thesis: 
C5 Assess the impact of contact force in the creation of effective linear ablation lesions. 
Catheter ablation of CTI dependent flutter has high efficacy and low complication rates. 
Catheter ablation has been shown to be superior to antiarrhythmic therapy with 
maintenance of sinus rhythm seen in 80-92% of patients undergoing a single catheter 
ablation procedure, compared to 36% of patients receiving drug therapy (138, 139). 
Success rates are improved by the use of pacing manoeuvres to confirm bidirectional 
block across the CTI (140). Drug therapy is rarely effective for non-CTI dependent 
macro-re-entry, and catheter ablation using advanced mapping techniques (see above) is 
more likely to offer a cure. Due to the complexity of the circuits involved however, 
success rates are more variable than for CTI-dependent flutter. 
Localised Re-Entry 
Localised re-entry is characterised by a small re-entry circuit, typically 1-2cm in size. 
Localised re-entry is most commonly seen following catheter ablation for persistent AF 
(141). Even in the presence of an apparently focal tachycardia, up to three quarters may 
actually be the result of localised re-entry (122). Whether they are drivers for atrial 
fibrillation or just a consequence of ablation is not known. 
Atrial Fibrillation 
Epidemiology, Classification and Impact 
Atrial fibrillation (AF), a supraventricular tachyarrhythmia characterised by 
uncoordinated atrial activation, is the most common sustained cardiac arrhythmia (142). 
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The prevalence of AF increases with age from 0.5% in the 6th decade to at least 9% in 
the 9th decade and each year around 46,000 people in the United Kingdom are affected 
with the condition (143, 144). In 2004, it was estimated that the direct cost of AF 
constituted approximately 1% of the NHS budget (145). Moreover owing to an aging 
population, a rising prevalence of chronic heart disease and also improved diagnosis, 
there has been a 66% rise in hospital admissions for AF over the past two decades (142). 
AF is more prevalent in men than women, and whilst the prevalence of AF in women is 
constant the prevalence of AF in men has more than doubled from the 1970s to the 1990s 
(146). 
AF is classified according to the duration of episodes (142). Given the occurrence of two 
or more episodes AF is said to be recurrent and classified as "paroxysmal" or "persistent". 
Paroxysmal AF involves self-terminating episodes lasting <7 days (and usually <24 
hours). Persistent AF involves episodes lasting >7 days. AF is termed permanent when 
cardioversion does not terminate the arrhythmia (or is not attempted due to a low 
anticipated chance of success). The term "lone AF" refers to AF occurring in young 
patients (<65 years) with structurally normal hearts and no evidence of other causative 
pathology. 
AF leads to deterioration in atrial mechanical function, stasis of blood, endothelial 
damage and consequently a significantly increased long-term risk of stroke (147, 148). In 
the Framingham study, the presence of AF independently increased mortality in men by 
1.5 fold and in women by 1.9 fold (149). With an increasingly elderly population, the 
prevalence of AF is set to rise, conferring substantial mortality, morbidity and economic 
burden. 
The treatment of AF involves the treatment of any underlying causes (e.g. hypertension), 
drugs to control the heart rate or maintain sinus rhythm, anticoagulant drugs to reduce the 
risk of stroke and, increasingly, catheter ablation in selected patients for symptom control. 
Electrophysiological Basis of AF 
Automatic Focus Theory  
The possibility of a focal trigger of atrial fibrillation has long been suggested by 
experimental studies (150) and a pivotal development in the understanding of human AF 
was the demonstration of paroxysmal AF triggered by pulmonary vein (PV) ectopy (151, 
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152). Although PVs are the most common source of ectopy, foci have also been found in 
the superior caval vein, ligament of Marshall, left posterior free wall, crista terminalis and 
coronary sinus. 
Multiple Wavelet Theory  
For many years the multiple-wavelet hypothesis overshadowed automaticity as the 
primary driver of AF. In this theory fractionation of wave fronts propagating throughout 
the atria results in the formation of multiple self-perpetuating wavelets (153). Increasing 
atrial size, shortening refractory period and slowing conduction velocity increase the 
number of wavelets present and the likelihood of AF persistence. 
Importance of the Atrial Substrate  
Whilst experimental (154) and clinical (155) mapping studies support an automatic focus 
over multiple wavelets as the trigger of AF, the importance of the atrial substrate in 
maintaining AF remains. For example in some patients with persistent AF, PVI may 
terminate AF whereas in others AF persists following PVI but does not recur after 
cardioversion. Specific electrophysiological differences can be observed in the atria of 
AF patients including increased dispersion of atrial refractoriness and greater ability to 
induce AF (156), widespread distribution of abnormal fractionated electrograms 
predictive of progression to persistent AF (157) and prolonged intra-atrial conduction in 
patients with persistent AF following successful cardioversion to sinus rhythm (158). 
In canine models of AF, characterized by different extents of electrical and structural 
remodelling, mechanisms of AF perpetuation appear to relate to abnormalities of the 
substrate (159, 160). In models with primary atrial electrical remodelling (i.e. rapid atrial 
pacing or methylcholine infusion), AF is characterized by multiple high frequency areas 
and multiple wavelets. However, in models with primary atrial structural remodelling (i.e. 
mitral regurgitation or heart failure), AF is characterized by a stable high frequency area 
consistent with the presence of micro-re-entry giving rise to a focal rotor or a focal 
impulse source. Recently, localized rotors and/or focal impulse sources have also been 
identified in a high proportion of cases of human AF (97%) with their ablation associated 
with significantly higher acute and short term success than conventional ablation 
strategies (161). Despite these remarkable results other mapping studies have not 
demonstrated the presence of stable foci or rotors (162), or only demonstrated organized 
patterns in a minority of cases (163). 
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In summary, altered refractoriness and conduction with spatial heterogeneity throughout 
the atria may provide a milieu for the maintenance of AF, and support the initiation of 
AF in response to a focal trigger, but the relative contributions of trigger and substrate to 
the initiation and/or maintenance and/or progression of AF is unclear. 
Electrical and Structural Remodelling in AF 
The natural history of AF is characterised by a gradual worsening over time, with 
progressively longer episodes of arrhythmia eventually leading to persistent AF. Such 
progression is potentially explained by the finding that AF itself produces changes in 
atrial function and structure. 
Electrical Remodelling  
The concept of tachycardia-induced atrial electrical remodelling was introduced by two 
independent experimental studies (164, 165). In a dog model of prolonged rapid atrial 
pacing, the atrial ERP was reduced by about 15% and there was increased dispersion of 
atrial refractoriness (165). In goats, AF maintained by automatic burst atrial pacing in 
response to sinus rhythm, resulted in an even more marked shortening of atrial refractory 
period from 146±19ms to 81±22ms and a loss (or even reversal) of the normal rate 
adaptation of the refractory period (164). Significantly, these studies showed that long-
term rapid atrial pacing led to a progressive increase in the susceptibility to AF. After 6 
weeks of rapid atrial pacing, episodes of AF lasting >15 minutes could be induced in 82% 
of the dogs. In 10 out of 11 goats, after maintaining AF for 7.1±4.8 days, the arrhythmia 
sustained itself for >24 hours, compared to periods of only 6±3 s at the start of the 
experiment. 
In humans, electrical remodelling with decreased right atrial action potential duration 
(APD) has been reported (166) and reversal of electrical remodelling has been 
demonstrated following treatment of AF by DC cardioversion (167). In pacemaker 
patients with detected atrial tachyarrhythmias, increased P-wave duration without 
shortening of the atrial effective refractory period (ERP) is observed (168) which is 
similar to the atrial electrical changes noted in the rapid ventricular pacing canine heart 
failure model (169). 
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Structural Remodelling  
In addition to electrical remodelling, structural remodelling involving myocardial fibrosis 
is inextricably linked to the progression of AF (170, 171). Structural remodelling 
contributes synergistically with electrical remodelling to form the arrhythmogenic 
substrate in AF. There is an increase in atrial fibrosis, not only in patients with AF and 
underlying heart disease, but also in patients with lone AF (172, 173) and furthermore 
there appears to be a positive correlation between the extent of fibrosis and the persistence 
of AF (78). 
Rapid atrial pacing in the dog causes atrial fibrosis (174) comparable with many clinical 
forms of AF (169). Notably, in this canine model atrial fibrosis causes localised regions 
of conduction slowing and increased conduction heterogeneity, consistent with the 
electrical remodelling seen in humans. In other canine models of AF fibrosis is also 
observed, but AF becomes sustained before fibrosis occurs (160). 
In canine models of AF with heart failure, induced by ventricular tachypacing, there is 
electrical as well as structural remodelling with pronounced interstitial fibrosis (175). 
After cessation of pacing and a 5-week recovery period there was complete recovery of 
the electrical remodelling but AF vulnerability was still higher than baseline suggesting 
that structural remodelling leads to continued AF susceptibility (175). 
Catheter Ablation of AF 
Although the AFFIRM study demonstrated that rhythm control conferred no prognostic 
benefit over rate control, a sub-study of this trial has shown that if sinus rhythm (SR) 
could be achieved without the use of anti-arrhythmic drugs there may be a substantial 
mortality benefit (176). Pharmacological management has been the mainstay of treatment 
for AF but is limited by concerns about efficacy, side effects and safety. Therefore 
catheter ablation has emerged as an effective and potentially curative approach for 
patients with symptomatic paroxysmal and persistent AF, who have failed drug therapy. 
The demonstration that paroxysmal AF is frequently triggered by ectopy arising from 
within the PVs has led to the emergency of PV isolation (PVI) as a widely practised 
therapy for this arrhythmia and even as a first line therapy in selected patients (152, 177). 
Whilst it was first suggested to ablate only PVs with foci of spontaneous activity (152, 
178), high recurrence rates, the increasing recognition that all PVs can initiate AF and 
technological developments mean it is now routine practice to isolate all four PVs (142). 
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In the context of PVI for paroxysmal AF, incomplete or non-transmural circumferential 
ablation lesions may lead to immediate or delayed reconnection of the PVs, which can be 
documented in many cases of AF recurrence (179, 180). Reconnection is possibly due to 
an acute inflammatory response at the time of ablation causing tissue oedema and 
temporary electrical isolation of the PVs whilst at the same time preventing delivery of 
sufficient radiofrequency energy to cause tissue necrosis (181). 
The demonstration of non-PV ectopy initiating paroxysmal AF has led to modification of 
ablation procedures to include supplementary ablation in selected patients (182, 183). 
Whilst paroxysmal AF is usually caused by foci from the thoracic veins it is recognised 
that pulmonary vein isolation alone is unlikely to be sufficient for the catheter ablation of 
persistent AF (93). An alternative anatomic approach targets complex fractionated 
electrograms either as an adjunct to, or instead of, pulmonary vein isolation (184). 
Recently, a further approach suggests mapping to identify electrical rotors or focal 
impulses as targets for ablation (161). All of these approaches, with the exception of rotor-
ablation that is pending assessment, have variable success rates when performed in 
unselected patients in multiple centres (93). Indeed the addition of CFE ablation or linear 
ablation to PVI alone has failed to increase freedom from AF in a large multicentre 
randomised controlled trial (185). Hence, there is currently no agreed strategy to identify 
which patients are likely to benefit from each of these strategies, or indeed which are 
likely to benefit from none. This observation leads to the following two aims for this 
thesis: 
C3 Develop a tool to quantify electrical remodelling in paroxysmal AF and determine if 
population heterogeneities are present that could be used to predict response to 
catheter ablation. 
C4 Examine the role of CMR in predicting the electrical substrate in patients with a 
spectrum of AF disease severity. 
1.4 Arrhythmia Substrate Representation Techniques 
Electrogram Display 
The aim of electrogram display processes is to represent cardiac electrical signals in a 
clinically relevant way with minimal artefact. In modern electrophysiological procedures, 
electrograms are represented digitally, but a variety of inventive methods have previously 
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been used to record cardiac activation, including the capillary electrometer, string 
galvanometer and amplifier electrograph. 
The first device that was sufficiently sensitive to record the surface electrocardiogram 
was the capillary electrometer (186). This device consisted of a glass capillary tube filled 
with mercury and immersed in sulphuric acid. Owing to the collection of charge on the 
meniscus of the mercury, the surface of the mercury moved as a potential difference was 
applied between the mercury and the sulphuric acid. By using photographic paper, the 
movement of the mercury could be recorded over time. Just as in modern recording 
systems, the capillary electrometer was subject to sources of error. In particular friction 
between the mercury column and the capillary tube resulted in a non-linear relationship 
between the applied electric potential and the movement of the column. This error was 
partially overcome through mathematical correction of the recorded waveform (37), 
which although resulting in effective correction, was computationally expensive.  
The capillary electrometer was superseded with the invention of the string galvanometer 
(38, 187). The string galvanometer consists of a long silver-coated (hence electrically-
conductive) filament passed under tension between electromagnets. Movement of an 
electric current within the filament resulted in displacement of the filament, and this 
displacement after magnification was again recorded on photographic paper. The string 
galvanometer had much higher sensitivity than the capillary electrometer achieving 
sufficiently high quality recordings to enter clinical practice.  
A sometimes-overlooked stage in the development of electrogram detection and display 
technologies was the invention of the ‘amplifier electrograph’ which, for the first time, 
relied on electronic amplification of the ECG signal (using vacuum tubes), rather than the 
mechanical amplification relied on with the string galvanometer (39). Similarly a further 
important innovation was reported with the invention of a 'liquid jet recorder' 
(mingograph) for recording the electrical data (188). Compared to the use of photographic 
paper, this device provided an instant representation of the cardiograph. 
Eventually, digital systems were introduced to facilitate the display, storage and retrieval 
of electrogram information. Two important parameters describe the performance of an 
analogue to digital convertor (ADC): sampling rate and resolution. According to 
information theory, analogue signals must be sampled at a frequency at least double the 
maximal frequency in the signal (189). Put another way, the maximal signal frequency 
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that can be recorded by an ADC is half of the sampling frequency, this being known as 
the Nyquist frequency (190). If a component of the input signal exceeds the Nyquist 
frequency, then aliasing results. Resolution determines the accuracy to which the digital 
signal processing system can represent each signal sample. For example, with a resolution 
of 12 bits, the amplification system can encode each signal sample into one of 212 (4096) 
discrete levels. That is, given a maximum input amplitude of 10mV, then the smallest 
change in signal that can be recorded is 2.44µV (10mV ÷ 4096). Typically, intracardiac 
electrograms are sampled at 1024Hz with a resolution of 12- to 16-bits. 
Electroanatomic Mapping Systems 
Electroanatomic mapping systems provide a number of functions facilitating complex 
electrophysiology procedures. All conventional electroanatomic mapping systems 
provide three key features: catheter location, anatomical representation and map 
construction. 
Catheter location 
Three main technologies facilitate catheter location in mainstream mapping systems: 
electromagnetic catheter location, impedance based catheter location and electric field 
based catheter location. A fourth technology combining cross sectional imaging and 
fluoroscopy has also been proposed (191). 
Electromagnetic catheter location depends on the creation of three independent magnetic 
fields by an electromagnetic attachment positioned below the operating table (192). The 
intracardiac catheters compatible with this system contain three distally embedded 
orthogonally orientated coils in which currents are induced by the magnetic fields. 
Measurement of these currents allows the orientation and position of the tip to be 
calculated. Electromagnetic catheter location was first used in the Carto system (Biosense 
Webster, Diamond Bar, CA, USA). 
Impedance based catheter location (introduced in the Carto 3 system, Biosense Webster, 
Diamond Bar, CA, USA) has been used in clinical systems to supplement electromagnetic 
catheter location (193). Six body surface patches are applied to the thorax. A small current 
is passed through the catheter electrodes allowing the impedance between the electrode 
and each of the surface patches to be calculated. Initially, the relationship between 
impedance and position is unknown, but by manoeuvring a magnetic-based catheter 
 58 
throughout the field of interest this relationship is determined. Thereafter electrodes on 
the catheter shaft (or indeed non-magnetic locator catheters) may be visualised.  
Electric field based catheter location depends on the creation of three high frequency 
electric fields within the patient using surface patches (194). By measuring the potential 
of each field at an intracardiac electrode, the distance between the electrode and the source 
patch is calculated allowing the position of the electrode to be determined. Importantly, 
this method only determines relative electrode positions meaning a stable reference 
catheter is usually used (e.g. the CS catheter). Later versions of this system allow one of 
the body surface patches to be used for the reference. Whilst this mitigates against 
inadvertent movement of the intracardiac reference, it is more sensitive to changes in 
intra-thoracic impedance during the procedure. Electric field based catheter location is 
used in the Velocity platform (St Jude Medical). 
Anatomical Representation 
Electroanatomic mapping systems can represent cardiac anatomy determined during the 
mapping procedure, or predetermined using cross sectional imaging. By establishing the 
anatomical limits of catheter movement the internal extent (i.e. endocardial surface) may 
be defined. This method typically represents the available geometry accurately, but does 
not necessarily represent the entire chamber anatomy. For example, pulmonary venous 
ostia may be effectively represented, whilst if the catheter has not been placed in the 
appendage then it will not be represented. Cardiac chamber geometry represented in this 
way has been shown to faithfully represent chamber shape determined by CT imaging 
(195). Nevertheless, the accuracy of the chamber geometry depends on a number of 
factors. In particular the interpolating algorithm type and sensitivity must be sufficient to 
smooth areas of the geometry sampled sparsely whilst not resulting in the formation of 
'false' regions of geometry. 
An alternative approach is to merge anatomical information from cross sectional imaging, 
typically CT or MRI. Cross sectional imaging has the advantage of representing the entire 
chamber without requiring an extensive map creation phase during the mapping 
procedure, but the chamber shell must be registered to fiducial markers determined by 
catheter positions on the day of the procedure. For the left atrium, points including the 
PV ostia, atrial roof and mitral valve annulus are typically selected for initial registration. 
Selection of suitable fiducial points is crucial to the successful registration of the cross-
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sectional geometry. Even with careful registration this process can be challenging. For 
example defining appropriate anatomical landmarks such as the mitral annulus across 
different modalities (electroanatomic mapping vs. cross sectional imaging) can result in 
registration errors. Furthermore, loading conditions may result in variations of chamber 
geometry between the day of the scan and the day of the mapping procedure. In this regard 
hybrid labs combining fluoroscopy, electroanatomic mapping and cross sectional 
imaging are likely to be beneficial.  
Electroanatomic Map Display 
With ever increasing complexity in electrophysiological datasets comes an increasing 
requirement to represent those data in a clinically meaningful way. Electrophysiological 
data typically varies in multiple dimensions including time, magnitude and direction as 
well as varying across the complicated three-dimensional geometry of the heart. 
Meanwhile, data display techniques are limited in the number of dimensions that can be 
represented. Hence a number of strategies are employed to reduce the complexity of 
electrophysiological data in order that it may be displayed to the operator. For example, 
electrical data varying in two dimensions (e.g. time and magnitude) can be reduced to one 
of these dimensions by assigning a local activation time relative to a fixed reference 
electrogram or by determining magnitude (i.e. voltage) within a window of interest. Once 
the dimensionality of the data is reduced, it can be represented within a three-dimensional 
geometry, for example by colouring the cardiac surface according to activation time 
(isochronal activation map) or by electrogram voltage (voltage map).  
One mapping technique has been designed which avoids the need to reduce the 
dimensionality of electrical data (196). By drawing the electrograms as moving bars 
normal to a surface, the polarity and magnitude of the electrogram can be represented as 
bar colour and size respectively. In this way spatial distribution of the electrograms is 
maintained whilst at the same time also representing both the timing and magnitude of 
the electrograms. Further development of this system has allowed the display of two 
datasets by representing the first with moving bars and the second with geometry surface 
colouring (197). The display of two datasets in this context is limited to electrogram data 
plus a scalar field. It is not possible for instance to display two static scalar fields using 
this technique.  
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In order to display multiple such datasets on a single cardiac chamber shell a number of 
techniques have previously been used. For example, user input can be sought to switch 
between display of one or other dataset, an alpha channel can be used to add transparency 
to one set of data, or two ‘linked scenes’ can be displayed with alternative datasets drawn 
side by side. All of these methods of multiple data set display have limitations, including 
reductions in fidelity of one or other datasets and the reliance on human perception to 
determine the spatial relationship between datasets. This observation leads to the 
following two aims: 
R1 Develop a system for concomitant representation of multiple electrophysiological 
parameters within a 3D geometry.  
R2 Validate that system to assess dataset display fidelity and ease of dataset integration. 
1.5 Aims for this Thesis 
The aims of this thesis are subdivided into arrhythmia characterisation and arrhythmia 
representation techniques and introduced in the above sections. They are summarised 
below. 
Characterisation of Arrhythmia Substrates 
C1 Examine the role of surface ECG in characterising the arrhythmia substrate in the 
context of idiopathic ventricular fibrillation. 
C2 Determine the optimal point sampling density for intra-cardiac contact mapping in 
the diagnosis of tachycardia mechanism in a variety of atrial tachycardias. 
C3 Develop a tool to quantify electrical remodelling in paroxysmal AF and determine if 
population heterogeneities are present that could be used to predict response to 
catheter ablation. 
C4 Examine the role of CMR in predicting the electrical substrate in patients with a 
spectrum of AF disease severity. 
C5 Assess the impact of contact force in the creation of effective linear ablation lesions. 
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Representation of Arrhythmia Substrates 
R1 Develop a system for concomitant representation of multiple electrophysiological 
parameters within a 3D geometry.  
R2 Validate that system to assess dataset display fidelity and ease of dataset integration. 
I begin in the next chapter by addressing aim C1 and the role of the surface ECG in 




























SECTION TWO: CHARACTERISATION OF 
ARRHYTHMIA SUBSTRATES 
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2 Surface Electrocardiography: Early 
Repolarization in Hypothermia 
2.1 Introduction 
Early repolarization (ER) is a common ECG finding, with a prevalence of 5-13% (198, 
199). Previously, ER was thought to be a benign variant, or a marker of cardiovascular 
health (200, 201). However, robust data now indicate that ER is a marker of elevated 
ventricular fibrillation (VF) risk and cardiac arrest. This is true in otherwise-healthy 
individuals (idiopathic VF) (198, 199, 202, 203) and in those with coronary artery disease 
(204–206). The degree of ER, quantified as J-point elevation (JPE) magnitude, appears 
to determine arrhythmia risk. Thus patients with JPE magnitude >0.2 mV have around 
double the risk of cardiac arrhythmic death as those with JPE defined using the 
conventional threshold (≥0.1 mV) (198). Similarly, JPE magnitude in patients with ER 
who have experienced an episode of VF is around twice that seen in those without 
arrhythmia (207). 
ER syndrome is part of a spectrum of conditions, including the Brugada syndrome, 
collectively termed the J-wave syndromes (208). These conditions are defined by J-point 
elevation, terminal QRS complex slurring and ST segment elevation. A similar ionic 
mechanism appears to be responsible for each of the J-wave syndromes: an enhanced net 
repolarizing current gives rise to a marked epicardial action potential notch and hence a 
J-wave (209). Elevated ventricular arrhythmia risk in the J-wave syndromes therefore 
likely results from increased transmural dispersion of repolarization. Although J-waves 
are a well-established feature of hypothermia, usually being referred to as Osborn waves 
in this context (210, 211), interactions between hypothermia and ER have not previously 
been studied in a clinical context. 
The motivation for examining this relationship arises from arrhythmia substrate 
characterisation methods employed in other settings, where exogenous effects are used to 
provoke characteristic ECG changes to provide a clinical diagnosis or risk stratification. 
For example, in the exercise tolerance test the effect of an increased sinus rate is useful 
in establishing the diagnosis of catecholaminergic polymorphic ventricular tachycardia 
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(see Catecholaminergic PMVT, p. 47). Similarly the ajmaline test serves to apply sodium 
channel blockade in selected individuals to reveal the Brugada ECG pattern and aid in 
risk stratification of these patients (see Brugada Syndrome, p. 47). There have also been 
isolated case reports of hypothermia revealing a Brugada-type ECG pattern (212). 
This study hypothesised that the effect of therapeutic on the magnitude of JPE may be 
greater in idiopathic VF (ID-VF) than coronary artery disease-related VF (CAD-VF) 
arrest survivors, leading to the possible development of a diagnostic tool for risk 
stratification of patients with early repolarisation. Data obtained from a population of 
adult survivors of cardiac arrest treated with therapeutic hypothermia was used to 
investigate interactions between ER and hypothermia. 
2.2 Methods 
All survivors of sudden cardiac arrest with an initial rhythm of VF treated at the critical 
care unit at St. Thomas’ Hospital, London between 2005 and 2012 were assessed for 
inclusion. Data collection and analysis for this study were part of on-going real-time data 
collection processes during physician-directed patient care.  
Patient Selection 
Cases were eligible for inclusion if: 1) their management included therapeutic 
hypothermia, 2) ECGs obtained at baseline temperature and during cooling were available 
and 3) sufficient data (echocardiograms, coronary angiograms, cardiac magnetic 
resonance imaging (CMR) studies and/or electrophysiology studies) were available to 
determine whether the arrest was attributable to myocardial ischemia. Cases were 
excluded if ventricular conduction abnormalities, other underlying arrhythmic disorders 
or clear confounding factors such as recent cardiothoracic surgery or cocaine use were 
present.  
Cases were classified as ID-VF if criteria specified in guidelines were met (213), that is 
there was no structural heart disease (as indicated by an echocardiogram showing normal 
biventricular dimensions and function), no coronary artery disease (as indicated by a 
normal coronary angiogram) and no known repolarization abnormalities. Cases were 
classified as CAD-VF if A) there was a pre-existing diagnosis of coronary artery disease 
or B) significant coronary artery disease was demonstrated on an angiogram, a significant 
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troponin rise from baseline was observed and regional wall motion abnormalities were 
present either on echocardiography or CMR.  
Data Collection and Analysis 
ECGs were obtained close to the mid-point of the period of therapeutic hypothermia 
(‘cooled’ ECG), during which patients’ core temperatures fell to between 32 and 34°C, 
and again prior to discharge (‘baseline’ ECG). Records were digitally scanned (300dpi, 
24-bit colour) and read at 4x magnification by two independent observers. ECGs were 
assessed for the presence of ER and the magnitude of JPE, manifest as slurring or 
notching of the downslope of the R wave in at least two contiguous inferior (II, III, aVF) 
or lateral (I, aVL, V4-6) leads. ER was assessed at typical (≥0.1mV) and high-risk 
(>0.2mV) amplitudes, as well as on morphological criteria alone (JPE <0.1mV). The 
following data were recorded for each patient: the number and location of leads 
displaying ER, the mean and maximum amplitudes of JPE in each lead, PR interval, QRS 
duration and QTc interval (derived using Bazett's formula). For each ECG displaying ER 
≥0.1mV, ST segment morphology was classified as “concave/rapidly ascending” when 
there was >0.1mV ST segment elevation within 100ms after the J-point and the ST 
segment merged gradually with the T wave, or “horizontal/descending” when the ST 
segment elevation was ≤0.1mV within 100ms of the J-point and continued as a flat 
segment until T wave onset. 
Statistical analysis was performed using SPSS (SPSS Inc., Chicago, IL). Categorical 
variables were compared using a two-tailed Fisher’s exact test or an exact McNemar test 
for paired data as appropriate. Continuous variables were compared using a two-tailed 
Student’s T-test (paired or unpaired as appropriate) and reported as means ± standard 
errors. Owing to the nature of the study, no adjustments were made for multiple 
comparisons. All tests were two-sided, and P values <0.05 were considered statistically 
significant.  
2.3 Results 
Of the 89 cases reviewed, 43 met the inclusion criteria. Reasons for exclusion were: 
paired ECGs not available (n=21), abnormal baseline ECG (n=17: left bundle branch 
block, right bundle branch block, paced rhythm, Brugada syndrome), insufficient clinical 
details to confirm VF aetiology (n=4), other confounding factors (n=4: dilated 
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cardiomyopathy, cardiothoracic surgery, drug use, myocarditis). Baseline characteristics 







Age	(years)		 42.9	±	4.7		 61.5	±	2.3		 0.0004	*	
Males		 8	(80%)		 31	(94%)		 0.23		
Females		 2	(20%)		 2	(6%)		 0.23		
Hypertension		 1	(10%)		 14	(42%)		 0.13		




Diabetes	mellitus		 0	(0%)		 5	(15%)		 0.320		
Family	history	of	ischemic	heart	disease		 0	(0%)		 2	(6%)		 1.000		
VF	 indicates	 ventricular	 fibrillation;	MI,	 myocardial	 infarction;	 ID-VF,	 idiopathic	 VF;	 CAD-VF,	 coronary	
artery	disease-related	VF,	*	indicates	statistical	significance.	
Effect of Cooling on ER  
Overall, ER pattern was present in a significantly greater proportion of patients during 
cooling than at baseline (32/43 during cooling vs. 22/43 at baseline, P=0.024). The mean 
J-point elevation (JPE) amplitude for inferolateral ECG leads was significantly greater 
during cooling than at baseline (0.78±0.10 mV during cooling vs. 0.56±0.09 mV at 
baseline, P=0.038). The maximum JPE amplitude seen in any single lead of each ECG 
was greater during cooling than at baseline (1.15±0.15 mV during cooling vs. 0.68±0.11 
mV at baseline, P=0.002).  Figure 2-1 illustrates typical ID-VF and CAD-VF cases in 
which ER morphology was augmented by cooling. 
Temperature-dependent Prevalence of ER in ID-VF and CAD-VF Arrest Survivors 
When defining the presence of ER as any JPE (manifest as terminal QRS notching or 
slurring) with or without ST segment elevation, ER was more common among survivors 
of ID-VF as compared to CAD-VF both at baseline (80.0% vs. 42.4%) and during cooling 
(100% vs. 66.7%), but the difference reached statistical significance only during cooling 
(Figure 2-2A and B). In contrast, JPE of a magnitude ≥0.1mV was present significantly 
more frequently in the ID-VF as compared to the CAD-VF group at baseline (70.0% vs. 
27.3%, Figure 2-2C), but the significance threshold was not met during cooling (80.0% 
vs. 42.4%, Figure 2-2D). Finally, there was no significant difference in the prevalence of 
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ER between ID-VF and CAD-VF at baseline (20.0% vs. 3.0%) or during cooling (40.0% 
vs. 15.2%) when defining ER as a JPE magnitude >0.2mV (Figure 2-2E and F). Cooling 
was not associated with the de novo development of ER in either those with ID-VF (8/10 







In	 a	 single	 CAD-VF	 patient,	 terminal	 QRS	 slurring	 develops	 in	 the	 lateral	 leads	 during	 hypothermia.	

























Baseline/normothermic	 ECGs	 were	 obtained	 following	 rewarming	 after	 the	 period	 of	 therapeutic	
hypothermia.	VF	indicates	ventricular	fibrillation;	ID-VF,	idiopathic	VF;	CAD-VF,	coronary	artery	disease-
related	VF;	*	indicates	statistical	significance.	
ST Segment Morphology in ID-VF and CAD-VF Arrest Survivors with ER  
Considering only the cases with JPE ≥0.1mV (Figure 2-3), a greater proportion of the ID-
VF group than the CAD-VF group (71.4% vs. 33.3%) displayed horizontal or down-
sloping ST segments at baseline temperature. Similarly, in the CAD-VF group 
horizontal/down-sloping ST segments were more prevalent during hypothermia than at 
baseline temperature (53.8% vs. 33.3%). Neither of these differences reached statistical 
significance, possibly reflecting the small sample size. There was no difference between 
the ID-VF and CAD-VF groups in the proportion of patients with horizontal or down-









































































Figure	 2-3.	 ST-segment	Morphology	 in	 ID-	 and	 CAD-VF	 Survivors	 with	 Early	 Repolarisation	 (J-wave	
amplitude	>0.1mV)	
Proportion	of	cases	with	horizontal/down-sloping	(high	risk)	vs.	concave/up-sloping	ST	segments	(benign)	
in	 each	 group	 at	 normothermia	 and	 while	 cooled	 are	 shown.	 ST	 segment	 morphology	 was	 defined	
according	to	criteria	in	(214).	Baseline/normothermic	ECGs	were	obtained	following	rewarming	after	the	
period	 of	 therapeutic	 hypothermia.	 VF	 indicates	 ventricular	 fibrillation;	 ID-VF,	 idiopathic	 VF;	 CAD-VF,	
coronary	artery	disease-related	VF.	
Temperature-dependent Amplitude of JPE in ID-VF and CAD-VF Arrest Survivors 
Mean and maximum JPE amplitude were significantly greater amongst the ID-VF group, 
as compared to the CAD-VF group, both at baseline and during cooling (Table 2-2). 
Maximum, but not mean, JPE magnitude increased significantly on cooling in the ID-VF 
group (Figure 2-4A). Both mean and maximum JPE magnitude increased on cooling in 
the CAD-VF group (Figure 2-4B). There was no difference in the proportion of patients 
in the ID-VF group as compared to the CAD-VF group in whom JPE magnitude increased 
on cooling (6/10 vs. 16/33, P=0.72 for mean and 9/10 vs. 18/33, P=0.063 for maximum). 
Similarly, there was no difference in the magnitude of the increase in either mean or 
maximum JPE on cooling between the groups (ΔJPE, Table 2-2). 
QRS duration and QTc intervals 
QRS duration and QTc interval increased significantly on cooling in both the ID-VF and 
CAD-VF groups (Table 2-3). There were no differences in QRS duration or QTc interval 


























Baseline		 0.102	±	0.021		 0.042	±	0.009		 0.005	*		
Cooled		 0.116	±	0.018		 0.070	±	0.011		 0.044	*		
Δ	JPE	 0.014	±	0.053	 0.028	±	0.073	 0.577	
Maximum		
Baseline		 0.118	±	0.024		 0.053	±	0.012		 0.015	*		
Cooled		 0.169	±	0.029		 0.099	±	0.016		 0.042	*		
Δ	JPE	 0.052	±	0.065	 0.046	±	0.101	 0.861	












ID-VF		 89.1	±	2.3		 97.9	±	3.4		 0.002	*		
CAD-VF		 94.3	±	2.2		 100.5	±	2.5		 0.016	*		
QTc	interval		
ID-VF		 380.6	±	37.9		 493.2	±	16.5		 0.048	*		
CAD-VF		 420.7	±	4.6		 472.6	±	7.8		 <0.001*		

























































The main findings of this study are as follows. 1) Overall, ER was more common and of 
greater amplitude during cooling than at baseline. 2) ER amplitude was significantly 
greater in survivors of ID-VF arrest than survivors of CAD-VF arrest at all temperatures. 
3) Whilst the prevalence of ER was not significantly increased in either group on cooling, 
mean JPE was increased by cooling only in survivors of CAD-VF arrest. 
In recent years population-based studies have established an association between the early 
repolarization (ER) pattern and ventricular fibrillation (VF), whether idiopathic in nature 
or secondary to ischemia (118, 202, 204). At the same time, the tendency for hypothermia 
to result in similar electrocardiographic changes is well established (210, 211). 
Furthermore, in isolated cases therapeutic hypothermia itself has been described as 
potentially pro-arrhythmic (215). The previously common use of therapeutic hypothermia 
following cardiac arrest provided an important opportunity to examine in a systematic 
manner the impact of cooling on ER morphology in patients who have suffered either ID-
VF or CAD-VF arrest. This retrospective cohort study therefore assessed the impact of 
therapeutic hypothermia on the prevalence, morphology and magnitude of ER in all 
ventricular fibrillation patients receiving therapeutic hypothermia at our critical care unit 
over a 7-year period. 
A number of differences exist between this cohort and previously published descriptions 
of ER. Firstly, the overall frequency of ER in this study population is rather higher than 
that reported elsewhere. At baseline temperature 51% showed morphological ER. Even 
limiting to those patients with JPE ≥0.1mV, a widely accepted definition (118), the 
overall prevalence of ER in this cohort at baseline was still 37.2%. This prevalence is 
substantially higher than that seen in the European population overall (5%–13%) (198, 
199) and also markedly higher than that described in a recent study of patients who had 
suffered cardiac arrests attributable to a variety of causes (3%) (216). The former likely 
reflects the high-risk nature of the patients in our study population and the latter 
differences in underlying causes for VF between our cohort and that reported in Rolfast 
et al’s study. During cooling 74% of our study population showed the ER pattern (51.2% 
at the 0.1mV JPE threshold). The prevalence of ER is well established to vary with core 
temperature: case series of patients with accidental hypothermia suggest that, given the 
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relatively mild degree of hypothermia used in a therapeutic setting, the prevalence of ER 
would be expected to be close to zero (217, 218). Rolfast et al report 30% prevalence in 
their study population during cooling.  
Secondly, similarities and differences emerge between patients whose arrest was 
attributable to ID-VF, as compared to CAD-VF. Perhaps unsurprisingly, patients who 
suffered an episode of ID-VF were younger and apparently healthier than those who 
experienced CAD-VF. There were no differences in QRS duration or QTc between 
groups, though both parameters increased significantly on cooling. The latter finding has 
previously been established (218), with increased QTc having been described in the 
context of therapeutic hypothermia (216). The ER pattern was more common among 
survivors of ID-VF, as compared to CAD-VF, during cooling, though not at baseline 
temperature. Furthermore, JPE was of a greater magnitude in patients with idiopathic VF 
at both temperatures studied. Large magnitude JPE was seen more frequently among 
patients with ID-VF. This finding reached significance at baseline temperature but 
became less marked with the compounding influence of cooling. These observations are 
in keeping with a previous suggestion that the presence of ER in patients resuscitated 
following cardiac arrest is suggestive of a non-ischemic aetiology and that large-
magnitude JPE is associated with a particularly high risk of idiopathic VF (198, 219). 
This study was designed to identify differences in the effect of hypothermia between 
patients with ID-VF and CAD-VF. In this regard the study finds that cooling-related 
augmentation of J-point elevation was significant in the CAD-VF group but not the ID-
VF group. This finding may be attributable to differences in the underlying mechanisms 
giving rise to ischemic ER, idiopathic ER or ER associated with hypothermia. Ischemic 
ER is most likely attributable to local activation of ATP-sensitive K+ currents by ischemic 
mediators (220), and similarly idiopathic ER may result from augmentation of the 
transient outward current (Ito) resulting in a ‘spike-and-dome’ epicardial action potential 
notch and transmural voltage gradient early in repolarisation (209). Other currents 
influence phase 1 repolarisation and notably both blockage of Ito and augmentation of ICaL 
can reduce J-point and ST segment elevation in experimental models (221). Alternatively, 
idiopathic ER may arise from local conduction delay causing regional dispersion of 
depolarisation and resulting in the same transmural gradient as before. Indeed J-point 
elevation associated with conduction slowing has been termed ‘malignant’ and may be 
associated with ventricular arrhythmia (222). Given these alternate mechanisms two 
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hypotheses arise as to the mechanism of hypothermia-induced augmentation of the ER 
phenotype: increased conduction delay vs. increased outward current during phase 1 
repolarisation. Although the present study does not discern between these mechanisms a 
number of prior observations are made. In support of the conduction delay hypothesis, 
both severe (26°C) and therapeutic (32-34°C) hypothermia result in prolonged action 
potential duration (223) with significantly decreased conduction velocity (224), and on a 
cellular level severe hypothermia completely abolishes Ito (225). However in the post-
ischemic setting, mild hypothermia has actually been shown to increase conduction 
velocity compared to the normothermic post-ischemic period (226) casting doubt on the 
conduction delay hypothesis as an explanation for J-point elevation augmentation in this 
study. In support of the altered repolarisation current hypothesis recent work in coronary-
perfused canine left ventricular wedge preparations has found a key role for Ito in J-point 
elevation during hypothermia, especially in conditions modelling idiopathic ER (227). 
The pro-arrhythmic nature of hypothermia in the setting of the ‘early repolarisation 
phenotype’ in this model (arising from phase 2 re-entry) is consistent with reports of the 
pro-arrhythmic nature of therapeutic hypothermia in ER patients (215). Drugs inhibiting 
of Ito (e.g. quinidine) and augmenting ICaL (e.g. milrinone) were able to reduce 
hypothermia-induced ER augmentation, suggesting that greater inhibition of ICaL than Ito 
at the same level of hypothermia may leave Ito unopposed and able to accentuate the 
epicardial action potential notch (227). 
It is also instructive to compare the present findings with other work examining the 
dynamicity of J waves in relation to heart rate. In one cohort, pause-dependent 
augmentation of J-wave amplitude was highly specific (but not sensitive) for the 
occurrence of idiopathic VF (207). Conversely in another cohort of non-VF patients, 
tachycardia (rather than bradycardia) augmentation of J waves was observed (228). 
Considering that Ito is known to be rate-dependent (209), decreasing at higher rates and 
increasing at lower rates, these observations support the hypothesis that early 
repolarisation in idiopathic VF is dependent on Ito. Similarly, Ito (or at least its surrogate, 
the epicardial action potential notch) is augmented by hypothermia (209). The fact that 
the J wave was augmented by hypothermia primarily in the CAD-VF group (but not the 
ID-VF) group in the present study may represent a capacity phenomenon whereby 
hypothermia augments the action potential notch in CAD-VF, which is already fully 
augmented in ID-VF. The observation that J-point elevation was greater during 
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normothermia in the ID-VF as compared to the CAD-VF group lends support to this 
hypothesis. 
As will be seen later in this thesis, the combination of multiple substrate characterisation 
techniques may frequently be the most revealing of the underlying arrhythmia mechanism. 
Two recent studies serve to illustrate this point. By using CMR imaging to examine the 
association between ER and ventricular morphology in the absence of known structural 
heart disease, the presence of J-waves has been associated with abnormalities of right (but 
not left) ventricular morphology and function (229). Although this study did not provide 
any prospective follow-up data it does lead to the important hypothesis that structural 
right ventricular changes may help to identify patients with the ER phenotype who are at 
highest risk of future syncope and/or sudden cardiac death. Similarly, ECGI has been 
applied in patients with idiopathic VF associated with ER, and has identified areas of 
abnormally short activation-recovery intervals (reflecting short action potential duration) 
in the right ventricle (230). As with the CMR study of Takeuchi et al, this second study 
supports the hypothesis that idiopathic VF with the ER phenotype could be a right 
ventricular disease. However, PVC’s mapped in these patients originated from the 
inferolateral LV, and in a further patient with idiopathic VF and ER, VF rotors anchored 
in the inferior-lateral LV wall (231). Given the variability of these findings, and lack of 
prospective follow-up data, the role of ECGI in risk stratification of ER phenotype 
remains to be determined. 
Limitations 
While this study reports the association between ER and both idiopathic and CAD-related 
VF, the mechanisms underlying arrhythmia in either setting cannot be conclusively 
identified. Traditionally ER has been associated with arrhythmia initiated by phase 2 re-
entry (221, 232). It is possible, however, that patients in the CAD-VF group who had 
previously experienced a myocardial infarction (one third of this group) might in fact 
have suffered an episode of scar-related VT that subsequently deteriorated into VF. 
Patients in the idiopathic VF group were younger than those in the CAD-VF group. Since 
the prevalence of early repolarization decreases with age (233) it is possible that this 
confounding factor could have contributed to some of the differences observed between 
the ID-VF and CAD-VF groups. Finally, the baseline (normothermic) ECGs were 
obtained following rewarming after the arrest. Whether the same results would have been 
seen had pre-morbid baseline ECGs been available is not known.    
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2.5 Conclusions 
In conclusion, the data presented in this chapter indicate that early repolarization is more 
strongly associated with idiopathic VF than with coronary artery disease related VF. 
Hypothermia increases both the prevalence and magnitude of early repolarization in 
cardiac arrest survivors: however, the mean amplitude of J-point elevation is increased in 
survivors of coronary artery disease related VF, but not of idiopathic VF.  
In this chapter, I explored the use of the surface ECG to risk stratify a candidate substrate 
for ventricular arrhythmias. In the next chapter, the role of intracardiac electrogram 
analysis in the diagnosis atrial arrhythmias is examined and Aim C2 (determine the 
optimal point sampling density for intra-cardiac contact mapping in the diagnosis of 
tachycardia mechanism in a variety of atrial tachycardias) is addressed. 
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3 Intra-Cardiac Mapping: Optimized Local 
Activation Time Sampling Density 
3.1 Introduction 
In the last chapter the role of the surface ECG in arrhythmia substrate characterisation 
was examined. It has long been recognised that the surface ECG lacks resolution for the 
accurate diagnosis of both ventricular and atrial arrhythmias, and this limitation 
eventually resulted in the development of electroanatomic mapping systems capable of 
recording intracardiac electrograms and facilitating invasive arrhythmia treatments with 
catheter ablation techniques. Local activation time (LAT) mapping (see Intracardiac 
Contact Mapping, p. 31) using electroanatomic mapping systems now forms the 
cornerstone of invasive diagnosis of complex atrial arrhythmias.  
The creation of LAT maps to determine the mechanism of an atrial tachycardia (AT) 
involves four key steps: 1) creation of a three dimensional model of the anatomy, 2) 
analysis of intracardiac electrograms to identify activation time relative to a fixed 
temporal reference, 3) interpolation of the activation times across the anatomical model 
and 4) representation of the interpolated data across the anatomical model, usually in the 
form of a color map. 
Although the underlying technologies providing spatial localization differ between 
systems (magnetic-, impedance- and electric field-based), all contemporary EAM 
systems provide a number of core functionalities including cardiac chamber 
representation, catheter localization and electrophysiological data representation. 
Anatomic accuracy of LA electroanatomic chamber models has been compared to cross 
sectional imaging with CT/MRI (234), showing faithful representation of pulmonary vein 
dimensions and geometry. Similarly, catheter localization has been assessed both in vitro 
and in vivo in animal models and human subjects and has been shown to be both 
reproducible and highly accurate (235, 236). Despite these reports, it is notable that to 
date there are no studies examining the electrical accuracy of interpolated LAT maps 
generated with point-by-point contact mapping. Rather, recommendations on the number 
of sampling locations required to create an accurate map are primarily based on operator 
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experience (237). At the same time device manufacturers continue to innovate to increase 
the achievable resolution of mapping systems (238–241). Meanwhile the end goal of 
achieving effective diagnosis and treatment whilst minimizing procedure times for 
patients remains. To this end this study presents an optimal point sampling strategy for 
atrial arrhythmias, based on systematic analysis of in silico and in vivo LAT mapping 
data. The relative impact of chamber geometry complexity and activation pattern 
complexity on the optimal sampling density for mapping the arrhythmia is also examined. 
3.2 Methods 
Atrial Monolayer Model 
A 4x4cm atrial tissue model was meshed using triangular elements (84,346 triangles, 
42,511 nodes, average edge length ∆l=0.2 mm). At each node the atrial cell membrane 
model developed by Nygren et al (242) was implemented which, in tissue simulations, is 
characterized by the propagation of stable re-entrant waves (97). Anisotropic conduction, 
with fibre orientation parallel to the x-axis, was used between nodes with longitudinal and 
transverse conductivities of 0.28 S/m and 0.026 S/m for focal and linear activation. 
Isotropic conduction with equal conductivities of 0.15 S/m was employed for re-entrant 
and spiral wave activation. Following the application of voltage stimuli (see below), 
electrical propagation was determined by solving the monodomain system of equations 
with a time step of ∆t=25 ms. The Cardiac Arrhythmia Research Package (103) was used 
to perform atrial tissue simulations. 
All stimuli were applied as transmembrane voltages (-1000mV, 1ms duration). To create 
uniform linear activation, a 2mm region at the left edge of the tissue was stimulated. To 
create focal activation a 1x1mm region close to the centre of the monolayer was 
stimulated. To create re-entry, a circular non-conducting region (diameter 1.5cm) was 
introduced at the centre of the monolayer. A dual stimulus protocol was used to initiate 
re-entry by delivering the second stimulus at a critical time point when half of the 
stimulated region remained refractory. To create spiral wave activation, two linear stimuli 
were used. The first stimulus activated the full height of the monolayer in a linear fashion 
from the leftmost edge whilst the second, critically timed stimulus, being only ¾ height 
initiated spiral wave re-entry. In silico isochronal maps  were constructed from the 
transmembrane potential fields by calculating the time elapsed between a fixed temporal 
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reference and the time at which the transmembrane potential exceeded a pre-defined 
voltage threshold (-20mV). 
In Vivo Procedures 
A total of 26 electroanatomic maps were included in the analysis. Isochronal local 
activation time maps were created using the Carto 3 mapping system (Biosense Webster, 
Diamond Bar, CA, USA) by taking the activation time at each acquired point as the time 
from reference activation (typically an atrial coronary sinus electrogram) to earliest 
activation on the bipolar mapping catheter signal.  
Animal Studies 
Animal studies complied fully with Danish law on animal experiments. Eight male 
Göttingen mini-pigs (41.2±7.2kg) were pre-sedated with intramuscular azaperone 
(4mg/kg) and midazolam (0.5mg/kg). General anaesthesia was induced with intravenous 
ketamine (5mg/kg) and midazolam (0.5mg/kg), and the animals were intubated and 
mechanically ventilated. Anaesthesia was maintained with a continuous intravenous 
infusion of propofol (3mg/kg/h) and fentanyl (15µg/kg/h). Two 8F sheaths were placed 
percutaneously in the right femoral vein, followed by an intravenous injection of 
100IU/kg heparin. Fluoroscopy was used to position a 6F decapolar reference catheter in 
the coronary sinus (CS) and a 7.5F ablation catheter was advanced to the RA and used to 
create a LAT map during proximal CS pacing. Incomplete inter-caval linear ablation was 
performed, with an approximately 5mm conduction gap positioned at the centre of the 
linear lesion, before repeat LAT mapping of the new activation detour. 
Human Studies 
Ten patients undergoing ablation for left atrial tachycardia were studied. Data collection 
for this study was part of ongoing real-time data collection processes during physician-
directed patient care. All procedures were performed under general anaesthesia. 
Following trans-septal puncture, a 20-pole circular mapping catheter (Lasso Nav, 
Biosense Webster, Diamond Bar, CA, USA) was advanced and used to create a 3D 
geometry of the left atrium. High-density local activation time maps were constructed 
during tachycardia using points acquired with the ablation catheter. Coverage of the entire 
LA was ensured, even once tachycardia mechanism was established, with a mean number 
of points per map of 355±137, corresponding to a sampling point density of 2.5±0.8 
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points/cm2. Local activation times were automatically assigned and all points were re-
annotated to ensure correct identification of the first component of each atrial electrogram. 
Local Activation Map Construction 
Re-interpolated LAT maps (for both in silico and in vivo studies) were created by down-
sampling the number of acquired points and performing bilinear interpolation of the 
resulting activation field across the 2D domain for the simulated activation patterns or 3D 
geometry (i.e. electroanatomic shell) for the clinical tachycardias. When performing re-
interpolation on the clinical datasets, a distance threshold of 10mm was used meaning 
that the interpolant was only interrogated for mesh nodes lying within 10mm of an 
original mapped point. Points beyond this distance were assigned indeterminate local 
activation times and are represented as grey in the accompanying figures. 
LAT Map Accuracy Quantification 
For simulated activation patterns the reference map was defined as the high-resolution 
isochronal map created from the activation times calculated at every node. For clinical 
activation patterns the reference map was defined as the LAT map created by the clinical 
mapping system (Carto 3, Biosense Webster, Diamond Bar, CA, USA) using all available 
LAT points. Reference and re-interpolated maps were compared quantitatively by 
computing the sum of squared differences between activation times at every mesh node 
within a distance threshold of 10mm of an original sampling point. Results are presented 
per node in order to normalize for inter-case differences in the number of nodes per 
geometry. 
Optimal Sampling Density Measurement 
The optimal sampling density for each LAT map (simulated and clinical) was defined as 
the lowest sampling density that resulted in an error reduction rate of less than 0.05ms 
per mesh node per additional point sampled. This measurement was made as shown in 
Figure 3-1. Firstly, each map was re-interpolated with point sampling densities in the 
range 0.25 to 10 points/cm2 (step size 0.125 points/cm2, repetitions = 10). The mean LAT 
map accuracy (see above) for each density was plotted against sampling density and a 
power series of the form Q 0 = R0S + T  was fitted to the resulting mean accuracies 
(where 0 is the sampling density). Taking the first derivative of this power series (i.e. QU 0 = RV0SMN) gives the relative improvement in map accuracy per additional point 
sampled. Finally, this equation was solved for QU 0 = −0.05 in order to determine the 
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sampling density at which minimal further improvement in map accuracy is achieved by 






at	 each	 sampling	 density	 is	 calculated	 by	 comparing	 activation	 times	 at	 each	 node	 with	 the	 original	
activation	times	in	A.	D	–	Taking	the	first-derivative	of	the	curve	in	C	indicates	the	sampling	density	at	
which	minimal	further	improvement	in	map	accuracy	is	generated.	
Data Analysis and Statistics 
Custom software was written for determining the optimal sampling point density 
(MATLAB 8.2, The Mathworks Inc., Natick, MA). Subsequent data analysis was 
performed using GraphPad Prism version 6.0c (GraphPad Software, San Diego, 
















































unpaired t-test was used to compare group mean. A significance level of P<0.05 was 
considered statistically significant. 
3.3 Results 
Simulated Activation Patterns 
Four simulated activation patterns were studied (linear, focal, spiral-wave and re-entrant 
activation). Initiation of these activation patterns is shown in Figure 3-2. Reference LAT 
maps were created from local activation times defined at every mesh node, resulting in a 
sampling density of ~2500 points/cm2. In the case of linear and focal activation, local 
activation times were taken as the first activation of each node. In the case of spiral and 
re-entrant activation, a window of interest (WOI) incorporating 100% of the tachycardia 
cycle length (TCL) was defined. Calculated optimal sampling densities (Figure 3-7A) for 
focal, spiral-wave and re-entrant activation patterns were 1.09±0.14 points/cm2, 
1.44±0.49 points/cm2, and 1.50±0.34 points/cm2, respectively. Linear activation in a 2-
dimensional domain represents a special case where map accuracy is independent of 
sampling density Figure 3-3. 
Examples of re-interpolated isochronal LAT maps at sub-optimal, optimal and supra-
optimal sampling densities for focal, re-entrant and spiral-wave activation patterns are 
shown in Figure 3-4, Figure 3-5 and Figure 3-6, respectively. For the focal activation 
pattern, sub-optimal sampling density resulted in incorrect focus localization. For the re-
entrant activation pattern, sub-optimal sampling density resulted in an activation pattern 
more consistent with a focal source. Finally, sub-optimal sampling of the spiral-wave 
activation pattern failed to reveal rotational activity in the resulting re-interpolated map. 
Notably, in each case, there was limited morphological improvement in the isochronal 
map appearances at supra-optimal compared to optimal sampling densities (compare 
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Determination	of	optimal	sampling	density	 for	 linear	activation	 is	shown.	A	–	 (Top)	Original	activation	
pattern.	(Middle)	Re-interpolated	LAT	map	errors.	(Bottom)	LAT	map	error	reduction	rate.	B	–	Examples	
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Clinical Left Atrial Tachycardias 
Ten clinical left atrial tachycardias were studied (focal tachycardia, n=2; localized re-
entry, n=3; macro-re-entrant tachycardia, n=5). The mean LA surface area calculated 
from the electroanatomic shells was 151±26cm2 with an original sampled point density 
of 2.3±0.9points/cm2. There was a trend toward higher optimal sampling densities for 
localized re-entry and macro-re-entry tachycardias (Figure 3-7B) but this difference did 
not reach statistical significance (calculated sampling densities 0.96±0.11 points/cm2 for 
focal tachycardias, 1.15±0.39 points/cm2 for macro-re-entrant tachycardias and 
1.30±0.35 points/cm2 for localized re-entry, P=0.5968). The focal tachycardia maps re-
interpolated at optimal density (i.e. LAT error rate reduction <0.05ms/node/point) 
resulted in correct localisation of the foci of earliest activation (Figure 3-8A); anterior to 
the right veins in one case and posterior to the right veins in the other. In the re-entrant 
tachycardias (Figure 3-8B) re-interpolation at optimal sampling density resulted in the 
same overall map appearance, with the same macro-re-entrant circuit remaining 
identifiable. However, some variations in map appearance at the extremes of interpolation 
(e.g. beyond the pulmonary vein ostia) were identifiable. The localized re-entrant maps 
re-interpolated at optimum sampling density (Figure 3-8C) were remarkably similar in 
appearance to the original maps; but again some variations were evident in activation 
timing interpolated into the left-sided pulmonary veins in one case. 
 
Figure	3-7.	Optimal	Sampling	Densities	
Calculated	 optimal	 sampling	 densities	 are	 shown	 for	 simulated	 activation	 patterns	 (A)	 and	 clinical	
tachycardias	(B).	FO	=	focal	origin;	MA	=	macro	re-entry;	MI	=	micro	(localised)	re-entry.	





































































































Porcine Right Atrial Activation and Chamber Geometry Complexity 
Eight pre-ablation LAT maps created under proximal CS pacing were studied. In the 
absence of ablation, activation proceeded superiorly in a linear fashion around the tubular 
right atrium in all cases. After incomplete inter-caval linear ablation, a new activation 
detour was evident in all maps (see Figure 3-9). Mean pre-ablation optimal LAT sampling 
density was 0.45±0.13 points/cm2 and mean post-ablation optimal LAT sampling density 
was 0.78±0.17 points/cm2. Increasing activation morphology complexity resulted in a 
significant increase in the optimal LAT sampling density (P=0.0008). Even in the setting 
of increased activation complexity introduced by the presence of incomplete linear 
ablation, the overall optimal point sampling density for the geometrically-simple porcine 
right atrium (0.78±0.17 points/cm2) was significantly less than that for the geometrically-







The main findings of this study are as follows: 1) optimal sampling densities can be 
identified for a variety of tachycardia mechanisms to maximize the diagnostic yield of 
interpolated local activation time maps; 2) optimal sampling density is dependent on 

































complicated activation sequences including macro-re-entry and spiral-wave activation; 
3) optimal sampling density is also dependent on chamber geometry, with increasing 
geometric complexity necessitating an increased optimal sampling density; 4) for both 
focal and re-entrant clinical left atrial tachycardias there appears to be no additional 
benefit in performing LAT sampling at a density greater than 1.5 points/cm2.  
The aim of tachycardia activation mapping is two-fold: to determine the arrhythmia 
mechanism and thereby inform an ablation strategy. The ablation strategy is guided by 
the site of tachycardia origin (focal mechanism) or a critical isthmus of conduction (re-
entrant mechanism). Three-dimensional electro-anatomic mapping systems provide a 
framework for visualization of electrical activation sequences as an aid to identifying the 
tachycardia mechanism and corresponding ablation target. Recent technological advances 
have enabled significant increases in the spatial resolution achievable within reasonable 
timescales with both established (243) and emerging (244) contact mapping platforms. 
Whilst high sampling density is clearly important for substrate-mapping accuracy, for 
example in identifying areas of low voltage or fractionated signals (245–247) important 
to arrhythmogenesis, it is not known whether high-resolution mapping results in clinical 
benefit during activation mapping, where the primary aim is to reliably identify the 
tachycardia mechanism. Indeed high-resolution activation mapping is at odds with earlier 
strategies aiming to minimize procedure time without impacting success by providing a 
logical framework for directing the acquisition of LAT points (248). To this end, this 
study shows that in systems using interpolation methods to create isochronal LAT maps 
from a number of sampled LAT times, a theoretical maximal sampling density is reached 
at which further clinically-relevant improvements in LAT map accuracy are minimal. By 
using both simulated data in addition to clinical data this study has demonstrated that 
maximal sampling density is within the same range (0.9-1.5 points/cm2) irrespective of 
the resolution at which the 'gold standard' activation sequence is defined. 
The identification of atrial spiral-waves has received renewed attention recently as a 
strategy to identify ablation targets in atrial fibrillation (161, 249). Whilst rotors have 
been identified in animal (154) and computer models (250, 251) of atrial activation, there 
is some debate as to which technologies can reliably detect the occurrence of rotational 
activity in vivo (74, 252, 253). Clinical approaches to identifying rotors typically involve 
phase mapping in order to average activation over many cardiac cycles. This approach 
has successfully identified rotors in the left atrium using a 64-pole basket catheter (254). 
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Taking atrial endocardial surface area to be 150 cm2 (as in this study) and assuming 
maximal electrode contact this equates to a sampling density of only 0.43 points/cm2. 
Furthermore, suboptimal contact of the basket catheter results in even lower sampling 
densities (e.g. 56 electrodes equates to 0.37 points/cm2, 48 electrodes to 0.32 points/cm2 
and 32 electrodes to 0.21 points/cm2). All of these densities are below the optimal 
sampling density for spiral-wave activity identified in this study. Of note an alternative 
approach using dynamic voltage mapping applied to identical clinical data failed to 
identify sustained rotational activity in 100% (n=11) of cases (253). This result is 
consistent with our finding that a significantly higher sampling density of around 1.5 
points/cm2 should be required to optimally reproduce spiral-wave activity from known 
local activation time points.  
The results presented here should not be interpreted to indicate that sampling densities 
above 1.5 points/cm2 are never of clinical benefit in activation mapping. One limitation 
of the 'optimally' resampled clinical maps shown in Figure 3-8 is that interpolation at 
regions distant to the body of points (e.g. extending into the pulmonary veins or LAA) 
may be inaccurate. In such circumstances a local density of greater than 1.5 points/cm2 
may well be required to correctly identify the origin of a focal tachycardia. The results of 
this study support the argument that once an upper global sampling density of 1.5 
points/cm2 has been reached (equivalent to around 225 points for a typical LA with 
endocardial surface area of 150cm2) then the tachycardia mechanism should be evident 
or strongly suggested. In the event where this is not the case rather than collecting further 
points a better approach may be to begin a new activation map perhaps with a different 
window of interest, reference electrogram or LAT assignment technique. 
Limitations 
1) In calculating the optimal sampling density for clinical tachycardias it is not possible 
to completely separate the effects of activation sequence complexity and chamber 
geometry complexity. For example, a more complex geometry in the context of an 
identical tachycardia may require a higher optimal sampling density. This may 
explain the variation in macro-re-entrant sampling densities indicated in Figure 3-7B. 
Similarly, regional geometric differences (e.g. PV insertion angles and geometric 
map resolution) may contribute to inaccuracies in the calculated optimal sampling 
densities.  
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2) A practical limitation involves the identification of 'gold standard' references maps 
for the clinical cases. The interpolation algorithm implemented by the commercial 
mapping platform is likely to have differed from the bilinear interpolation algorithm 
employed here. Whilst this would lead to a systematic error in the error value for an 
interpolated activation map it should not change the identification of the optimal 
sampling density (map accuracy improvement with additional sampling points (i.e. 
Figure 3-1D) should remain unchanged). 
3) The question of whether the same optimal sampling densities would be found in other 
settings (e.g. complex multiple re-entry or geometrically complex ACHD cases) has 
not been addressed in this study, although it is reasonable to speculate that such 
optimal sampling densities may well be higher, but perhaps only on a regional basis. 
3.5 Conclusions 
In conclusion, this work demonstrates for a variety of tachycardia mechanisms that the 
majority of information discernible from LAT maps can be obtained with a limited 
sampling density strategy. The exact sampling density required depends on tachycardia 
mechanism and clinical characteristics. The results presented here do not attempt to guide 
regional variations in sampling density required for optimal LAT mapping, and this 
would present an obvious future research avenue for development. 
In this chapter, I explored the use of intracardiac mapping to diagnose regular atrial 
tachycardias. Intracardiac mapping can also be used for substrate assessment in order to 
assess the tissue-specific electrical properties in patients with arrhythmias. In the next 
chapter, the role of intracardiac electrogram analysis in assessing the atrial fibrillation 
substrate is examined, and Aim C3 (to develop a tool to quantify electrical remodelling 
in paroxysmal AF and determine if population heterogeneities are present that could be 
used to predict response to catheter ablation) is addressed. 
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4 Intra-Cardiac Mapping: Atrial Programmed 
Stimulation Reveals Substrate Heterogeneity 
Between Paroxysmal AF Patients 
4.1 Introduction 
Atrial fibrillation (AF) is a diverse disease with varying extents of electrical and structural 
remodelling seen in patients with paroxysmal and persistent AF (245, 255, 256). However, 
current clinical classification systems are based solely on duration of AF episodes, rather 
than physiological markers of disease severity. For example, paroxysmal AF (PAF) is 
defined as AF lasting for less than 7 days, and persistent AF (PsAF) as AF lasting for 
more than 7 days (142). A number of observations suggest that within the single clinical 
entity of paroxysmal AF, a spectrum of disease may be present (257). Firstly, AF ablation 
is more successful in some patients than others, even when controlling for confounding 
factors including co-morbidities and left atrial dimensions. Secondly, some patients with 
paroxysmal AF may require multiple ablation procedures to achieve freedom from AF, 
whereas others may require only a single procedure. Finally, the natural history of AF 
varies, with differing rates of progression to PsAF seen (258). 
Given this heterogeneity, a number of studies have examined clinically-measurable 
factors that may describe the ‘severity’ of AF in order to predict rates of disease 
progression or freedom from AF after catheter ablation. Co-morbidities including 
hypertension, obesity and obstructive sleep apnoea have been associated with increased 
AF burden and recurrence of AF after pulmonary vein isolation, but not all studies 
demonstrate a clear relationship between the presence of co-morbidities and AF disease 
severity (259). Similarly, there is debate over the predictive value of basic measures like 
left atrial size for outcome of pulmonary vein isolation, with some studies demonstrating 
a highly significant association (259, 260) and other studies demonstrating no association 
at all (261). The impact of AF duration on recurrence rates is also controversial. A recent 
study found that left atrial volume was more important than the type of atrial fibrillation 
in predicting long-term success of catheter ablation (262), whilst other work finds that 
the only positive predictor of freedom from AF is a shorter duration of AF (263). As an 
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alternative to quantifying clinical characteristics, other studies have examined the 
electrophysiological properties of the atria in patients with AF. Again however this work 
is characterised by variable findings. For example left atrial low voltage, shortened 
refractoriness and reduced conduction velocity have all been associated with increasing 
severity, duration or recurrence of AF in some (245, 256, 264, 265), but not all (266–268) 
studies. Taken together these findings serve to highlight that there is a need for improved 
techniques to classify atrial fibrillation in order to guide treatment strategies. 
Paced electrogram fractionation analysis (PEFA) was originally used to characterise 
abnormal conduction in patients with hypertrophic cardiomyopathy (269, 270). The 
technique involves delivering pacing stimuli at progressively shorter coupling intervals 
from one site, and recording the response electrograms at another site. In the presence of 
normal conduction between pacing and recording sites, PEFA results in a single biphasic 
response electrogram, whereas in the presence of abnormal or discontinuous conduction, 
PEFA results in a fractionated electrogram response (269). Increased electrogram 
fractionation in PEFA has been associated with sudden cardiac death in hypertrophic 
cardiomyopathy, dilated cardiomyopathy and long QT syndrome, and was suggested as 
a tool for clinical risk stratification of these ventricular arrhythmias (271, 272). 
The rationale for using PEFA analysis in substrate assessment has been addressed in both 
ex vivo tissue preparations and simulation studies. Activation mapping of isolated 
myocardium demonstrated that slowed conduction with activation block (the underlying 
substrate for re-entry) results in delayed local electrograms that contain multiple potential 
deflections corresponding to the individual pathways of myocardial activation (273–275). 
In simulation studies these electrogram morphological characteristics have been shown 
to arise from myocardial fibrosis and action potential abnormalities (276). Of note, these 
are also the key properties of the electrical and structural remodelling that is thought to 
underlie the AF substrate. Indeed, atrial simulation studies reveal the importance of zones 
of slow conduction arising from microfibrosis in the genesis of complex fractionated 
atrial electrograms (277). Correspondingly PEFA has previously been found to detect 
abnormal atrial substrate in patients with paroxysmal AF, based upon measurements from 
the RA and CS (278, 279).  
Therefore, in this study a programmed stimulation protocol is used to quantify the left 
atrial electrical substrate underlying AF in a population of patients with paroxysmal atrial 
fibrillation. The protocol was designed to allow simultaneous measurement of atrial 
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conduction delay as well as morphological electrogram changes, which may be associated 
with atrial myocardial remodelling. The occurrence of inter-patient differences in the AF 
electrical substrate that may explain differing clinical presentations is examined. 
4.2 Methods 
Study Inception 
Prior to commencing the study a number of stakeholders were involved in the 
development of key documentation to support the study. These included the patient 
information sheets, consent forms, radiation assessment, risk assessments for non-CE 
marked devices including software and the pacing stimulator and medical physics 
approval for the custom-built equipment. Once completed, and following submission 
through the Integrated Research Application System, ethical approval for the study was 
granted by the National Research Ethics Service (REC reference number: 10/H0802/77). 
Patient Selection and Clinical Procedures 
15 consecutive patients undergoing first time ablation for paroxysmal atrial fibrillation 
were studied. Patients were excluded from the study if there was a history of ischemic 
heart disease, cardiac surgery or structural heart disease. Anti-arrhythmic drugs, including 
calcium channel blockers, were stopped at least 5 half-lives before ablation. Amiodarone 
was stopped at least 6 months prior to ablation. All clinical procedures were performed 
under general anaesthesia. Following femoral access and trans-septal puncture, two 8.5 
French SRO long sheaths and a PentaRay mapping catheter (Biosense Webster, Diamond 
Bar, CA, USA, 4-4-4mm electrode spacing) were advanced into the left atrium. Decapolar 
(St Jude Medical, St Paul, MN, USA) and pentapolar (Bard Electrophysiology, Lowell, 
MA, USA) catheters were sited in the coronary sinus and high right atrium respectively. 
The PentaRay catheter was manoeuvred to multiple sites in the body of the left atrium 
and at each site bipolar electrograms were recorded in response to pacing from the HRA 
and mid-CS. ‘Shadows’ of each spline of the Pentaray catheter were created using the 
mapping system and used to ensure that the catheter did not move during recording 
(Figure 4-1). 
Pacing Protocol 
The pacing protocol was designed to obtain a large number of S2-response electrograms 
(A2 electrograms) throughout the LA within a 30-minute window. The pacing protocol 
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was delivered using a custom-built pacing stimulator (Figure 4-2) comprising a USB 
digital I/O device (NI USB-6501, National Instruments, Austin, TX)  connected via an 
optical isolator (Figure 4-3) to the external trigger of the UHS 3000 stimulator (Biotronik 
SE & Co. KG, Berlin, Germany). The protocol consisted of a 2-beat 470ms drive train 
followed by a single premature extra-stimulus. The S1S2 coupling interval was reduced 
in -2% steps from 350ms to 200ms or loss of capture (J2$ = 0.98×J2$MN). All pacing 
stimuli were delivered at a voltage of at least twice threshold with a pulse width of 2ms.  
 
Figure	4-1.	Example	left	atrial	geometry	and	recording	locations	













Electrograms were digitised using the LabSystem PRO EP Recording System (Bard 
Electrophysiology, Lowell, MA) at 4kHz sampling rate. All signal processing was 
performed offline (MATLAB 8.2, MathWorks Inc., Natick, MA). Pacing timing was 
determined from the paced channel (HRA or CS). The first pacing cycle was used to 
determine the noise threshold and discarded from subsequent analysis. As such, the 
longest S2 interval studied was 343ms (350ms x 0.98). A2 electrograms were rejected 
from analysis where the signal was far-field, there was fusion with an atrial ectopic beat 
or the two preceding S1 beats had failed to capture the left atrium (Figure 4-4). A band-
pass filter (30-500Hz) was applied to the bipolar recordings, and the noise threshold 
defined as signal mean+/-3SD of the 100ms preceding the S2 component of the first cycle.  
To provide a quantitative analysis of PEFA, previous work has plotted local activation 
against S2 coupling interval, and quantified two metrics of these conduction curves: 1) 
the maximal increase in electrogram duration (ΔED) after an extrastimulus; and 2) the 
S1S2 interval (S1S2delay) below which the electrogram duration increased (270, 280). The 
previous studies of atrial PEFA derive these parameters for a limited number of recording 
sites, before presenting average values of S1S2delay and ΔED as a single observation per 
patient. In the present study, a large number of measurements are taken throughout the 
body of the LA to assess regional variation in the LA response to pacing. In order to 
represent all electrogram points from a region on a single conduction curve, varying path 
lengths (from pacing to recording site) and therefore conduction times must be accounted 
for. Hence in the following work the electrogram timings are normalized to the local atrial 
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response to drive-train pacing (A2 time) rather than the pacing extra coupling interval (S2 
time). This calculation is shown schematically in Figure 4-6. 
 
Figure	4-4.	Initial	Electrogram	Processing	








annulus;	 Lateral	 -	 between	 appendage,	mitral	 annulus	 and	 LIPV;	Septum	 -	medial	 border	 of	 chamber	
between	anterior	and	floor	regions;	Veins	-	within	1cm	of	vein	ostium.	
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A	 –	 Pacing	 drive	 trains	with	measured	 intervals	marked.	B	 –	 Conduction	 curves	 as	 published	 in	 prior	
literature	on	paced	fractionation.	C	–	The	same	data	as	‘B’	is	converted	into	S1S2-A1A2	curves	allowing	
determination	of	conduction	delay	and	conduction	block	times.	
LA Regional Analysis 
For analysis of regional variations within the left atrium, the chamber was divided into 8 
regions (Figure 4-5). The mean±SD number of recording sites for each region was 29±8 
(floor), 22±10 (anterior), 21±5 (posterior), 17±7 (septum), 11±5 (roof), 9±6 (veins), 4±3 
(lateral) and 4±3 (appendage). The five regions with the highest density were selected for 
further analysis (floor, anterior, posterior, septum, roof). 
Electrogram Analysis 
Conduction Delay and Conduction Block 
To assess the impact of pacing rate on local electrogram timing and morphology, S1S2-
A1A2 curves were plotted where each dot represents a single electrogram peak or trough. 
These curves were characterized by 1) a 1:1 relationship between S1S2 and A1A2 at long 
pacing cycle lengths (the line of identity), 2) a minimum achievable A1A2 at short cycle 
lengths (the flat segment) and 3) a curved transition period between the two regions. A 


















A1A2 = S2A2+ (S1S2− S1A1)




























fit line was represented as a hyperbola with asymptotes at y=c and y=x. In this way, the 
S1S2block was determined as the shortest S1S2 conducted to the left atrium and the 
S1S2delay was determined as the transition point between the two parts of the curve.  
Pacing Latency and Conduction Path Length 
To determine the impact of pacing site latency on the conduction curves, activation time 
within the CS close to the pacing site was measured. Pacing latency was defined as the 
time from pacing stimulation to detectable local activation on the next-nearest bipole to 
the stimulating pair showing a clear local atrial electrogram. For CS 5,6 pacing this was 
usually CS 7,8 or CS 9,10 bipoles. Conduction path length was measured as the geodesic 
distance from the site of earliest left atrial activation to the LA recording site (Figure 4-7). 
Distances were calculated along the surface of the left atrial geometry using the approach 
of Mitchell et al (281). A previously-published computationally efficient implementation 
of the algorithm (282) was employed using MATLAB 8.2 (MathWorks Inc., Natick, MA). 
 
Figure	4-7.	Determination	of	Geodesic	Conduction	Path	Lengths	
Conduction	 path	 lengths	 (black	 lines)	 are	 calculated	 as	 the	 geodesic	 distance	 from	 earliest	 chamber	
activation	to	local	electrogram	recording	sites	for	HRA	pacing	(A)	and	CS	pacing	(B)	
Electrogram Amplitude and Duration 
Baseline electrogram amplitude and duration were determined from the longest S2 pacing 
cycle length analysed (S2=343ms) at each site. The rate-dependence of electrogram 
amplitude was quantified by calculating the gradient of the best-fit line through S1S2 vs. 
electrogram amplitude curves. This parameter is named ΔEV (units, mV/s) and represents 
the change in electrogram voltage with pacing rate. The rate-dependence of electrogram 
duration was quantified from S1S2-A1A2 plots for each recording site. For each S2 cycle 
length, the 5th and 95th centile of A2 electrogram components were taken as the beginning 









duration between these curves minus the duration at 343ms. This parameter is named 
ΔED (units, ms) and represents the maximal change in electrogram duration with pacing 
rate. 
AF Inducibility 
Inducibility of AF was assessed during pacing from the HRA and CS. Sustained AF was 
defined as AF >30 seconds in duration (283, 284). Where AF resolved to an organised 
tachycardia, it was attempted to terminate the tachycardia using pacing. Electrical 
cardioversion was performed if AF/AT persisted beyond 5 minutes. Following electrical 
cardioversion, a blanking period of 10 minutes was used where no further electrical 
measurements were taken (267). 
Atrial Simulations 
To determine if the clinically observed changes in conduction could be explained by left 
atrial electrical remodelling two simulation experiments were employed using a 
4.0x4.0cm atrial monolayer with the Courtemanche cell model implemented at each node. 
Firstly, anisotropy was introduced into the intra- and extra-cellular conductances to 
represent longitudinal fibre orientation. The model was activated by introducing a current 
stimulus along the leftmost edge (longitudinal activation direction) and activation times 
of the centre node were recorded at a transmembrane potential (Vm) of -20mV. The cell 
model was modified, as previously described (98), to reflect the spectrum of electrical 
remodelling seen in atrial fibrillation by applying reductions in Ito (50%), IKur (50%), and 
ICa,L (70%) current densities and the experiment repeated. To assess the impact of changes 
in fibre orientation on conduction, the experiment was repeated with transverse activation 
direction. Secondly to determine the impact of conduction velocity and conduction 
velocity restitution on global LA conduction curves two activation time recording sites 
were used, separated by 1.5cm in the direction of propagation for both transverse and 
longitudinal conduction. Conduction curves were generated using the same S1S2 protocol 
as the clinical studies for the sinus rhythm Courtemanche model, the AF Courtemanche 
model and the AF model with additional reduction of INa of 52% (285). Conduction time, 
conduction delay and conduction velocity restitution were measured in the direction of 
propagation. The Cardiac Arrhythmia Research Package (103) was used to perform atrial 
tissue simulations. Computer scripts and for these experiments are given in Appendix B.7. 
 100 
Statistical Tests 
Data analysis was performed using GraphPad Prism version 6.0c (GraphPad Software, 
San Diego, California, USA, www.graphpad.com). Data are represented as mean±SD 
throughout. The Kolmogorov-Smirnov test was used to determine whether observed data 
differed significantly from the chosen distributions. Categorical variables were compared 
with the Fisher’s exact test. Continuous variables were compared using a two-tailed 
Student’s T-test. In all cases, a significance level of P<0.05 was considered statistically 
significant. 
4.3 Results 
Patient characteristics are shown in Table 4-1. Hypertension was present in 6 patients 
(15%), diabetes mellitus in 1 patient (6%) and the overall CHA2DS2VASc was 1.8±1.7. 
No patients had structural heart disease. DC cardioversion was performed in 4 (27%) 
patients. An operator blinded to the case details inspected the quality of every electrogram 
visually. Electrograms were rejected from analysis for the following reasons: lack of 
capture of the preceding drive train, far-field local electrogram or interference from far-
field ventricular electrograms. Overall, 34.6±17.6% (HRA pacing) and 35.9±17.7% (CS 
pacing) of PentaRay bipolar pairs yielded suitable electrograms for further analysis.  
Table	4-1.	Characteristics	of	Paroxysmal	AF	Patients	



















1	 F	 68	 4	 <1	 3.5	 65	 2	 65	 131	
2	 F	 46	 1	 2	 3.4	 70	 2	 46	 129	
3	 F	 72	 1	 30	 4.3	 55	 2	 69	 129	
4	 M	 70	 3	 3	 3.9	 55	 3	 66	 147	
5	 M	 77	 1	 2	 4.5	 48	 2	 80	 156	
6	 M	 47	 5	 1	 3.7	 60	 2	 113	 162	
7	 F	 73	 11	 <1	 3.3	 60	 2	 79	 141	
8	 F	 69	 1	 <1	 3.8	 55	 1	 64	 118	
9	 F	 44	 1	 4	 3.9	 60	 2	 77	 130	
10	 M	 62	 1	 12	 3.8	 60	 2	 116	 153	
11	 F	 67	 1	 1	 4.4	 60	 1	 74	 132	
12	 M	 61	 2	 1	 3.8	 60	 4	 96	 142	
13	 M	 60	 1	 15	 4.5	 60	 2	 96	 169	
14	 F	 72	 6	 12	 3.1	 60	 2	 72	 129	




Local Electrogram Morphologies 
Examples of unprocessed electrograms representing the complete pacing protocol under 
HRA and CS pacing from each case are given on pages 102 to 131. Attention is drawn to 
Case 8, a female in the 7th decade, showing bidirectional paced electrogram fractionation 
(pages 116-117, and Figure 4-8) and Case 13, a male in the 7th decade, showing uniform 
bidirectional conduction without fractionation (pages 126-127, and Figure 4-9). Both of 
these paroxysmal AF cases had an AF duration of ~1 year and similar LA dimensions 
(3.8cm vs. 4.5cm). In other cases unidirectional fractionation was evident. Attention is 
drawn to Case 4, a male in the 8th decade, showing unidirectional paced electrogram 
fractionation arising primarily from CS pacing (page 108, and Figure 4-10) and Case 11, 
a female in the 7th decade, showing unidirectional paced electrogram fractionation arising 
primarily from HRA pacing (page 123, and Figure 4-11). Again, these cases had similar 
LA dimensions (3.9cm, vs. 4.4cm) although the duration of PAF was longer in Case 4 
than Case 11 (3 years vs. 1 year). Overall, a spectrum of local electrogram morphologies 
was seen, ranging from early conduction delay/block without electrogram prolongation 
or fractionation (Figure 4-12A) to much later conduction delay/block with electrogram 
fractionation (Figure 4-12B). For further analysis, individual electrogram peaks were 
automatically detected for every local electrogram related to each S2 stimulus (S2A2 
times). The first peak of each local electrogram relating to the preceding S1 stimulus was 
also detected (S1A1 time). By subtracting S1A1 from S2A2, the local A1A2 time for 
each S2-related electrogram component is derived: \1\2 = J2\2 − J1\1  (Figure 
4-12C and D). Performing this correction for every recording site cancels the effect of 
conduction path length on the A2 electrogram components and allows all S2 responses 
for a case to be plotted on a single graph. Again, two patterns were identifiable from these 
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its	 preceding	 A1	 electrogram.	 Purple	 lines	 indicate	 a	 three-part	 curve	 fitted	 to	 the	 peaks	 to	 allow	
identification	of	S1S2delay	and	S1S2block.	
Conduction Delay, Conduction Block and Pacing Latency 
The distribution of conduction delay parameters measured across the whole population is 
shown in Figure 4-13. S1S2block was relatively evenly distributed on the range 200-300ms 
for both HRA pacing and CS pacing. S1S2delay showed a bimodal distribution with peaks 
for HRA / CS pacing at 275±11 / 271±11ms and 326±13 / 319±16ms. Within a single 
case, measured S1S2delay was uniform across the left atrium, and independent of activation 
direction (HRA vs. CS S1S2delay R2=0.7274, p<0.0001). Conversely, S1S2block varied 
with both pacing site (Figure 4-13C) and between LA regions. These findings suggest 
that S1S2block is significantly influenced by both pacing-site and left atrial 
electrophysiological properties, although the relative contributions of refractoriness and 











































































































































































































































intra-atrial conduction block are uncertain. In contrast, S1S2delay is more independent of 
pacing-site related properties. LA maps of S1S2delay and S1S2block are shown in Figure 
4-14. In order to determine where along the pathway of conduction (i.e. from pacing site 
to LA recording site) that conduction delay occurred a number of observations are made 
in Figure 4-15. Firstly, conduction delay close to the pacing site (termed ‘pacing latency’) 
was quantified as the delay between stimulation and earliest local electrogram on the next 
nearest bipole. Although pacing latency was significantly correlated with LA conduction 
delay (Figure 4-15A), it was insufficient alone to explain the overall conduction delay 
seen (compare circles and triangles in Figure 4-15B). Next, considering that intra-atrial 
conduction delay must therefore be present, individual local LA activation times were 
plotted against the preceding coupling interval (S1S2 time) and grouped according to the 
conduction path length (termed ‘Distance’ in Figure 4-15C and D). In the majority of 
cases, left atrial LAT was incrementally delayed as the recording site moved more distant 
from the stimulation site (Figure 4-15C), however a number of cases showed reduced or 
absent decrement (Figure 4-15D). These findings are summarised in Figure 4-15E and 
Figure 4-15F indicating that change in activation time was significantly larger for 
recording sites greater than 60mm from earliest LA activation. A distance of 60mm was 






























































































































































































































































































































































































































Electrogram duration is a marker of abnormal conduction, with electrogram prolongation 
seen in regions of microfibrosis (277). Therefore, electrogram duration was quantified 
using two parameters from the S1S2-A1A2 curves for each LA region: 1) electrogram 
duration at baseline S1S2=343ms (ED, ms); and 2) maximal increase in electrogram 
duration compared to baseline (ΔED, ms). Frequency distribution histograms for ED and 
ΔED are given in Figure 4-16.  
Mean ED across the population ranged from 11-57ms (HRA pacing) and 8-65ms (CS 
pacing). Considering the population as a whole there were generally no significant 
differences in regional ED under HRA pacing vs. CS pacing. The one exception was the 
anterior LA region where ED was significantly longer under HRA pacing, consistent with 
activation of this site from two directions originating from the septum and Bachman’s 
bundle (Figure 4-17B). ED did however vary significantly between LA regions for both 
HRA and CS pacing with longer ED universally seen in the LA septum compared to the 
four other regions (Figure 4-17B). Overall, there was a weak but significant correlation 
between HRA pacing ED and CS pacing ED (Figure 4-17A) indicating that ED is to a 
certain extent independent of wave front activation direction and possibly related to local 
LA myocardial properties (e.g. microfibrosis or multiple conducting pathways).   
Mean ΔED varied throughout the population with ranges of 0.3-53ms (HRA pacing) and 
3-57ms (CS pacing) and, as for ED, there was no overall difference in mean regional 
ΔEDs under HRA pacing as compared to CS pacing (Figure 4-17D). Considering the 
whole population ΔEDs recorded under HRA pacing were weakly correlated with ΔEDs 
recorded under CS pacing, although given the strength and significance of this association 
(R2=0.0217, P=0.0347) were both negligible (Figure 4-17C). As for ED, ΔED varied 
significantly between LA regions for both HRA and CS pacing, again with greater ΔED 
seen in septal regions. Examining patients individually revealed there to be some cases 
with very close ΔEDs comparing HRA to CS pacing (ΔED variation<10ms) and others 
with much greater variation in ΔED (ΔED variation>10ms). This finding indicates that, 
for some patients, ΔED is an activation direction-dependent phenomenon (which may 
therefore be functional in nature), whilst for other patients ΔED at a single recording site 









Electrogram voltage is a marker of abnormal atrial substrate, with reduced EV seen in 
regions of sodium channel blockade and reduced coupling (277). Therefore, electrogram 
voltage was quantified using two parameters from the S1S2-A1A2 curves for each LA 
region: 1) electrogram voltage at baseline S1S2=343ms (EV, mV); and 2) rate of change 
of electrogram voltage with S1S2 coupling interval (ΔEV, mV/s). Frequency distribution 
histograms for EV and ΔEV are given in Figure 4-16.  
Mean EV across the population ranged from 0.7-2.7mV (HRA pacing) and 1.0-2.4mV 
(CS pacing). Considering the population as a whole there were no significant differences 
in regional EV under HRA pacing vs. CS pacing (Figure 4-17F). Furthermore, EV varied 
between LA regions only under HRA pacing and not CS pacing. One possible explanation 
for this observation is wave front collision in the LA during HRA pacing with multiple 
RA-LA breakthrough sites. Consistent with the observation of greater septal ED, septal 
EV was however significantly lower than other LA regions, indicating that electrograms 
in this region are generally longer in duration and lower in amplitude than in other parts 
of the LA. Overall there was a significant correlation between HRA pacing EV and CS 
pacing EV (Figure 4-17E) indicating that EV is to a certain extent agnostic of activation 
direction and therefore likely to be influenced largely by local LA properties. 
Mean case ΔEV varied throughout the population with ranges of -2 to 11mV/s (HRA 
pacing) and 3 to 11mV/s (CS pacing) and, as for EV, there was no overall difference in 
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mean regional ΔEVs under HRA pacing as compared to CS pacing (Figure 4-17H). 
Considering the population as a whole ΔEVs recorded under HRA pacing were weakly 
correlated with ΔEVs recorded under CS pacing (Figure 4-17G) but, as for ΔED, the 
strength of the correlation was negligible (R2=0.02, P=0.0002). There were no intra-atrial 
regional variations in ΔEV for HRA pacing and regional variations in ΔEV for CS pacing 
were minimal (Figure 4-17H). Examining patients individually revealed there to be some 
cases with very close ΔEVs comparing HRA to CS pacing (ΔEV variation<4mV/s) and 
others with much greater variation in ΔEV (ΔEV variation>4mV/s). This finding 
indicates that, for some patients, ΔEV is partially activation direction-independent. One 
mechanism for this observation may be an underlying atrial myopathy with loss of 
recruitment of myocytes at shorter coupling intervals resulting in lower bipolar 







increase	 in	electrogram	duration	with	 coupling	 interval	 (∆ED);	E,	F	 –	electrogram	voltage	 (EV);	G,	H	 –	
change	in	electrogram	voltage	with	coupling	interval	(∆EV).	
AF Inducibility 
Overall, the study protocol induced atrial fibrillation in 9/15 (60%) of patients. HRA 
pacing induced AF more often than CS pacing (8/15 (53%) vs. 4/15 (27%)) but this 





















































































































































































































































difference was not statistically significant (P=0.2635). Of the cases where AF was 
induced, the majority of AF was triggered by HRA pacing alone (5/9 cases), followed by 
HRA and CS pacing (3/9 cases) and finally by CS pacing alone (1/9 cases). The mean S2 
coupling interval at which AF was induced was 281±25ms. There was no difference in 
the S2 interval at AF induction between HRA pacing and CS pacing (287±20ms vs. 
272±33ms). There was no significant difference in S1S2delay, S1S2block, electrogram 
voltage or electrogram duration between patients in whom the study protocol induced AF 
and those in whom AF was not induced for either HRA pacing or CS pacing (see Table 
4-2). However, dispersion of LA activation during extrastimulus testing was significantly 
greater amongst patients in whom AF was induced vs. those in whom AF was not induced 
(Figure 4-18). This difference was only evident at sites distant (>60mm) from earliest LA 
activation, suggesting that discontinuous conduction is likely to be present resulting in 
accumulation of conduction delay as propagation proceeds throughout the LA in patients 
with greater electrical remodelling. 
Table	4-2.	Electrical	Substrate	in	Patients	with	and	without	AF	Induction	
	 Study	parameter	 AF	Inducible	 AF	Non-Inducible	 Unpaired	t	test,	P=	
HRAp	 S1S2block	(ms)	 246	±	12	 234	±	19	 0.2293	
S1S2delay	(ms)	 323	±	27	 308	±	24	 0.3482	
EV	(mV)	 1.4	±	0.6	 1.6	±	0.4	 0.4971	
ED	(ms)	 29.0	±	4.7	 29.4	±	4.9	 0.8969	
ΔEV	(mV/s)	 5.9	±	4.5	 4.5	±	4.2	 0.5573	
ΔED	(ms/ms)	 25.4	±	16.0	 27.6	±	12.0	 0.7866	
CSp	 S1S2block	(ms)	 239	±	24	 243	±	28	 0.7493	
S1S2delay	(ms)	 320	±	23	 304	±	19	 0.1883	
EV	(mV)	 1.5	±	0.5	 1.5	±	0.3	 0.8091	
ED	(ms)	 30.7	±	8.5	 34.1	±	6.3	 0.4302	
ΔEV	(mV/s)	 6.2	±	2.9	 6.3	±	2.2	 0.9602	
ΔED	(ms/ms)	 29.2	±	17.6	 23.3	±	11.2	 0.4879	







Delay	between	earliest	and	 latest	LA	activation	 (∆LAT)	 is	given	 for	patients	 in	whom	AF	was	 inducible	
(white	bars)	and	non-inducible	(black	bars).	A	–	LA	sites	with	conduction	path	length	<60mm;	B	–	LA	sites	
with	conduction	path	length	>60mm.	See	Figure	4-15	for	calculation	of	∆LAT.	
Insights from Computational Modelling 
In the first experiment a 4x4cm atrial monolayer was created with fibre orientation 
perpendicular to one edge. By pacing from two sites, planar activation waves were created 
travelling parallel to and perpendicular to the fibre orientation. Typical S1S2-A1A2 
curves from two patients representing long conduction delay (Remodelling –) and short 
conduction delay (Remodelling +) are shown in Figure 4-19E and F for comparison. 
Introducing previously published reductions in Ito, IKur, and ICa,L to the cell model resulted 
in shortening and flattening of the single-cell action potential (Figure 4-19B). The model 
was interrogated to question 1) whether these changes in APD could account for the 
spectrum of S1S2-A1A2 curves seen across the population and 2) whether changing the 
incidence wave/fibre orientation angle could account for the differences seen in S1S2block 
(but not S1S2delay) between HRA pacing and CS pacing. As can be seen in Figure 4-19C, 
the standard Courtemanche cell model (SR AP) resulted in early conduction delay 
(S1S2delay ~300ms, S1S2block ~280ms) and an S1S2-A1A2 curve similar in morphology 
to ‘Remodelling –’ patients. In contrast, introducing the aforementioned channel 
conductance reductions into the cell model (AF AP, Figure 4-19D) resulted in much 
shorter conduction delay (S1S2delay ~230ms, S1S2block ~210ms) with an S1S2-A1A2 
curve more similar in morphology to that seen in ‘Remodelling +’ patients. Longitudinal 
vs. transverse wave incidence angle had no effect on conduction curve morphology or 
conduction delay for either SR AP or AF AP (compare open and closed triangles in Figure 











































In the second experiment, two recording sites were used, separated by 1.5cm and parallel 
to the direction of activation. As before, the same S1S2 protocol as in the human studies 
was applied and activation times were recorded at both sites. The experiment was 
repeated using the SR AP, the AF AP and the AF AP with further reductions in INa. In 
Figure 4-20A, B and C increasing degrees of ‘AF electrical remodelling’ result in 
conduction curves with progressively increasing conduction delay, consistent with the 
spectrum of activation seen clinically in Figure 4-15. Electrical remodelling in this model 
was associated with flatter conduction velocity restitution curves (Figure 4-20D, E and 
F), with significantly reduced maximal CV restitution slope (Figure 4-20J). As previously 
described, APD restitution curves were also flattened by electrical remodelling (Figure 
4-20G, H, I), although the introduction of additional sodium channel blockade had no 
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This study used a detailed extrastimulus mapping technique to characterise conduction 
and rate-dependent changes in electrogram voltage and duration throughout the left 
atrium. The main findings of this study are as follows: 1) left atrial conduction delay is 
bimodally distributed amongst patients with PAF; 2) baseline electrogram duration and 
voltage show significant variation between patients and LA regions; 3) extrastimulus-
dependent changes in electrogram duration and voltage are more uniform throughout the 
LA but often change with activation direction. In a subset of patients both can however 
be independent of pacing site, perhaps suggesting the presence of local discontinuous LA 
conduction at these sites; and 4) patients with inducible AF at the time of 
electrophysiological testing have significantly greater dispersion of LA activation times 
suggesting the presence of more advanced electrical remodelling in these patients. Overall, 
these clinical findings document for the first time significant electrophysiological 
variation between PAF cases undergoing first-time pulmonary vein isolation. 
Computational modelling illustrates that this variation could be explained in terms of 











































































































































action potential remodelling resulting in 1) shortened refractoriness and 2) flattened 
conduction velocity restitution.  
Comparison to Previous Studies of PEFA 
PEFA has previously been used to identify areas of abnormal electrical propagation in 
the ventricle (269, 280) arising due to myocardial fibrosis and action potential 
remodelling (276). In turn, PEFA applied in the atrium showed that such remodelling 
leads to increased intra-atrial conduction delay between the right atrium and coronary 
sinus in patients with AF as compared to controls (278). Similarly, right atrial electrogram 
prolongation has been shown to be increased in patients with atrial flutter/fibrillation 
(279). The results presented here agree with and extend these findings to indicate that 
within a clinically similar group of paroxysmal AF patients, a spectrum of electrical 
responses can be identified which are explained by varying degrees of LA electrical 
remodelling. In both of the prior studies the authors identify the critical S1S2 interval at 
which electrogram duration starts to prolong (S1S2delay). In both of the prior studies, 
S1S2delay was shown to be significantly longer in AF patients compared to controls (i.e. 
electrogram duration started to prolong at significantly longer coupling intervals). This 
finding is compared to the present data where shortening of the action potential duration 
(consistent with AF) can explain reductions in S1S2delay seen clinically and would suggest 
that S1S2delay could be expected to be shorter not longer in patients with significant LA 
electrical remodelling. The fact that S1S2delay was in fact longer in two prior studies may 
be explained by concomitant structural remodelling resulting in conduction delay, or by 
greater activation latency seen in some patients (286). 
Atrial Conduction Delay and Block 
Simulation studies have shown that atrial electrical remodelling in AF decreases the 
action potential duration (APD, for which ERP is a surrogate), resulting in shortening of 
the AF wavelength and increased duration of AF (265). In previous clinical studies of 
atrial refractoriness, ERP has been shown to increase with both age (287) and 
hypertension (284) in the absence of AF. In the presence of AF, ERP has also been shown 
to variably prolong as compared to controls (268), but as AF progresses from paroxysmal 
to persistent, measured ERP universally shortens (245). Therefore, prolongation of 
refractoriness appears to be an adaptive mechanism preventing the formation of AF in at-
risk states (age, hypertension) but shortening of refractoriness is associated with more 
severe forms of AF.  
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In the present study, S1S2block for an individual LA site was defined as the shortest S1S2 
coupling interval conducting from pacing catheter (positioned in HRA or CS) to that site 
in the LA. S1S2block represents conduction over a range of tissues, comprising tissue local 
to the pacing site, conducting tissue between pacing site and recording site and tissue 
local to the recording site. Pacing site refractoriness, conduction path refractoriness and 
conduction delay or functional block may all impact S1S2block. The findings presented 
here therefore indicate that the recording site of the ‘output’ interval can have a significant 
impact on measured ERP (S1S2block varied significantly throughout the LA chamber 
despite use of a single pacing site). Furthermore, there was no correlation between 
S1S2block measured at a single output site under differing incident wave directions 
(S1S2block for HRA pacing showed no correlation with S1S2block for CS pacing). Hence 
ERP measured in clinical studies depends not only on pacing site APD but also on 
conduction to the recording site, which itself may be influenced by regions of functional 
block or conduction delay. This finding may explain some of the variation seen in 
previous clinical studies of ERP responses in AF.  
In contrast, in the present study S1S2delay was uniform throughout the left atrium and 
independent of activation direction. Theoretical components of S1S2delay again include 
pacing site refractoriness and delay but also conduction delay along the LA conducting 
path. Prior studies have identified significant pacing site latency (286, 288) as a cause of 
intra-atrial conduction delay but in the present study pacing site latency (defined as 
conduction time within the CS) was insufficient to explain activation delay to the left 
atrium. Given its uniformity throughout the LA and close correlation under HRA and CS 
pacing conditions it is tempting to speculate that S1S2delay may provide a more reliable 
measure of the action potential response to changes in coupling interval. Indeed, by 
simulating activation proceeding along longitudinal and transverse fibre orientations this 
study shows that incorporating experimentally-measured reductions in Ito, Ikur and ICa,L 
conductances can explain the bimodal distributions of S1S2delay seen in the patients 
studied here.  
Conduction delay within the left atrium was also quantified by determining the spread of 
activation times seen within two ‘halves’ of the LA defined by the intraatrial conducting 
path length. Overall, sites within 60mm of earliest LA activation showed significantly 
less dispersion of activation than sites farther than 60mm from earliest LA activation, but 
with significant inter-individual differences. Cases showing less dispersion of activation 
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may be associated with flattened CV restitution as indicated by atrial electrical 
remodelling in the second simulation study. Conversely in the clinical study cases 
showing greater dispersion of activation were more likely to be AF-inducible at EP study. 
This later observation is entirely consistent with prior work indicating that the absence of 
conduction velocity restitution is protective against fibrillatory conduction / AF initiation 
(289) and suggests a potential role for these recording techniques in risk-stratification of 
PAF patients. 
Baseline Electrogram Voltage and Duration (EV, ED) 
A number of previous studies have identified reductions in sinus rhythm atrial voltages 
in patients with AF (266), patients with increasing severity of AF (245, 256) and patients 
with risk factors for AF, including age (287), hypertension (284) and congestive heart 
failure (290). However, other studies have failed to identify any difference between global 
and regional LA voltages between patients with and without AF (267), suggesting that 
voltage alone may be insufficient to define the electrical substrate for atrial fibrillation. 
Indeed in considering hypertension, LA voltage does not decrease (266), but other 
markers of atrial remodelling are increased (reduced RA conduction velocity and 
increased AF inducibility) (284) showing that LA voltage is a poor marker of 
electrophysiological substrate. The results presented here are in agreement with previous 
studies showing a spectrum of mean LA voltages between patients. Overall, mean 
chamber voltage was independent of activation direction. Previous studies found higher 
voltage in the posterior wall of the LA (291) or lower voltage in the posterior wall and 
septum (266). This study showed a minor regional variation (higher in the floor, posterior 
and roof regions) in voltage during HRA pacing which did not reach significance during 
CS pacing. Overall the variability of these findings suggests that baseline electrogram 
voltage is a poor marker of left atrial remodelling. 
Electrogram duration has been used as a marker of electrogram complexity in numerous 
previous studies (292). Mounting evidence suggests that fractionation during atrial 
fibrillation is functional in nature rather than indicative of the presence of a specific 
electrical substrate (246, 267, 293). In contrast complex fractionated signals with 
prolonged duration (>50ms) during sinus rhythm have been associated with increasing 
age, lower voltage and slower conduction velocity and may therefore represent the 
development of fibrotic change in the atrium with age (294). Given these findings it is 
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notable that in the present study electrogram duration varied significantly throughout the 
LA with septal regions typically having longest electrogram duration.  
Although histological and imaging studies have identified regional variation in fibrotic 
remodelling in the LA in AF (78, 295), these prior studies have shown the posterior wall 
to be predominantly affected by fibrosis, which is in contrast to the data presented here. 
Other histological studies have shown that fibrosis is a diffuse process affecting the atria 
uniformly (296). Furthermore, the present data also shows that there was limited 
correlation between local left atrial electrogram durations under different activation 
directions (HRA vs. CS pacing), which is in agreement with previous work demonstrating 
a lack of relationship between electrogram fractionation in sinus rhythm as compared to 
CS pacing (293). These findings suggest that, as for baseline voltage, prolonged baseline 
electrogram duration may be a passive phenomenon, for example related to wave 
collision, rather than indicative of a specific underlying electrical substrate.  
Rate-dependent Change in Voltage and Duration (ΔEV, ΔED) 
Maintenance of atrial fibrillation has previously been shown to depend on continually 
changing regions of slow conduction, functional conduction block and wave break (283, 
297–300). Whilst functional in nature, this AF substrate is critically dependent on the 
presence of conduction delay and action potential abnormalities (301). In this context, 
variations in electrogram voltage and electrogram duration in response to activation rate 
may detect abnormal or discontinuous conduction properties crucial to the maintenance 
of AF. ΔEV showed a rightward skewed normal distribution throughout the whole 
population, indicating that overall, ΔEV decreased with pacing rate but with significant 
inter-site variation. ΔEV was largely constant between left atrial regions however overall 
ΔED was significantly greater in the septum, consistent with the baseline voltage and 
duration data presented above. ΔEV and ΔED both showed very small but significant 
correlations between HRA pacing and CS pacing. Notably, examining individual patients 
revealed that the population dichotomised into patients with significant directional 
variation in ΔED and ΔEV and patients without significant directional variation in ΔED 
and ΔEV. Put another way, ΔEV and ΔED were markedly dependent on activation 
direction in some, but not all, patients. The presence of such dependence of electrogram 
duration on activation direction may suggest the presence of discontinuous conduction in 
these patients (302) indicative of more advanced disease. 
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Regional Variation of the LA substrate 
Previous studies have shown that electrical remodelling is non-uniform throughout the 
left atrium. The findings presented here are in agreement with this finding. Specifically, 
1) conduction at S1S2block (but not S1S2delay) varied throughout the atrium indicating that 
intra-atrial conduction is non-uniform; 2) baseline electrogram duration and baseline 
electrogram voltage varied throughout the atrium. Variation in AF electrical substrate has 
also previously been confirmed by ECGI. Using this technique, relative homogeneity is 
seen in the paroxysmal group compared to relative heterogeneity in the persistent group 
(72). The present study agrees with these findings but also extends them to indicate that 
relative heterogeneity may also be seen within paroxysmal AF patients. The impact of 
that heterogeneity on clinical outcomes remains to be determined. 
Limitations 
A number of limitations of the current study should be acknowledged. Data collection 
preceeded the adoption of force-sensing catheters and it is uncertain if variations in 
electrode-tissue contact may have impacted on the voltage data. Bipolar voltage may be 
significantly affected by incidence wave orientation and it is not clear to what extent, if 
any, standardisation for wave incidence angle would have altered the results. The 
stimulation protocol necessarily used a short (2-beat) drive train in order to permit 
mapping of the entire LA chamber. Some studies have identified cardiac memory in atrial 
myocytes (303, 304) and may have altered the response of the chamber towards the end 
of the pacing train compared to the start of the pacing train. The magnitude (if any) of 
this effect in the present study is unknown. Finally, no follow-up data is presented here. 
Future studies should correlate the electrophysiological properties described with AF 
duration, burden and response to AAD/ablation therapy. 
4.5 Conclusions 
In this chapter I have developed a methodology for substrate assessment in atrial 
fibrillation utilizing a simple pacing protocol to determine a number of 
electrophysiological parameters. Simulation work shows that variation in these 
parameters can be explained in terms of electrical remodelling in AF. Another approach 
to characterising the atrial substrate in atrial fibrillation is the use of CMR imaging. In 
the next chapter the relationship between atrial fibrosis measured with CMR and the 
electrical substrate defined with the techniques described here are examined. In doing so 
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Aim C4 (examine the role of CMR in predicting the electrical substrate in patients with 
a spectrum of AF disease severity) is addressed. 
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5 Imaging: The Relationship Between Atrial 
Structural Remodelling and AF 
Electrophysiological Substrate 
5.1 Introduction 
In the previous chapter a pacing protocol was developed to identify a number of dynamic 
(i.e. rate-dependent) properties of atrial tissue including conduction delay, change in 
electrogram amplitude with extrastimulus coupling interval and change in electrogram 
duration with extrastimulus coupling interval. Each of these parameters showed a 
spectrum of values between AF patients, and, owing to a similar spectrum of activation 
profiles in AF cell models, suggest a possible relationship between the measured 
electrical properties and disease severity. In this chapter the relationship between atrial 
structural remodelling (both fibrotic and geometric) determined by CMR imaging and 
these electrical parameters is examined. 
Evidence from both animal models and human studies implicates atrial fibrosis in the 
pathogenesis of atrial fibrillation. In canine models of AF triggered by rapid atrial pacing 
(305), congestive heart failure (169, 175) and mitral regurgitation (306), atrial fibrosis is 
associated with significantly increased AF duration. Similarly, tissue samples from AF 
patients undergoing cardiothoracic surgery or post-mortem examination indicate that 
atrial fibrosis is associated with both the presence (172, 307) and severity (296, 308) of 
AF. Such changes in the extracellular matrix may be mediated via cardiomyocyte control 
of fibroblast function (174), and show a varied distribution between regions of the left 
atrium (295).  
Despite the consistency of these findings, the relationship between atrial fibrosis and 
atrial electrophysiological properties is less clear. For example, effective refractory 
period (ERP) has been shown to both increase (306) and decrease (169, 305) following 
rapid atrial pacing in canine models. Similar disagreement exists over the effect of atrial 
fibrosis on conduction velocity. In simulation studies, atrial fibrosis is associated with 
decreased conduction velocity, consistent with gap junction decoupling by bands of 
fibrosis (265). Whilst this finding is supported by some animal studies (305), others have 
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failed to demonstrate a relationship between atrial fibrosis and conduction slowing (169, 
306). In addition to atrial fibrosis, atrial structural remodelling manifest as left atrial 
enlargement (geometric remodelling) has long been known to be associated with the 
occurrence and persistence of atrial fibrillation (309–312). These findings have been 
confirmed with cross-sectional imaging studies showing LA enlargement in unselected 
patients with atrial fibrillation (313) and in patients with AF recurrence after pulmonary 
vein isolation procedures (314). Furthermore, geometric remodelling may be a reversible 
process following pulmonary vein isolation with restoration of sinus rhythm resulting in 
a significant and progressive decline in LA diastolic and systolic volumes (314) as well 
as reversal of atrial dilatation (268). 
Against this background, late gadolinium enhancement CMR imaging (DE-MRI) has 
emerged as a candidate clinical tool to stage AF severity and guide therapeutic 
intervention. In clinical studies increasing fibrosis burden on DE-MRI (classified as mild 
(<15%), moderate (15-35%) and severe (>35%)) has been associated with increased post-
ablation AF recurrence rates (78, 90, 91). Similarly DE-MRI LA wall signal intensity is 
correlated with both time in continuous AF, and the presence of persistent or longstanding 
AF (315, 316). Whilst LA geometry has traditionally been assessed with 2D dimensions 
or 3D volumes, more recently the shape of the LA has been examined. ‘Left Atrial 
Sphericity’ (LASP) is a metric defining how closely the LA confirms to a best-fit sphere, 
and increasing LASP (i.e. more spherical LA geometry) has been shown to be an 
independent predictor of AF recurrence after ablation (317). Both LA volume and LASP 
decrease after pulmonary vein isolation (318). 
Providing a mechanistic explanation for these clinical findings has proved more 
challenging. Although post-ablation LA fibrosis, as defined by DE-MRI, is associated 
with reduced bipolar voltage on electroanatomic mapping (319–321) greater uncertainty 
exists around the ability of pre-ablation DE-MRI to predict pre-ablation LA voltage. 
Considering the LA chamber as a whole, the extent of fibrosis defined by DE-MRI has 
been weakly associated with the extent of fibrosis defined by low voltage on EAM 
(R2=0.61) (78), whilst in a mixed population (pre- and post-ablation), normalized LA wall 
signal intensity shows a log-linear relationship with bipolar voltage in some, but not all, 
patients (315). Furthermore, examining the relationship between ‘dense’ and ‘patchy’ left 
atrial DE-MRI indicates that areas of low bipolar voltage may be seen in all fibrosis 
densities as well as in regions of healthy tissue (247). Finally, other studies have failed to 
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demonstrate any relationship between LA voltage and DE-MRI (322) casting doubt on 
the direct relationship between DE-MRI and LA voltage in the pre-ablation setting. 
Given the conflicting data supporting the interplay between atrial electrical and structural 
remodelling, this study examines the relationship between the dynamic atrial 
electrophysiological properties defined in the previous chapter, atrial fibrosis (as 
determined by DE-MRI imaging) and atrial geometric remodelling. Three CMR output 
metrics are studied: 1) The image intensity ratio (IIR) is the mean atrial wall signal 
intensity divided by mean blood pool signal intensity; 2) LGE area is the percentage of 
LA wall above an IIR of 0.97; 3) LA sphericity (LASP) is an index describing the degree 
to which the left atrium conforms to a spherical shape. 
5.2 Methods 
12 consecutive patients undergoing first time ablation for paroxysmal atrial fibrillation 
(n=8) and persistent atrial fibrillation (n=4) were studied. Patients were excluded from 
the study if there was a history of ischemic heart disease, cardiac surgery or structural 
heart disease. Anti-arrhythmic drugs, including calcium channel blockers, were stopped 
at least 5 half-lives before ablation (6 months in the case of Amiodarone). 
Cardiac Magnetic Resonance 
Late-gadolinium enhancement CMR was performed 25±21 days prior to EP study using 
a 1.5T MR system (Achieva, Phillips Medical Systems, Best, The Netherlands) and a 32-
element cardiac phased array coil. First, survey and sensitivity encoding reference scans 
were obtained, followed by a 2D multi-cardiac phase cine scan acquired in a four-
chamber orientation. From this scan, the trigger delay was determined for all subsequent 
scans in order to minimize artefacts from atrial wall motion. Twenty minutes after 
administration of 0.2ml/kg Gadovist (Bayer HealthCare Pharmaceuticals, Berlin, 
Germany), axial 3D LGE imaging was performed [respiratory-navigated, ECG-triggered 
inversion recovery turbo field echo acquisition; spatial resolution = 1.3x1.3x4mm3 
(reconstructed to 0.6x0.6x2 mm3); TE/TR = 3.0/6.2ms; flip angle = 25°]. The inversion 
time was determined using a preceding Look-Locker sequence to achieve optimal 
suppression of the left ventricular myocardium. 
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LGE Intensity Quantification 
For regional LGE intensity calculations, the left atrial blood pool was manually 
segmented from the LGE sequences using ITK-Snap 3.0 (323) and a 3-dimensional 
surface shell representing the endocardium was created. For each vertex, the mean of the 
signal intensity values along a normal projection 3mm internal and external to the shell 
was determined (taken to represent the left atrial wall), before the shell was 'flattened' 
onto a 2-dimensional disc bounded by the mitral annulus (324). A mean projection normal 
to the shell was taken in order to take account of LGE signal intensity throughout the left 
atrial wall as previously described (315). The image intensity ratio (IIR) at each vertex 
on the flattened LA map was calculated as the mean regional signal intensity divided by 
the mean signal intensity of the left atrial blood pool. 
LGE Area Quantification 
For each LA region, the percentage LA wall with an IIR (mean wall divided by mean 
blood pool signal intensity) above 0.97 was determined. An IIR of >0.97 has previously 
been identified as an appropriate threshold to identify fibrotic LA tissue (315). 
LA Sphericity Quantification 
The LA sphericity (LASP) was obtained as previously described (317). Briefly, a 3D 
segmentation of the LA (excluding the left atrial appendage and pulmonary veins) was 
created manually using ITK-Snap 3.0 (323). The manual segmentation was smoothed 
using a well-known mesh smoothing technique known as Laplacian smoothing. In this 
technique, each mesh point was relocated to a new position based on the mean of its 
neighbours' positions. The centre and average radius (!") of a sphere best fitting the 
smoothed LA shell were calculated as the centre of mass of all the surface points (centre) 
and the mean of the distances between all points and that centre (radius). The LASP was 
then given by Equation 5-1: 
 #!$% = 1 − !"	*+,-.,/.	.012,+23-!" ×100 Equation	5-1	
Hence, an LASP of 100 indicates a perfectly spherical LA, whilst decreasing LASP 
indicates progressively non-spherical LA geometry. 
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Electrophysiological Parameters 
All parameters (conduction curve block and delay (S1S2block and S1S2delay), baseline 
electrogram voltage (EV), baseline electrogram duration (ED), change in voltage with 
coupling interval (ΔEV) and maximal increase in electrogram duration with coupling 
interval (ΔED)) were measured as described in Chapter 4. Mean electrophysiological 
parameters were calculated for each region of each chamber. For comparision between 
electrophysiological parameters and LA sphericity, mean parameters were calculated for 
the entire chamber. 
Statistical Tests 
Data analysis was performed using GraphPad Prism version 6.0c (GraphPad Software, 
San Diego, California, USA, www.graphpad.com). Data are represented as mean±SD 
throughout. Categorical variables were compared with the Fisher’s exact test. Continuous 
variables were compared using a two-tailed Student’s T-test or the Mann-Whitney U test 
for data not normally distributed (normality determined by the D'Agostino & Pearson 
test). In all cases, a significance level of P<0.05 was considered statistically significant. 
5.3 Results 
Patient Characteristics 
Patient characteristics are shown in Table 5-1. Paroxysmal and persistent AF patients 
were identical clinically with the only significant difference being serum creatinine level. 
Table	5-1.	Characteristics	of	Study	Patients	
	 Paroxysmal	AF	(n=8)	 Persistent	AF	(n=4)	 P	
Age	 62	±	11	 62	±	12	 0.9598	
Male	Sex	 2	(25%)	 4	(100%)	 0.0606	
Duration	of	AF	(years)	 3.4	±	3.6	 3.0	±	0.8	 0.8439	
LA	diameter	(cm)	 3.8	±	0.6	 4.2	±	0.8	 0.3732	
LVEF	(%)	 62	±	4	 58	±	6	 0.1495	
Hypertension	 3	(37.5%)	 2	(50%)	 1.0000	
Diabetes	mellitus	 0	(0%)	 0	(0%)	 1.0000	
CHA2DS2Vasc	 0.5	±	0.8	 0.5	±	0.6	 0.9999	
Creatinine	(μmol/l)	 76	±	16	 105	±	6	 0.006	*	
eGFR	(ml/min)	 77	±	21	 62	±	2	 0.1980	
Hb	(g/dl)	 134	±	14	 130	±	12	 0.3250	





Manual segmentations of the LA are shown in Figure 5-1 and processing steps in a case 
with anterior LGE in Figure 5-2A. Regional LGE was identifiable in all cases studied. To 
minimise interpretation of high signal from the respiratory navigator and/or aortic wall as 
regional enhancement, two oval regions of exclusion were included on the unfold maps 
prior to quantitative analysis (Figure 5-2B). One case (case 2) with significant respiratory 
navigator artefact was excluded from further analysis. Following this processing, regional 
differences in LA enhancement were identifiable with significantly lower signal intensity 
ratios seen in the floor and posterior regions as compared to the anterior, roof and septal 
regions of the LA (Figure 5-3). The distributions of signal intensity, LGE area and 
sphericity were assessed within the population subgroups (paroxysmal AF, n=8; 
persistent AF, n=4). As shown in Figure 5-4 there was no difference in any of the CMR 

















A	 –	 LA	 LGE	CMR	with	anterior	enhancement	 (white	arrows)	 is	 first	manually	 segmented	before	being	
registered	and	projected	onto	a	model	LA,	in	turn	allowing	creation	of	the	unfold	map	bounded	by	the	
mitral	annulus.	The	colour	scale	is	normalised	to	the	LA	signal	intensities	(brightest	LGE	=	red;	darkest	LGE	



































































A	 –	 Normalised	 signal	 intensities	 for	 each	 LA	 region	 (anterior,	 floor,	 posterior,	 roof,	 septum)	 for	
paroxysmal	(PAF,	n=8)	and	persistent	(PsAF,	n=4)	AF	cases.	B	–	LGE	Area	(%	LA	wall	with	image	intensity	
ratio	>	0.97)	for	each	LA	region	for	PAF	and	PsAF	cases.	C	–	Sphericity	indices	for	each	PAF	and	PsAF	case.	
Spectrum of Electrogram Morphologies 
A range of electrogram morphologies was seen ranging from early conduction delay with 
minimal decrement through much later conduction delay and significant stimulation site 
to recording site decrement. However, qualitatively there was no relationship between the 
degree of left atrial fibrosis (as defined by CMR LGE) and the type of electrical response 
seen globally in the chamber. As shown in Figure 5-5, a spectrum of conduction curve 
morphologies was identifiable in patients with similar CMR findings. 
CMR LGE and Electrical Remodelling 
Overall on a point-by-point basis there was no correlation between LGE signal intensity 
and conduction delay (S1S2block / S1S2delay), electrogram voltage (EV / ∆EV) or 
electrogram duration (ED / ∆ED) (Table 5-2). Similarly, again on a point-by-point basis 
there was no correlation between LGE Area and conduction delay (S1S2block / S1S2delay), 
electrogram voltage (EV / ∆EV) or electrogram duration (ED / ∆ED). However, baseline 
electrogram voltage (EV) was significantly lower in regions of high LGE signal intensity 
(IIR>0.97) as compared to regions of low LGE signal intensity (IIR<0.97) (Figure 5-6A). 
This finding indicates that there is a weak but significant correlation between atrial 
fibrosis (defined by a previously validated LGE signal intensity threshold) and atrial 
bipolar voltage, although it is important to acknowledge that a range of bipolar voltages 
is seen at all LGE signal intensities. Although there was a trend towards increasing ∆ED 
at regions of high signal intensity, this observation did not reach significance (Figure 
5-6D). There was no difference between the other electrophysiological parameters (ED, 



































































































































































































































































































































































































































































































































































































































































































































































	 R2	 P	 R2	 P	
EV	 0.0027	 ns	 0.0009	 ns	
ED	 0.0209	 ns	 0.0038	 ns	
∆EV	 0.0059	 ns	 0.0309	 ns	
∆ED	 0.0016	 ns	 0.0256	 ns	
S1S2delay	 0.0244	 ns	 0.0019	 ns	






	 R2	 P	 R2	 P	
EV	 4.8	x10-6	 ns	 0.0009	 ns	
ED	 0.0404	 ns	 1.6	x10-5	 ns	
∆EV	 0.0100	 ns	 0.0097	 ns	
∆ED	 0.0037	 ns	 0.0224	 ns	
S1S2delay	 0.0044	 ns	 0.0176	 ns	
























































































LA Sphericity and Electrical Remodelling 
Structural remodelling (quantified by LA sphericity) showed no correlation with 
conduction delay / block (S1S2delay, S1S2block), electrogram voltage (EV, ∆EV) or 








This study examined the relationship between atrial shape and fibrosis (assessed by CMR 
imaging) and AF electrical substrate (assessed by extra-stimulus mapping). In order to 
assess this relationship across a spectrum of AF disease severities, a mixed population 
was studied including paroxysmal and persistent patients with AF duration ranging from 
1 to 11 years. The main findings of the study are as follows. 1) In patients with AF a 
spectrum of LA late gadolinium enhancement is seen with signal intensity varying 
between patients. 2) Within the left atrium, distribution of LGE enhancement is non-



































































































































































uniform with anteroseptal regions associated with highest signal intensity and LGE area. 
3) Although electrogram voltage was significantly lower at sites of high LGE signal 
intensity, neither LGE signal intensity nor LA sphericity were predictive of electrogram 
duration or conduction delay. Taken together, these findings suggest that although DE-
MRI varies between patients with AF, this variation is not predictive of LA tissue 
electrical responses. As such, it remains possible that an electrical substrate for atrial 
fibrillation may be present regardless of the quantification of imaging findings. 
Atrial Remodelling and Clinical Outcomes 
A number of studies have investigated the utility of left atrial CMR imaging to predict 
clinical outcomes in atrial fibrillation. Pre-ablation left atrial scarring/fibrosis (defined by 
DE-MRI) has been associated with increased duration of AF (316), AF recurrence after 
ablation (78, 90, 320) and reduced success of AF ablation (91). However, not all studies 
report a positive association between DE-MRI and clinical outcomes (322), and DE-MRI 
has been shown to be independent of traditional risk factors for AF in some studies (91). 
The same observations are made for geometrical LA structural remodelling. LA size 
determined by MRI is predictive of clinical outcome to ablation (325), and greater pre-
ablation scar is associated with LA dilatation in some (320), but not all (322) studies.  
In this context, it is notable that the findings presented here indicate a disconnect between 
electrical and structural remodelling in AF (as defined by DE-MRI), with a spectrum of 
electrical responses seen in clinically similar patients as defined by DE-MRI. This is in 
agreement with the above studies indicating variable success in using DE-MRI to predict 
clinical outcomes and indicates that varying degrees of electrical and structural 
remodelling may be responsible for the initiation and/or maintenance of AF in these 
patients. Indeed the observation of variable electrical remodelling demonstrated with 
extrastimulus mapping in these patients (independent of LA structural remodelling) may 
go some way to explain the observation that even in the presence of DE-MRI structural 
remodelling AF ablation can be successful, whereas in the absence of DE-MRI structural 
remodelling AF ablation may still fail (81.82% success has been reported in patients with 
wall fibrosis ≤5%) (91). 
Atrial Fibrosis, Dilation and Electrical Remodelling 
In order to identify a mechanistic explanation for these variable clinical findings, a 
number of previous studies have investigated the relationship between CMR-defined LA 
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structural remodelling and invasively determined LA electrical parameters. These studies 
have primarily focussed on voltage mapping as a surrogate for left atrial fibrosis although 
the relationship with electrogram morphological changes has also been assessed. In doing 
so a number of studies have identified strong relationships between DE-MRI and LA 
bipolar voltage (247, 315, 326), but as for clinical outcomes this finding is not repeated 
by all studies (322), and the data appear to indicate significant overlap between DE-MRI 
between voltage groups (320). The present study is consistent with this data indicating 
that bipolar voltage is indeed lower at regions of high LGE signal intensity. The strength 
of this relationship is however low and there are significant overlaps between the groups. 
Consistent with the lack of a relationship between DE-MRI and electrogram duration 
presented here is the clinical observation that electrogram fractionation may actually be 
reduced at sites of atrial fibrosis defined by DE-MRI (247). 
Several observations suggest that atrial dilatation is implicated in the pathogenesis of AF. 
Using CT studies, LA volume has been shown to be larger in patients with recurrence 
after AF ablation than in patients without recurrence (327). Similarly, reversal of left 
atrial remodelling (characterised by decreased LA diastolic and systolic volumes as well 
as increased LA ejection fraction) has been demonstrated after successful, but not 
unsuccessful, AF ablation (314). Furthermore, LA volume assessed by CMR (diastolic 
cut-off >112ml) is predictive of freedom from AF at 1 year post ablation with a sensitivity 
of 80% and specificity of 70% (325). The results presented here failed to show a 
relationship between electrical remodelling and atrial dilatation (defined by the sphericity 
index). The observation that there was no relationship between atrial conduction indices 
and atrial dilatation in this clinical study is consistent with previous studies in a goat 
model of chronic atrial dilatation (328). Importantly however, AF stability in this model 
was related to intra-atrial conduction delay rather than reduced refractoriness or fibrosis 
(329). 
Regional LGE 
The population studied here showed significant regional differences in DE-MRI 
throughout the LA chamber. Most notably, the normalized signal intensity and fibrosis 
burdens were greater in the anterior, roof and septal regions as compared to the floor and 
posterior regions (both P<0.0001). This finding is consistent with previous reports 
indicating that LA fibrosis is non-uniform throughout the LA chamber, as determined 
both by DE-MRI imaging (78) and histological assessment (295). It is however in 
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disagreement with a detailed histological assessment of the LA roof, posterior and floor 
regions showing no difference in the amount of fibrosis (296).  
Limitations 
A number of limitations must be acknowledged in the present study. Firstly, the sample 
size is small and the population of patients is heterogeneous, with a spectrum of AF 
disease severities studied. This approach was taken in order to maximise the opportunity 
for identifying a spectrum of CMR-electrical correlates although whether the same 
findings would be present with a more homogeneous population is not known. Future 
work would also benefit from an animal model in which to test the underlying 
mechanisms for the observations made (e.g. imaging and electrical correlations with 
histologically-defined atrial fibrosis). 
It must also be acknowledged that left atrial LGE imaging is technically challenging and 
fundamentally limited by the current resolution of the scanning techniques available. The 
voxel size employed in the current study was 1.3x1.3x4mm3 (reconstructed to 0.6x0.6x2 
mm3) which may be approximately the LA wall thickness in certain regions. Although 
there are limited histological correlates of atrial LGE (330), LGE imaging of the atrium 
is likely to be limited in sensitivity and this observation may at least partially explain 
some of the negative findings presented above. 
A variety of techniques have been employed to quantify pre-ablation LA fibrosis using 
LGE CMR. By necessity, all techniques require a frame of reference and previous studies 
have either used the atrial blood pool (315), the LV myocardium (326) or the fibrotic 
mitral valve (326) as signal intensity references. In this study, the atrial blood pool for a 
number of reasons. Firstly, the blood pool is a large region not open to partial volume 
effects. Secondly, in comparison to the atrial wall, the blood pool is large enough so as to 
be more easily defined. Whether a different analysis would impact on the results is not 
certain, but given the qualitative disparity between the unprocessed scans and spectrum 
of electrical responses it seems unlikely.  
Calculation of the IIR requires manual segmentation of the left atrial wall, before dividing 
the mean signal intensity for each LA region by the mean signal intensity of the blood 
pool (315). Delineation of the LA wall from blood pool is an error-prone process, 
especially where increased LA wall signal intensity (i.e. late gadolinium enhancement) 
renders the wall signal intensity equivalent to the blood pool signal intensity. To eliminate 
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potential bias introduced during manual segmentation, the segmentations used here were 
instead performed on the LA blood pool. It is possible however that different 
segmentation techniques may account for some of the variation between this work and 
published literature described above. 
5.5 Conclusions 
In summary, the data presented here provide evidence that electrical remodelling in atrial 
fibrillation may occur independently of left atrial fibrosis, as determined by late 
gadolinium enhancement CMR and show that inter-patient variability of the AF substrate 
can be detected in the absence of significant qualitative or quantitative differences in late 
gadolinium CMR findings. The contribution of the described electrical remodelling to 
predicting clinical outcomes compared to the published DE-MRI studies remains to be 
determined. 
Having now examined three independent modalities (surface ECG, intra-cardiac mapping 
and CMR imaging) in characterising arrhythmia substrates, the next chapter integrates 
multiple modalities (intra-cardiac mapping, imaging and histology) together for 
arrhythmia substrate characterisation. Incomplete linear ablation is a major determinant 
of the occurrence of post-ablation atrial tachycardias, so these techniques are now used 
to consider factors important in the success of linear ablation. In doing so Aim C5 (to 
assess the impact of contact force in the creation of effective linear ablation lesions) is 
addressed. 
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6 Multi-modality Substrate Characterisation: 
Impact of Catheter-Myocardium Contact Force 
on Atrial Radiofrequency Ablation Lesion 
Formation 
6.1 Introduction 
Catheter-tissue contact force is a key determinant of radiofrequency (RF) ablation lesion 
formation in both ex vivo (331–334) and in vivo non-myocardial (335–337) ablation 
models. Similarly, increasing CF leads to increased lesion depth and diameter in vivo in 
the canine ventricle (338). Whilst high contact force has been associated with increased 
ventricular lesion size, whether the same is true of the thin-walled left atrium is not known. 
Procedural safety profiles are also affected by CF. Risk of tamponade is directly related 
to applied contact force with a minimum force of 38g being sufficient for perforation in 
ex vivo human atrial tissue (339). In a study of porcine atrial ablation, application of 
radiofrequency energy reduced the perforating force by 23% (340) and perforating forces 
were significantly lower through recently ablated than non-ablated atrial tissue (341). 
Furthermore, contact force itself is an independent predictor of steam pops and thrombus 
formation (336). Ideal CF targets for atrial ablation must therefore balance both lesion 
effectiveness and safety of application. 
Notably the majority of ablation models have utilized power-controlled generator settings, 
which deliver fixed power output regardless of catheter tip temperature. Meanwhile, 
temperature-controlled ablation has been shown to reduce the incidence of impedance 
rise, steam pops and charring/thrombus formation (342), and has become the standard 
approach to left atrial ablation in some centres. This study therefore explored the 
relationship between catheter myocardium contact force and lesion formation in an in 
vivo chronic porcine atrial ablation model. The model was designed to replicate human 
atrial ablation and utilized standard clinical-grade ablation equipment throughout. By 
controlling for all ablation-related parameters, including catheter stability, the effect of 
contact force on ablation lesion creation is determined in isolation. 
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6.2 Methods 
Animal Model and Protocol 
Animal studies complied fully with Danish law on animal experiments. Eight male 
Göttingen mini-pigs (41.2±7.2kg) were pre-sedated with intramuscular azaperone 
(4mg/kg) and midazolam (0.5mg/kg). General anesthesia was induced with intravenous 
ketamine (5mg/kg) and midazolam (0.5mg/kg), and the animals were intubated and 
mechanically ventilated. Anesthesia was maintained with a continuous intravenous 
infusion of propofol (3mg/kg/h) and fentanyl (15µg/kg/h). 
Two of the eight mini-pigs underwent pre-ablation cardiovascular magnetic resonance 
(CMR) imaging and all eight mini-pigs subsequently underwent electroanatomic 
mapping (EAM) and ablation according to the protocols described below. Immediately 
post-ablation all animals were transferred for CMR imaging before being recovered from 
anesthesia and returned to the farm for 2 months. Mini-pigs were used to ensure minimal 
growth during the recovery period. After 2 months, animals were anesthetized according 
to the same protocol and underwent chronic CMR imaging followed by EAM. 
Subsequently a midline sternotomy was performed in all animals, the hearts were 
removed en bloc and perfusion fixed ready for subsequent analysis. 
Electroanatomic Maps and Ablation 
Two 8F sheaths were placed percutaneously into the right femoral vein, followed by an 
intravenous injection of 100IU/kg heparin. A 6F decapolar reference catheter was 
positioned in the coronary sinus (CS). An 8F ablation catheter (ThermoCool SmartTouch, 
D curve, Biosense Webster, Diamond Bar, CA, USA) was advanced to the right atrium 
(RA). A 3D geometry of the RA was created using Carto3-MEM (Biosense Webster, 
Diamond Bar, CA, USA) and a high-density pre-ablation peak-to-peak bipolar voltage 
map was constructed during proximal CS pacing. 
Linear RF ablation (42°C, 30W, 17ml/min irrigation) was performed from the superior 
vena cava (SVC) to the inferior vena cava (IVC) along the posterior wall of the RA. The 
RA intercaval region was selected since this region can be accessed with minimal catheter 
manipulation, is uniform in wall thickness and easily accessible for subsequent dissection 
(343). Prior to ablation, smooth catheter movement along the proposed line was 
confirmed. RF energy was delivered in temperature-controlled mode between the distal 
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electrode of the ablation catheter (3.5mm) and a reference patch affixed to the skin 
overlying the thigh muscle. A 5.3±1.5mm gap was left in the ablation line mid-chamber, 
and alternate ends of the ablation line were delivered at either 'high' (HF, >20g) or 'low' 
(LF, <10g) contact force. Ablation was performed as a continuous drag with the catheter 
moved every 30s. Following completion of the inter-caval linear lesion, a second high-
density voltage map was immediately acquired during proximal CS pacing. Delivery of 
effective ablation was confirmed by the absence of pace capture (3mA output, 2ms pulse-
width) along the ablation line and the presence of a new activation detour during CS 
pacing. Following recovery (2-months) post-ablation chronic voltage maps were created 
following the same protocol.  
Cardiac Magnetic Resonance 
Cardiac magnetic resonance was performed on a 1.5T MR system (Achieva, Phillips 
Medical Systems, Best, The Netherlands) and a five-element cardiac phased array coil. 
First, survey and sensitivity encoding reference scans were obtained, followed by a 2D 
multi-cardiac phase cine scan acquired in a four-chamber orientation. From this scan, the 
trigger delay was determined for all subsequent scans in order to minimize artefacts from 
atrial wall motion. 
Sagittal T2W images were acquired [multi-slice turbo spin echo with a double inversion 
recovery pre-pulse and spectral pre-saturation with inversion recovery fat suppression; 
effective echo time (TE) = 45ms; repetition time (TR) = twice the cardiac cycle length; 
spatial resolution = 1.5 x 1.5mm2 (reconstructed to 1.0x1.0mm2); slice thickness = 3mm] 
using the respiratory navigator to minimize motion artefacts and to ensure acquisition at 
end-expiration for all slices. 
Thirty minutes after administration of 0.2ml/kg Gadovist (Bayer HealthCare 
Pharmaceuticals, Berlin, Germany), axial 3D LGE imaging was performed [respiratory-
navigated, ECG-triggered inversion recovery turbo field echo acquisition; spatial 
resolution = 1.3x1.3x4mm3 (reconstructed to 0.6x0.6x2 mm3); TE/TR = 3.0ms/6.2ms; 
flip angle = 25°]. The inversion time was determined using a preceding Look-Locker 
sequence to achieve optimal suppression of the atrial blood pool signal. 
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Macroscopic and Microscopic Examination 
After the animals were euthanized, the hearts were explanted and suspended in normal 
saline. The aorta and main pulmonary artery were cannulated and the pulmonary veins, 
IVC and SVC were cross-clamped. Retrograde perfusion fixation of each whole heart 
was performed using 1 litre of Karnovsky's fixative (Solmedia Ltd, Shrewsbury, UK) per 
heart. The ablation line and surrounding tissue were excised en bloc and mounted in 
plastic frames, allowing two 5mm sections to be removed from the caudal and cranial 
ends of the ablation line. Each section was photographed then dehydrated, embedded in 




Catheter stability at each end of the ablation line was determined using the Carto3 Visitag 
module, with stability filters set to 2.5mm/10seconds. The number of Visitags created 
during ablation per unit length of ablation line was taken to represent catheter stability 
within that ablation region. 
Electroanatomic Mapping 
Chronic voltage maps were registered to post-ablation maps by 3D translation and 
rotation using the SVC, IVC, RA appendage and azygos veins as registration landmarks. 
Short axis clipping planes were applied to remove the SVC above the right atrial 
appendage, to remove the IVC below the coronary sinus and to divide the chamber 
through the centre of the ablation gap. Low voltage (<0.5mV) area arising from ablation 
was quantified using the ablation index (AI). For each half of the chamber, AI was defined 
as the post-ablation low voltage area minus the pre-ablation low voltage area divided by 
ablation area. Pre- and post-ablation low voltage area was defined as the area of the caudal 
or cranial ends of the shell <0.5mV. Ablation area was defined as the area of the shell 
indicated by Carto ablation tags. AI was calculated for post-ablation acute (AIacute) and 
chronic (AIchronic) voltage maps, as shown in Figure 6-1. Scar density and mean ablation 
region voltage were calculated as follows. First, 3D scar regions were removed from the 
Carto3 geometries using a box clipping function (Kitware Inc, New York, USA). The 
resulting 3-dimensional posterior RA regions were resolved to 2-dimensions using a 
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surface parameterization technique (324). Ablation regions were thereby determined by 
projecting the ablation region (determined by intra-procedural ablation tags) onto the 
post-ablation acute and chronic patches to allow quantification of the voltages recorded 






Cardiac Magnetic Resonance 
Acute and chronic wall thickness was measured manually on axial T2W images. Chronic 
LGE enhancement was quantified by two metrics. Ablation volume at each end of the 
ablation line was determined as follows. First, a region of interest encompassing the entire 
posterior RA wall was manually created on the axial LGE images. Next, enhancement 
within the region of interest was identified by applying automatic signal intensity 
thresholds at a range of standard deviations above the mean atrial blood pool signal 
intensity. Finally, the image slice representing the centre of ablation gap was identified 
as the middle slice on the thresholded isosurface at which the distance of the apparent gap 
was minimized. From this standardized reference a 1cm region was taken either side of 
the central ablation gap thereby allowing relative ablation volumes to be compared 
between the animals at 3SD above the blood pool mean for chronic LGE images. Fibrosis 
intensity was quantified as the maximum and mean LGE signal intensity found within the 
AIAcute =((AA – AP)(/(Aabl




















posterior RA region of interest. Intensities are presented as the image intensity ratio (IIR), 
being the ratio of ablation region signal intensity divided by the mean right atrial blood 
pool signal intensity. Mean IIR was simply defined as the mean of the IIRs for each voxel 
in the 1cm region of interest defined above. Peak IIR was determined by manually 
drawing a 2-dimensional region of interest in the posterior RA wall for each slice of the 
axial LGE image. The maximal intensity within these regions for each imaging slice was 
plotted against distance along the ablation line, thereby allowing peak IIR to be 
determined for caudal and cranial ends of the ablation line. 
Microscopic Examination 
Ablation scar was defined as transmural where a contiguous region of scar was evident 
from endocardial to epicardial aspects on the transverse sections. Fibrosis scoring of the 
ablation scar was determined as follows. Whole sections were digitized (10x 
magnification) using a scanning brightfield microscope (Leica Microsystems, Milton 
Keynes, UK). The ratio of blue to red staining of three rectangular zones within the 
ablation scar was quantified using an image ImageJ macro as previously described (344): 
 1 run("Brightness/Contrast..."); 
 2 run("RGB Stack"); 
 3 run("Convert Stack to Images"); 
 4 run("Image Calculator...", "image1=Blue operation=Divide image2=Red create 32-bit"); 
 5 run("Brightness/Contrast..."); 
 6 run("Subtract...", "value=1.2"); 
 7 run("Multiply...", "value=10000000"); 
 8 run("Brightness/Contrast..."); 
 9 run("Max...", "value=1"); 
10 run("Min...", "value=0"); 
11 run("Measure"); 
Statistical Analysis 
Data analysis was performed using GraphPad Prism version 6.0c (GraphPad Software, 
San Diego, California, USA, www.graphpad.com). Results are presented as meanSD. 
Student's unpaired t-test was used to compare group means between HF and LF regions. 
One-way analysis of variance was used to compare group means when considering caudal 
and cranial HF and LF regions separately. In all cases, a significance level of P<0.05 was 
considered statistically significant. 
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6.3 Results 
Procedural and Ablation Parameters 
All 8 animals survived until the end of the protocol and no animals were excluded from 
analysis due to premature death. No procedural complications occurred. Mean applied 
contact force was 22.6±11.4g in HF zones and 7.8±4.0g in LF zones (P<0.0001, Figure 
6-2A and B) resulting in average force-time integrals of 1170±509gs (HF) and 272±94gs 
(LF) (Figure 6-2C and D). Total ablation time for the lines was 16±4 minutes. Catheter 
stability was identical between HF and LF zones with mean VisiTag densities of 
3.87±0.65 tags/cm and 3.84±0.94 tags/cm, respectively (P=0.7508). Contact force 
resulted in a significant increase in impedance (measured mid-chamber) from baseline, 
up to 25g, with a plateau thereafter (Figure 6-2E). Overall, a significantly greater 
proportion of ablation lesions was delivered at maximum power output at regions of LF 
compared to regions of HF ablation (Figure 6-2F) and this difference was seen in every 
animal. Mean power during ablation was 24.8±6.6W vs. 28.7±4.0W in the HF and LF 









Pre-ablation, post-ablation and chronic mapping was performed in all animals, resulting 
in a total of 24 electroanatomic maps with an average of 1161 points per map. Achieved 
ablation size was quantified for acute and chronic post-ablation maps using the Ablation 
Index (AI), which represents the area of new low voltage on post-ablation voltage maps 
indexed to the area of RF energy application. There was no difference in AIacute or AIchronic 
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electroanatomic mapping as the proportion of the ablation zone below 0.5mV. There was 
no excess reduction in scar density between acute and chronic time points for scar created 
with LF ablation as compared to HF ablation (Figure 6-4). Similarly, there was no 
increase in ablation region voltage between acute and chronic time points for either HF 
or LF ablation (Figure 6-5). 
 
Figure	6-3.	Ablation	Index	
The	 ablation	 index	 quantifies	 the	 area	 of	 applied	 radiofrequency	 ablation	 that	 is	 converted	 into	 low	
voltage	scar	on	bipolar	voltage	mapping.	There	was	no	significant	difference	between	the	ablation	index	
at	either	acute	or	chronic	time	points.	
Cardiac Magnetic Resonance 
Consistent with prior experience, no appreciable pre-ablation T2W or LGE enhancement 
was seen in either pig undergoing pre-ablation imaging (343). Acute T2W wall thickness 
was significantly greater for HF vs. LF ablation, and this difference persisted when cranial 
and caudal ends of the ablation line were considered separately (Figure 6-6). In contrast, 
there was no difference in chronic LGE scar volume between HF and LF ablation regions 
(Figure 6-7).  Similarly, there was no difference in mean (Figure 6-8A) or peak (Figure 
6-8B) LGE IIR between HF and LF ablation regions. 
Macroscopic and Microscopic Examination 
Macroscopic photographs of chronic ablation lesions following perfusion fixation are 
shown in Figure 6-9. The ablation line was sectioned perpendicular to the axis of ablation 
through HF and LF regions, resulting in 16 sections (Figure 6-10). In all 16 sections, 
replacement of normal atrial wall with fibrous scar tissue was identified. Transmural scar 
was seen in 14 out of 16 sections with both non-transmural ablation scars occurring in 

















HF ablation zones. There was no significant difference in quantified fibrosis density 






















































































































































































































































A	 –	 LGE	 appearances	 (white	 arrows)	 for	 high	 force	 (HF)	 and	 low	 force	 (LF)	 ablation	 regions.	 B	 –	























































































































































The main findings of this study are: 1) Low force ablation results in equivalent RF 
ablation lesion size, quality and transmurality as high force ablation; 2) Catheter-
myocardium-blood pool interface impedance is proportional to contact force within the 
range 0-25g and reaches a plateau thereafter; 3) During temperature-controlled RF energy 
delivery, higher generator power output may compensate for reduced catheter-
myocardium energy transfer at low contact force. 
With the advent of intra-procedural contact force monitoring catheters, it has become 
possible to not only confirm contact of the catheter tip with a physical barrier (i.e., 
myocardium) but also to directly measure the force (magnitude and direction) exerted by 
that barrier on the catheter tip. In clinical studies the use of contact force monitoring has 














































































applied (345), and low contact force has been associated both with procedural failure 
(346) and with sites of pulmonary venous reconnection (347). Despite these findings, use 
of contact force sensing technology does not universally lead to improved procedural 
outcomes (348), raising the possibility that other confounding factors may at least 
partially explain the relationship between contact force and outcome in clinical studies. 
Examining lesion sizes created in the ex-vivo studies lends further weight to this argument. 
As can be seen in Figure 6-11, most studies show a linear relationship between CF and 
lesion depth at low contact forces before reaching a plateau somewhere between 10 and 
20g. Of particular importance however is that even at minimal contact force even the 
shortest duration applications achieved a lesion depth of almost 4mm. Considering the 
typical thickness of the human LA wall ranging up to 3-4mm (349, 350) it follows that 
even low force ablation can achieve transmural scarring in atrial ablation. This hypothesis 
is supported by in vivo studies of ventricular radiofrequency ablation (demonstrating 
5.0mm to 5.9mm lesion depth even at low contact force (338)), but has not been tested in 
an in vivo atrial model. 
 
Figure	6-11.	Contact	Force	/	Lesion	Depth	Reiationship	in	Prior	Studies	
Lesion	 depth	 is	 plotted	 against	 contact	 force	 for	 prior	 ex-vivo	 and	 in-vivo	 non-myocardial	 studies.	 RF	
application	durations	are	shown	in	parentheses.	
Based on these observations, the present study aimed to assess the size, quality and 
transmurality of atrial ablation lesions created at low force (<10g, mean 7.8g) as 
compared to lesions created at high force (>20g, mean 22.6g). A previously validated 
porcine right atrial ablation model, representing an ablation site similar in thickness to 
the human left atrium (351), was used. The low force and high force targets were selected 
based on previous work demonstrating consistent contact at 9.9±8.6g and tissue tenting 



























at 25.0±14.0g of contact force (352). Crucially, equal stability was ensured between low 
and high force regions by using the Visitag module in the Carto-3 mapping system, and 
any effect of regional variation in tissue characteristics was negated by performing 
ablation in counterbalanced order with both high and low force being used at caudal and 
cranial ends of the ablation line. Under these controlled conditions, there were no 
differences in lesion size, quality or transmurality either acutely or at 2 months post-
ablation between the low force and high force strategies. Therefore, equivalent procedural 
success should be achievable with low force ablation, whenever consistent catheter-
myocardium contact can be established. 
Whilst our study was not powered to detect procedural complications, it is logical that 
increased contact force may be associated with complications, especially cardiac 
perforation, tamponade and damage to extra-cardiac structures. Although studies 
examining perforating forces have generally identified higher minimum perforating 
forces than those used in our study it is still desirable to utilize the minimum contact force 
required in order to increase the safety margin. A recent ex vivo human study 
demonstrated that perforating forces are reduced by radiofrequency ablation, and that 
forces as low as 38g could result in atrial myocardial perforation (339). Given that AF 
was absent in all but one patient in this study, and that atrial wall thinning has been 
identified in AF (353), the minimum perforating contact force may well have been 
overestimated in the above study.  
Of note in our study, T2-weighted wall thickness was significantly greater at regions of 
high force than low force. Two possible hypotheses are suggested for this finding. Firstly, 
even though low force achieved transmurality, high force may still have resulted in 
greater (unnecessary) energy transfer leading to more atrial wall oedema. Secondly, since 
tissue tenting has been identified on intracardiac ultrasound with forces around 25g (352), 
high force ablation in this study may have resulted in heating and oedema of extra-cardiac 
structures. This finding is consistent with previous work identifying an independent role 
for catheter-myocardium contact force in oesophageal injury during left atrial ablation 
(354), as well as CMR studies identifying increased aortic and oesophageal LGE post-
LA ablation (355, 356). 
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Limitations 
1) The results presented here describe the effect of contact force on linear ablation in an 
animal model. Given the similarity of wall thickness and profile of the porcine RA to the 
human LA, similar findings would be expected in the human LA. However it is 
acknowledged that this extrapolation is a limitation of any animal model of human cardiac 
tissue. 
2) In order to most closely resemble clinical practice, drag lesions rather than point lesions 
were created. It is possible that the lesions will therefore overlap, resulting in a cumulative 
effect on tissue heating.  
3) By performing ablation solely at the posterior RA the range of contact force vectors is 
limited. While this is necessary to isolate the effect of contact force on lesion formation 
it is acknowledged that this is a limitation of the data when extrapolating the findings to 
human LA ablation with a larger range of force vectors. 
4) Since the animals were anaesthetised during ablation, the respiratory cycle was 
uniform and likely contributed to the ability to achieve good catheter stability. This may 
not always be the case during human atrial ablation, especially in the absence of general 
anaesthesia. Similarly variations in contact force may be required to achieve equal 
stability around the pulmonary venous ostia in human left atrial ablation. 
6.5 Conclusions 
In summary, by using a combined electro-anatomical mapping, imaging and histological 
examination approach this study demonstrated equivalent chronic ablation lesion 
formation at low and high catheter-myocardium contact force. Appropriate contact force 
targets for left atrial ablation may be lower than previously described, especially with 
concomitant use of novel stability-sensing technologies, and adoption of lower force 
targets may lead to improved procedure safety. 
This study concludes the thesis section on arrhythmia substrate characterisation. I have 
shown the role of surface ECG, intracardiac contact mapping and imaging in 
characterising a variety of arrhythmia substrates. In the next section I explore problems 












SECTION THREE: REPRESENTATION OF 
ARRHYTHMIA SUBSTRATES 
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7 Arrhythmia Substrate Representation: Dot 
Mapping 
7.1 Introduction 
Substrate-based catheter ablation strategies form the cornerstone of treatment of multiple 
atrial and ventricular arrhythmias. In identifying the arrhythmia substrate a variety of 
physiological parameters are used, for example post-pacing interval and late potentials in 
ventricular tachycardia or complex fractionated electrograms and dominant frequency in 
atrial fibrillation. In certain situations combinations of multiple such datasets become 
especially valuable, for example bipolar voltage combined with local activation time in 
macro-re-entrant atrial tachycardia and ventricular tachycardia. Furthermore, emerging 
technologies such as non-invasive body surface mapping and contact rotor mapping 
provide novel physiological information describing the arrhythmia substrate. In addition 
to these electrical parameters, pre-procedural assessment with both atrial and ventricular 
imaging identifies areas of scar or fibrosis, which may be crucial to arrhythmogenesis. 
See Arrhythmia Substrate Characterisation Techniques, p. 27, for a full discussion of 
these techniques. 
Despite this array of complimentary clinical datasets, no contemporary electro-anatomic 
mapping technologies are available to concurrently and statically display more than one 
dataset on a single cardiac chamber model. In this chapter I therefore develop such a 
technology, and demonstrate its use in data representation for both atrial and ventricular 
arrhythmias. The underlying aim is to represent multiple scalar datasets within a single 
spatial domain whilst minimizing 1) any loss of fidelity in the original datasets and 2) any 
operator-dependent manual segmentation or threshold selection of either dataset. 
7.2 Methods 
Dot Mapping 
The technology developed here (Dot Mapping) represents the first dataset by chamber 
surface shading with a colour spectrum proportionally related to the scalar value of the 
first dataset. For surface models, the second dataset is represented with single-pixel-sized 
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white dots drawn just above the underlying coloured surface. For volumetric models, the 
second dataset is represented with single-pixel sized white dots drawn throughout the 
chamber wall. The dots are related to the dataset in two ways: 1) the location of the dots 
represents the location of the scalar dataset value being represented; 2) the density of the 
dots is proportional to the underlying scalar value. Examples of such scalar values might 
be late gadolinium signal intensity from CMR imaging or bipolar voltage from electro-
anatomical contact mapping. Importantly, since only a fraction of available screen space 
is used to represent the second dataset (dots), it remains possible to ‘see through’ the dots 
to the underlying surface in order to retain the ability to perceive the first data set 
represented by surface colour shading. Dot Mapping was implemented using a 
commercial software package (MATLAB 8.2, The Mathworks Inc., Natick, MA). Source 
code for the Dot Mapping software is given in Appendix B.8. 
The input datasets must be represented as either surface or volumetric meshes with 
associated scalar fields encoding the physiological parameter(s) of interest. Each element 
within the mesh is assigned a weight (6) based on the area (or volume) of the element (!), 
the scalar field value for the element ($) and the ratio of the squares of the starting distance 
to the object (7) to the current distance to the object (78): 
 6 = !×$×79789  Equation	7-1	
A random number : is then chosen from the set of positive integers (i.e. ; ∈ ℕ>) such 
that the probability of : = ; is given by the Poisson distribution with mean and variance 6: 
 % : = ; = 6?0@?;!  Equation	7-2	
In this way, an integer number of dots (BC) is drawn within each element 2, based on the 
scalar field value for that element but additionally corrected for element size and viewing 
position. The coordinates of each dot are calculated based on a random spatial distribution 
within each element. For each triangular element !DE this spatial distribution is given 
by: 
 % = 1 − /> ! + /> 1 − /9 D + />/9E Equation	7-3	
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Where, /> and /9 are two numbers chosen from a uniform distribution of random numbers 
in the interval [0,1]. For each tetrahedral element !DE7  the spatial distribution is 
calculated in a two-step process. Let " be a three-element array where />, /9, and /G are 
three numbers chosen from a uniform distribution of random numbers in the interval [0,1]. "8 and "88 are then defined as: 




"8 2H	/>8 + /98 + /G8 ≤ 1/>81 − /G81 − />8 − /98 2H	/>8 + /98 + /G8 > 1	,-.	/98 + /G8 > 11 − /98 − /G8/98/>8 + /98 + /G8 − 1 2H	/>8 + /98 + /G8 > 1	,-.	/98 + /G8 ≤ 1
 Equation	7-5	
Then, the Cartesian co-ordinates (%) of the random points for the dots are given by: 
 % = !DE7 ∘
1 − "88/>88/988/G88  Equation	7-6	
The Dot Mapping interface allows the user to adjust the ‘brightness’ and ‘contrast’ of the 
Dot Map by adjusting a constant (L), and power (M), applied to each element weight (6) 
to result in a new element weight (6NOP): 
 6NOP = L6Q Equation	7-7	
 This new element weight is then used as the mean and variance of the Poisson 
distribution (Equation 7-2). Further controls allow the user to toggle display of one or 
both datasets as well as perform the standard manipulation functions of rotate, pan and 
zoom. 
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Optionally, to improve computational efficiency, the algorithm can determine whether 
the number of dots for any one simplex should be limited. If ! is the area or volume of 
the simplices, and R is a system-defined constant, then the maximum number of dots for 
each simplex (S) is given by:  
 S = R! Equation	7-8	
If the required number of dots (BC, Equation 7-2) for a simplex, 2, is greater than -C, then 
the number of dots for that simplex is limited to -C. The constant R is chosen such that 
'dot-density' curves remain flat within expected operational zoom, brightness and contrast 
levels. 
Data Perception 
To test the simultaneous perception of dual datasets with Dot Mapping the sample 
problems shown in Figure 7-1 were displayed. Orientation of two uniformly changing 
scalar fields across a circular geometry was varied and the perceived angle of the axis of 
maximum rate of change of the dataset was recorded for colour alone, dots alone and 
combined Dot Mapping (100 repetitions). In a second test, correct localisation of a focal 
source was determined with traditional colour mapping and Dot Mapping (100 
repetitions). Finally, propagation direction perception accuracy (colour) was determined 
in the presence and absence of a randomly located region of scar represented by Dot 
Mapping (100 repetitions). 
Clinical Data Collection and Pre-Processing 
Atrial Cases 
Two patients requiring atrial catheter instrumentation were studied. One patient had 
previously undergone LA catheter ablation for persistent AF using a stepwise approach 
incorporating wide area pulmonary vein encirclement and linear ablation at the mitral 
isthmus (case 1). The other patient had previously undergone surgical correction of 
RVOT and LVOT obstruction requiring right and left atriotomies. As part of the clinical 
procedures for both cases a 3D geometry of the left atrium was created using the Carto 3 
mapping system (Biosense Webster, Diamond Bar, CA, USA). High-density pre-ablation 
peak-to-peak bipolar voltage and local activation time maps were constructed using 
points acquired with the ablation catheter in order to give coverage of the entire left atrium. 
Case 1 underwent CMR imaging 3 weeks prior to catheter ablation, including 3D 
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balanced steady-state free precession (b-SSFP) and 3D late gadolinium enhancement 
(LGE) imaging. CMR images were processed according to previously described methods 
(357). Briefly, after semi-automatic segmentation of the atrial blood pool, the LGE 
images were registered to the b-SSFP images and a 3D manifold ‘shell’ of the LA was 
created with surface LGE data calculated by maximum intensity projection normal to the 
shell. CMR LGE data was registered to the endocardial EAM geometry using landmark 






represent	 the	 propagation	 direction	 of	 the	 dataset	 represented	 with	 dots.	 C	 –	 Focal	 activation	 sites	
identified	with	colour	mapping	(left),	dots	(middle)	and	combined	colour-Dot	Mapping	(right).	
Ventricular cases 
A patient requiring left ventricular instrumentation for catheter ablation of ischaemic 
heart disease-related ventricular tachycardia was studied. Endocardial access was 





subxiphoid percutaneous approach. Using the Carto 3 EAM system (Biosense Webster, 
Diamond Bar, CA, USA) 3D geometries representing the endocardial and epicardial 
surfaces of the left ventricle were created. High-density peak-to-peak bipolar voltage 
maps were constructed during sinus rhythm. Prior to ablation the patient underwent CMR 
imaging including high-resolution 3D LGE imaging. The left ventricular myocardium 
was segmented on a slice-by-slice basis using Seg3D (Scientific Computing and Imaging 
Institute, University of Utah) to create a 3D binary image. A tetrahedral mesh was created 
from the binary image with mean signal intensity within each tetrahedron represented as 
the absolute signal intensity value above the mean blood pool value. Finally, the 
endocardial Carto 3 maps were registered to the endocardial surface of the CMR 
segmentation using landmark registration followed by an iterative closest point algorithm. 
Operator Experience 
Operator experience using Dot Mapping was assessed in three domains (diagnostic 
accuracy, dataset fidelity and ease of use) and compared with traditional display 
techniques. Each domain was assessed using two atrial paired datasets (electrogram 
voltage vs. local activation time). Operators (n=15) reviewed the paired datasets with and 
without Dot Mapping for 1 minute and, after each 1-minute period, the three domains 
























Data analysis was performed using GraphPad Prism version 6.0c (GraphPad Software, 
San Diego, California, USA, www.graphpad.com). Continuous variables are expressed 
as mean±standard deviation. Groups were compared using the one-way analysis of 
variance (ANOVA) with Tukey's multiple comparisons test used post-hoc to identify 
differences between groups. Likert score results are presented as median scores and 
differences were assessed with the Wilcoxon two-sample signed rank test. 
7.3 Results 
Dot Mapping Graphical User Interface 
The Dot Mapping Graphical User Interface (GUI) was implemented within the MATLAB 
programming environment (MATLAB 8.2, The Mathworks Inc., Natick, MA) and a 
screenshot is shown in Figure 7-2. Key components of the GUI include the display 
window and the control bar. Within the display window a colour scale for the colour-
represented dataset is indicated. The control bar contains a variety of control elements for 
loading data and manipulating the Dot Map. Other controls allow the Dot Map and the 
colour map to be toggled independently. Further detlails of the controls are given in the 
figure legend. 
Dot Mapping Algorithm Performance 
To test the performance of the Dot Mapping algorithm, a simple 2-dimensional test case 
was created as shown in Figure 7-3A consisting of 16 identical isosceles triangles with 
signal intensities between 1/3rd and 1.0. The Dot Mapping software defaults to brightness 
and contrast of 1.5 (L = 1.5, M = 1.5, Equation 7-7). The effect of adjusting L and M on 
the ranges 1.5-2.5 is shown in Figure 7-3B. Typically, a brightness of <1.5 and contrast 
~2-2.5 achieves good image contrast whilst allowing adequate perception of the 
underlying colour datasets (shown as uniform black in Figure 7-3B). 
A core aim of the Dot Mapping algorithm is to ensure that the screen dot density (that is 
the number of dots per unit screen area) remains constant for each simplex (or region of 
simplices with uniform signal intensity) regardless of the zoom level of the scene. In 
Figure 7-4A, a flat 'screen dot density' curve is demonstrated for a region of uniform 
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signal intensity on the 2-dimensional test case. Operational zoom levels are restricted by 
adjusting R (Equation 7-8) first to 100,000 (Figure 7-4B) and then to 20,000 (Figure 






determine	whether	 the	Dot	Map	 is	 uniform	 in	 density	 or	 proportional	 to	 the	 underlying	 dataset;	4	 –	
controls	 for	 the	 brightness,	 contrast	 and	 threshold	 of	 the	 Dot	Map;	5	 –	 controls	 for	 the	 colour	map	
including	fill	threshold	for	interpolation;	6	–	data	loading	controls.	
 













In the tests of dataset perception, two colour scales were examined. The rainbow colour 
scale (e.g. Figure 7-1A) varying from red to purple is typically used in electroanatomic 




























































tends to introduce the perception of artificial zones in uniform data. A simple two-hue 
colour scale (e.g. blue-green, Figure 7-1B) provides a smoother transition consistent with 
the gradient of underlying data, and whilst it has found use in representation of imaging 
data it is yet to be employed in electroanatomic mapping systems. In the tests of 
propagation perception, colour mapping out-performed Dot Mapping when using the 
rainbow colour scale, but not the blue-green colour scale where propagation perception 




with	 colour	 and	 dots	 alone	 (Colour,	 Dots)	 and	 combined	 (Colour-C,	 Dots-C).	 Lower	 panels	 represent	
examples	 of	 the	 test	 cases,	 with	 propagation	 represented	 by	 colour	 preceding	 towards	 45˚	 and	
propagation	represented	by	dots	preceding	towards	90˚.	White	arrows	indicate	a	user	response	with	0˚	




There was no difference between perception accuracy of the Dot Map in the presence or 
absence of an additional propagation colour dataset when that dataset was represented 
with the blue-green colour scale. There was only a slight decrease in propagation direction 
perception accuracy using Dot Mapping when the rainbow colour scale was employed 
(4.8° vs. 6.6°, p=0.0005). Localisation of a focal source was slightly more accurate using 
colour mapping than Dot Mapping (Figure 7-6), but the difference in error was less than 
1mm. Importantly, when dual datasets were represented using colour mapping and Dot 
Mapping, localisation accuracy with each modality was maintained compared to 
individual dataset representation. Finally, the inclusion of a localised dataset (e.g. 
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representing electrogram voltage or scar) had no effect on the perception of the 
underlying colour propagation direction. 
 
Figure	7-6.	Focal	Region	Perception	Accuracy	
A	 –	 Absolute	 error	 in	 the	 perception	 of	 the	 location	 of	 a	 focal	 source	 (mm)	 is	 shown	 for	 datasets	
represented	with	colour	and	dots	alone	 (Colour,	Dots)	and	combined	 (Colour-C,	Dots-C).	B	–	Absolute	




In the following sections, three clinical cases (two atrial and one ventricular) are used to 
demonstrate applications of Dot Mapping for representing various types of electrical and 
imaging data.  
Right Atrial Electrogram Voltage with Local Activation Time 
Figure 7-7 shows an example of Dot Mapping representing electro-anatomical mapping 
data. In (A) a traditional isochronal activation map created by point-by-point mapping of 
the right atrium is shown. The activation pattern is consistent with typical right atrial 
flutter. In (B) a voltage map is shown with a threshold of 0.5mV applied, revealing a 
lateral scar (purple) consistent with the previous atriotomy. In (C) the combination of 
voltage and activation data highlights a possible second circuit involving the region of 
scar in the lateral right atrium. Entrainment in this case confirmed that this was in fact the 
primary tachycardia circuit. 












































A	 –	 Right	 atrial	 local	 activation	 time	 (LAT)	map.	B	 –	 Right	 atrial	 voltage	map	 (purple	 =	 <0.5mV).	C	 –	
Combined	LAT/voltage	represented	with	Dot	Mapping.	LAT,	local	activation	time;	Bip,	bipolar	voltage.	
Left Atrial Electrogram Voltage and CMR Late Gadolinium Enhancement 
Dot mapping can be used to combine datasets from multiple modalities. In Figure 7-8, a 
left atrial chamber model from a patient with post-ablation atrial tachycardia is shown. In 
(A) the EAM bipolar voltage map created in sinus rhythm demonstrated clearly delineated 
zones of low voltage around the pulmonary veins. In (B) the late gadolinium enhancement 
shell shows similar enhancement (green). The combination of both datasets in (C) using 
Dot Mapping allows the qualitative relationship between scar and voltage to be perceived. 
In particular, the density of the scar can be perceived with dot density reflecting the 
underlying signal intensity. Furthermore, by turning off the colour shell and displaying 
only the LGE data with Dot Mapping, it becomes possible to simultaneously see the 3-




















Ventricular Endocardial and Epicardial Voltage Maps 
In the atrial cases discussed above the Dot Map is drawn a small distance above the 
surface of the shell. Extending this approach can allow the Dot Map to be drawn some 
distance from the surface of the underlying colour shell allowing the technique to be 
applied to ventricular endocardial and epicardial mapping. In this setting, a solid grey 
background is used to retain contrast with any dots not overlying the solid colour chamber. 
In Figure 7-9, combined endocardial and epicardial voltage maps are shown using Dot 
Mapping. Compared to the individual colour shells (A - endocardial, B - epicardial), Dot 
Mapping (C) allows continued perception of the endocardial voltage map even when it is 
overlaid with the epicardial map. Furthermore, by manipulating the orientation of the 
combined Dot Map, it becomes possible to perceive the relationship between endocardial 




















Ventricular Voltage Mapping and LGE CMR 
The Dot Mapping software accepts volumetric datasets in addition to surface shells. In 
Figure 7-10 the same case as in Figure 7-9 is displayed using Dot Mapping to display a 
combination of endocardial voltage and late gadolinium enhancement CMR. The pre-
ablation CMR scan in this patient identified a 75% thickness subendocardial scar in the 
mid to basal inferolateral wall (white arrows, A). By representing the CMR data with 
volumetric Dot Mapping it becomes possible to perceive the relationship between the 


















With 5 items in each domain, the maximum score per domain is 25. Dot Mapping out-
performed traditional colour mapping in the "Dataset co-registration" domain (median 
score 24.5 vs. 10, p<0.05). "Diagnostic accuracy" (17 vs. 21) and "Display fidelity" (18 
vs. 20) scored similarly; indicating that Dot Mapping software faithfully represents the 
input datasets and is therefore non-inferior to the separate display of the individual 
datasets. 
7.4 Discussion 
The main findings of this study are as follows. 1) Dot Mapping is a new technique which 
can display the combination of at least two independent datasets within a common spatial 
domain whilst minimizing loss of fidelity of either dataset; 2) Dot Mapping can be 
successfully applied to electrophysiological and imaging datasets in both the atrium and 












dataset in the context of a first dataset. The underlying aim of Dot Mapping is to facilitate 
the simultaneous display of multiple datasets in a single spatial domain.  
Motivation 
Three developments over the course of the last two decades have promoted the design of 
the Dot Mapping system. Firstly, the quantity of data available to support clinical 
diagnoses of arrhythmia mechanisms in electrophysiology procedures is increasing. In 
early ablation procedures, activation times at a limited number of electrodes were used to 
diagnose the arrhythmia and demonstrate successful application of RF energy (133), but 
in modern procedures, mapping may be achieved using catheters with tens or even 
hundreds of electrodes. The corresponding increase in the quantity of clinical data has led 
to techniques to summarise this data, reducing the number of dimensions involved and 
facilitating its display on 3-dimensional representations of the cardiac chamber in 
question (see Electroanatomic Map Display, p. 59). Secondly, with greater geometrical, 
position and electrical accuracy of mapping systems, the opportunity has arisen to 
interpret the basic electrograms in an increasing number of ways, including amplitude 
(voltage), timing (local activation time), complexity (fractionation) and under an 
increasing number of conditions (e.g. sinus rhythm, during tachyarrhythmia and during 
pacing). Finally, with an increased understanding of underlying arrhythmia mechanisms 
has come a requirement to consider combinations of these parameters simultaneously (e.g. 
voltage or imaging-derived scar and local activation time) in order to reach a clinical 
diagnosis. 
A limited number of techniques have previously been used to facilitate the co-display of 
more than one dataset across a spatial domain. Some of these are specific to 
electrophysiological procedures whilst some are not. They include surface transparency, 
linked scenes and the Ripple Mapping system. All of these have disadvantages for the co-
display of scalar fields in electrophysiology. The use of surface transparency does allow 
simultaneous colouring of a shell to represent two datasets, but combinations of colours 
result in confusion for interpretation and in practice this technique limits the number of 
colours that can be used in one (or both) datasets. Displaying linked scenes, with two 
copies of the same geometry coloured differently and either side-by-side or toggled on 
user selection relies on greater geometrical perception by the operator. Finally, in the 
Ripple Mapping system, neither of these limitations applies, but the system specifically 
represents electrogram voltage over time along with one other dataset, and requires the 
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display to be played as a moving scene, the spatial perception of which requires 
habituation to interpret the data. 
Rationale 
Considering the requirement for multiple data set display in electrophysiological 
procedures and the aforementioned limitations of the existing techniques, this study 
aimed to develop a system that could display at least two independent scalar fields across 
the surface of a single cardiac chamber shell. One dataset is represented using a colour 
field whilst the second dataset is represented using finely spaced dots of uniform colour. 
In doing so, perception of the datasets depends on the entirely different visual inputs of 
colour or quantity. That the dots are displayed as single pixels with a limited maximum 
density is a deliberate approach to ensure at all times that the underlying colour data set 
can still be perceived. 
Future Work 
Although the Dot Mapping software can display volumetric datasets (for example Figure 
7-10), the perception of the position of the dots requires additional input. This can be in 
the form of automatic or manual map movement, but new technologies for three-
dimensional visualisation could circumvent such input. 
7.5 Conclusions 
This study has developed a new technology that facilitates the display and clinical 
interpretation of multiple datasets related to electrophysiological procedures. In doing so 
Aims R1 (develop a system for concomitant representation of multiple 
electrophysiological parameters within a 3D geometry) and R2 (validate that system to 
assess dataset display fidelity and ease of dataset integration) have been met. Future work 
should assess the utility of Dot Mapping in improving clinical workflow, diagnosis and 












SECTION FOUR: CONCLUDING REMARKS 
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8 Conclusions and Future Directions 
In this thesis I have explored diverse aspects of the characterisation of arrhythmia 
substrates. By considering arrhythmia characterisation techniques of a range of 
complexities from surface ECG, through intra-cardiac mapping and cardiac magnetic 
resonance imaging I have examined only a subset of the currently available modalities. 
In the course of the last 100 years, tremendous advances have been made in both the 
characterisation and representation of arrhythmia substrates. I provided an overview of 
the key technologies in use before developing new applications of existing techniques 
(surface ECG, intra-cardiac mapping and CMR imaging) for the characterisation of 
arrhythmia substrates. I further developed a system for representation of complex datasets 
in electroanatomic mapping systems. 
The aims of this thesis (introduced in Section 1.5) were subdivided into arrhythmia 
characterisation and arrhythmia representation techniques. They are summarised below. 
Characterisation of Arrhythmia Substrates 
C1 Examine the role of surface ECG in characterising the arrhythmia substrate in the 
context of idiopathic ventricular fibrillation. 
C2 Determine the optimal point sampling density for intra-cardiac contact mapping in 
the diagnosis of tachycardia mechanism in a variety of atrial tachycardias. 
C3 Develop a tool to quantify electrical remodelling in paroxysmal AF and determine if 
population heterogeneities are present that could be used to predict response to 
catheter ablation. 
C4 Examine the role of CMR in predicting the electrical substrate in patients with a 
spectrum of AF disease severity. 
C5 Assess the impact of contact force in the creation of effective linear ablation lesions. 
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Representation of Arrhythmia Substrates 
R1 Develop a system for concomitant representation of multiple electrophysiological 
parameters within a 3D geometry.  
R2 Validate that system to assess dataset display fidelity and ease of dataset integration. 
These aims have been met as follows. In Chapter 2, I addressed Aim C1 by exploring the 
role of the surface ECG in characterising the arrhythmia substrate for idiopathic 
ventricular fibrillation. Idiopathic ventricular fibrillation has been associated with the 
early repolarisation ECG phenotype, which coincidently is the same phenotype seen 
during hypothermia. Taking influence from previous ‘augmentation’ techniques for the 
surface ECG (e.g. exercise testing or ajmaline testing) I studied whether the application 
of therapeutic hypothermia to patients with early repolarisation would identify patients at 
high risk of idiopathic ventricular fibrillation. The results indicated that although early 
repolarisation was more strongly associated with idiopathic ventricular fibrillation than 
coronary-artery disease related ventricular fibrillation, the magnitude of early 
repolarisation was most increased in coronary-artery disease related ventricular 
fibrillation survivors. As such hypothermia is unlikely to be a useful risk stratification 
tool, but the exact cellular pathways responsible for these different morphological 
changes remain to be determined. 
In Chapter 3 I addressed Aim C2 by determining the optimal point sampling density for 
intra-cardiac mapping in atrial tachycardias. Contact mapping forms the cornerstone of 
diagnosis of atrial tachycardias, but frequently local activation time mapping can be 
challenging. One particular challenge is identifying when sufficient data has been 
collected to correctly diagnose the tachycardia mechanism. By using the combination of 
a modelling approach to simulate arrhythmias and retrospective analysis of local 
activation time maps from clinical procedures I was able to identify an optimal point 
sampling density of ~1.7 points/cm2. This sampling density neither guarantees a diagnosis, 
nor is it necessarily required for diagnosis, but it does provide a useful ‘end point’ for 
mapping: if the diagnosis is not made once this density is reached, an alternative mapping 
approach may better serve the patient than continued data collection. 
In Chapter 4 I addressed Aim C3 by developing a pacing technique and data analysis 
technique in order to characterise the electrical remodelling seen in atrial fibrillation. 
Specifically, changes in electrogram morphology with pacing rate together with 
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refractory periods were calculated. By applying computer simulations to the clinical data 
I was able to identify that electrical remodelling (i.e. changes in action potential current 
densities) could explain most of the variation seen within a clinically homogeneous 
population of atrial fibrillation patients. This is important, because whilst appearing 
similar through clinical metrics, patients with atrial fibrillation can follow very different 
clinical courses. The technique developed in Chapter 4 may allow future disease 
stratification to guide clinical interventions in certain patients with atrial fibrillation. 
In Chapter 5, Aim C4 was addressed by taking the techniques for electrical AF substrates 
characterisation developed in Chapter 4 and examining the association with structural 
remodelling (geometrical and fibrotic) quantified with CMR imaging. CMR imaging has 
previously been shown to predict clinical course and procedural outcomes in atrial 
fibrillation, but significant variation is seen in the literature. As in Chapter 4 with clinical 
outcomes, in Chapter 5 I was able to show that in patients with very similar structural 
remodelling, a spectrum of electrical remodelling may be seen. This may therefore 
explain some of the discrepancies seen in the literature with CMR and clinical outcomes 
in atrial fibrillation. 
In Chapter 6, Aim C5 was addressed by combining the above arrhythmia characterisation 
modalities to provide a detailed assessment of the effects of contact force on linear 
ablation lesion creation. This is important for the pathogenesis of post-ablation atrial 
tachycardias, and by using contact mapping together with imaging and histological 
assessment I was able to demonstrate that low force ablation is able to achieve equally 
effective, transmural lesions as high force ablation. This finding could have important 
implications for procedural safety as well as efficacy. 
Moving on from arrhythmia characterisation techniques in the next section (Chapter 7) I 
examined technologies for representation of arrhythmia substrates. In doing so the final 
two aims of the thesis (R1 and R2) were addressed. Through the above work (and other 
work in the field) vast quantities of electrophysiological data are created, and it is 
becoming a challenge to display all that information in a clinically meaningful way. I 
focused in this chapter on the problem of displaying multiple datasets simultaneously and 
developed a new software tool (Dot Mapping) to meet this aim. I further demonstrated 
that Dot Mapping was effectively able to co-display two datasets in both atrial and 
ventricular arrhythmias without any significant loss of dataset fidelity.  
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The work presented in this thesis leads to a number of opportunities (and challenges) for 
future work. For example, whilst therapeutic hypothermia did not appear to be a useful 
candidate marker to dichotomise between benign and malignant early repolarisation, this 
was not tested in a prospective analysis of clinical outcomes. Regardless, as therapeutic 
hypothermia becomes less frequently used in post-resuscitation care, the opportunity to 
study hypothermia as a clinical risk marker for malignant arrhythmias is reducing. Other 
physiological ECG augmentation techniques (for example J-wave relationship with R-R 
interval (207, 228)) may instead prove to be more useful (and practical) for the risk 
stratification of patients with ER phenotype.  
Similarly, the data presented on intracardiac mapping should be validated through 
translational clinical studies. The optimal activation sampling densities identified for 
atrial tachycardias should be prospectively assessed against the end points of tachycardia 
diagnosis and procedure duration. Such a clinical study would ideally recruit patients 
from multiple centres and operators. Likewise the AF substrate characterisation 
techniques require correlation with a variety of clinical parameters including AF duration, 
AF burden and freedom of AF post-PVI. These are important translational studies that, if 
positive, would have a substantial opportunity to improve the current management of AF. 
In agreement with the data presented in Chapter 5, other recent work has shown a 
disconnect between atrial fibrosis and electrical remodelling (358). Taken together these 
findings suggest that imaging and electrical assessment may ultimately contribute 
synergistically to substrate assessment in AF.  
Likewise, imaging and electrical assessment were combined in Chapter 6 in the 
assessment of linear ablation lesions. I demonstrated that transmural lesion formation was 
possible at lower contact forces than currently recommended. Further work is therefore 
necessary in order to reconcile this finding with the relevant clinical studies of contact 
force in AF ablation (347, 359). As such, the next key question to be answered is the 
effect of contact force on lesion continuity (as opposed to transmurality). In a more 
general sense, the factors that affect lesion continuity should be the focus of future studies 
aiming to improve the success of atrial ablation procedures. 
Finally, although the arrhythmia representation work presented here demonstrates that 
Dot Mapping is an effective software tool for co-representation of multiple datasets, it 
too requires validation in the clinical setting. Collaboration with EAM manufacturers will 
allow Dot Mapping to be assessed either within existing EAM platforms or as a stand-
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alone device alongside EAM platforms. Whether Dot Mapping could result in tangible 
clinical benefits (i.e. reduced procedure time or improved procedure success) is likely to 
be highly dependent on clinician preference. 
In summary this thesis has explored the characterisation and representation of arrhythmia 
substrates. Established characterisation techniques have been examined and expanded, 
and new characterisation techniques have been developed. Tools for the representation of 
the data thus created have been developed. Future work should test the clinical application 
of the tools and technologies created within this thesis. 
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Appendix B. Computer Code 
B.1 Dual-loop Re-entry Used in Chapter 3 
File	B-1	pentaray.par	
  1 num_gregions    =   2 
  2   
  3 gregion[0].num_IDs  =   6 
  4 gregion[0].name     =   "viable" 
  5 gregion[0].g_il =    0.28 
  6 gregion[0].g_it =    0.026 
  7 gregion[0].g_el         =       0.22 
  8 gregion[0].g_et         =       0.13 
  9 gregion[0].ID[0]    =   1 
 10 gregion[0].ID[1]    =   721  
 11 gregion[0].ID[2]    =   722 
 12 gregion[0].ID[3]    =   723 
 13 gregion[0].ID[4]    =   724 
 14 gregion[0].ID[5]    =   725 
 15  
 16 gregion[1].num_IDs  =   1 
 17 gregion[1].name     =   "scar" 
 18 gregion[1].g_il =    0 
 19 gregion[1].g_it =    0 
 20 gregion[1].g_el     =   0.22 
 21 gregion[1].g_et     =   0.13 
 22 gregion[1].ID[0]    =   921 
 23  
 24 # Equation 
 25   
 26 bidomain    = 0  
 27 dt      = 20    #microseconds 
 28 parab_solve     = 1 
 29 #ellip_solve     = 1 
 30 vm_per_phie     = 4 
 31   
 32 # I/O 
 33 spacedt     = 1 
 34 timedt      = 1 #milliseconds; ie 1 = 1kHz   
 35 gridout_i   = 2 
 36 #gridout_e  = 2 
 37  
 38 # Local Activation Times 
 39   
 40 num_LATs          = 2 
 41 lats[0].all       = 0 
 42 lats[0].measurand = 0 
 43 lats[0].method    = 1 
 44 lats[0].threshold = -20    #mV? 
 45 lats[0].ID        = "latfile" 
 46  
 47 lats[1].all   = 1 
 48 lats[1].measurand = 0 
 49 lats[1].method    = 1 
 50 lats[1].threshold = -20 
 51 lats[1].ID        = "latfile-all" 
 52  
 53 # Tag regions 
 54  
 55 numtagreg = 7 
 56  
 57 tagreg[0].name = tissue 
 58 tagreg[0].type = 2 
 59 tagreg[0].tag = 1 
 60 tagreg[0].p0[0] = 0 
 61 tagreg[0].p0[1] = 0 
 62 tagreg[0].p0[2] = 0 
 63 tagreg[0].p1[0] = 40000 
 64 tagreg[0].p1[1] = 40000 
 65 tagreg[0].p1[2] = 0 
 66  
 67 tagreg[1].name = scar 
 68 tagreg[1].type = 1 
 69 tagreg[1].tag = 921 
 228 
 70 tagreg[1].p0[0] = 20000 
 71 tagreg[1].p0[1] = 20000 
 72 tagreg[1].p0[2] = 0 
 73 tagreg[1].radius = 7500 
 74  
 75 tagreg[2].name = stim 
 76 tagreg[2].type = 2 
 77 tagreg[2].tag = 721 
 78 tagreg[2].p0[0] = 19000 
 79 tagreg[2].p0[1] = 20000 
 80 tagreg[2].p0[2] = 0 
 81 tagreg[2].p1[0] = 21000 
 82 tagreg[2].p1[1] = 21000 
 83 tagreg[2].p1[2] = 0 
 84  
 85 tagreg[3].name = ground 
 86 tagreg[3].type = 2 
 87 tagreg[3].tag = 722 
 88 tagreg[3].p0[0] = 19000 
 89 tagreg[3].p0[1] = 19000 
 90 tagreg[3].p0[2] = 0 
 91 tagreg[3].p1[0] = 21000 
 92 tagreg[3].p1[1] = 20000 
 93 tagreg[3].p1[2] = 0 
 94  
 95 tagreg[4].name = isthmus 
 96 tagreg[4].type = 2 
 97 tagreg[4].tag = 723 
 98 tagreg[4].p0[0] = 19000 
 99 tagreg[4].p0[1] = 0 
100 tagreg[4].p0[2] = 0 
101 tagreg[4].p1[0] = 21000 
102 tagreg[4].p1[1] = 40000 
103 tagreg[4].p1[2] = 0 
104  
105 tagreg[5].name = stimrentry 
106 tagreg[5].type = 2 
107 tagreg[5].tag = 724 
108 tagreg[5].p0[0] = 19000 
109 tagreg[5].p0[1] = 26500 
110 tagreg[5].p0[2] = 0 
111 tagreg[5].p1[0] = 21000 
112 tagreg[5].p1[1] = 27500 
113 tagreg[5].p1[2] = 0 
114  
115 tagreg[6].name = groundrentry 
116 tagreg[6].type = 2 
117 tagreg[6].tag = 725 
118 tagreg[6].p0[0] = 19000 
119 tagreg[6].p0[1] = 25500 
120 tagreg[6].p0[2] = 0 
121 tagreg[6].p1[0] = 21000 
122 tagreg[6].p1[1] = 26500 
123 tagreg[6].p1[2] = 0 
	
File	B-2.	run_carp.sh	
  1 export NPROC=12 
  2 export LAUNCHER=mpirun 
  3  
  4 echo Set the file references ... 
  5 SIM_NAME=square 
  6 MESH_NAME=./geometry/square.1 
  7 PARAM_FILE=./pentaray.par 
  8 CARPEXECUTABLE=/home/localstn10/src/carp-dcse-pt/CARP/carp.petsc.pt 
  9  
 10 echo Set up the stimulus ... 
 11 VOLTAGE=1000 
 12 STIMDURATION=1 
 13  
 14 echo Define which runs to execute ... 
 15 DOBLOCKSTIM=0 # Initial stimulation 
 16 DOROTORINIT=0 # Rotor initialization 
 17 DOFINALRRUN=0 # Extra rotor run at end 
 18 DOLATMAPRUN=1 # Get the activation time 
 19  
 20 echo Set up the stimulus ... 
 21 STIM=2 
 22 GROUND=3 
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 23 STIM_ROTOR=5 
 24 GROUND_ROTOR=6 
 25  
 26 echo Set up the t ends ... 
 27 t_1=1  # length of first stimulus  
 28 t_2=275 # length of first run 
 29 t_3=1  # length of second stimulus 
 30 t_4=10000 # length of second run 
 31 t_5=2500 # length of the final run for getting activation times, must be greater than TCL 
 32 t_6=370 # duration of the lat map run 
 33  
 34 DURATION_ACT=$t_1 
 35 DURATION_RUN=$(($DURATION_ACT+$t_2)) 
 36 DURATION_ROTOR_ACT=$(($DURATION_RUN+$t_3)) 
 37 DURATION_ROTOR_RUN=$(($DURATION_ROTOR_ACT+$t_4)) 
 38 DURATION_ROTOR_RUN_FINAL=$(($DURATION_ROTOR_RUN+$t_5)) 
 39 DURATION_LAT_MAP=$(($DURATION_ROTOR_ACT+t_6)) 
 40  
 41 echo Set up the cell model ... 
 42 CELLMODEL=NYGREN 
 43  
 44 echo Set up the output directories ... 
 45 OUTPUTDIR_ACTIVATION=./${SIM_NAME}_act 
 46 OUTPUTDIR_RESTART=./${SIM_NAME}_run 
 47 OUTPUTDIR_ROTOR_ACTIVATION=./${SIM_NAME}_rotor_act 
 48 OUTPUTDIR_ROTOR_RESTART=./${SIM_NAME}_rotor_run 
 49 OUTPUTDIR_ROTOR_RESTART_FINAL=./${SIM_NAME}_rotor_final 
 50 OUTPUTDIR_LAT_MAP=./${SIM_NAME}_latmap 
 51  
 52 if [ $DOBLOCKSTIM == 1 ] 
 53   then 
 54     echo Launch CARP for the activation run ... 
 55     $LAUNCHER -np $NPROC ${CARPEXECUTABLE} \ 
 56     +F $PARAM_FILE \ 
 57     -meshname $MESH_NAME \ 
 58     -simID $OUTPUTDIR_ACTIVATION \ 
 59     -num_tsav 2 \ 
 60     -tsav[0] $DURATION_ACT.0 \ 
 61     -tend $DURATION_ACT \ 
 62     -num_stim 1 \ 
 63     -stimulus[0].stimtype 3 \ 
 64     -stimulus[0].strength 0 \ 
 65     -stimulus[0].geometry $GROUND \ 
 66     -stimulus[0].duration $STIMDURATION \ 
 67     -stimulus[0].stimtype 0 \ 
 68     -stimulus[0].strength $VOLTAGE \ 
 69     -stimulus[0].start 0 \ 
 70     -stimulus[0].duration $STIMDURATION \ 
 71     -stimulus[0].geometry $STIM \ 
 72     -ellip_options_file ./amg_xl_opts \ 
 73     -parab_options_file ./ilu_cg_opts \ 
 74     -num_imp_regions 1 \ 
 75     -imp_region[0].im $CELLMODEL 
 76  
 77     echo Launch CARP for the restart run ... 
 78     RESTART=${OUTPUTDIR_ACTIVATION}/state.${DURATION_ACT}.0 #state 
 79     $LAUNCHER -np $NPROC ${CARPEXECUTABLE} \ 
 80     +F $PARAM_FILE \ 
 81     -meshname $MESH_NAME \ 
 82     -simID $OUTPUTDIR_RESTART \ 
 83     -num_tsav 1 \ 
 84     -tsav[0] $DURATION_RUN.0 \ 
 85     -start_statef $RESTART \ 
 86     -tend $DURATION_RUN \ 
 87     -ellip_options_file ./amg_xl_opts \ 
 88     -parab_options_file ./ilu_cg_opts \ 
 89     -num_imp_regions 1 \ 
 90     -imp_region[0].im $CELLMODEL 
 91 fi 
 92  
 93 if [ $DOROTORINIT == 1 ]  
 94   then 
 95     echo Launch CARP for the rotor activation run ... 
 96     RESTART_ROTOR_ACT=${OUTPUTDIR_RESTART}/state.${DURATION_RUN}.0 #state 
 97     $LAUNCHER -np $NPROC ${CARPEXECUTABLE} \ 
 98     +F $PARAM_FILE \ 
 99     -meshname $MESH_NAME \ 
100     -simID $OUTPUTDIR_ROTOR_ACTIVATION \ 
101     -num_tsav 1 \ 
102     -tsav[0] $DURATION_ROTOR_ACT.0 \ 
103     -start_statef $RESTART_ROTOR_ACT \ 
104     -tend $DURATION_ROTOR_ACT \ 
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105     -num_stim 2 \ 
106     -stimulus[0].stimtype 3 \ 
107     -stimulus[0].strength 0 \ 
108     -stimulus[0].geometry $GROUND_ROTOR \ 
109     -stimulus[0].duration $STIMDURATION \ 
110     -stimulus[0].stimtype 0 \ 
111     -stimulus[0].strength $VOLTAGE \ 
112     -stimulus[0].geometry $STIM_ROTOR \ 
113     -stimulus[0].start $(($DURATION_ROTOR_ACT-1)) \ 
114     -stimulus[0].duration $STIMDURATION \ 
115     -ellip_options_file ./amg_xl_opts \ 
116     -parab_options_file ./ilu_cg_opts \ 
117     -num_imp_regions 1 \ 
118     -imp_region[0].im $CELLMODEL 
119  
120     echo Launch CARP for the rotor restart run ... 
121     RESTART_ROTOR_RUN=${OUTPUTDIR_ROTOR_ACTIVATION}/state.${DURATION_ROTOR_ACT}.0 #state 
122     $LAUNCHER -np $NPROC ${CARPEXECUTABLE} \ 
123     +F $PARAM_FILE \ 
124     -meshname $MESH_NAME \ 
125     -simID $OUTPUTDIR_ROTOR_RESTART \ 
126     -num_tsav 1 -tsav[0] $DURATION_ROTOR_RUN.0 \ 
127     -start_statef $RESTART_ROTOR_RUN \ 
128     -tend $DURATION_ROTOR_RUN \ 
129     -ellip_options_file ./amg_xl_opts \ 
130     -parab_options_file ./ilu_cg_opts \ 
131     -num_imp_regions 1 \ 
132     -imp_region[0].im $CELLMODEL 
133 fi 
134  
135 if [ $DOFINALRRUN == 1 ] 
136   then 
137     echo Launch CARP one final time to get activation times ... 
138     RESTART_ROTOR_RUN_FINAL=${OUTPUTDIR_ROTOR_RESTART}/state.${DURATION_ROTOR_RUN}.0 
#state 
139     $LAUNCHER -np $NPROC ${CARPEXECUTABLE} \ 
140     +F $PARAM_FILE \ 
141     -meshname $MESH_NAME \ 
142     -simID $OUTPUTDIR_ROTOR_RESTART_FINAL \ 
143     -num_tsav 1 -tsav[0] $DURATION_ROTOR_RUN_FINAL.0 \ 
144     -start_statef $RESTART_ROTOR_RUN_FINAL \ 
145     -tend $DURATION_ROTOR_RUN_FINAL \ 
146     -ellip_options_file ./amg_xl_opts \ 
147     -parab_options_file ./ilu_cg_opts \ 
148     -num_imp_regions 1 \ 
149     -imp_region[0].im $CELLMODEL 
150 fi 
151  
152 if [ $DOLATMAPRUN == 1 ] 
153   then 
154     echo Launch CARP again at the best time to get LATs for a map 
155     echo For dual loop, this is at the time of the second stimulus 
156     RESTART_ROTOR_RUN=${OUTPUTDIR_ROTOR_ACTIVATION}/state.${DURATION_ROTOR_ACT}.0 # 
respecify 
157     $LAUNCHER -np $NPROC ${CARPEXECUTABLE} \ 
158     +F $PARAM_FILE \ 
159     -meshname $MESH_NAME \ 
160     -simID $OUTPUTDIR_LAT_MAP \ 
161     -start_statef $RESTART_ROTOR_RUN \ 
162     -tend $DURATION_LAT_MAP \ 
163     -ellip_options_file ./amg_xl_opts \ 
164     -parab_options_file ./ilu_cg_opts \ 
165     -num_imp_regions 1 \ 
166     -imp_region[0].im $CELLMODEL 
167 fi 
B.2 Focal Activation Used in Chapter 3 
File	B-3.	pentaray.par	
 1 num_gregions    =   1 
 2   
 3 gregion[0].num_IDs  =   3 
 4 gregion[0].name     =   "viable" 
 5 gregion[0].g_il =    0.28 
 6 gregion[0].g_it =    0.026 
 7 gregion[0].g_el         =       0.22 
 8 gregion[0].g_et         =       0.13 
 231 
 9 gregion[0].ID[0]    =   1 
10 gregion[0].ID[1]        =       721 
11 gregion[0].ID[2]        =       722 
12   
13 # Equation 
14   
15 bidomain    = 0  
16 dt      = 10    #microseconds 
17 parab_solve     = 1 
18 #ellip_solve     = 1 
19 vm_per_phie     = 4 
20   
21 # I/O 
22 spacedt     = 1 
23 timedt      = 1 #milliseconds; ie 1 = 1kHz   
24 gridout_i   = 2 
25 #gridout_e  = 2 
26  
27 # Local Activation Times 
28   
29 num_LATs          = 1 
30 lats[0].all       = 0 
31 lats[0].measurand = 0 
32 lats[0].method    = 1 
33 lats[0].threshold = -20    #mV? 
34 lats[0].ID        = "latfile" 
35  
36 # Tag regions 
37   
38 numtagreg = 3 
39  
40 tagreg[0].name = tissue 
41 tagreg[0].type = 2 
42 tagreg[0].tag = 1 
43 tagreg[0].p0[0] = 0 
44 tagreg[0].p0[1] = 0 
45 tagreg[0].p0[2] = 0 
46 tagreg[0].p1[0] = 40000 
47 tagreg[0].p1[1] = 40000 
48 tagreg[0].p1[2] = 0 
49   
50 tagreg[1].name = stim 
51 tagreg[1].type = 2 
52 tagreg[1].tag = 721 
53 tagreg[1].p0[0] = 23500 
54 tagreg[1].p0[1] = 19500 
55 tagreg[1].p0[2] = 0 
56 tagreg[1].p1[0] = 24500 
57 tagreg[1].p1[1] = 20500 
58 tagreg[1].p1[2] = 0 
59  
60 tagreg[2].name = ground 
61 tagreg[2].type = 2 
62 tagreg[2].tag = 722 
63 tagreg[2].p0[0] = 27500 
64 tagreg[2].p0[1] = 19500 
65 tagreg[2].p0[2] = 0 
66 tagreg[2].p1[0] = 28500 
67 tagreg[2].p1[1] = 20500 
68 tagreg[2].p1[2] = 0 
	
File	B-4.	run_carp.sh	
 1 export NPROC=12 
 2 export LAUNCHER=mpirun 
 3  
 4 echo Set the file references ... 
 5 SIM_NAME=square 
 6 MESH_NAME=./geometry/square.1 
 7 PARAM_FILE=./pentaray.par 
 8 CARPEXECUTABLE=/home/localstn10/src/carp-dcse-pt/CARP/carp.petsc.pt 
 9  









18 echo Set up the t ends ... 
19 t_1=1  # length of first stimulus  





25 echo Set up the cell model ... 
26 CELLMODEL=NYGREN 
27  




32 echo Launch CARP for the activation run ... 
33 $LAUNCHER -np $NPROC ${CARPEXECUTABLE} \ 
34 +F $PARAM_FILE \ 
35 -meshname $MESH_NAME \ 
36 -simID $OUTPUTDIR_ACTIVATION \ 
37 -num_tsav 1 \ 
38 -tsav[0] $DURATION_ACT.0 \ 
39 -tend $DURATION_ACT \ 
40 -num_stim 2 \ 
41 -stimulus[0].stimtype 3 \ 
42 -stimulus[0].strength 0 \ 
43 -stimulus[0].geometry $GROUND \ 
44 -stimulus[0].duration $STIMDURATION \ 
45 -stimulus[1].stimtype 0 \ 
46 -stimulus[1].strength $VOLTAGE \ 
47 -stimulus[1].geometry $STIM \ 
48 -stimulus[1].start 0 \ 
49 -stimulus[1].duration $STIMDURATION \ 
50 -ellip_options_file ./amg_xl_opts \ 
51 -parab_options_file ./ilu_cg_opts \ 
52 -num_imp_regions 1 \ 
53 -imp_region[0].im $CELLMODEL  
54  
55 echo Launch CARP for the restart run ... 
56 RESTART=${OUTPUTDIR_ACTIVATION}/state.${DURATION_ACT}.0 
57 $LAUNCHER -np $NPROC ${CARPEXECUTABLE} \ 
58 +F $PARAM_FILE \ 
59 -meshname $MESH_NAME \ 
60 -simID $OUTPUTDIR_RESTART \ 
61 -num_tsav 1 \ 
62 -tsav[0] $DURATION_RUN.0 \ 
63 -start_statef $RESTART \ 
64 -tend $DURATION_RUN \ 
65 -ellip_options_file ./amg_xl_opts \ 
66 -parab_options_file ./ilu_cg_opts \ 
67 -num_imp_regions 1 \ 
68 -imp_region[0].im $CELLMODEL 
B.3 Linear Activation Used in Chapter 3 
File	B-5.	pentaray.par	
 1 num_gregions    =   1 
 2   
 3 gregion[0].num_IDs  =   3 
 4 gregion[0].name     =   "viable" 
 5 gregion[0].g_il =    0.28 
 6 gregion[0].g_it =    0.026 
 7 gregion[0].g_el         =       0.22 
 8 gregion[0].g_et         =       0.13 
 9 gregion[0].ID[0]    =   1 
10 gregion[0].ID[1]    =   721  
11 gregion[0].ID[2]    =   722 
12  
13 # Equation 
14   
15 bidomain    = 0  
16 dt      = 20    #microseconds 
17 parab_solve     = 1 
18 #ellip_solve     = 1 
19 vm_per_phie     = 4 
20   
21 # I/O 
 233 
22 spacedt     = 1 
23 timedt      = 1 #milliseconds; ie 1 = 1kHz   
24 gridout_i   = 2 
25 #gridout_e  = 2 
26  
27 # Local Activation Times 
28   
29 num_LATs          = 1 
30 lats[0].all       = 0 
31 lats[0].measurand = 0 
32 lats[0].method    = 1 
33 lats[0].threshold = -20    #mV? 
34 lats[0].ID        = "latfile" 
35  
36 # Tag regions 
37  
38 numtagreg = 3 
39  
40 tagreg[0].name = tissue 
41 tagreg[0].type = 2 
42 tagreg[0].tag = 1 
43 tagreg[0].p0[0] = 0 
44 tagreg[0].p0[1] = 0 
45 tagreg[0].p0[2] = 0 
46 tagreg[0].p1[0] = 40000 
47 tagreg[0].p1[1] = 40000 
48 tagreg[0].p1[2] = 0 
49  
50 tagreg[1].name = stim 
51 tagreg[1].type = 2 
52 tagreg[1].tag = 721 
53 tagreg[1].p0[0] = 1000 
54 tagreg[1].p0[1] = 0 
55 tagreg[1].p0[2] = 0 
56 tagreg[1].p1[0] = 2000 
57 tagreg[1].p1[1] = 40000 
58 tagreg[1].p1[2] = 0 
59  
60 tagreg[2].name = ground 
61 tagreg[2].type = 2 
62 tagreg[2].tag = 721 
63 tagreg[2].p0[0] = 0 
64 tagreg[2].p0[1] = 0 
65 tagreg[2].p0[2] = 0 
66 tagreg[2].p1[0] = 1000 
67 tagreg[2].p1[1] = 40000 
68 tagreg[2].p1[2] = 0 
	
File	B-6.	run_carp.sh	
 1 export NPROC=12 
 2 export LAUNCHER=mpirun 
 3  
 4 echo Set the file references ... 
 5 SIM_NAME=square 
 6 MESH_NAME=./geometry/square.1 
 7 PARAM_FILE=./pentaray.par 
 8 CARPEXECUTABLE=/home/localstn10/src/carp-dcse-pt/CARP/carp.petsc.pt 
 9  








18 echo Set up the t ends 
19 t_1=1  # length of first stimulus  





25 echo Set up the cell model ... 
26 CELLMODEL=NYGREN 
27  





32 echo Launch CARP for the activation run ... 
33 $LAUNCHER -np $NPROC ${CARPEXECUTABLE} \ 
34 +F $PARAM_FILE \ 
35 -meshname $MESH_NAME \ 
36 -simID $OUTPUTDIR_ACTIVATION \ 
37 -num_tsav 2 \ 
38 -tsav[0] $DURATION_ACT.0 \ 
39 -tend $DURATION_ACT \ 
40 -num_stim 1 \ 
41 -stimulus[0].stimtype 3 \ 
42 -stimulus[0].strength 0 \ 
43 -stimulus[0].geometry $GROUND \ 
44 -stimulus[0].duration $STIMDURATION \ 
45 -stimulus[0].stimtype 0 \ 
46 -stimulus[0].strength $VOLTAGE \ 
47 -stimulus[0].start 0 \ 
48 -stimulus[0].duration $STIMDURATION \ 
49 -stimulus[0].geometry $STIM \ 
50 -ellip_options_file ./amg_xl_opts \ 
51 -parab_options_file ./ilu_cg_opts \ 
52 -num_imp_regions 1 \ 
53 -imp_region[0].im $CELLMODEL 
54  
55 echo Launch CARP for the restart run ... 
56 RESTART=${OUTPUTDIR_ACTIVATION}/state.${DURATION_ACT}.0 #state 
57 $LAUNCHER -np $NPROC ${CARPEXECUTABLE} \ 
58 +F $PARAM_FILE \ 
59 -meshname $MESH_NAME \ 
60 -simID $OUTPUTDIR_RESTART \ 
61 -num_tsav 1 \ 
62 -tsav[0] $DURATION_RUN.0 \ 
63 -start_statef $RESTART \ 
64 -tend $DURATION_RUN \ 
65 -ellip_options_file ./amg_xl_opts \ 
66 -parab_options_file ./ilu_cg_opts \ 
67 -num_imp_regions 1 \ 
68 -imp_region[0].im $CELLMODEL 
B.4 Spiral Wave Activation Used in Chapter 3 
File	B-7.	pentaray.par	
 1 num_gregions    =   1 
 2   
 3 gregion[0].num_IDs  =   5 
 4 gregion[0].name     =   "viable" 
 5 gregion[0].g_il =    0.15 
 6 gregion[0].g_it =    0.15 
 7 gregion[0].g_el     =   0.15 
 8 gregion[0].g_et     =   0.15 
 9 gregion[0].ID[0]    =   1 
10 gregion[0].ID[1]    =   721  
11 gregion[0].ID[2]    =   722 
12 gregion[0].ID[3]    =   723 
13 gregion[0].ID[4]    =   724 
14  
15 # Equation 
16   
17 bidomain    = 0  
18 dt      = 20    #microseconds 
19 parab_solve     = 1 
20 #ellip_solve     = 1 
21 vm_per_phie     = 4 
22   
23 # I/O 
24 spacedt     = 1 
25 timedt      = 1 #milliseconds; ie 1 = 1kHz   
26 gridout_i   = 2 
27 #gridout_e  = 2 
28  
29 # Local Activation Times 
30  
31 num_LATs          = 2 
32  
33 lats[0].all       = 0 
34 lats[0].measurand = 0 
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35 lats[0].method    = 1 
36 lats[0].threshold = -20    #mV? 
37 lats[0].ID        = "latfile" 
38  
39 lats[1].all       = 1 
40 lats[1].measurand = 0 
41 lats[1].method    = 1 
42 lats[1].threshold = -20 
43 lats[1].ID        = "latfile-all" 
44  
45 # Tag regions 
46  
47 numtagreg = 5 
48  
49 tagreg[0].name = tissue 
50 tagreg[0].type = 2 
51 tagreg[0].tag = 1 
52 tagreg[0].p0[0] = 0 
53 tagreg[0].p0[1] = 0 
54 tagreg[0].p0[2] = 0 
55 tagreg[0].p1[0] = 40000 
56 tagreg[0].p1[1] = 40000 
57 tagreg[0].p1[2] = 0 
58  
59 tagreg[1].name = stim 
60 tagreg[1].type = 2 
61 tagreg[1].tag = 721 
62 tagreg[1].p0[0] = 1000 
63 tagreg[1].p0[1] = 0 
64 tagreg[1].p0[2] = 0 
65 tagreg[1].p1[0] = 2000 
66 tagreg[1].p1[1] = 40000 
67 tagreg[1].p1[2] = 0 
68  
69 tagreg[2].name = ground 
70 tagreg[2].type = 2 
71 tagreg[2].tag = 722 
72 tagreg[2].p0[0] = 0 
73 tagreg[2].p0[1] = 0 
74 tagreg[2].p0[2] = 0 
75 tagreg[2].p1[0] = 1000 
76 tagreg[2].p1[1] = 40000 
77 tagreg[2].p1[2] = 0 
78  
79 tagreg[3].name = stimrotor 
80 tagreg[3].type = 2 
81 tagreg[3].tag = 723 
82 tagreg[3].p0[0] = 19000 
83 tagreg[3].p0[1] = 0 
84 tagreg[3].p0[2] = 0 
85 tagreg[3].p1[0] = 20000 
86 tagreg[3].p1[1] = 30000 
87 tagreg[3].p1[2] = 0 
88  
89 tagreg[4].name = groundrotor 
90 tagreg[4].type = 2 
91 tagreg[4].tag = 724 
92 tagreg[4].p0[0] = 20000 
93 tagreg[4].p0[1] = 0 
94 tagreg[4].p0[2] = 0 
95 tagreg[4].p1[0] = 21000 
96 tagreg[4].p1[1] = 30000 
97 tagreg[4].p1[2] = 0 
	
File	B-8.	run_carp.sh	
  1 export NPROC=12 
  2 export LAUNCHER=mpirun 
  3  
  4 echo Set the file references ... 
  5 SIM_NAME=square 
  6 MESH_NAME=./geometry/square.1 
  7 PARAM_FILE=./pentaray.par 
  8 CARPEXECUTABLE=/home/localstn10/src/carp-dcse-pt/CARP/carp.petsc.pt 
  9  
 10 echo Set up the stimulus ... 
 11 VOLTAGE=1000 
 12 STIMDURATION=1 
 13  
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 14 echo Define which runs to execute ... 
 15 DOBLOCKSTIM=1 
 16 DOROTORINIT=1 
 17  
 18 echo Set up the stimulus ... 
 19 STIM=1 
 20 STIM_ROTOR=3 
 21 GROUND=2 
 22 GROUND_ROTOR=4 
 23  
 24 echo Set up the t ends ... 
 25 t_1=1  # length of first stimulus  
 26 t_2=285 # length of first run 
 27 t_3=1  # length of second stimulus 
 28 t_4=10000 # length of second run 
 29 t_5=1000 # length of the final run for getting activation times, must be greater than TCL 
 30  
 31 DURATION_ACT=$t_1 
 32 DURATION_RUN=$(($DURATION_ACT+$t_2)) 
 33 DURATION_ROTOR_ACT=$(($DURATION_RUN+$t_3)) 
 34 DURATION_ROTOR_RUN=$(($DURATION_ROTOR_ACT+$t_4)) 
 35 DURATION_ROTOR_RUN_FINAL=$(($DURATION_ROTOR_RUN+$t_5)) 
 36  
 37 echo Set up the cell model ... 
 38 CELLMODEL=NYGREN 
 39  
 40 echo Set up the output directories ... 
 41 OUTPUTDIR_ACTIVATION=./${SIM_NAME}_act 
 42 OUTPUTDIR_RESTART=./${SIM_NAME}_run 
 43 OUTPUTDIR_ROTOR_ACTIVATION=./${SIM_NAME}_rotor_act 
 44 OUTPUTDIR_ROTOR_RESTART=./${SIM_NAME}_rotor_run 
 45 OUTPUTDIR_ROTOR_RESTART_FINAL=./${SIM_NAME}_rotor_final 
 46  
 47 if [ $DOBLOCKSTIM == 1 ] 
 48   then 
 49     echo Launch CARP for the activation run ... 
 50     $LAUNCHER -np $NPROC ${CARPEXECUTABLE} \ 
 51     +F $PARAM_FILE \ 
 52     -meshname $MESH_NAME \ 
 53     -simID $OUTPUTDIR_ACTIVATION \ 
 54     -num_tsav 2 \ 
 55     -tsav[0] $DURATION_ACT.0 \ 
 56     -tend $DURATION_ACT \ 
 57     -num_stim 1 \ 
 58     -stimulus[0].stimtype 3 \ 
 59     -stimulus[0].strength 0 \ 
 60     -stimulus[0].geometry $GROUND \ 
 61     -stimulus[0].duration $STIMDURATION \ 
 62     -stimulus[0].stimtype 0 \ 
 63     -stimulus[0].strength $VOLTAGE \ 
 64     -stimulus[0].start 0 \ 
 65     -stimulus[0].duration $STIMDURATION \ 
 66     -stimulus[0].geometry $STIM \ 
 67     -ellip_options_file ./amg_xl_opts \ 
 68     -parab_options_file ./ilu_cg_opts \ 
 69     -num_imp_regions 1 \ 
 70     -imp_region[0].im $CELLMODEL 
 71  
 72     echo Launch CARP for the restart run ... 
 73     RESTART=${OUTPUTDIR_ACTIVATION}/state.${DURATION_ACT}.0 #state 
 74     $LAUNCHER -np $NPROC ${CARPEXECUTABLE} \ 
 75     +F $PARAM_FILE \ 
 76     -meshname $MESH_NAME \ 
 77     -simID $OUTPUTDIR_RESTART \ 
 78     -num_tsav 1 \ 
 79     -tsav[0] $DURATION_RUN.0 \ 
 80     -start_statef $RESTART \ 
 81     -tend $DURATION_RUN \ 
 82     -ellip_options_file ./amg_xl_opts \ 
 83     -parab_options_file ./ilu_cg_opts \ 
 84     -num_imp_regions 1 \ 
 85     -imp_region[0].im $CELLMODEL 
 86 fi 
 87  
 88 if [ $DOROTORINIT == 1 ]  
 89   then 
 90     echo Launch CARP for the rotor activation run ... 
 91     RESTART_ROTOR_ACT=${OUTPUTDIR_RESTART}/state.${DURATION_RUN}.0 #state 
 92     $LAUNCHER -np $NPROC ${CARPEXECUTABLE} \ 
 93     +F $PARAM_FILE \ 
 94     -meshname $MESH_NAME \ 
 95     -simID $OUTPUTDIR_ROTOR_ACTIVATION \ 
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 96     -num_tsav 1 \ 
 97     -tsav[0] $DURATION_ROTOR_ACT.0 \ 
 98     -start_statef $RESTART_ROTOR_ACT \ 
 99     -tend $DURATION_ROTOR_ACT \ 
100     -num_stim 2 \ 
101     -stimulus[0].stimtype 3 \ 
102     -stimulus[0].strength 0 \ 
103     -stimulus[0].geometry $GROUND_ROTOR \ 
104     -stimulus[0].duration $STIMDURATION \ 
105     -stimulus[0].stimtype 0 \ 
106     -stimulus[0].strength $VOLTAGE \ 
107     -stimulus[0].geometry $STIM_ROTOR \ 
108     -stimulus[0].start $(($DURATION_ROTOR_ACT-1)) \ 
109     -stimulus[0].duration $STIMDURATION \ 
110     -ellip_options_file ./amg_xl_opts \ 
111     -parab_options_file ./ilu_cg_opts \ 
112     -num_imp_regions 1 \ 
113     -imp_region[0].im $CELLMODEL 
114  
115     echo Launch CARP for the rotor restart run ... 
116     RESTART_ROTOR_RUN=${OUTPUTDIR_ROTOR_ACTIVATION}/state.${DURATION_ROTOR_ACT}.0 #state 
117     $LAUNCHER -np $NPROC ${CARPEXECUTABLE} \ 
118     +F $PARAM_FILE \ 
119     -meshname $MESH_NAME \ 
120     -simID $OUTPUTDIR_ROTOR_RESTART \ 
121     -num_tsav 1 -tsav[0] $DURATION_ROTOR_RUN.0 \ 
122     -start_statef $RESTART_ROTOR_RUN \ 
123     -tend $DURATION_ROTOR_RUN \ 
124     -ellip_options_file ./amg_xl_opts \ 
125     -parab_options_file ./ilu_cg_opts \ 
126     -num_imp_regions 1 \ 
127     -imp_region[0].im $CELLMODEL 
128 fi 
129  
130 echo Launch CARP one final time to get activation times ... 
131 RESTART_ROTOR_RUN_FINAL=${OUTPUTDIR_ROTOR_RESTART}/state.${DURATION_ROTOR_RUN}.0 #state 
132 $LAUNCHER -np $NPROC ${CARPEXECUTABLE} \ 
133 +F $PARAM_FILE \ 
134 -meshname $MESH_NAME \ 
135 -simID $OUTPUTDIR_ROTOR_RESTART_FINAL \ 
136 -num_tsav 1 -tsav[0] $DURATION_ROTOR_RUN_FINAL.0 \ 
137 -start_statef $RESTART_ROTOR_RUN_FINAL \ 
138 -tend $DURATION_ROTOR_RUN_FINAL \ 
139 -ellip_options_file ./amg_xl_opts \ 
140 -parab_options_file ./ilu_cg_opts \ 
141 -num_imp_regions 1 \ 
142 -imp_region[0].im $CELLMODEL 
B.5 Single Loop Anisotropic Activation Used in Chapter 3 
File	B-9.	pentaray.par	
  1 num_gregions    =   2 
  2   
  3 gregion[0].num_IDs  =   5 
  4 gregion[0].name     =   "viable" 
  5 gregion[0].g_il =    0.28 
  6 gregion[0].g_it =    0.026 
  7 gregion[0].g_el         =       0.22 
  8 gregion[0].g_et         =       0.13 
  9 gregion[0].ID[0]    =   1 
 10 gregion[0].ID[1]    =   721  
 11 gregion[0].ID[2]    =   722 
 12 gregion[0].ID[3]    =   723 
 13 gregion[0].ID[4]    =   724 
 14  
 15 gregion[1].num_IDs  =   1 
 16 gregion[1].name     =   "scar" 
 17 gregion[1].g_il =    0 
 18 gregion[1].g_it =    0 
 19 gregion[1].g_el     =   0.22 
 20 gregion[1].g_et     =   0.13 
 21 gregion[1].ID[0]    =   921 
 22  
 23 # Equation 
 24   
 25 bidomain    = 0  
 26 dt      = 20    #microseconds 
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 27 parab_solve     = 1 
 28 #ellip_solve     = 1 
 29 vm_per_phie     = 4 
 30   
 31 # I/O 
 32 spacedt     = 1 
 33 timedt      = 1 #milliseconds; ie 1 = 1kHz   
 34 gridout_i   = 2 
 35 #gridout_e  = 2 
 36  
 37 # Local Activation Times 
 38   
 39 num_LATs          = 2 
 40  
 41 lats[0].all       = 0 
 42 lats[0].measurand = 0 
 43 lats[0].method    = 1 
 44 lats[0].threshold = -20    #mV? 
 45 lats[0].ID        = "latfile" 
 46  
 47 lats[1].all       = 1 
 48 lats[1].measurand = 0 
 49 lats[1].method    = 1 
 50 lats[1].threshold = -20 
 51 lats[1].ID        = "latfile-all" 
 52  
 53 # Tag regions 
 54  
 55 numtagreg = 6 
 56  
 57 tagreg[0].name = tissue 
 58 tagreg[0].type = 2 
 59 tagreg[0].tag = 1 
 60 tagreg[0].p0[0] = 0 
 61 tagreg[0].p0[1] = 0 
 62 tagreg[0].p0[2] = 0 
 63 tagreg[0].p1[0] = 40000 
 64 tagreg[0].p1[1] = 40000 
 65 tagreg[0].p1[2] = 0 
 66  
 67 tagreg[1].name = stim 
 68 tagreg[1].type = 2 
 69 tagreg[1].tag = 721 
 70 tagreg[1].p0[0] = 0 
 71 tagreg[1].p0[1] = 16000 
 72 tagreg[1].p0[2] = 0 
 73 tagreg[1].p1[0] = 20000 
 74 tagreg[1].p1[1] = 17000 
 75 tagreg[1].p1[2] = 0 
 76  
 77 tagreg[2].name = ground 
 78 tagreg[2].type = 2 
 79 tagreg[2].tag = 722 
 80 tagreg[2].p0[0] = 0 
 81 tagreg[2].p0[1] = 17000 
 82 tagreg[2].p0[2] = 0 
 83 tagreg[2].p1[0] = 20000 
 84 tagreg[2].p1[1] = 18000 
 85 tagreg[2].p1[2] = 0 
 86  
 87 tagreg[3].name = stimrentry 
 88 tagreg[3].type = 2 
 89 tagreg[3].tag = 723 
 90 tagreg[3].p0[0] = 0 
 91 tagreg[3].p0[1] = 22000 
 92 tagreg[3].p0[2] = 0 
 93 tagreg[3].p1[0] = 20000 
 94 tagreg[3].p1[1] = 23000 
 95 tagreg[3].p1[2] = 0 
 96  
 97 tagreg[4].name = groundrentry 
 98 tagreg[4].type = 2 
 99 tagreg[4].tag = 724 
100 tagreg[4].p0[0] = 0 
101 tagreg[4].p0[1] = 23000 
102 tagreg[4].p0[2] = 0 
103 tagreg[4].p1[0] = 20000 
104 tagreg[4].p1[1] = 24000 
105 tagreg[4].p1[2] = 0 
106  
107 tagreg[5].name = scar 
108 tagreg[5].type = 1 
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109 tagreg[5].tag = 921 
110 tagreg[5].p0[0] = 20000 
111 tagreg[5].p0[1] = 20000 
112 tagreg[5].p0[2] = 0 
113 tagreg[5].radius = 7500 
	
File	B-10.	run_carp.sh	
  1 export NPROC=12 
  2 export LAUNCHER=mpirun 
  3  
  4 echo Set the file references ... 
  5 SIM_NAME=square 
  6 MESH_NAME=./geometry/square.1 
  7 PARAM_FILE=./pentaray.par 
  8 CARPEXECUTABLE=/home/localstn10/src/carp-dcse-pt/CARP/carp.petsc.pt 
  9  
 10 echo Set up the stimulus ... 
 11 VOLTAGE=1000 
 12 STIMDURATION=1 
 13  
 14 echo Define which runs to execute ... 
 15 DOBLOCKSTIM=0 # Initial stimulation 
 16 DOROTORINIT=0 # Rotor initialisation 
 17 DOFINALRRUN=1 # Extra rotor run at end 
 18  
 19 echo Set up the stimulus ... 
 20 STIM=2 
 21 STIM_ROTOR=4 
 22 GROUND=3 
 23 GROUND_ROTOR=5 
 24  
 25 echo Set up the t ends ... 
 26 t_1=1  # length of first stimulus  
 27 t_2=250 # length of first run 
 28 t_3=1  # length of second stimulus 
 29 t_4=10000 # length of second run 
 30 t_5=500 # length of the final run for getting activation times, must be greater than TCL 
 31  
 32 DURATION_ACT=$t_1 
 33 DURATION_RUN=$(($DURATION_ACT+$t_2)) 
 34 DURATION_ROTOR_ACT=$(($DURATION_RUN+$t_3)) 
 35 DURATION_ROTOR_RUN=$(($DURATION_ROTOR_ACT+$t_4)) 
 36 DURATION_ROTOR_RUN_FINAL=$(($DURATION_ROTOR_RUN+$t_5)) 
 37  
 38 echo Set up the cell model ... 
 39 CELLMODEL=NYGREN 
 40  
 41 echo Set up the output directories ... 
 42 OUTPUTDIR_ACTIVATION=./${SIM_NAME}_act 
 43 OUTPUTDIR_RESTART=./${SIM_NAME}_run 
 44 OUTPUTDIR_ROTOR_ACTIVATION=./${SIM_NAME}_rotor_act 
 45 OUTPUTDIR_ROTOR_RESTART=./${SIM_NAME}_rotor_run 
 46 OUTPUTDIR_ROTOR_RESTART_FINAL=./${SIM_NAME}_rotor_final 
 47  
 48 if [ $DOBLOCKSTIM == 1 ] 
 49   then 
 50     echo Launch CARP for the activation run ... 
 51     $LAUNCHER -np $NPROC ${CARPEXECUTABLE} \ 
 52     +F $PARAM_FILE \ 
 53     -meshname $MESH_NAME \ 
 54     -simID $OUTPUTDIR_ACTIVATION \ 
 55     -num_tsav 2 \ 
 56     -tsav[0] $DURATION_ACT.0 \ 
 57     -tend $DURATION_ACT \ 
 58     -num_stim 1 \ 
 59     -stimulus[0].stimtype 3 \ 
 60     -stimulus[0].strength 0 \ 
 61     -stimulus[0].geometry $GROUND \ 
 62     -stimulus[0].duration $STIMDURATION \ 
 63     -stimulus[0].stimtype 0 \ 
 64     -stimulus[0].strength $VOLTAGE \ 
 65     -stimulus[0].start 0 \ 
 66     -stimulus[0].duration $STIMDURATION \ 
 67     -stimulus[0].geometry $STIM \ 
 68     -ellip_options_file ./amg_xl_opts \ 
 69     -parab_options_file ./ilu_cg_opts \ 
 70     -num_imp_regions 1 \ 
 71     -imp_region[0].im $CELLMODEL 
 72  
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 73     echo Launch CARP for the restart run ... 
 74     RESTART=${OUTPUTDIR_ACTIVATION}/state.${DURATION_ACT}.0 #state 
 75     $LAUNCHER -np $NPROC ${CARPEXECUTABLE} \ 
 76     +F $PARAM_FILE \ 
 77     -meshname $MESH_NAME \ 
 78     -simID $OUTPUTDIR_RESTART \ 
 79     -num_tsav 1 \ 
 80     -tsav[0] $DURATION_RUN.0 \ 
 81     -start_statef $RESTART \ 
 82     -tend $DURATION_RUN \ 
 83     -ellip_options_file ./amg_xl_opts \ 
 84     -parab_options_file ./ilu_cg_opts \ 
 85     -num_imp_regions 1 \ 
 86     -imp_region[0].im $CELLMODEL 
 87 fi 
 88  
 89 if [ $DOROTORINIT == 1 ]  
 90   then 
 91     echo Launch CARP for the rotor activation run ... 
 92     RESTART_ROTOR_ACT=${OUTPUTDIR_RESTART}/state.${DURATION_RUN}.0 #state 
 93     $LAUNCHER -np $NPROC ${CARPEXECUTABLE} \ 
 94     +F $PARAM_FILE \ 
 95     -meshname $MESH_NAME \ 
 96     -simID $OUTPUTDIR_ROTOR_ACTIVATION \ 
 97     -num_tsav 1 \ 
 98     -tsav[0] $DURATION_ROTOR_ACT.0 \ 
 99     -start_statef $RESTART_ROTOR_ACT \ 
100     -tend $DURATION_ROTOR_ACT \ 
101     -num_stim 2 \ 
102     -stimulus[0].stimtype 3 \ 
103     -stimulus[0].strength 0 \ 
104     -stimulus[0].geometry $GROUND_ROTOR \ 
105     -stimulus[0].duration $STIMDURATION \ 
106     -stimulus[0].stimtype 0 \ 
107     -stimulus[0].strength $VOLTAGE \ 
108     -stimulus[0].geometry $STIM_ROTOR \ 
109     -stimulus[0].start $(($DURATION_ROTOR_ACT-1)) \ 
110     -stimulus[0].duration $STIMDURATION \ 
111     -ellip_options_file ./amg_xl_opts \ 
112     -parab_options_file ./ilu_cg_opts \ 
113     -num_imp_regions 1 \ 
114     -imp_region[0].im $CELLMODEL 
115  
116     echo Launch CARP for the rotor restart run ... 
117     RESTART_ROTOR_RUN=${OUTPUTDIR_ROTOR_ACTIVATION}/state.${DURATION_ROTOR_ACT}.0                           
#state 
118     $LAUNCHER -np $NPROC ${CARPEXECUTABLE} \ 
119     +F $PARAM_FILE \ 
120     -meshname $MESH_NAME \ 
121     -simID $OUTPUTDIR_ROTOR_RESTART \ 
122     -num_tsav 1 -tsav[0] $DURATION_ROTOR_RUN.0 \ 
123     -start_statef $RESTART_ROTOR_RUN \ 
124     -tend $DURATION_ROTOR_RUN \ 
125     -ellip_options_file ./amg_xl_opts \ 
126     -parab_options_file ./ilu_cg_opts \ 
127     -num_imp_regions 1 \ 
128     -imp_region[0].im $CELLMODEL 
129 fi 
130  
131 if [ $DOFINALRRUN == 1 ] 
132   then 
133     echo Launch CARP one final time to get activation times ... 
134     RESTART_ROTOR_RUN_FINAL=${OUTPUTDIR_ROTOR_RESTART}/state.${DURATION_ROTOR_RUN}.0 
#state 
135     $LAUNCHER -np $NPROC ${CARPEXECUTABLE} \ 
136     +F $PARAM_FILE \ 
137     -meshname $MESH_NAME \ 
138     -simID $OUTPUTDIR_ROTOR_RESTART_FINAL \ 
139     -num_tsav 1 -tsav[0] $DURATION_ROTOR_RUN_FINAL.0 \ 
140     -start_statef $RESTART_ROTOR_RUN_FINAL \ 
141     -tend $DURATION_ROTOR_RUN_FINAL \ 
142     -ellip_options_file ./amg_xl_opts \ 
143     -parab_options_file ./ilu_cg_opts \ 
144     -num_imp_regions 1 \ 
145     -imp_region[0].im $CELLMODEL 
146 fi 
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B.6 Single Loop Isotropic Activation Used in Chapter 3 
File	B-11.	pentaray.par	
  1 num_gregions    =   2 
  2   
  3 gregion[0].num_IDs  =   5 
  4 gregion[0].name     =   "viable" 
  5 gregion[0].g_il =    0.15 
  6 gregion[0].g_it =    0.15 
  7 gregion[0].g_el         =       0.15 
  8 gregion[0].g_et         =       0.15 
  9 gregion[0].ID[0]    =   1 
 10 gregion[0].ID[1]    =   721  
 11 gregion[0].ID[2]    =   722 
 12 gregion[0].ID[3]    =   723 
 13 gregion[0].ID[4]    =   724 
 14  
 15 gregion[1].num_IDs  =   1 
 16 gregion[1].name     =   "scar" 
 17 gregion[1].g_il =    0 
 18 gregion[1].g_it =    0 
 19 gregion[1].g_el     =   0.22 
 20 gregion[1].g_et     =   0.13 
 21 gregion[1].ID[0]    =   921 
 22  
 23 # Equation 
 24   
 25 bidomain    = 0  
 26 dt      = 20    #microseconds 
 27 parab_solve     = 1 
 28 #ellip_solve     = 1 
 29 vm_per_phie     = 4 
 30   
 31 # I/O 
 32 spacedt     = 1 
 33 timedt      = 1 #milliseconds; ie 1 = 1kHz   
 34 gridout_i   = 2 
 35 #gridout_e  = 2 
 36  
 37 # Local Activation Times 
 38   
 39 num_LATs          = 2 
 40  
 41 lats[0].all       = 0 
 42 lats[0].measurand = 0 
 43 lats[0].method    = 1 
 44 lats[0].threshold = -20    #mV? 
 45 lats[0].ID        = "latfile" 
 46  
 47 lats[1].all       = 1 
 48 lats[1].measurand = 0 
 49 lats[1].method    = 1 
 50 lats[1].threshold = -20 
 51 lats[1].ID        = "latfile-all" 
 52  
 53 # Tag regions 
 54  
 55 numtagreg = 6 
 56  
 57 tagreg[0].name = tissue 
 58 tagreg[0].type = 2 
 59 tagreg[0].tag = 1 
 60 tagreg[0].p0[0] = 0 
 61 tagreg[0].p0[1] = 0 
 62 tagreg[0].p0[2] = 0 
 63 tagreg[0].p1[0] = 40000 
 64 tagreg[0].p1[1] = 40000 
 65 tagreg[0].p1[2] = 0 
 66  
 67 tagreg[1].name = stim 
 68 tagreg[1].type = 2 
 69 tagreg[1].tag = 721 
 70 tagreg[1].p0[0] = 0 
 71 tagreg[1].p0[1] = 16000 
 72 tagreg[1].p0[2] = 0 
 73 tagreg[1].p1[0] = 20000 
 74 tagreg[1].p1[1] = 17000 
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 75 tagreg[1].p1[2] = 0 
 76  
 77 tagreg[2].name = ground 
 78 tagreg[2].type = 2 
 79 tagreg[2].tag = 722 
 80 tagreg[2].p0[0] = 0 
 81 tagreg[2].p0[1] = 17000 
 82 tagreg[2].p0[2] = 0 
 83 tagreg[2].p1[0] = 20000 
 84 tagreg[2].p1[1] = 18000 
 85 tagreg[2].p1[2] = 0 
 86  
 87 tagreg[3].name = stimrentry 
 88 tagreg[3].type = 2 
 89 tagreg[3].tag = 723 
 90 tagreg[3].p0[0] = 0 
 91 tagreg[3].p0[1] = 22000 
 92 tagreg[3].p0[2] = 0 
 93 tagreg[3].p1[0] = 20000 
 94 tagreg[3].p1[1] = 23000 
 95 tagreg[3].p1[2] = 0 
 96  
 97 tagreg[4].name = groundrentry 
 98 tagreg[4].type = 2 
 99 tagreg[4].tag = 724 
100 tagreg[4].p0[0] = 0 
101 tagreg[4].p0[1] = 23000 
102 tagreg[4].p0[2] = 0 
103 tagreg[4].p1[0] = 20000 
104 tagreg[4].p1[1] = 24000 
105 tagreg[4].p1[2] = 0 
106  
107 tagreg[5].name = scar 
108 tagreg[5].type = 1 
109 tagreg[5].tag = 921 
110 tagreg[5].p0[0] = 20000 
111 tagreg[5].p0[1] = 20000 
112 tagreg[5].p0[2] = 0 
113 tagreg[5].radius = 7500 
	
File	B-12.	run_carp.sh	
  1 export NPROC=12 
  2 export LAUNCHER=mpirun 
  3  
  4 echo Set the file references ... 
  5 SIM_NAME=square 
  6 MESH_NAME=./geometry/square.1 
  7 PARAM_FILE=./pentaray.par 
  8 CARPEXECUTABLE=/home/localstn10/src/carp-dcse-pt/CARP/carp.petsc.pt 
  9  
 10 echo Set up the stimulus ... 
 11 VOLTAGE=1000 
 12 STIMDURATION=1 
 13  
 14 echo Define which runs to execute ... 
 15 DOBLOCKSTIM=1 # Initial stimulation 
 16 DOROTORINIT=1 # Rotor initialisation 
 17 DOFINALRRUN=1 # Extra rotor run at end 
 18  
 19 echo Set up the stimulus ... 
 20 STIM=2 
 21 STIM_ROTOR=4 
 22 GROUND=3 
 23 GROUND_ROTOR=5 
 24  
 25 echo Set up the t ends ... 
 26 t_1=1  # length of first stimulus  
 27 t_2=240 # length of first run 
 28 t_3=1  # length of second stimulus 
 29 t_4=1000 # length of second run 
 30 t_5=500 # length of the final run for getting activation times, must be greater than TCL 
 31  
 32 DURATION_ACT=$t_1 
 33 DURATION_RUN=$(($DURATION_ACT+$t_2)) 
 34 DURATION_ROTOR_ACT=$(($DURATION_RUN+$t_3)) 
 35 DURATION_ROTOR_RUN=$(($DURATION_ROTOR_ACT+$t_4)) 
 36 DURATION_ROTOR_RUN_FINAL=$(($DURATION_ROTOR_RUN+$t_5)) 
 37  
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 38 echo Set up the cell model ... 
 39 CELLMODEL=NYGREN 
 40  
 41 echo Set up the output directories ... 
 42 OUTPUTDIR_ACTIVATION=./${SIM_NAME}_act 
 43 OUTPUTDIR_RESTART=./${SIM_NAME}_run 
 44 OUTPUTDIR_ROTOR_ACTIVATION=./${SIM_NAME}_rotor_act 
 45 OUTPUTDIR_ROTOR_RESTART=./${SIM_NAME}_rotor_run 
 46 OUTPUTDIR_ROTOR_RESTART_FINAL=./${SIM_NAME}_rotor_final 
 47  
 48 if [ $DOBLOCKSTIM == 1 ] 
 49   then 
 50     echo Launch CARP for the activation run ... 
 51     $LAUNCHER -np $NPROC ${CARPEXECUTABLE} \ 
 52     +F $PARAM_FILE \ 
 53     -meshname $MESH_NAME \ 
 54     -simID $OUTPUTDIR_ACTIVATION \ 
 55     -num_tsav 2 \ 
 56     -tsav[0] $DURATION_ACT.0 \ 
 57     -tend $DURATION_ACT \ 
 58     -num_stim 1 \ 
 59     -stimulus[0].stimtype 3 \ 
 60     -stimulus[0].strength 0 \ 
 61     -stimulus[0].geometry $GROUND \ 
 62     -stimulus[0].duration $STIMDURATION \ 
 63     -stimulus[0].stimtype 0 \ 
 64     -stimulus[0].strength $VOLTAGE \ 
 65     -stimulus[0].start 0 \ 
 66     -stimulus[0].duration $STIMDURATION \ 
 67     -stimulus[0].geometry $STIM \ 
 68     -ellip_options_file ./amg_xl_opts \ 
 69     -parab_options_file ./ilu_cg_opts \ 
 70     -num_imp_regions 1 \ 
 71     -imp_region[0].im $CELLMODEL 
 72  
 73     echo Launch CARP for the restart run ... 
 74     RESTART=${OUTPUTDIR_ACTIVATION}/state.${DURATION_ACT}.0 #state 
 75     $LAUNCHER -np $NPROC ${CARPEXECUTABLE} \ 
 76     +F $PARAM_FILE \ 
 77     -meshname $MESH_NAME \ 
 78     -simID $OUTPUTDIR_RESTART \ 
 79     -num_tsav 1 \ 
 80     -tsav[0] $DURATION_RUN.0 \ 
 81     -start_statef $RESTART \ 
 82     -tend $DURATION_RUN \ 
 83     -ellip_options_file ./amg_xl_opts \ 
 84     -parab_options_file ./ilu_cg_opts \ 
 85     -num_imp_regions 1 \ 
 86     -imp_region[0].im $CELLMODEL 
 87 fi 
 88  
 89 if [ $DOROTORINIT == 1 ]  
 90   then 
 91     echo Launch CARP for the rotor activation run ... 
 92     RESTART_ROTOR_ACT=${OUTPUTDIR_RESTART}/state.${DURATION_RUN}.0 #state 
 93     $LAUNCHER -np $NPROC ${CARPEXECUTABLE} \ 
 94     +F $PARAM_FILE \ 
 95     -meshname $MESH_NAME \ 
 96     -simID $OUTPUTDIR_ROTOR_ACTIVATION \ 
 97     -num_tsav 1 \ 
 98     -tsav[0] $DURATION_ROTOR_ACT.0 \ 
 99     -start_statef $RESTART_ROTOR_ACT \ 
100     -tend $DURATION_ROTOR_ACT \ 
101     -num_stim 2 \ 
102     -stimulus[0].stimtype 3 \ 
103     -stimulus[0].strength 0 \ 
104     -stimulus[0].geometry $GROUND_ROTOR \ 
105     -stimulus[0].duration $STIMDURATION \ 
106     -stimulus[0].stimtype 0 \ 
107     -stimulus[0].strength $VOLTAGE \ 
108     -stimulus[0].geometry $STIM_ROTOR \ 
109     -stimulus[0].start $(($DURATION_ROTOR_ACT-1)) \ 
110     -stimulus[0].duration $STIMDURATION \ 
111     -ellip_options_file ./amg_xl_opts \ 
112     -parab_options_file ./ilu_cg_opts \ 
113     -num_imp_regions 1 \ 
114     -imp_region[0].im $CELLMODEL 
115  
116     echo Launch CARP for the rotor restart run ... 
117     RESTART_ROTOR_RUN=${OUTPUTDIR_ROTOR_ACTIVATION}/state.${DURATION_ROTOR_ACT}.0 #state 
118     $LAUNCHER -np $NPROC ${CARPEXECUTABLE} \ 
119     +F $PARAM_FILE \ 
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120     -meshname $MESH_NAME \ 
121     -simID $OUTPUTDIR_ROTOR_RESTART \ 
122     -num_tsav 1 -tsav[0] $DURATION_ROTOR_RUN.0 \ 
123     -start_statef $RESTART_ROTOR_RUN \ 
124     -tend $DURATION_ROTOR_RUN \ 
125     -ellip_options_file ./amg_xl_opts \ 
126     -parab_options_file ./ilu_cg_opts \ 
127     -num_imp_regions 1 \ 
128     -imp_region[0].im $CELLMODEL 
129 fi 
130  
131 if [ $DOFINALRRUN == 1 ] 
132   then 
133     echo Launch CARP one final time to get activation times ... 
134     RESTART_ROTOR_RUN_FINAL=${OUTPUTDIR_ROTOR_RESTART}/state.${DURATION_ROTOR_RUN}.0 
#state 
135     $LAUNCHER -np $NPROC ${CARPEXECUTABLE} \ 
136     +F $PARAM_FILE \ 
137     -meshname $MESH_NAME \ 
138     -simID $OUTPUTDIR_ROTOR_RESTART_FINAL \ 
139     -num_tsav 1 -tsav[0] $DURATION_ROTOR_RUN_FINAL.0 \ 
140     -start_statef $RESTART_ROTOR_RUN_FINAL \ 
141     -tend $DURATION_ROTOR_RUN_FINAL \ 
142     -ellip_options_file ./amg_xl_opts \ 
143     -parab_options_file ./ilu_cg_opts \ 
144     -num_imp_regions 1 \ 
145     -imp_region[0].im $CELLMODEL 
146 fi 
 
B.7 S1S2 Protocol Used in Chapter 4 APD/CV Restitution Experiments 
File	B-13.	run_carp.sh	–	standard	Courtemanche	cell	model;	longitudinal	fibre	direction	
  1 export NPROC=12 
  2 export LAUNCHER=mpirun 
  3  
  4 echo Set the file references ... 
  5 SIM_NAME=square 
  6 MESH_NAME=./geometry/square.1 
  7 PARAM_FILE=./param_long.par 
  8 CARPEXECUTABLE=/home/localstn10/src/carp-dcse-pt/CARP/carp.petsc.pt 
  9  
 10 echo Set up the stimulus ... 
 11 VOLTAGE=1000 
 12 STIMDURATION=1 
 13 STIM=1 
 14 GROUND=2 
 15  
 16 echo Set up the t ends ... 
 17 t_1=1    # length of first stimulus  
 18 t_2=470  # length of first run 
 19 t_3=1    # length of the second stimulus 
 20 t_4=1    # length of the S2 stimulus 
 21 t_5=100  # length of the S2 runs 
 22 DURATION_ACT1=$t_1 
 23 DURATION_RUN1=$(($DURATION_ACT1+$t_2)) 
 24 DURATION_ACT2=$(($DURATION_RUN1+$t_3)) 
 25  
 26 echo Set up the cell model ... 
 27 CELLMODEL=COURTEMANCHE 
 28  
 29 echo Set up the output directories ... 
 30 OUTPUTDIR_ACTIVATION1=./${SIM_NAME}_act1 
 31 OUTPUTDIR_RESTART1=./${SIM_NAME}_run1 
 32 OUTPUTDIR_ACTIVATION2=./${SIM_NAME}_act2 
 33 OUTPUTDIR_RESTART2=./${SIM_NAME}_run2 
 34 OUTPUTDIR_S2_ACT=./S2_act 
 35 OUTPUTDIR_S2_RUN=./S2_run 
 36  
 37 echo Define the S2 coupling intevals 
 38 S2INTS=(295 290 285 280 275 270 265) # S2 CIs defined here 
 39  
 40 # First pace at 0ms and 470ms 
 41 echo Launch CARP for activation run 1 ... 
 42 $LAUNCHER -np $NPROC ${CARPEXECUTABLE} \ 
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 43 +F $PARAM_FILE \ 
 44 -meshname $MESH_NAME \ 
 45 -simID $OUTPUTDIR_ACTIVATION1 \ 
 46 -num_tsav 1 \ 
 47 -tsav[0] $DURATION_ACT1.0 \ 
 48 -tend $DURATION_ACT1 \ 
 49 -num_stim 2 \ 
 50 -stimulus[0].stimtype 3 \ 
 51 -stimulus[0].strength 0 \ 
 52 -stimulus[0].geometry $GROUND \ 
 53 -stimulus[0].duration $STIMDURATION \ 
 54 -stimulus[1].stimtype 0 \ 
 55 -stimulus[1].strength $VOLTAGE \ 
 56 -stimulus[1].geometry $STIM \ 
 57 -stimulus[1].start 0 \ 
 58 -stimulus[1].duration $STIMDURATION \ 
 59 -ellip_options_file ./amg_xl_opts \ 
 60 -parab_options_file ./ilu_cg_opts \ 
 61 -num_imp_regions 1 \ 
 62 -imp_region[0].im $CELLMODEL  
 63  
 64 echo Launch CARP for restart run 1 ... 
 65 RESTART=${OUTPUTDIR_ACTIVATION1}/state.${DURATION_ACT1}.0 
 66 $LAUNCHER -np $NPROC ${CARPEXECUTABLE} \ 
 67 +F $PARAM_FILE \ 
 68 -meshname $MESH_NAME \ 
 69 -simID $OUTPUTDIR_RESTART1 \ 
 70 -num_tsav 1 \ 
 71 -tsav[0] $DURATION_RUN1.0 \ 
 72 -start_statef $RESTART \ 
 73 -tend $DURATION_RUN1 \ 
 74 -ellip_options_file ./amg_xl_opts \ 
 75 -parab_options_file ./ilu_cg_opts \ 
 76 -num_imp_regions 1 \ 
 77 -imp_region[0].im $CELLMODEL 
 78  
 79 echo Launch CARP for activation run 2 ... 
 80 RESTART=${OUTPUTDIR_RESTART1}/state.${DURATION_RUN1}.0 
 81 $LAUNCHER -np $NPROC ${CARPEXECUTABLE} \ 
 82 +F $PARAM_FILE \ 
 83 -meshname $MESH_NAME \ 
 84 -simID $OUTPUTDIR_ACTIVATION2 \ 
 85 -num_tsav 1 \ 
 86 -tsav[0] $DURATION_ACT2.0 \ 
 87 -start_statef $RESTART \ 
 88 -tend $DURATION_ACT2 \ 
 89 -num_stim 2 \ 
 90 -stimulus[0].stimtype 3 \ 
 91 -stimulus[0].strength 0 \ 
 92 -stimulus[0].geometry $GROUND \ 
 93 -stimulus[0].duration $STIMDURATION \ 
 94 -stimulus[1].stimtype 0 \ 
 95 -stimulus[1].strength $VOLTAGE \ 
 96 -stimulus[1].geometry $STIM \ 
 97 -stimulus[1].start $DURATION_RUN1 \ 
 98 -stimulus[1].duration $STIMDURATION \ 
 99 -ellip_options_file ./amg_xl_opts \ 
100 -parab_options_file ./ilu_cg_opts \ 
101 -num_imp_regions 1 \ 
102 -imp_region[0].im $CELLMODEL  
103  
104 # Restart after the second S1 stim, only run until required S2 
105 for i in "${S2INTS[@]}" 
106 do 
107     DURATION_RUN2=$(($DURATION_ACT2+$i)) 
108     DURATION_S2_act=$(($DURATION_RUN2+$t_4)) 
109     DURATION_S2_run=$(($DURATION_S2_act+$t_5)) 
110  
111     echo Launch CARP for restart run 2 ... 
112     RESTART=${OUTPUTDIR_ACTIVATION2}/state.${DURATION_ACT2}.0 
113     $LAUNCHER -np $NPROC ${CARPEXECUTABLE} \ 
114     +F $PARAM_FILE \ 
115     -meshname $MESH_NAME \ 
116     -simID $OUTPUTDIR_RESTART2 \ 
117     -num_tsav 1 \ 
118     -tsav[0] $DURATION_RUN2.0 \ 
119     -start_statef $RESTART \ 
120     -tend $DURATION_RUN2 \ 
121     -ellip_options_file ./amg_xl_opts \ 
122     -parab_options_file ./ilu_cg_opts \ 
123     -num_imp_regions 1 \ 
124     -imp_region[0].im $CELLMODEL 
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125  
126     echo Launch CARP for S2 activation $i ... 
127     RESTART=${OUTPUTDIR_RESTART2}/state.${DURATION_RUN2}.0 
128     $LAUNCHER -np $NPROC ${CARPEXECUTABLE} \ 
129     +F $PARAM_FILE \ 
130     -meshname $MESH_NAME \ 
131     -simID ${OUTPUTDIR_S2_ACT}${i} \ 
132     -num_tsav 1 \ 
133     -tsav[0] $DURATION_S2_act.0 \ 
134     -start_statef $RESTART \ 
135     -tend $DURATION_S2_act \ 
136     -num_stim 2 \ 
137     -stimulus[0].stimtype 3 \ 
138     -stimulus[0].strength 0 \ 
139     -stimulus[0].geometry $GROUND \ 
140     -stimulus[0].duration $STIMDURATION \ 
141     -stimulus[1].stimtype 0 \ 
142     -stimulus[1].strength $VOLTAGE \ 
143     -stimulus[1].geometry $STIM \ 
144     -stimulus[1].start $DURATION_RUN2 \ 
145     -stimulus[1].duration $STIMDURATION \ 
146     -ellip_options_file ./amg_xl_opts \ 
147     -parab_options_file ./ilu_cg_opts \ 
148     -num_imp_regions 1 \ 
149     -imp_region[0].im $CELLMODEL  
150      
151     echo Launch CARP for S2 restart $i 
152     RESTART=${OUTPUTDIR_S2_ACT}${i}/state.${DURATION_S2_act}.0 
153     $LAUNCHER -np $NPROC ${CARPEXECUTABLE} \ 
154     +F $PARAM_FILE \ 
155     -meshname $MESH_NAME \ 
156     -simID ${OUTPUTDIR_S2_RUN}${i} \ 
157     -start_statef $RESTART \ 
158     -tend $DURATION_S2_run \ 
159     -ellip_options_file ./amg_xl_opts \ 
160     -parab_options_file ./ilu_cg_opts \ 
161     -num_imp_regions 1 \ 
162     -imp_region[0].im $CELLMODEL 




  1 export NPROC=12 
  2 export LAUNCHER=mpirun 
  3  
  4 echo Set the file references ... 
  5 SIM_NAME=square 
  6 MESH_NAME=./geometry/square.1 
  7 PARAM_FILE=./param_long.par 
  8 CARPEXECUTABLE=/home/localstn10/src/carp-dcse-pt/CARP/carp.petsc.pt 
  9  
 10 echo Set up the stimulus ... 
 11 VOLTAGE=1000 
 12 STIMDURATION=1 
 13 STIM=1 
 14 GROUND=2 
 15  
 16 echo Set up the t ends ... 
 17 t_1=1    # length of first stimulus  
 18 t_2=470  # length of first run 
 19 t_3=1    # length of the second stimulus 
 20 t_4=1    # length of the S2 stimulus 
 21 t_5=100  # length of the S2 runs 
 22 DURATION_ACT1=$t_1 
 23 DURATION_RUN1=$(($DURATION_ACT1+$t_2)) 
 24 DURATION_ACT2=$(($DURATION_RUN1+$t_3)) 
 25  
 26 echo Set up the cell model ... 
 27 CELLMODEL=COURTEMANCHE 
 28  
 29 echo Set up the output directories ... 
 30 OUTPUTDIR_ACTIVATION1=./${SIM_NAME}_act1 
 31 OUTPUTDIR_RESTART1=./${SIM_NAME}_run1 
 32 OUTPUTDIR_ACTIVATION2=./${SIM_NAME}_act2 
 33 OUTPUTDIR_RESTART2=./${SIM_NAME}_run2 
 34 OUTPUTDIR_S2_ACT=./S2_act 
 35 OUTPUTDIR_S2_RUN=./S2_run 
 36  
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 37 echo Define the S2 coupling intevals 
 38 S2INTS=(295 290 285 280 275 270 265) # S2 CIs defined here 
 39  
 40 # First pace at 0ms and 470ms 
 41 echo Launch CARP for activation run 1 ... 
 42 $LAUNCHER -np $NPROC ${CARPEXECUTABLE} \ 
 43 +F $PARAM_FILE \ 
 44 -meshname $MESH_NAME \ 
 45 -simID $OUTPUTDIR_ACTIVATION1 \ 
 46 -num_tsav 1 \ 
 47 -tsav[0] $DURATION_ACT1.0 \ 
 48 -tend $DURATION_ACT1 \ 
 49 -num_stim 2 \ 
 50 -stimulus[0].stimtype 3 \ 
 51 -stimulus[0].strength 0 \ 
 52 -stimulus[0].geometry $GROUND \ 
 53 -stimulus[0].duration $STIMDURATION \ 
 54 -stimulus[1].stimtype 0 \ 
 55 -stimulus[1].strength $VOLTAGE \ 
 56 -stimulus[1].geometry $STIM \ 
 57 -stimulus[1].start 0 \ 
 58 -stimulus[1].duration $STIMDURATION \ 
 59 -ellip_options_file ./amg_xl_opts \ 
 60 -parab_options_file ./ilu_cg_opts \ 
 61 -num_imp_regions 1 \ 
 62 -imp_region[0].im $CELLMODEL -imp_region[0].im_param g_Kr-50%,g_CaL-70%,g_to-50% 
 63  
 64 echo Launch CARP for restart run 1 ... 
 65 RESTART=${OUTPUTDIR_ACTIVATION1}/state.${DURATION_ACT1}.0 
 66 $LAUNCHER -np $NPROC ${CARPEXECUTABLE} \ 
 67 +F $PARAM_FILE \ 
 68 -meshname $MESH_NAME \ 
 69 -simID $OUTPUTDIR_RESTART1 \ 
 70 -num_tsav 1 \ 
 71 -tsav[0] $DURATION_RUN1.0 \ 
 72 -start_statef $RESTART \ 
 73 -tend $DURATION_RUN1 \ 
 74 -ellip_options_file ./amg_xl_opts \ 
 75 -parab_options_file ./ilu_cg_opts \ 
 76 -num_imp_regions 1 \ 
 77 -imp_region[0].im $CELLMODEL -imp_region[0].im_param g_Kr-50%,g_CaL-70%,g_to-50% 
 78  
 79 echo Launch CARP for activation run 2 ... 
 80 RESTART=${OUTPUTDIR_RESTART1}/state.${DURATION_RUN1}.0 
 81 $LAUNCHER -np $NPROC ${CARPEXECUTABLE} \ 
 82 +F $PARAM_FILE \ 
 83 -meshname $MESH_NAME \ 
 84 -simID $OUTPUTDIR_ACTIVATION2 \ 
 85 -num_tsav 1 \ 
 86 -tsav[0] $DURATION_ACT2.0 \ 
 87 -start_statef $RESTART \ 
 88 -tend $DURATION_ACT2 \ 
 89 -num_stim 2 \ 
 90 -stimulus[0].stimtype 3 \ 
 91 -stimulus[0].strength 0 \ 
 92 -stimulus[0].geometry $GROUND \ 
 93 -stimulus[0].duration $STIMDURATION \ 
 94 -stimulus[1].stimtype 0 \ 
 95 -stimulus[1].strength $VOLTAGE \ 
 96 -stimulus[1].geometry $STIM \ 
 97 -stimulus[1].start $DURATION_RUN1 \ 
 98 -stimulus[1].duration $STIMDURATION \ 
 99 -ellip_options_file ./amg_xl_opts \ 
100 -parab_options_file ./ilu_cg_opts \ 
101 -num_imp_regions 1 \ 
102 -imp_region[0].im $CELLMODEL -imp_region[0].im_param g_Kr-50%,g_CaL-70%,g_to-50% 
103  
104 # Restart after the second S1 stim, only run until required S2 
105 for i in "${S2INTS[@]}" 
106 do 
107     DURATION_RUN2=$(($DURATION_ACT2+$i)) 
108     DURATION_S2_act=$(($DURATION_RUN2+$t_4)) 
109     DURATION_S2_run=$(($DURATION_S2_act+$t_5)) 
110  
111     echo Launch CARP for restart run 2 ... 
112     RESTART=${OUTPUTDIR_ACTIVATION2}/state.${DURATION_ACT2}.0 
113     $LAUNCHER -np $NPROC ${CARPEXECUTABLE} \ 
114     +F $PARAM_FILE \ 
115     -meshname $MESH_NAME \ 
116     -simID $OUTPUTDIR_RESTART2 \ 
117     -num_tsav 1 \ 
118     -tsav[0] $DURATION_RUN2.0 \ 
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119     -start_statef $RESTART \ 
120     -tend $DURATION_RUN2 \ 
121     -ellip_options_file ./amg_xl_opts \ 
122     -parab_options_file ./ilu_cg_opts \ 
123     -num_imp_regions 1 \ 
124     -imp_region[0].im $CELLMODEL -imp_region[0].im_param g_Kr-50%,g_CaL-70%,g_to-50% 
125  
126     echo Launch CARP for S2 activation $i ... 
127     RESTART=${OUTPUTDIR_RESTART2}/state.${DURATION_RUN2}.0 
128     $LAUNCHER -np $NPROC ${CARPEXECUTABLE} \ 
129     +F $PARAM_FILE \ 
130     -meshname $MESH_NAME \ 
131     -simID ${OUTPUTDIR_S2_ACT}${i} \ 
132     -num_tsav 1 \ 
133     -tsav[0] $DURATION_S2_act.0 \ 
134     -start_statef $RESTART \ 
135     -tend $DURATION_S2_act \ 
136     -num_stim 2 \ 
137     -stimulus[0].stimtype 3 \ 
138     -stimulus[0].strength 0 \ 
139     -stimulus[0].geometry $GROUND \ 
140     -stimulus[0].duration $STIMDURATION \ 
141     -stimulus[1].stimtype 0 \ 
142     -stimulus[1].strength $VOLTAGE \ 
143     -stimulus[1].geometry $STIM \ 
144     -stimulus[1].start $DURATION_RUN2 \ 
145     -stimulus[1].duration $STIMDURATION \ 
146     -ellip_options_file ./amg_xl_opts \ 
147     -parab_options_file ./ilu_cg_opts \ 
148     -num_imp_regions 1 \ 
149     -imp_region[0].im $CELLMODEL -imp_region[0].im_param g_Kr-50%,g_CaL-70%,g_to-50% 
150      
151     echo Launch CARP for S2 restart $i 
152     RESTART=${OUTPUTDIR_S2_ACT}${i}/state.${DURATION_S2_act}.0 
153     $LAUNCHER -np $NPROC ${CARPEXECUTABLE} \ 
154     +F $PARAM_FILE \ 
155     -meshname $MESH_NAME \ 
156     -simID ${OUTPUTDIR_S2_RUN}${i} \ 
157     -start_statef $RESTART \ 
158     -tend $DURATION_S2_run \ 
159     -ellip_options_file ./amg_xl_opts \ 
160     -parab_options_file ./ilu_cg_opts \ 
161     -num_imp_regions 1 \ 
162     -imp_region[0].im $CELLMODEL -imp_region[0].im_param g_Kr-50%,g_CaL-70%,g_to-50% 




 1 num_gregions    =   1 
 2   
 3 gregion[0].num_IDs  =   3 
 4 gregion[0].name     =   "viable" 
 5 gregion[0].g_il         =       0.5 
 6 gregion[0].g_it         =       0.25 
 7 gregion[0].g_el         =       0.5 
 8 gregion[0].g_et         =       0.25 
 9 gregion[0].ID[0]    =   1 
10 gregion[0].ID[1]        =       721 
11 gregion[0].ID[2]        =       722 
12   
13 # Equation 
14   
15 bidomain    = 0  
16 dt      = 10    #microseconds 
17 parab_solve     = 1 
18 #ellip_solve     = 1 
19 vm_per_phie     = 4 
20   
21 # I/O 
22 spacedt     = 1 
23 timedt      = 1 #milliseconds; ie 1 = 1kHz   
24 gridout_i   = 2 
25 #gridout_e  = 2 
26  
27 # Local Activation Times 
28   
29 num_LATs          = 1 
30 lats[0].all       = 1 
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31 lats[0].measurand = 0 
32 lats[0].method    = 1 
33 lats[0].threshold = -20    #mV? 
34 lats[0].ID        = "latfile" 
35  
36 # Tag regions 
37   
38 numtagreg = 3 
39  
40 tagreg[0].name = tissue 
41 tagreg[0].type = 2 
42 tagreg[0].tag = 1 
43 tagreg[0].p0[0] = 0 
44 tagreg[0].p0[1] = 0 
45 tagreg[0].p0[2] = 0 
46 tagreg[0].p1[0] = 40000 
47 tagreg[0].p1[1] = 40000 
48 tagreg[0].p1[2] = 0 
49   
50 tagreg[1].name = stim 
51 tagreg[1].type = 2 
52 tagreg[1].tag = 721 
53 tagreg[1].p0[0] = 2000 
54 tagreg[1].p0[1] = 19500 
55 tagreg[1].p0[2] = 0 
56 tagreg[1].p1[0] = 3000 
57 tagreg[1].p1[1] = 20500 
58 tagreg[1].p1[2] = 0 
59  
60 tagreg[2].name = ground 
61 tagreg[2].type = 2 
62 tagreg[2].tag = 722 
63 tagreg[2].p0[0] = 39000 
64 tagreg[2].p0[1] = 0 
65 tagreg[2].p0[2] = 0 
66 tagreg[2].p1[0] = 40000 
67 tagreg[2].p1[1] = 40000 
68 tagreg[2].p1[2] = 0 
	
File	B-16.	param_trans.par	
 1 num_gregions    =   1 
 2   
 3 gregion[0].num_IDs  =   3 
 4 gregion[0].name     =   "viable" 
 5 gregion[0].g_il         =       0.5 
 6 gregion[0].g_it         =       0.25 
 7 gregion[0].g_el         =       0.5 
 8 gregion[0].g_et         =       0.25 
 9 gregion[0].ID[0]    =   1 
10 gregion[0].ID[1]        =       721 
11 gregion[0].ID[2]        =       722 
12   
13 # Equation 
14   
15 bidomain    = 0  
16 dt      = 10    #microseconds 
17 parab_solve     = 1 
18 #ellip_solve     = 1 
19 vm_per_phie     = 4 
20   
21 # I/O 
22 spacedt     = 1 
23 timedt      = 1 #milliseconds; ie 1 = 1kHz   
24 gridout_i   = 2 
25 #gridout_e  = 2 
26  
27 # Local Activation Times 
28   
29 num_LATs          = 1 
30 lats[0].all       = 1 
31 lats[0].measurand = 0 
32 lats[0].method    = 1 
33 lats[0].threshold = -20    #mV? 
34 lats[0].ID        = "latfile" 
35  
36 # Tag regions 
37   
38 numtagreg = 3 
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39  
40 tagreg[0].name = tissue 
41 tagreg[0].type = 2 
42 tagreg[0].tag = 1 
43 tagreg[0].p0[0] = 0 
44 tagreg[0].p0[1] = 0 
45 tagreg[0].p0[2] = 0 
46 tagreg[0].p1[0] = 40000 
47 tagreg[0].p1[1] = 40000 
48 tagreg[0].p1[2] = 0 
49   
50 tagreg[1].name = stim 
51 tagreg[1].type = 2 
52 tagreg[1].tag = 721 
53 tagreg[1].p0[0] = 19500 
54 tagreg[1].p0[1] = 2000 
55 tagreg[1].p0[2] = 0 
56 tagreg[1].p1[0] = 20500 
57 tagreg[1].p1[1] = 3000 
58 tagreg[1].p1[2] = 0 
59  
60 tagreg[2].name = ground 
61 tagreg[2].type = 2 
62 tagreg[2].tag = 722 
63 tagreg[2].p0[0] = 39000 
64 tagreg[2].p0[1] = 0 
65 tagreg[2].p0[2] = 0 
66 tagreg[2].p1[0] = 40000 
67 tagreg[2].p1[1] = 40000 
68 tagreg[2].p1[2] = 0 
 
Activation times are read from file with the following commands: 
more latfile-thresh.dat | grep "\<4\s" #centre node 
more latfile-thresh.dat | grep "\<25942\s" #longitudinal conduction 
more latfile-thresh.dat | grep "\<27513\s" #transverse conduction 
 
B.8 Dot Mapping Software used in Chapter 7 
File	B-17.	colorShell.m	
function dataField = colorShell(hSurf, pts, data, t, varargin) 
%     ********************************************************************** 
%     * The contents of this package are copyright (c) King's College London 
%     * 
%     * They may not be reproduced, distributed, modified or sold for any  
%     * purpose 
%     * 
%     * Author:     Dr S. E. Williams 
%     * Address:    Division of Imaging Sciences and Biomedical Engineering, 
%     *             King's College London 
%     *             St Thomas' Hospital 
%     * 
%     * March 2014 
%     ********************************************************************** 
  
% COLORSHELL shades the surface hSurf according to the scalar field data 
% given across pts 
% 
% Usage: 
%   colorShell(hSurf, pts, data, t) 
%   colorShell(..., 'propertyname', propertyvalue) 
% 
% Where: 
%   hSurf - see plotVelocityGeometry 
%   pts - the data position coordinates. Size mpts x ndim 
%   data - the data at each location of pts. Size mpts x ndata 
%   t - threshold distance greater than which shell will not be coloured 
% 
% COLORSHELL shades the surface of a shell according to the scalar field 
% data. If the property-value pair coloraxis is set then color thresholding 
% is performed: 
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%   triangles with |data|>max(caxis) - purple 
%   triangles with |data|<min(caxis) - brown 
% The property-value pair datatype is used to tell the colormap whether to 
% flip or not (otherwise jet is back-to-front for isochronal maps) 
% 
% Properties: 
%   showcolorbar        'show' | {'hide'} 
%   colorbarlocation    'north' | 'south' | 'east' | {'west'} | 'northoutside' | 
%                       'southoutside' | 'eastoutside' | 'westoutside' 
%   coloraxis           [caxismin caxismax] | {[min(min(data)) max(max(data))]} 
%   datatype            {'activation'} | 'force' | 'voltage' 
%   interpolation       {'on'} | 'off' 
%   colororder          {'forward'} | 'reverse' 
% 
% Author: Steven Williams (2013) 
% Modifications - 
% 
% Info on Code Testing: 
% --------------------------------------------------------------- 
% % 1. Color by height 
%     DISTANCETHRESH = 12; 
%     [elec, hSurf, ~, ~] = plotVelocityGeometry(VelocityData, 'all', 'bip'); 
%     data = elec.Position(:,3); 
%     colorShell(hSurf, elec.Position, data, DISTANCETHRESH); 
% 
% % 2. Color by a random dataset 
%     DISTANCETHRESH = 12; 
%     [elec, hSurf, ~, ~] = plotVelocityGeometry(VelocityData, 'all', 'bip'); 
%     data = rand(size(elec.Position(:,3))); 
%     colorShell(hSurf, elec.Position, data, DISTANCETHRESH); 
% 
% % 3. Color by a single site with high values 
%     SITE = 4; 
%     DISTANCETHRESH = 12; 
%     [elec, hSurf, ~, ~] = plotVelocityGeometry(VelocityData, 'all', 'bip'); 
%     data = zeros(size(elec.Position(:,3))); 
%     data(1+10*SITE:10+10*SITE) = 1; 
%     colorShell(hSurf, elec.Position, data, DISTANCETHRESH); 
% 
% % 4. Color by a number of different sites with high values and step thru 
%     SITE = [1 2 3 4 5 6 7 8 9 10]; 
%     DISTANCETHRESH = 12; 
%     [elec, hSurf, ~, ~] = plotVelocityGeometry(VelocityData, 'all', 'bip'); 
%     data = zeros(size(elec.Position(:,3))); 
%     data = repmat(data, 1, numel(SITE)); 
%     for i = 1:numel(SITE) 
%         data(10*(SITE(i)-1)+1:10+10*(SITE(i)-1), i) = 1; 
%     end 
%     colorShell(hSurf, elec.Position, data, DISTANCETHRESH); 
% 
% % 5. Color by individual points with high values and step thru 
%     SITE = 1:100; 
%     DISTANCETHRESH = 12; 
%     [elec, hSurf, ~, ~] = plotVelocityGeometry(VelocityData, 'all', 'bip'); 
%     data = zeros(size(elec.Position(:,3))); 
%     data = repmat(data, 1, numel(SITE)); 
%     for i = 1:numel(SITE) 
%         data(SITE(i), i) = 1; 
%     end 
%     colorShell(hSurf, elec.Position, data, DISTANCETHRESH); 
% 
% % 6. Force shell 
%     clf; 
%     hSurf = trisurf(userdata.surface.triRep); 
%     axis equal vis3d; 
%     DISTANCETHRESH = 4; 
%     colorShell(hSurf, userdata.electric.egmSurfX, userdata.electric.force.force, 
DISTANCETHRESH ...  
%       , 'showcolorbar', 'show' ... 
%       , 'coloraxis', [1 40] ... 
%       , 'datatype', 'force' ... 
%     ); 
% 
% % 7. Activation map based on interpolated Carto data 
%     clf 
%     hSurf = trisurf(userdata.surface.triRep); 
%     axis equal vis3d 
%     DISTANCETHRESH = 10; 
%     t_min = min(userdata.surface.act_bip(:,1)); 
%     t_max = max(userdata.surface.act_bip(:,1)); 
%     colorShell(hSurf, userdata.electric.egmSurfX, userdata.surface.act_bip(:,1), 
DISTANCETHRESH ... 
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%         , 'showcolorbar', 'show' ... 
%         , 'coloraxis', [t_min t_max] ... 
%         , 'datatype', 'activation' ... 
%         , 'interpolation', 'off' ... 







% Validate input 





p.addParamValue('showcolorbar', 'hide', @(x)isstr(x) &&(strcmpi(x,'hide') || strcmpi(x, 
'show'))); 
p.addParamValue('colorbarlocation', 'west', @(x)isstr(x) && (strcmpi(x, 'north') ... 
    || strcmpi(x, 'south') || strcmpi(x, 'east') || strcmpi(x, 'west') ... 
    || strcmpi(x, 'northoutside') || strcmpi(x, 'southoutside') ... 
    || strcmpi(x, 'eastoutside') || strcmpi(x, 'westoutside') ... 
    )); 
p.addParamValue('coloraxis', [], @isnumeric); 
p.addParamValue('datatype', 'activation', @isstr); 
p.addParamValue('colororder', 'forward', @isstr);  
p.addParamValue('interpolation', 'on', @isstr); 
p.parse(hSurf, pts, data, t, varargin{:}); 
inputs = p.Results; 
showcolorbar = inputs.showcolorbar; 
colorbarlocation = inputs.colorbarlocation; 
coloraxis = inputs.coloraxis; 
datatype = inputs.datatype; 
colororder = inputs.colororder; 
doInterpolation = inputs.interpolation; 
  
% Get a handle to the figure 
hFig = get(get(hSurf,'parent'),'parent'); 
  
% Draw the sliderbar, if there is more than one dataset 
if size(data,2)>1 
    hSl = uicontrol(hFig, 'style', 'slider' ... 
        , 'units', 'normalized' ... 
        , 'position', [.8 .1 .15 .05] ... 
        , 'callback', @adjustSlider ... 
        , 'min', 1 ... 
        , 'max', size(data,2) ... 
        , 'value', 1 ... 
        , 'sliderstep', [1/(size(data,2)-1) 1/(size(data,2)-1)] ... 
        ); 
end 
  
% Call adjust slider for the first time 
adjustSlider(); 
  
    function adjustSlider(~, ~, ~) 
                 
        % Get the value of the sliderbar, if it exists 
        if exist('hSl', 'var') 
            i = round(get(hSl, 'value')); 
        else 
            i = 1; 
        end 
         
        % Every point in the surface - r for required. 
        rPts = get(hSurf, 'Vertices'); 
         
        % If necessary perform interpolation 
        switch doInterpolation 
            case 'on' 
                % Set up the interpolation 
                warning('off','MATLAB:scatteredInterpolant:DupPtsAvValuesWarnId'); 
                tempdata = data(:,i); 
                temppts = pts; 
                indexRemove = isnan(tempdata); 
                tempdata(indexRemove,:)=[]; 
                temppts(indexRemove,:)=[]; 
                F = scatteredInterpolant(temppts, tempdata ... 
                    , 'natural' ... %interpolation method - linear, nearest or natural 
                    , 'linear' ... %extrapolation method - linear, nearest or none 
                    );  
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                dataField = F(rPts); 
            case 'off' 
                dataField = data(:,i); 
                temppts = pts; 
        end 
         
        if isempty(dataField) 
            return 
        end 
         
        % Find the shortest distance from every point in the surface to the dataset 
        % pointcloud 
        id = knnsearch(temppts, rPts); 
        cPts = temppts(id,:); %c for closest 
        d = distBetweenPoints(cPts, rPts); 
         
        % if coloraxis has been specified set up for raw data thresholding now 
        tAboveCAxis = zeros(size(d)); 
        tBelowCAxis = zeros(size(d)); 
        if ~isempty(coloraxis) 
            tAboveCAxis(dataField>max(coloraxis)) = 1; 
            tBelowCAxis(dataField<min(coloraxis)) = 1; 
        end 
         
        % Define magenta and brown 
        magenta = [1 0 1]; 
        brown = [92 51 23]  /256; 
        if strcmpi(colororder, 'reverse') 
            disp('hi') 
            tmp = brown; 
            brown = magenta; 
            magenta = tmp; 
        end 
             
         
        % Get the appropriate color map 
        switch datatype 
            case 'activation' 
                colormap(ones([64,3])); 
                cMap = hsv; 
                if length(cMap)==64 
                    cMap(end-8:end,:) = []; 
                end 
            case 'force' 
                cMap = jet; 
            case 'voltage' 
                cMap = jet; 
                %otherwise 
                %    disp('IN OTHERWISE'); 
                %    cMap = hsv; 
                %    if length(cMap)==64 
                %        cMap(end-36:end,:) = []; 
                %    end 
                %    %assume activation if not specified 
        end 
         
        % Limit the size of the colormap 
        if length(cMap) > 256; 
            cMap = downsample(cMap, round(length(cMap)/256)); 
        end 
        %set(gcf, 'colormap', cMap); 
        colormap(cMap); 
        disp(['Length of cMap is: ' num2str(length(cMap))]); 
         
        scaledDataField = round(scaleData( dataField(~tAboveCAxis & ~tBelowCAxis), [1 
size(cMap,1)] )); 
        iC = ones(size(dataField)); 
        iC(find(~tAboveCAxis & ~tBelowCAxis)) = scaledDataField; %#ok<FNDSB> 
        thresholdNaN = isnan(iC); 
        iC(thresholdNaN) = 1; 
        col = cMap(iC,:); 
         
        % At this point the color map col is correct for all non-nan points 
        % p satisfying the expression min(caxis)<dataField(p)<max(caxis) 
         
        % threshold based on coloraxis 
        if ~isempty(coloraxis) 
            col(logical(tAboveCAxis),:) = repmat(magenta, [numel(find(tAboveCAxis)),1]); 
            col(logical(tBelowCAxis),:) = repmat(brown, [numel(find(tBelowCAxis)),1]); 
        end 
         
        % Threshold based on the distance t 
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        thresholdDistance = zeros(size(d)); 
        thresholdDistance(d>t) = 1; 
         
        % Create the color data matrix, making any vertex grey when it is greater 
        % than t distance from the point cloud. 
        col(logical(thresholdDistance),:) = .6; %ie [.6 .6 .6] grey 
        col(logical(thresholdNaN),:) = .6; % ie [1 1 1] white 
         
        % Update the color of the surface 
        set(hSurf, 'FaceVertexCData', col ... 
            ,'FaceColor', 'interp' ... 
            ,'FaceAlpha', 1 ... 
            ); 
         
         
        % Set the figure color axis 
        colorAxis = [min(min(data)) max(max(data))]; 
        if ~isnan(colorAxis(1)) && ~isnan(colorAxis(2)) 
            caxis(colorAxis); 
             
             
            % Create the figure color map 
            if range(coloraxis)>0 
                incrementOfCMap = length(cMap) / range(coloraxis); 
                 
                nMagenta = ceil( (max(data(:,i)) - max(coloraxis)) * incrementOfCMap ); 
                 
                nBrown = ceil( (min(coloraxis) - min(data(:,i)) ) * incrementOfCMap ); 
                 
                cMapMagenta = repmat(magenta, [nMagenta, 1]); 
                cMapBrown = repmat(brown, [nBrown, 1]); 
                figureCMap = vertcat(cMapBrown, cMap, cMapMagenta); 
                 
            else 
                % there is a single threshold 
                thresh = min(coloraxis); 
                nColors = 256; 
                nMagenta = ceil( ((max(data(:,i)) - thresh)/range(data(:,i))) * nColors ); 
                nBrown = ceil( ((thresh)/range(data(:,i))) * nColors ); 
                cMapMagenta = repmat(magenta, [nMagenta, 1]); 
                cMapBrown = repmat(brown, [nBrown, 1]); 
                figureCMap = vertcat(cMapBrown, cMapMagenta); 
            end 
            set(gcf, 'colormap', figureCMap); 
             
        end 
         
        % Show the colorbar 
        if strcmpi(showcolorbar, 'show') 
            % show the color bar 
            colorbar('delete'); 
            colorbar('location', colorbarlocation); 
             
        elseif strcmpi(showcolorbar, 'hide') 
            % hide the color bar 
            colorbar('delete'); 
        end 
         
        % Return the scaledData if asked for 
        if strcmpi(datatype,'force') 
            dataField(logical(thresholdDistance),:) = 0; 
            dataField(logical(thresholdNaN),:) = 0; 
        end 
         




function D = distBetweenPoints(A, B, varargin) 
%     ********************************************************************** 
%     * The contents of this package are copyright (c) King's College London 
%     * 
%     * They may not be reproduced, distributed, modified or sold for any  
%     * purpose 
%     * 
%     * Author:     Dr S. E. Williams 
%     * Address:    Division of Imaging Sciences and Biomedical Engineering, 
%     *             King's College London 
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%     *             St Thomas' Hospital 
%     * 
%     * March 2014 
%     ********************************************************************** 
  
% DISTBETWEENPOINTS Returns the distance from A to B. 
% Usage: 
%   D = DISTBETWEENPOINTS(A, B) 
% Where: 
%   A - is the first point(s) 
%   B - is the second point(s) 
% 
% DISTBETWEENPOINTS returns the distance from A to B. A and B are specified 
% as row vectors [x, y, z] or matrices, with rows representing different 
% points. 
% 
% Author: Steven Williams (2013) 
% Modifications - 
% 
% Info on Code Testing: 
% --------------------------------------------------------------- 








    warn = varargin{1}; 
else 
    warn = false; 
end 
if size(A,2) ~= size(B,2); 
    error('DISTBETWEENPOINTS: dimensions of points in A and B must be equal'); 
end 
if size(A,1) ~= size(B,1); 
    if size(A,1) ~= 1 
        error('DISTBETWEENPOINTS: if npoints in A and B are different A must specify one and 
only one point'); 
    else 
        A = repmat(A, size(B,1), 1); 
        if warn 
            warning('DISTBETWEENPOINTS: A has been replicated size(B,1) times'); 
        end 
    end 
end 
  
diffsq = (A - B).^2; 
  






classdef DotGuiStatic < hgsetget 
%     ********************************************************************** 
%     * The contents of this package are copyright (c) King's College London 
%     * 
%     * They may not be reproduced, distributed, modified or sold for any  
%     * purpose 
%     * 
%     * Author:     Dr S. E. Williams 
%     * Address:    Division of Imaging Sciences and Biomedical Engineering, 
%     *             King's College London 
%     *             St Thomas' Hospital 
%     * 
%     * March 2014 
%     ********************************************************************** 
  
    % DOTGUI objects draw scar datasets using Dot Mapping 
    % 
    % Usage: 
    %   hDg = DotGui(); 
    % 
    % Where: 
    %   tf - is a boolean variable indicating whether headtracking is used 
    %   hDg - is a handle to the DotGui object 
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    % 
    % DOTGUI objects draw scar datasets using Dot Mapping. DOTGUI uses 
    % dialogue boxes to access either a VTK file or a MAT file. Details for 
    % for each are as follows: 
    %   (1) VTK file: input     - VTKReader object 
    %                 scar data - CellData of VTKReader 
    %   (2) MAT file: input     - Local function of pbhLoad_call() method 
    %                 scar data - inferred from bipolar voltage 
    %                             (userdata.surface.act_bip(:,2) 
    % - In the case of a VTK file only one data set is displayed (scar). 
    % - In the case of a MAT file, two datasets may be displayed (scar and 
    %   activation time). 
    % 
    % Possible Improvement - store two data sets in a .vtk file (LGE/scar 
    % information represented in CellData and voltage or activation time 
    % represented in PointsData. 
    % 
    % Having access the required dataset, DOTGUI reformats the shell 
    % (scaling to unit size, rotating as necessary to face the anterior 
    % wall and centering on the origin). The GUI is created 
    % programmatically. 
    % 
    % The DOTGUI constructor creates the following objects : 
    %   hDg.hDM     - DotMap 
    %   hDg.hP3D    - Pseudo3D 
    %   hDg.hVisAx  - VisualizerAxis 
    % 
    % Author: Steven Williams (2012) 
    % Modifications - 
    % 
    % Info on Code Testing: 
    % --------------------- 
    % 
    % --------------------- 
    % 
    % Use warnings with the following format 
    %    disp('DOTGUI: warning.') 
    % 
    % --------------------------------------------------------------- 
    % code 
    % --------------------------------------------------------------- 
     
    properties (SetAccess = private, GetAccess = public) 
        Brightness = 1 
        Contrast = 1 
        Mode = 'scar' 
        GeometryDOTS 
        GeometryCOLOR 
        SigIntensity = 1 
        hDM 
        IsVertexAtRim 
        hLight 
    end 
     
    properties (SetAccess = public, GetAccess = public) 
        S % structure of ui element handles 
        DATASETCOLOR 
        DATASETDOTS 
        DATASETDOTS_processed 
        DATASETCOLOR_processed 
        SAMPLEPOSITIONSCOLOR 
        SAMPLEPOSITIONSDOTS 
        ColorMapType = 'activation' 
        CvData 
    end 
     
     
    properties (SetAccess = private, GetAccess = private) 
        AxisListener 
    end 
     
    methods 
        % Constructor 
        function hDg = DotGuiStatic(varargin) 
            % Set up the GUI 
            hDg.initialiseGui(); 
             
            % Set up the DotMap (sample data) 
            sampleTr = TriRep([1 2 3], [0 0 0; 0 0 0; 0 0 0]); 
            hDg.hDM = DotMapRim(sampleTr, 0); 
             
            if numel(varargin)>0 
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                hDg.loadInitialisation(varargin{1}); 
            end 
             
            % Set up the listner for camera position changes 
            hDg.AxisListener = addlistener(hDg.S.ax, 'CameraPosition' ... 
                , 'PostSet', @hDg.cameraMoved); 
        end 
         
        % Initialise the GUI 
        function hDg = initialiseGui(hDg) 
            % Figure window 
         
            hDg.S.fh = figure('units', 'pixels' ... 
                , 'position', [100 200 820 450] ... 
                , 'menubar', 'none' ... 
                , 'numbertitle', 'off' ... 
                , 'name', 'Dot Map - Surface Shell' ... 
                , 'resize', 'on' ... 
                , 'renderer', 'zbuffer' ... 
                ); 
            cameratoolbar(hDg.S.fh, 'setcoordsys', 'none'); 
             
            hDg.S.uip1 = uipanel(hDg.S.fh ... 
                , 'units', 'normalized' ... 
                , 'position', [0 .1 1 .9] ... 
                , 'backgroundcolor', [.6 .6 .6] ... 
                ); 
            hDg.S.uip2 = uipanel(hDg.S.fh ... 
                , 'units', 'normalized' ... 
                , 'position', [0 0 1 .1] ... 
                ); 
            hDg.S.uip2a = uipanel(hDg.S.uip2 ... 
                , 'units', 'normalized' ... 
                , 'position', [0 0 .05 1] ... 
                , 'title', 'View' ... 
                ); 
            hDg.S.uip2b = uipanel(hDg.S.uip2 ... 
                , 'units', 'normalized' ... 
                , 'position', [.05 0 .1 1] ... 
                , 'title', 'Show' ... 
                ); 
            hDg.S.uip2c = uipanel(hDg.S.uip2 ... 
                , 'units', 'normalized' ... 
                , 'position', [.25 0 .4 1] ... 
                , 'title', 'Dot' ... 
                ); 
            hDg.S.uip2d = uipanel(hDg.S.uip2 ... 
                , 'units', 'normalized' ... 
                , 'position', [.65 0 .3 1] ... 
                , 'title', 'Color' ... 
                ); 
            hDg.S.uip2e = uipanel(hDg.S.uip2 ... 
                , 'units', 'normalized' ... 
                , 'position', [.95 0 .05 1] ... 
                , 'title', 'File' ... 
                ); 
             
            % Axis 
            hDg.S.ax = axes('Parent', hDg.S.uip1 ... 
                , 'units', 'normalized' ... 
                , 'Position', [0 0 1 1] ... 
                , 'xcolor','k' ... 
                , 'ycolor','k' ... 
                , 'xtick',[] ... 
                , 'ytick',[] ... 
                , 'Color', 'k' ... 
                ); 
            hDg.hLight = light; 
  
             
            % Popup Menu - Color 
            hDg.S.pumColor = uicontrol(hDg.S.uip2d ... 
                , 'Style', 'popup' ... 
                , 'String', 'LAT|Voltage' ... 
                , 'units', 'normalized' ... 
                , 'position', [.1 1/3 .8 1/3] ... 
                , 'callback', {@hDg.pumColor_call} ... 
                ); 
            % Sliderbar - Color 
            hDg.S.sbThreshCondVel = uicontrol(hDg.S.uip2d ... 
                , 'Style', 'slider' ... 
                , 'Units', 'normalized' ... 
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                , 'Position', [.1 2/3 .8 1/3] ... 
                , 'value', 1500 ... 
                , 'min', 1, 'max', 3000 ... 
                , 'callback', {@hDg.sbThreshCondVel_call} ... 
                , 'visible', 'off' ... 
                ); 
            % Pushbutton - load .mat file 
            hDg.S.pbhLoad = uicontrol(hDg.S.uip2e ... 
                , 'Style', 'pushbutton' ... 
                , 'String', 'LOAD .mat' ... 
                , 'Units', 'normalized' ... 
                , 'Position', [0 0 1 .5] ... 
                , 'callback', {@hDg.pbhLoadMat_call} ... 
                ); 
            % Pushbutton - load .vtk files 
            hDg.S.pbhLoad = uicontrol(hDg.S.uip2e ... 
                , 'Style', 'pushbutton' ... 
                , 'String', 'LOAD .vtk' ... 
                , 'Units', 'normalized' ... 
                , 'Position', [0 .5 1 .5] ... 
                , 'callback', {@hDg.pbhLoadVtk_call} ... 
                ); 
            % Pushbutton - graph 
            hDg.S.pbhGraph = uicontrol(hDg.S.uip2 ... 
                , 'Style', 'pushbutton' ... 
                , 'String', 'GRAPH' ... 
                , 'Units', 'normalized' ... 
                , 'Position', [0.17 0 0.06 1] ... 
                , 'callback', {@hDg.pbhGraph_call} ... 
                , 'visible', 'off' ... 
                ); 
            % Pushbutton - rotate 
            hDg.S.pbhRotate = uicontrol(hDg.S.uip2a ... 
                , 'Style', 'pushbutton' ... 
                , 'String','Rotate' ... 
                , 'Units', 'normalized' ... 
                , 'Position', [0 0 1 1/3] ... 
                , 'callback', {@hDg.pbhRotate_call} ... 
                ); 
            % Pushbutton - zoom 
            hDg.S.pbhZoom = uicontrol(hDg.S.uip2a ... 
                , 'Style', 'pushbutton' ... 
                , 'String', 'Zoom' ... 
                , 'Units', 'normalized' ... 
                , 'Position', [0 1/3 1 1/3] ... 
                , 'callback', {@hDg.pbhZoom_call} ... 
                ); 
            % Pushbutton - pan 
            hDg.S.pbhPan = uicontrol(hDg.S.uip2a ... 
                , 'Style', 'pushbutton' ... 
                , 'String','Pan' ... 
                , 'Units', 'normalized' ... 
                , 'Position', [0 2/3 1 1/3] ... 
                , 'callback', {@hDg.pbhPan_call} ... 
                ); 
            % Sliderbar - brightness 
            hDg.S.sbBrightness = uicontrol(hDg.S.uip2c ... 
                , 'Style', 'slider' ... 
                , 'Units', 'normalized' ... 
                , 'Position', [.6 0 .35 1/3] ... 
                , 'value', 0.5 ... 
                , 'callback', {@hDg.sbBrightness_call} ... 
                ); 
            % Sliderbar - contrast 
            hDg.S.sbContrast = uicontrol(hDg.S.uip2c ... 
                , 'Style', 'slider' ... 
                , 'Units', 'normalized' ... 
                , 'Position', [.6 1/3 .35 1/3] ... 
                , 'value', 0.5 ... 
                , 'callback', {@hDg.sbContrast_call} ... 
                ); 
            % Sliderbar - threshold 
            hDg.S.cbThreshold = uicontrol(hDg.S.uip2c ... 
                , 'Style', 'checkbox' ... 
                , 'Units', 'normalized' ... 
                , 'Position', [.6 0.75 .05 0.25] ... 
                , 'Value', 0 ... 
                , 'callback', {@hDg.cbThreshold_call} ... 
                ); 
            hDg.S.sbThreshold = uicontrol(hDg.S.uip2c ... 
                , 'Style', 'slider' ... 
                , 'Units', 'normalized' ... 
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                , 'Position', [.65 2/3 .20 1/3] ... 
                , 'min', 0 ... 
                , 'max', 10 ... 
                , 'value', 0.5 ... 
                , 'callback', {@hDg.sbThreshold_call} ... 
                ); 
            hDg.S.stThresholdValue = uicontrol(hDg.S.uip2c ... 
                , 'Style', 'text' ... 
                , 'Units', 'normalized' ... 
                , 'Position', [.85 2/3 .1 1/3] ... 
                ); 
            % Text 
            hDg.S.stBrightness = uicontrol(hDg.S.uip2c ... 
                , 'Style', 'text' ... 
                , 'Units', 'normalized' ... 
                , 'Position', [.4 0 .2 1/3] ... 
                , 'String', 'Brightness' ... 
                ); 
            hDg.S.stContrast = uicontrol(hDg.S.uip2c ... 
                , 'Style', 'text' ... 
                , 'Units', 'normalized' ... 
                , 'Position', [.4 1/3 .2 1/3] ... 
                , 'String', 'Contrast' ... 
                ); 
            hDg.S.stThreshold = uicontrol(hDg.S.uip2c ... 
                , 'Style', 'text' ... 
                , 'Units', 'normalized' ... 
                , 'Position', [.4 2/3 .2 1/3] ... 
                , 'String', 'Threshold' ... 
                ); 
            % Togglebutton - surface 
            hDg.S.tbSurface = uicontrol(hDg.S.uip2b ... 
                , 'Style', 'toggle' ... 
                , 'Units', 'normalized' ... 
                , 'Position', [0 0 1 .5] ... 
                , 'String', 'Surface' ... 
                , 'callback', {@hDg.tbSurface_call} ... 
                ); 
            set(hDg.S.tbSurface, 'Value', get(hDg.S.tbSurface, 'Max')); 
            % Togglebutton - dots 
            hDg.S.tbDots = uicontrol(hDg.S.uip2b ... 
                , 'Style', 'toggle' ... 
                , 'Units', 'normalized' ... 
                , 'Position', [0 .5 1 .5] ... 
                , 'String', 'Dots' ... 
                , 'callback', {@hDg.tbDots_call} ... 
                ); 
            set(hDg.S.tbDots, 'Value', get(hDg.S.tbDots, 'Max')); 
            % Radiobuttons - mode 
            hDg.S.bghMode = uibuttongroup('Parent', hDg.S.uip2c ... 
                , 'Title', '' ... 
                , 'Units', 'normalized' ... 
                , 'Position', [0 0 .4 1] ... 
                , 'SelectionChangeFcn', {@hDg.bghMode_call} ... 
                ); 
            hDg.S.rbhScar = uicontrol(hDg.S.bghMode ... 
                , 'Style', 'radiobutton' ... 
                , 'Units', 'normalized' ... 
                , 'Position', [0 0 1 .5] ... 
                , 'String', 'Scar' ... 
                , 'Tag', 'dotsScar' ... 
                ); 
            hDg.S.rbhUniform = uicontrol(hDg.S.bghMode ... 
                , 'Style', 'radiobutton' ... 
                , 'Units', 'normalized' ... 
                , 'Position', [0 .5 1 .5] ... 
                , 'String', 'Uniform' ... 
                , 'Tag', 'dotsUniform' ... 
                );  
        end 
         
        % reset instance variables 
        function hDg = resetInstanceVariables(hDg) 
             
            %variables 
            hDg.Brightness = 1; 
            hDg.Contrast = 1; 
            hDg.Mode = 'scar'; 
            hDg.SigIntensity = 1; 
            hDg.IsVertexAtRim = []; 
            hDg.S % structure of ui element handles 
            hDg.DATASETCOLOR = []; 
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            hDg.DATASETDOTS = []; 
            hDg.DATASETDOTS_processed = []; 
            hDg.DATASETCOLOR_processed = []; 
            hDg.SAMPLEPOSITIONSCOLOR = []; 
            hDg.SAMPLEPOSITIONSDOTS = []; 
            hDg.ColorMapType = 'activation'; 
            hDg.CvData = []; 
             
            %gui 
            set(hDg.S.pumColor, 'value', 1); 
            set(hDg.S.sbThreshCondVel, 'value', 1500); 
            set(hDg.S.sbBrightness, 'value', 0.5); 
            set(hDg.S.sbContrast, 'value', 0.5); 
            set(hDg.S.cbThreshold, 'value', 0); 
            set(hDg.S.sbThreshold, 'value', 0.5); 
            set(hDg.S.tbDots, 'value', get(hDg.S.tbDots, 'max')); 
            set(hDg.S.bghMode, 'selectedobject', hDg.S.rbhScar); 
             
            % Set up the listner for camera position changes 
            hDg.AxisListener = addlistener(hDg.S.ax, 'CameraPosition' ... 
                , 'PostSet', @hDg.cameraMoved); 
        end 
         
        % // Callback // - CameraMoved: Called by the listener if cameraposition changes 
        function cameraMoved(hDg, src, event) %#ok<INUSD> 
            axis = hDg.S.ax; 
             
            %Calculate the new distance from the camera to the target 
            lightPosNew = get(axis, 'CameraPosition') .* 5; 
             
            %Reposition the light 
            set(hDg.hLight, 'position', lightPosNew); 
        end 
         
        % // Callback // - Load: Called by hDg.S.pbhLoadMat 
        function pbhLoadMat_call(hDg, src, evt) %#ok<INUSD> 
            % reset instance variables 
            hDg.resetInstanceVariables(); 
             
            % Use a dialogue to get the .vtk or .mat file 
            persistent openDir 
            if isempty(openDir) 
                openDir = stevematlabroot(); 
            end 
            if ~isdir(openDir) 
                openDir = stevematlabroot(); 
            end 
            [filename, pathname] = uigetfile( ... 
                {'*.mat','MatLab Files (*.mat)'} ... 
                , 'Select a file' ... 
                , openDir ... 
                , 'MultiSelect', 'off'); 
            if isequal(filename,0) || isequal(pathname,0) 
                return; 
            else 
                openDir = pathname; 
                abspath = strcat(pathname, filesep(), filename); 
            end 
             
            load(abspath); 
             
            % -- user selected a MAT file            
            GeometryColor = userdata.surface.triRep; 
            GeometryDots = userdata.surface.triRep; 
            DataColor = userdata.surface.act_bip(:,1); 
            DataDots = userdata.surface.act_bip(:,2); 
            SamplePosColor = userdata.electric.egmSurfX; 
            SamplePosDots = userdata.electric.egmSurfX; 
            isVertexAtRim = userdata.surface.isVertexAtRim; 
             
            hDg.loadInitialisation(GeometryColor, GeometryDots, DataColor, DataDots, 
SamplePosColor, SamplePosDots, isVertexAtRim);      
        end 
         
        % // Callback // - Load: Called by hDg.S.pbhLoadVtk 
        function pbhLoadVtk_call(hDg, scr, evt) 
            % reset instance variables 
            hDg.resetInstanceVariables(); 
             
           % Use a dialog to get the .vtk files 
           persistent openDir 
           if isempty(openDir) 
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               openDir = stevematlabroot(); 
           end 
           if ~isdir(openDir) 
               openDir = stevematlabroot(); 
           end 
           [filename1, pathname1] = uigetfile( ... 
               {'*.vtk', 'VTK Files (*.vtk)'} ... 
               , 'Select the VTK file to be drawn in color' ... 
               , openDir ... 
               , 'MultiSelect', 'off'); 
           if isequal(filename1,0) || isequal(pathname1,0) 
               return; 
           else 
               openDir = pathname1; 
               absPathVtkFile1 = strcat(pathname1, filesep(), filename1); 
           end 
           [filename2, pathname2] = uigetfile( ... 
               {'*.vtk', 'VTK Files (*.vtk)'} ... 
               , 'Select the VTK file to be drawn in dots' ... 
               , openDir ... 
               , 'MultiSelect', 'off'); 
           if isequal(filename2,0) || isequal(pathname2,0) 
               return; 
           else 
               openDir = pathname2; 
               absPathVtkFile2 = strcat(pathname2, filesep(), filename2); 
           end 
            
           %load the vtk files 
           vtk1 = VTKReader(absPathVtkFile1); 
           vtk1.readAllData(); 
           vtk2 = VTKReader(absPathVtkFile2); 
           vtk2.readAllData(); 
            
           % -- user selected a VTK file            
            GeometryColor = TriRep(vtk1.Cells+1, vtk1.Points); 
            GeometryDots = TriRep(vtk2.Cells+1, vtk2.Points); 
            DataColor = vtk1.PointData; 
            %DataDots = 1000 * (max(vtk2.PointData) - vtk2.PointData); 
            DataDots = vtk2.PointData; 
             
            SamplePosColor = GeometryColor.X; %pretend sampled at every point 
            SamplePosDots = GeometryDots.X; %pretend sampled at every point 
            isVertexAtRim = []; 
             
            hDg.loadInitialisation(GeometryColor, GeometryDots, DataColor, DataDots, 
SamplePosColor, SamplePosDots, isVertexAtRim);      
        end 
         
        function loadInitialisation(hDg, GeometryColor, GeometryDots, DataColor, DataDots, 
SamplePosColor, SamplePosDots, isVertexAtRim) 
            % The contract is that this method must set the following 
            % properties in DotGuiStatic: 
            %   hDg.Mode 
            %   hDg.SAMPLEPOSITIONSCOLOR 
            %   hDg.DATASETCOLOR_processed 
            %   hDg.DATASETCOLOR 
            %   hDg.IsVertexAtRim 
            %   hDg.DATASETDOTS_processed 
            %   hDg.DATASETDOTS 
            %   hDg.GeometryCOLOR 
            %   hDg.GeometryDOTS 
            % The following properties must also be set in DotMapRim 
            %   hDM.MmScale 
             
            % Store the geometry 
            points = GeometryColor.X; 
            Rx = rotationmatrix(pi/2, pi, pi/2); 
            [points, divFactor, centre] = local_rotateScaleCentre(points, Rx); 
            hDg.GeometryCOLOR = TriRep(GeometryColor.Triangulation, points); 
            samplePointsColor = local_rotateScaleCentre(SamplePosColor, Rx, divFactor, 
centre); 
             
            points = GeometryDots.X; 
            [points, ~, ~] = local_rotateScaleCentre(points, Rx, divFactor, centre); % use 
previous divFactor and centre 
            hDg.GeometryDOTS = TriRep(GeometryDots.Triangulation, points); 
            samplePointsDots = local_rotateScaleCentre(SamplePosDots, Rx, divFactor, centre); 
             
            % Store the size of 1 mm in the new coordinate system 
            hDg.hDM.MmScale = 1/divFactor; 
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            % Store the raw datasets 
            hDg.DATASETCOLOR = DataColor; 
            hDg.DATASETDOTS = DataDots; 
             
            % Store and threshold the voltage 
            state = get(hDg.S.cbThreshold, 'value'); 
            switch state 
                case 0 
                    threshold = Inf; 
                case 1 
                    threshold = get(hDg.S.sbThreshold, 'value'); 
            end 
            hDg.DATASETDOTS_processed = 
local_thresholdVertexDataAndConvertToFaceData(hDg.DATASETDOTS, hDg.GeometryDOTS, threshold); 
             
            % Store the valve orifices 
            if ~isempty(isVertexAtRim) 
                hDg.IsVertexAtRim = isVertexAtRim; 
            else 
                hDg.IsVertexAtRim = []; 
            end 
             
            % By default, colour faces according to DATASETCOLOR, show scar 
            hDg.DATASETCOLOR_processed = hDg.DATASETCOLOR; 
            hDg.SAMPLEPOSITIONSCOLOR = samplePointsColor; 
            hDg.SAMPLEPOSITIONSDOTS = samplePointsDots; 
            hDg.Mode = 'scar'; 
            set(gca, 'CameraPosition', [10 0 0]); 
             
            hDg.updateDotMap(); 
        end         
         
        % --- Helper function to update the state of the DotMap object 
        function hDg = updateDotMap(hDg) 
             
            % set the state of Threshold 
            state = get(hDg.S.cbThreshold, 'value'); 
            switch state 
                case 0 
                    hDg.hDM.Threshold = 'off'; 
                case 1 
                    hDg.hDM.Threshold = 'on'; 
            end 
            hDg.hDM.ThresholdValue = get(hDg.S.sbThreshold, 'value'); 
             
            % display the threshold value 
            thresholdValue = get(hDg.S.sbThreshold, 'Value'); 
            set(hDg.S.stThresholdValue, 'String', thresholdValue); 
             
            % display the colorbar 
            colorbar('off') 
            caxis([min(hDg.DATASETCOLOR_processed) max(hDg.DATASETCOLOR_processed)]); 
            colorbar('west'); 
            
            % factor to scale brightness and contrast by 
            brightness = hDg.Brightness * 1.5; 
            contrast = hDg.Contrast * 1.5; 
             
            % Set the values in DotMapRim 
            hDg.hDM.IsVertexAtRim = hDg.IsVertexAtRim; 
            hDg.hDM.ColorMapType = hDg.ColorMapType; 
            hDg.hDM.DATASETCOLOR = hDg.DATASETCOLOR_processed; 
            hDg.hDM.SAMPLEPOSITIONSCOLOR = hDg.SAMPLEPOSITIONSCOLOR; 
            hDg.hDM.SAMPLEPOSITIONSDOTS = hDg.SAMPLEPOSITIONSDOTS; 
            hDg.hDM.GeometryDOTS = hDg.GeometryDOTS; 
            hDg.hDM.GeometryCOLOR = hDg.GeometryCOLOR; 
            switch hDg.Mode 
                case 'scar' 
                    hDg.hDM.DATASETDOTS = (hDg.DATASETDOTS_processed * 100 * brightness) .^ 
contrast; 
                case 'uniform' 
                    hDg.hDM.DATASETDOTS = (100 * brightness) ^ contrast; 
            end 
        end 
         
        % % IMAGE CONTROL % % 
        function pbhRotate_call(hDg, src, evt) %#ok<INUSD> 
            fig = hDg.S.fh; 
            ax = hDg.S.ax; 
            set(fig, 'WindowButtonDownFcn', {@moveCamera1, fig, ax, 'down', 'rotate'}); 
        end 
        function pbhZoom_call(hDg, src, evt) %#ok<INUSD> 
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            fig = hDg.S.fh; 
            ax = hDg.S.ax; 
            set(fig, 'WindowButtonDownFcn', {@moveCamera1, fig, ax, 'down', 'zoom'}); 
        end 
        function pbhPan_call(hDg, src, evt) %#ok<INUSD> 
            fig = hDg.S.fh; 
            ax = hDg.S.ax; 
            set(fig, 'WindowButtonDownFcn', {@moveCamera1, fig, ax, 'down', 'pan'}); 
        end 
         
        % % INTENSITY CONTROL % % 
        function cbThreshold_call(hDg, src, evt) 
            state = get(src, 'value'); 
            switch state 
                case 0 
                    hDg.DATASETDOTS_processed = 
local_thresholdVertexDataAndConvertToFaceData(hDg.DATASETDOTS, hDg.GeometryDOTS, Inf); 
                    hDg.updateDotMap(); 
                case 1 
                    threshold = get(hDg.S.sbThreshold, 'Value'); 
                    hDg.DATASETDOTS_processed = 
local_thresholdVertexDataAndConvertToFaceData(hDg.DATASETDOTS, hDg.GeometryDOTS, threshold); 
                    hDg.updateDotMap(); 
            end 
        end 
         
        function sbThreshold_call(hDg, src, evt) %#ok<INUSD> 
            state = get(hDg.S.cbThreshold, 'value'); 
            switch state 
                case 0 
                    threshold = Inf; 
                case 1 
                    threshold = get(src, 'value'); 
            end 
            hDg.DATASETDOTS_processed = 
local_thresholdVertexDataAndConvertToFaceData(hDg.DATASETDOTS, hDg.GeometryDOTS, threshold); 
            hDg.updateDotMap(); 
        end 
        function sbBrightness_call(hDg, src, evt) %#ok<INUSD> 
            hDg.Brightness = ( 2 * get(src, 'Value') ); 
            hDg.updateDotMap(); 
        end 
        function sbContrast_call(hDg, src, evt) %#ok<INUSD> 
            hDg.Contrast = ( 2 * get(src, 'Value') ); 
            hDg.updateDotMap(); 
        end 
         
        % % SETUP CONTROL % % 
        function tbSurface_call(hDg, src, evt) %#ok<INUSD> 
            hSurfState = get(src,'Value'); 
            if hSurfState == get(src,'Max') 
                set(hDg.hDM.hSurf, 'Visible', 'on'); % -- surface is off, turn it on 
            elseif hSurfState == get(src,'Min') 
                set(hDg.hDM.hSurf, 'Visible', 'off'); % -- surface is on, turn it off 
            end 
        end 
        function tbDots_call(hDg, src, evt) %#ok<INUSD> 
            hLineState = get(src,'Value'); 
            if hLineState == get(src,'Max') 
                set(hDg.hDM.hLine, 'Visible', 'on'); % -- dots are off, turn them on 
            elseif hLineState == get(src,'Min') 
                set(hDg.hDM.hLine, 'Visible', 'off'); % -- dots are on, turn them off 
            end 
        end 
        function hDg = bghMode_call(hDg, src, evt) %#ok<INUSL> 
            switch get(evt.NewValue, 'Tag') 
                case 'dotsUniform' 
                    hDg.Mode = 'uniform'; 
                case 'dotsScar' 
                    hDg.Mode = 'scar'; 
            end 
            hDg.updateDotMap(); 
        end 
         
        % Color selection callback 
        function pumColor_call(hDg, src, evt) %#ok<INUSD> 
            val = get(src, 'Value'); 
            switch val 
                case 1 
                    hDg.DATASETCOLOR_processed = hDg.DATASETCOLOR; 
                    hDg.ColorMapType = 'activation'; 
                case 2 
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                    hDg.DATASETCOLOR_processed = hDg.DATASETDOTS; 
                    hDg.ColorMapType = 'voltage'; 
            end 
            hDg.updateDotMap(); 
        end 
         
        function sbThreshCondVel_call(hDg, src, evt) %#ok<INUSD> 
            threshCV = get(src, 'Value'); 
            hDg.CvData = local_getCondVelData(hDg.DATASETCOLOR, hDg.GeometryCOLOR, threshCV); 
            hDg.DATASETCOLOR_processed = hDg.CvData; 
            hDg.updateDotMap(); 
        end 
        % OUTPUT CONTROL 
        function pbhGraph_call(hDg, src, evt) 
           figure 
           voltage = trVertToFaceData(hDg.GeometryDOTS, hDg.DATASETDOTS); 
           cv = 1./hDg.CvData; 
           scatter(voltage, cv); 
        end 
    end 
end %classdef 
  
function fDataThresholded = local_thresholdVertexDataAndConvertToFaceData(vData, tr, 
threshold) 
% local_thresholdVertexDataAndConvertToFaceData thresholds the data and  
%   converts from vertex 
% to face data. 
% Usage: 
%   tData = local_thresholdVertexDataAndConvertToFaceData(data, threshold) 
% Where: 
%   voltage - is an m*1 matrix of scalar values indexing into points of the 
%             triangulation, tr 
%   tr - is a Trirep 
%   threshold - is the threshold above which dataset is considered 
%               normal (e.g. no scar) and no dots will be drawn. 









             
vDataThresholded = vData; 
vDataThresholded(vDataThresholded>threshold) = max(vData); 
vDataThresholded(vDataThresholded==0) = NaN; 
vDataThresholded = scaleData(max(vDataThresholded)./vDataThresholded, [0 9]); 
vDataThresholded(isnan(vDataThresholded)) = 0; 








function tCv = local_getCondVelData(DATASETCOLOR, tr, threshold) 
% LOCAL_GETCONDVELDATA thresholds the conduction velocity data. 
% Usage: 
%   tCv = local_getCondVelData(data, threshold) 
% Where: 
%   DATASETCOLOR - is an m*1 matrix of scalar values indexing into points of the 
%             triangulation, tr 
%   tr - is a Trirep 





% [cvloc cvgrad] = trigrad(tr, DATASETCOLOR); 
% cvvec = cvgrad - cvloc; 
% [~, ~, cv] = cart2sph(cvvec(:,1), cvvec(:,2), cvvec(:,3)); 
% cv(cv>threshold) = NaN; 
% cv(isnan(cv)) = max(cv); 
% tCv = cv; 
threshold = threshold/1000; 
disp(threshold); 
  
[loc, cv] = lat2condvel(tr, DATASETCOLOR, threshold); 
tCv = abs(cv); 
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function [points, divFactor, centre] = local_rotateScaleCentre(points, Rx, varargin) 
% LOCAL_ROTATESCALECENTRE adjusts image data input for DotGui. 
% Usage: 
%   points = local_rotateScaleCentre(points, Rx) 
% Where: 
%   points - is an m*3 matrix of x,y,z coordinates of the vertices 
%   Rx - is the required rotation matrix 
%   points - is returned as the output 
%   mm - is the size of 1 mm in the new system 
% LOCAL_ROTATESCALECENTRE is used to standardise image data input for 
% DotGui. A rotation, Rx, is applied to ensure the image is presented AP. 





points = points * Rx; 
  
if nargin>=3 
    %divFactor has been passed in 
    divFactor = varargin{1}; 
    centre = varargin{2}; 
else 
    diff = max(points) - min(points); 
    divFactor = max(diff); 
end 
points = points ./ divFactor; 
if nargin<4 
    centre = mean ([min(points); max(points)]); 
end 




classdef DotMapRim < hgsetget 
%     ********************************************************************** 
%     * The contents of this package are copyright (c) King's College London 
%     * 
%     * They may not be reproduced, distributed, modified or sold for any  
%     * purpose 
%     * 
%     * Author:     Dr S. E. Williams 
%     * Address:    Division of Imaging Sciences and Biomedical Engineering, 
%     *             King's College London 
%     *             St Thomas' Hospital 
%     * 
%     * March 2014 
%     ********************************************************************** 
  
    % DOTMAP objects describe dot maps and plot them on an axis.n 
    % 
    % Usage: 
    %   hDM = DotMap(tr, sigInt); 
    % Where: 
    %   tr - is a TriRep object to be dot mapped 
    %   sigInt - is the signal intensity. If sigInt is a scalar value, 
    %       uniform dot intensity is used. If sigInt is an m*1 array (where 
    %       tr.Triangulation is m*3) varied dot intensity is used. 
    %   hDM - is a handle to the dot map 
    % 
    % DOTMAP detailed description. 
    % 
    % Author: Steven Williams (2012) 
    % Modifications - 
    % 
    % Info on Code Testing: 
    % --------------------- 
    % test code 
    % --------------------- 
    % 
    % Use warnings with the following format 
    %    disp('DOTMAP: warning.') 
    % 
    % --------------------------------------------------------------- 
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    % code 
    % --------------------------------------------------------------- 
     
    properties (SetAccess = private, GetAccess = public) 
        hDotAx 
        hDotFig 
        hLine 
        hLine2 
        hSurf 
        hValve 
        SigIntensity 
        DataListener    % -- listens for GeometryDOTS or DATASETDOTS changes 
        AxisListener    % -- listens for axis camera property changes 
         
    end 
     
    properties (SetObservable, AbortSet) 
        % Can define PreSet/PostSet property listeners for these properties 
        %OrigSigIntensity %has been changed to DATASETDOTS 
        %VertexActTime %has been changed to DATASETCOLOR 
        DATASETDOTS 
        DATASETCOLOR 
        GeometryDOTS 
        GeometryCOLOR 
        IsVertexAtRim 
        SAMPLEPOSITIONSCOLOR 
        SAMPLEPOSITIONSDOTS 
        MmScale 
        ColorMapType 
        Threshold 
        ThresholdValue 
    end 
     
    properties (SetAccess = private, GetAccess = public) 
        points 
        nT 
        area 
        tricentroids 
        fn 
        p1 
        p2 
        p3 
        camDistOrigSq   % -- previous camera position (updated as camera moves) 
        camDistStartSq  % -- starting camera position (never changes) 
    end 
     
    methods 
        % Constructor 
        function hDM = DotMapRim(tr, sigIntensity) 
            % Assign data to instance variables 
            hDM.GeometryDOTS = tr; 
            hDM.DATASETDOTS = sigIntensity; 
             
            hDM.hDotAx = gca(); 
            set(hDM.hDotAx ... 
                , 'Visible' , 'off' ... 
                , 'Color', [.6 .6 .6] ... 
                , 'XColor','y' ... 
                , 'YColor','y' ... 
                , 'ZColor','y' ... 
                , 'CameraTarget', [0 0 0] ... 
                ); 
            axis(hDM.hDotAx, 'equal', 'vis3d'); 
             
            % Draw the dot map (one time only) 
            hDM.hLine = line(); 
             
            platform = computer; 
            switch platform(1) 
                case 'P' 
                    markersize = 1; 
                otherwise 
                    markersize = 1.5; 
            end 
             
            set(hDM.hLine ... 
                , 'LineStyle', 'none' ... 
                , 'Marker', 'o' ... 
                , 'MarkerSize', markersize ... 
                , 'MarkerEdgeColor', [1 1 1] ... 
                , 'MarkerFaceColor', [1 1 1] ... 
                ); 
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            hDM.hSurf = patch('faces', [1 2 3] ... 
                , 'vertices', [0 0 0; 0 0 0; 0 0 0] ... 
                , 'facecolor', [0.1 0.7 0.3] ... 
                , 'edgecolor', 'none' ... 
                , 'facelighting', 'gouraud' ... 
                , 'specularstrength', 0.2 ... 
                , 'diffusestrength', 0.22 ... 
                ); 
                         
            % Draw the valve 
            hDM.hValve = line(); 
            set(hDM.hValve ... 
                , 'LineStyle', '-' ... 
                , 'Color', 'r' ... 
                , 'LineWidth', 2 ... 
                ); 
             
            % During setup, provide the initial camDistOrigSq. Recorded 
            % this for all time as camDistStartSq. 
            camPosOrig = get(hDM.hDotAx, 'CameraPosition'); 
            camTarOrig = get(hDM.hDotAx, 'CameraTarget'); 
            hDM.camDistOrigSq = sum( (camPosOrig - camTarOrig).^2 ); 
            hDM.camDistStartSq = hDM.camDistOrigSq; 
             
            % Perform the dot mapping calculations and update the line 
            hDM.initialise(); 
            hDM.calcDotMap(); 
             
            % Set up the listener for anatomy changes 
            propNamesAnatomy = {'GeometryDOTS', 'GeometryCOLOR', 'DATASETDOTS', 
'DATASETCOLOR'}; 
            hDM.DataListener = addlistener(hDM, propNamesAnatomy ... 
                , 'PostSet', @hDM.dataChanged); 
             
            % Set up the listner for camera position changes 
            propNamesCamera = {'CameraPosition','CameraTarget','CameraViewAngle'}; 
            hDM.AxisListener = addlistener(hDM.hDotAx, propNamesCamera ... 
                , 'PostSet', @hDM.cameraMoved); 
        end 
         
        % INITIALISE() should be called if hDM GeometryDOTS or DATASETDOTS 
        % properties have changed. INITIALISE() sets up the triangulation 
        % parameters (nT, area, fn), the points arrays of X, Y and Z for 
        % each simplex) and the signal intensity array (SigIntensity) 
        function hDM = initialise(hDM) 
             
            hDM.nT = size(hDM.GeometryDOTS.Triangulation); 
            hDM.area = triarea(hDM.GeometryDOTS); 
            hDM.fn = faceNormals(hDM.GeometryDOTS, (1:hDM.nT)'); 
            [~, hDM.tricentroids] = tricentroid(hDM.GeometryDOTS); 
             
            hDM.p1 = hDM.GeometryDOTS.X(hDM.GeometryDOTS.Triangulation(:,1),:); 
            hDM.p2 = hDM.GeometryDOTS.X(hDM.GeometryDOTS.Triangulation(:,2),:); 
            hDM.p3 = hDM.GeometryDOTS.X(hDM.GeometryDOTS.Triangulation(:,3),:); 
             
            %Generate the sigIntensity array if needed, or assign if passed 
            disp(['size(hDM.DATASETDOTS)=' num2str(size(hDM.DATASETDOTS))]); 
            disp(['min(hDM.DATASETDOTS)=' num2str(min(hDM.DATASETDOTS))]); 
            disp(['max(hDM.DATASETDOTS)=' num2str(max(hDM.DATASETDOTS))]); 
             
            if isscalar(hDM.DATASETDOTS) 
                hDM.SigIntensity = repmat(hDM.DATASETDOTS, ... 
                    [size(hDM.GeometryDOTS.Triangulation,1) 1]); 
            else 
                hDM.SigIntensity = hDM.DATASETDOTS; 
            end 
             
            % If camDisgStartSq and camDistOrigSq are different then camera 
            % has moved from its starting position so adjust SigIntensity 
            if round(hDM.camDistStartSq) == round(hDM.camDistOrigSq) 
                return; 
            else 
                hDM.SigIntensity = hDM.SigIntensity .* 
((hDM.camDistStartSq/hDM.camDistOrigSq)); 
            end 
             
            %Update the surface 
            % A field, originalPoints, is added to UserData for 
            % compatibility with VisualizerAxis 
            u.originalPoints = hDM.GeometryCOLOR.X .* 0.99; 
             
            set(hDM.hSurf, 'faces', hDM.GeometryCOLOR.Triangulation ... 
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                , 'vertices', hDM.GeometryCOLOR.X .* 0.99 ... 
                , 'userdata', u ... 
                ); 
             
            DISTANCETHRESH = 10 * hDM.MmScale; 
            t_min = min(hDM.DATASETCOLOR); 
            t_max = max(hDM.DATASETCOLOR); 
             
            switch hDM.Threshold 
                case 'on' 
                    switch hDM.ColorMapType 
                        case 'voltage' 
                            coloraxis = hDM.ThresholdValue; 
                            colororder = 'reverse'; 
                        case 'activation' 
                            coloraxis = [t_min t_max]; 
                            colororder = 'forward'; 
                    end    
                case 'off' 
                    switch hDM.ColorMapType 
                        case 'voltage' 
                            coloraxis = [t_min t_max]; 
                            colororder = 'reverse'; 
                        case 'activation' 
                            coloraxis = [t_min t_max]; 
                            colororder = 'forward'; 
                    end  
            end 
             
            if ~isempty(hDM.SAMPLEPOSITIONSCOLOR) 
            colorShell(hDM.hSurf, hDM.SAMPLEPOSITIONSCOLOR, hDM.DATASETCOLOR, DISTANCETHRESH 
... 
                , 'showcolorbar', 'show' ... 
                , 'coloraxis', coloraxis ... 
                , 'colororder', colororder ... 
                , 'datatype', hDM.ColorMapType ... 
                , 'interpolation', 'off' ... 
            ); 
            end 
             
            % draw a line around the valves 
            if ~isempty(hDM.IsVertexAtRim) 
                % make a local copy 
                isVertexAtRim = hDM.IsVertexAtRim; 
                 
                e = edges(hDM.GeometryCOLOR); 
                edgeIsRim = isVertexAtRim(e); 
                edgeIsRim = edgeIsRim(:,1) & edgeIsRim(:,2); 
                 
                rimEdges = e(edgeIsRim,:); 
                 
                n = size(rimEdges,1); 
                x = nan(3*n,1); 
                y = nan(size(x)); 
                z = nan(size(x)); 
                 
                for i = 0:(n-1); 
                    loc1 = hDM.GeometryCOLOR.X(rimEdges(i+1,1),:); 
                    loc2 = hDM.GeometryCOLOR.X(rimEdges(i+1,2),:); 
                     
                    x(3*i+1) = loc1(1); 
                    y(3*i+1) = loc1(2); 
                    z(3*i+1) = loc1(3); 
                     
                    x(3*i+2) = loc2(1); 
                    y(3*i+2) = loc2(2); 
                    z(3*i+2) = loc2(3); 
                end 
                set(hDM.hValve ... 
                    , 'XData', x .* 0.99 ... 
                    , 'YData', y .* 0.99 ... 
                    , 'ZData', z .* 0.99 ... 
                    , 'LineWidth', 3 ... 
                    , 'Color', [0 64 0]/256 ... 
                    , 'visible', 'on' ... 
                    ); 
                 
                pos = get(hDM.hDotAx, 'CameraPosition'); 
                va = get(hDM.hDotAx, 'CameraViewAngle'); 
                 
                camva(va); 
                campos(pos); 
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            else 
                set(hDM.hValve, 'visible', 'off'); 
            end 
        end 
         
        % CALCDOTMAP() should be called if the hDM hDotAx camera properties 
        % have changed. CALCDOTMAP() creates n random coordinates within 
        % each triangle simplex of hDM.GeometryDOTS where n is a random integer 
        % from the Poisson distribution with parameter lambda. Lambda is 
        % weighted dependent on the triangle area and signal intensity for 
        % that triangle. CALCDOTMAP() assigns the x, y and z values to the 
        % hDM properties XData, yData and ZData. 
        function hDM = calcDotMap(hDM) 
            % Calculate number of dots per triangle using Poisson distribution 
            lambda = hDM.area .* hDM.SigIntensity; 
            nDots = poissrnd(lambda); 
             
            maxDots = floor(hDM.area .* 200000); 
            iTooMany = nDots>maxDots; 
            if any(iTooMany) 
                nDots(iTooMany) = maxDots(iTooMany); 
                disp('Dot Numbers restricted') 
            end 
             
            activeTriangles = (1:hDM.nT)'; 
             
            % TODO: CHANGE TO SAMPLEPOSITIONSDOTS IN THIS BLOCK OF CODE 
            if ~isempty(hDM.SAMPLEPOSITIONSDOTS) 
                % remove triangles greater than DISTANCETHRESH 
                DISTANCETHRESH = 10 * hDM.MmScale; 
                % Find the shortest distance from every point in the surface to 
                % the dataset pointcloud 
                id = knnsearch(hDM.SAMPLEPOSITIONSDOTS, hDM.tricentroids); 
                cPts = hDM.SAMPLEPOSITIONSDOTS(id,:); %c for closest 
                d = distBetweenPoints(cPts, hDM.tricentroids); 
                % Threshold based on the distance t 
                thresholdDistance = ones(size(d)); 
                thresholdDistance(d>DISTANCETHRESH) = 0; 
                activeTriangles = activeTriangles(logical(thresholdDistance)); 
                nDots = nDots(logical(thresholdDistance)); 
            end 
             
            % remove triangles with no dots 
            kInactive = (nDots<=0); 
            activeTriangles(kInactive) = []; 
            nDots(kInactive) = []; 
             
            if isempty(nDots) 
                set([hDM.hLine hDM.hLine2],    'XData', [] ... 
                    , 'YData', [] ... 
                    , 'ZData', [] ... 
                    ); 
                return 
            end 
             
            cumNDots = cumsum(nDots); 
            iStart = [ 1 ; 1+cumNDots(1:(end-1))]; 
            totalDots = cumNDots(end); 
             
            % Now create a vector of length totalDots, where the value of 
            % iDot2iTri(iDot) gives the ACTIVE triangle in which iDot lies, 
            % i.e. iDot2iTri = [1 1 1 1 1  2 2 2 2 2 2 2  3 3 3 3  4 4 4 4 
            % .... ] where the number of 1's is nDots(1), the number of 2's 
            % is nDots(2) etc. 
            iDot2iTri = zeros(totalDots,1); 
            iDot2iTri(iStart) = 1; 
            iDot2iTri = cumsum(iDot2iTri); 
             
            % Now get back the original indices 
            iDot2iTri = activeTriangles(iDot2iTri); 
             
            % Create two vectors of random numbers in (0,1) for each dot 
            p = rand(totalDots,1); 
            q = rand(totalDots,1); 
            sqP = sqrt( p ); % numel = totalDots 
             
            % Calculate the set of random points for each triangle. 
            k1 = 1 - sqP; 
            k2 = sqP .* (1-q);      % k1,k2,k3 all have numel=totalDots 
            k3 = q .* sqP; 
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            X = k1 .* hDM.p1(iDot2iTri,1)  +   k2 .* hDM.p2(iDot2iTri,1)  +  k3 .* 
hDM.p3(iDot2iTri,1); 
            Y = k1 .* hDM.p1(iDot2iTri,2)  +   k2 .* hDM.p2(iDot2iTri,2)  +  k3 .* 
hDM.p3(iDot2iTri,2); 
            Z = k1 .* hDM.p1(iDot2iTri,3)  +   k2 .* hDM.p2(iDot2iTri,3)  +  k3 .* 
hDM.p3(iDot2iTri,3); 
             
            % Set the XData, YData and ZData of hDM.hLine 
            % A field, originalPoints, is added to UserData for 
            % compatibility with VisualizerAxis 
            u.originalPoints.x = X; 
            u.originalPoints.y = Y; 
            u.originalPoints.z = Z; 
            set([hDM.hLine],    'XData', X ... 
                , 'YData', Y ... 
                , 'ZData', Z ... 
                , 'UserData', u ... 
                );             
        end 
    end 
     
    methods (Static) 
        % Called by the listener if GeometryDOTS or DATASETDOTS change 
        function dataChanged(~, event) 
            hDM = event.AffectedObject; 
             
            hDM.initialise(); 
            hDM.calcDotMap(); 
             
        end 
    end 
     
    methods 
        % Called by the listener if hDotAx camera properties change 
        function cameraMoved(hDM, src, event) %#ok<INUSD> 
            axis = hDM.hDotAx; 
             
            %Calculate the new distance from the camera to the target 
            camPosNew = get(axis, 'CameraPosition'); 
            camTarNew = get(axis, 'CameraTarget'); 
            camDistNewSq = sum( (camPosNew - camTarNew).^2 ); 
             
            %Work out if the distance has changed 
            if round(hDM.camDistOrigSq) == round(camDistNewSq) 
                return; 
            else 
                hDM.SigIntensity = hDM.SigIntensity * ((hDM.camDistOrigSq/camDistNewSq)); 
                hDM.calcDotMap(); 
                hDM.camDistOrigSq = camDistNewSq; 
            end 
        end 
    end 




function [loc, cv] = lat2condvel(tri, lat, threshold) 
%     ********************************************************************** 
%     * The contents of this package are copyright (c) King's College London 
%     * 
%     * They may not be reproduced, distributed, modified or sold for any  
%     * purpose 
%     * 
%     * Author:     Dr S. E. Williams 
%     * Address:    Division of Imaging Sciences and Biomedical Engineering, 
%     *             King's College London 
%     *             St Thomas' Hospital 
%     * 
%     * March 2014 
%     ********************************************************************** 
  
% LAT2CONDVEL returns the CV across a TriRep. 
% Usage: 
%   [loc condvel] = lat2condvel(tri, lat, threshold) 
% Where: 
%   tri - is the TriRep 
%   lat - is the value of the LAT at each point in tri.X 
%   threshold - the maximum conduction velocity possible 
 271 
%   loc - contains the position at the centroid of each face in tri 
%   cv - contains the conduction velocity at each point in loc 
% 
% LAT2CONDVEL converts local activation time (LAT) to conduction velocity 
% (CV) using trigrad. Output units depends on the input units. If points in 
% tri.X are described in meters and times in lat described in seconds then 
% the units of cv are m/s. 
% 
% Author: Steven Williams (2012) 
% Modifications - 
% 
% Info on Code Testing: 
% --------------------------------------------------------------- 
% test code 
% --------------------------------------------------------------- 
% % construct a linear trirep 
% LENGTH = 200; 
% %X = (-LENGTH/2:LENGTH-LENGTH/2) .* 0.1; 
% X = (1:LENGTH) .* 0.1; 
% for i = 1:LENGTH 
%     iStart = i * 2 - 1; 
%     iEnd = iStart + 1; 
%     p(iStart:iEnd, 1) = X(i); 
%     p(iStart,2) = 0; 
%     p(iEnd,2) = 1; 
% end 
% p(:,3) = 0; 
% for i = 1:LENGTH * 2 - 2 
%    tri(i, :) = [i i+1 i+2]; 
% end 
% tri = TriRep(tri,p); 
%  
% % Calculate the scalar field 
% EXP = 1; 
% K = 2; 
% lat = K .* p(:,1) .^ EXP; 
%  
% % Calculate the gradient of the scalar field; convert to CV (x axis) 
% [loc cv] = lat2condvel(tri, lat); 
%  
% % Plot the results 
% subplot(4,1,1); 




% line(loc(:,1), lat(2:end-1)); 
% title(['Local Activation Time Field (x direction) t=s^' num2str(EXP)]); 




% title('Conduction Velocity (x direction) ds/dt = 1/dt/ds'); 
% xlabel('Distance, s');ylabel('Velocity, ds/dt'); 
% 
% Use warnings with the following format 






[loc, grad] = trigrad(tri,lat); 
[~, ~, r] = cart2sph(grad(:,1), grad(:,2), grad(:,3));  
  
cv = 1./r; 
cv(cv>threshold) = threshold; 





function ret=moveCamera1(src, eventdata, hfig, haxes, arg, action) %#ok<INUSL> 
%     ********************************************************************** 
%     * The contents of this package are copyright (c) King's College London 
%     * 
%     * They may not be reproduced, distributed, modified or sold for any  
%     * purpose 
%     * 
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%     * Author:     Dr S. E. Williams 
%     * Address:    Division of Imaging Sciences and Biomedical Engineering, 
%     *             King's College London 
%     *             St Thomas' Hospital 
%     * 
%     * March 2014 
%     ********************************************************************** 
  
% MOVECAMERA1 provides click to move functionality. 
% 
% Usage: 
%   ret = moveCamera(src, eventdata, hfig, haxes, arg, action) 
% 
% Where: 
%   src, event - mandatory inputs 
%   hfig - handle to the figure containing the axis 
%   haxes - handle to the axis for which the camera position is altered 
%   arg - call with 'down'. Other options are for local calls only: 'motion', or 'up' 
%   action - 'zoom', 'rotate' or 'pan' 
%   ret - returns 1 after satisfactory completion 
% 
% MOVECAMERA provides a mechanism to access the camera toolbar functions  
% through event listeners: 
%   To move the camera forward/backward:- 
%       set(fig, 'WindowButtonDownFcn', {@moveCamera1, fig, ax, 'down', 'zoom'}); 
%   To rotate the camera:- 
%       set(fig, 'WindowButtonDownFcn', {@moveCamera1, fig, ax, 'down', 'rotate'}); 
%   To pan the camera:- 
%       set(fig, 'WindowButtonDownFcn', {@moveCamera1, fig, ax, 'down', 'pan'}); 
% In this way, mouse movement is captured to control the desired function 
% (rotate, zoom or pan). The event listeners could for example be called by 




% 1) Use the mouse buttons to control a figure. Use within another 
% function. 
%   % Set the WindowButtonDownFcn callback to respond to mouse clicks 
%   set(fig, 'WindowButtonDownFcn', {@mouseButtonFcn, fig, ax}); 
% 
%   function mouseButtonFcn(src, evt, fig, ax) 
%       switch get(fig, 'selectiontype')            
%           % left mouse button to rotate 
%           case 'normal' 
%               set(fig, 'WindowButtonMotionFcn', {@moveCamera1, fig, ax, 'down', 'rotate'}) 
%           % middle mouse button to pan 
%           case 'extend' 
%               set(fig, 'WindowButtonMotionFcn', {@moveCamera1, fig, ax, 'down', 'pan'}) 
%           % right mouse button to zoom 
%           case 'alt' 
%               set(hFig, 'WindowButtonMotionFcn', {@moveCamera1, hFig, hAx, 'down', 'zoom'}) 
%        end 
%    end 
% --------------------------------------------------------------- 
% 
% Author: Steven Williams (2013) 
% Modifications - 
% 
% Use warnings with the following format 







     
    % Respond to WindowButtonDownFcn events. This is the only event that 
    % should be called externally to this function. This section sets the 
    % corresponding Up and Motion functions. 
    case 'down' 
        pt = hgconvertunits(hfig,[0 0 get(hfig,'CurrentPoint')], ... 
            get(hfig,'Units'),'pixels',0); 
        pt = pt(3:4); 
        Udata.figStartPoint = pt; 
        Udata.figLastPoint  = pt; 
        Udata.moving = 0; 
        Udata.coordsys = 'z'; 
        if strcmp(action, 'zoom') 
            Udata.mode = 'dollyfb'; 
        elseif strcmp(action, 'rotate') 
            Udata.mode = 'orbit'; 
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        elseif strcmp(action, 'pan') 
            Udata.mode = 'pan'; 
        end 
        setUdata(hfig,Udata) 
        %Set the WindowButtonUpFcn (call to self) 
        set(hfig, 'WindowButtonUpFcn', {@moveCamera1, hfig, haxes, 'up'}); 
        %Set the WindowButtonMotionFcn (call to self) 
        set(hfig, 'WindowButtonMotionFcn', {@moveCamera1, hfig, haxes, 'motion'} ... 
            ); 
     
    case 'motion' 
        Udata = getUdata(hfig); 
        if isstruct(Udata) 
            pt = hgconvertunits(hfig,[0 0 get(hfig,'CurrentPoint')],... 
                get(hfig,'Units'),'pixels',0); 
            pt = pt(3:4); 
            deltaPix  = pt-Udata.figLastPoint; 
            Udata.figLastPoint = pt; 
            Udata.moving = 1; 
            mode = lower(Udata.mode); 
            setUdata(hfig,Udata) 
            % Now perform the desired event from the rotation. 
            switch mode 
                case 'orbit' 
                    orbitPangca(hfig,haxes,deltaPix, 'o'); 
                case 'pan' 
                    orbitPangca(hfig,haxes,deltaPix, 'p'); 
                case 'dollyfb' 
                    forwardBackgca(hfig,haxes,deltaPix, 'c'); 
            end 
        end 
         
    case 'up' 
        Udata = getUdata(hfig); 
        set(hfig,'WindowButtonMotionFcn',''); 
        Udata.moving = 0; 
        pt = hgconvertunits(hfig,[0 0 get(hfig,'CurrentPoint')],... 
            get(hfig,'Units'),'pixels',0); 
        pt = pt(3:4); 
        Udata.figLastPoint = pt; 
        setUdata(hfig,Udata); 
  
    otherwise 
        error('MOVECAMERA:unrecognizedinput','Unknown action string.'); 
  
end 




    % Calling drawnow will result in hang, see g201318 
    Udata = getUdata(hfig); 
    if feature('HGUsingMATLABClasses') 
        drawnow update; 
        return 
    end 
    if Udata.moving == 1 
        drawnow; 
    else 
        drawnow expose 
    end 
end 
  
function orbitPangca(hfig,haxes,xy, mode) 
    %mode = 'o' -> orbit; mode = 'p' -> pan 
    Udata = getUdata(hfig); 
    coordsys = lower(Udata.coordsys); 
    if coordsys(1)=='n' 
        coordsysval = 0; 
    else 
        coordsysval = coordsys(1) - 'x' + 1; 
    end 
    xy = -xy; 
    if mode=='p' %pan 
        panxy = xy*camva(haxes)/500; 
    end 
    if coordsysval>0 
        d = [0 0 0]; 
        d(coordsysval) = 1; 
        up = camup(haxes); 
        upsidedown = (up(coordsysval) < 0); 
        if upsidedown 
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            xy(1) = -xy(1); 
            d = -d; 
        end 
        % Check if the camera up vector is parallel with the view direction; 
        % if not, set the up vector 
        if any(crossSimple(d,campos(haxes)-camtarget(haxes))) 
            camup(haxes,d) 
        end 
    end 
    %while sum(abs(xy))> 0 && isstruct(Udata) && (flag || Udata.moving==1) && 
ishghandle(haxes) 
    if Udata.moving==1 
        %Udata = getUdata(hfig); 
        if ishghandle(haxes) 
            if mode=='o' %orbit 
                if coordsysval==0 %unconstrained 
                    camorbit(haxes,xy(1), xy(2), coordsys) 
                else 
                    camorbit(haxes,xy(1), xy(2), 'data', coordsys) 
                end 
            else %pan 
                if coordsysval==0 %unconstrained 
                    campan(haxes,panxy(1), panxy(2), coordsys) 
                else 
                    campan(haxes,panxy(1), panxy(2), 'data', coordsys) 
                end 
            end 
            localDrawnow(hfig); 
        end 
    end 
end 
  
function forwardBackgca(hfig,haxes,xy, mode) 
    q = max(-.9, min(.9, sum(xy)/70)); 
    if mode=='b' 
        camdolly(haxes,0,0,q); 
    else 
        posOld = get(haxes,'CameraPosition'); 
        camdolly(haxes,0,0,q, 'f'); 
        %If the dolly puts us too close to the target, undo the move: 
        dist = norm(get(haxes,'CameraPosition')-get(haxes,'CameraTarget')); 
        if dist > 3.3316e+003 || dist < 0.4 
            set(haxes,'CameraPosition',posOld); 
        end 
    end 
    localDrawnow(hfig); 
end 
  
function Udata = getUdata(hfig) 
    Udata = getappdata(hfig, 'ctb200jaz'); 
    % Since the camera toolbar IS NOT serialized by design, Udata will have  
    % an invalid toolbar handle when opening a fig file since the figure  
    % object, which IS serialized, stores the Udata. 
    if isfield(Udata,'mainToolbarHandle') && ~any(ishghandle(Udata.mainToolbarHandle)) 
        Udata = []; 




    setappdata(hfig, 'ctb200jaz', Udata); 
end 
  
% simple cross product 
function c=crossSimple(a,b) 
    c(1) = b(3)*a(2) - b(2)*a(3); 
    c(2) = b(1)*a(3) - b(3)*a(1); 




function [ newData ] = scaleData( data, limits ) 
%     ********************************************************************** 
%     * The contents of this package are copyright (c) King's College London 
%     * 
%     * They may not be reproduced, distributed, modified or sold for any  
%     * purpose 
%     * 
%     * Author:     Dr S. E. Williams 
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%     * Address:    Division of Imaging Sciences and Biomedical Engineering, 
%     *             King's College London 
%     *         St Thomas' Hospital 
%     * 
%     * March 2014 
%     ********************************************************************** 
  
%SCALEDATA performs linear scaling of a data series to the desired limits. 
% Usage: 
%   newData = scaleData(data, limits) 
% Where: 
%   data - is the input data series 
%   limits - the desired bounds of the rescaled data series, [lower upper] 
% 
% SCALEDATA detailed description. 
% 
% Author: Steven Williams (2012) 
% Modifications - 
% 
% Info on Code Testing: 
% --------------------- 
% test code 
% --------------------- 
% 
% Use warnings with the following format 






% if the data has no range, return the data at max or min of limits 
if nansum(diff(data))==0 
    newData = data; 
    if nanmin(data)>=limits(2) 
        newData(~isnan(newData)) = limits(2); 
    elseif nanmax(data)<=limits(1) 
        newData(~isnan(newData)) = limits(1);  
    end 
    return; 
end 
  
% Scale the data onto [0 1] 
n = (data - min(data(:))) / (max(data(:)) - min(data(:))); 
  
% Scale the data onto range(limits) 
n = n * range(limits); 
  
% Start the data at limits(1) 






function [ faceData ] = trVertToFaceData( tr, vertexData ) 
%     ********************************************************************** 
%     * The contents of this package are copyright (c) King's College London 
%     * 
%     * They may not be reproduced, distributed, modified or sold for any  
%     * purpose 
%     * 
%     * Author:     Dr S. E. Williams 
%     * Address:    Division of Imaging Sciences and Biomedical Engineering, 
%     *             King's College London 
%     *             St Thomas' Hospital 
%     * 
%     * March 2014 
%     ********************************************************************** 
  
% TRVERTTOFACEDATA converts vertex to face data for a TriRep object. 
% Usage: 
%   faceData = trVertToFaceData(tr, vertexData) 
% Where: 
%   tr - is a TriRep object with the following dimensions: 
%           tr.Triangulation    q * 3 
%           tr.X                p * 1 
%   vertexData - is an p*1 array of scalar data (by vertex) 
%   faceData - is a q*1 array of scalar data (by face) 
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% 
% TRVERTTOFACEDATA detailed description. 
% 
% Author: Steven Williams (2012) 
% Modifications -  
% 
% Info on Code Testing: 
                        % --------------------- 
                        % test code 
                        % --------------------- 
% 
% Use warnings with the following format 






faceData = zeros(length(tr.Triangulation), 1); 
  
for i = 1:length(tr.Triangulation); 
    v1 = tr.Triangulation(i, 1); 
    v2 = tr.Triangulation(i, 2); 
    v3 = tr.Triangulation(i, 3); 
     





classdef VTKReader < hgsetget 
%     ********************************************************************** 
%     * The contents of this package are copyright (c) King's College London 
%     * 
%     * They may not be reproduced, distributed, modified or sold for any  
%     * purpose 
%     * 
%     * Author:     Dr S. E. Williams 
%     * Address:    Division of Imaging Sciences and Biomedical Engineering, 
%     *             King's College London 
%     *         St Thomas' Hospital 
%     * 
%     * March 2014 
%     ********************************************************************** 
  
% VTKREADER Reads VTK files. 
% Usage: 
%   hVTK = VTKReader(filename) 
%   hVTK = VTKReader('openfile') 
% 
% Where: 
%   a is the input 
%   b is the output 
% 
% VTKREADER Methods: 
%   readPoints 
%   readPoly 
%   readPointData 
%   readCellData 
%   readAllData 
% 
% Author: Steven Williams (2013) 
% Modifications - 
% 
% Info on Code Testing: 
% --------------------------------------------------------------- 






     
    properties 
        Filename 
        IndexPoint 
        IndexPointData 
        IndexCell 
        IndexCellData 
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        IndexNormals 
        Points 
        PointNormals 
        PointData 
        Cells 
        CellNormals 
        CellData 
    end 
     
    methods 
         
        function hVTK = VTKReader(filename) 
            % CONSTRUCTOR loads and checks the file and populates the 
            % indices 
            if strcmpi(filename, 'openfile'); 
                [filename, pathname] = uigetfile('*.vtk', 'Select VTK file to open ...'); 
                filename = [pathname filename]; 
            end 
             
            hVTK.Filename = filename; 
             
            % Open the file 
            [dataFileID, message] = fopen(hVTK.Filename, 'r'); 
            if dataFileID == (-1) 
                disp('VTKREADER.M: There was a problem opening the file:') 
                error(message) 
            end 
             
            % Check the file is a VTK file 
            str = fgets(dataFileID);   % -1 if eof 
            if ~strcmp(str(1:5), '# vtk') 
                error('The file is not a valid VTK file.'); 
            end 
             
            % Read the header and confirm that the dataset is POLYDATA 
            str = fgets(dataFileID); 
            str = fgets(dataFileID); 
            str = fgets(dataFileID); 
            if ~strcmp(str(9:16), 'POLYDATA') 
                error('The file does not contain a polydata dataset'); 
            end 
             
            % Scan the file finding indexes to the Points polygon, pointdata and celldata 
sections 
            fseek(dataFileID, 0, 'bof'); 
             
            %format = '%s %*[^\n]'; %read first word of each line 
            format = '%s'; 
             
            %segarray = textscan(dataFileID,format); 
            segarray = textscan(dataFileID, format, 'delimiter', '\n'); 
             
            for i = 1:size(segarray{1},1) 
                firstSpace = regexpi(segarray{1}(i), ' '); 
                 
                if(size(firstSpace{1},1)==0) 
                    firstSpace = length(segarray{1}{i}) + 1; 
                else 
                    firstSpace = firstSpace{1}(1); 
                end 
                 
                holdingString = segarray{1}(i); 
                holdingString = holdingString{1}; 
                 
                word = holdingString(1:firstSpace-1); 
                segarray{1}{i} = word; 
            end 
             
            identifiers = {'POINTS' 
                'POLYGONS' 
                'CELL_DATA' 
                'POINT_DATA' 
                'NORMALS'}; 
             
            for i = 1:5 
                logical = strstartcmp(identifiers{i}, segarray{1}); 
                if sum(logical) == 1 
                    index{i} = find(logical); 
                elseif sum(logical) < 1 
                    index{i} = NaN; 
                    disp(strcat('VTKREADER: ', identifiers{i}, ' not found. NaN assigned to 
index.')); 
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                elseif sum(logical) > 1 && i ~= 5 
                    index{i} = NaN; 
                    disp(strcat('VTKREADER: Multiple ', identifiers{i}, ' found. NaN assigned 
to index.')); 
                else 
                    index{i} = find(logical); 
                end 
                 
                 
            end 
             
            hVTK.IndexPoint = index{1}; 
            hVTK.IndexCell = index{2}; 
            hVTK.IndexCellData = index{3}; 
            hVTK.IndexPointData = index{4}; 
            hVTK.IndexNormals = index{5}; 
             
            % Close the file 
            fclose (dataFileID); 
        end 
         
        function hVTK = readPoints(hVTK) 
            if ~isnan(hVTK.IndexPoint) 
                % Access a private external function to read the data 
                [data,normals,dataCnt,normalsCnt] = readData('points' ... 
                    , '%*s %d %*s' ... 
                    , '%f %f %f' ... 
                    , hVTK.IndexPoint ... 
                    , hVTK.Filename ... 
                    , 0 ... 
                    , 3 ... 
                    , true ... 
                    , hVTK.IndexNormals ... 
                    ); 
                data = reshape(data, 3, dataCnt/3); 
                vertex = data.'; 
                % Assign the Points to the instance variable 
                hVTK.Points = vertex; 
                 
                if normalsCnt~=0 
                    normals = reshape(normals, 3, normalsCnt/3); 
                    normals = normals.'; 
                    % Assign the normals data to the instance variable 
                    hVTK.PointNormals = normals; 
                end 
            else 
                hVTK.Points = []; 
            end 
        end 
         
        function hVTK = readCells(hVTK) 
            if ~isnan(hVTK.IndexCell) 
                % Access a private external function to read the data 
                [data,normals,dataCnt,normalsCnt] = readData('cells' ... 
                    , '%*s %d %*d' ... 
                    , '%*f %f %f %f' ... 
                    , hVTK.IndexCell ... 
                    , hVTK.Filename ... 
                    , 0 ... 
                    , 3 ... 
                    , false ... 
                    , hVTK.IndexNormals ... 
                    ); 
                data = reshape(data, 3, dataCnt/3); 
                polygon = data.'; 
                % Assign the Cells to the instance variable 
                hVTK.Cells = polygon; 
                 
                if normalsCnt~=0 
                    normals = reshape(normals, 3, normalsCnt/3); 
                    normals = normals.'; 
                    % Assign the normals data to the instance variable 
                    hVTK.CellNormals = normals; 
                end 
            else 
                hVTK.Cells = []; 
            end 
        end 
         
        function hVTK = readPointData(hVTK) 
            if ~isnan(hVTK.IndexPointData) 
                % Access a private external function to read the data 
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                [data,normals,dataCnt,normalsCnt] = readData('point data' ... 
                    , '%*s %d' ... 
                    , '%f' ... 
                    , hVTK.IndexPointData ... 
                    , hVTK.Filename ... 
                    , 2 ... 
                    , 1 ... 
                    , false ... 
                    , 0 ... 
                    ); 
                data = reshape(data, 1, dataCnt); 
                pointData = data.'; 
                % Assign the Cells to the instance variable 
                hVTK.PointData = pointData; 
            else 
                hVTK.PointData = []; 
            end 
        end 
         
        function hVTK = readCellData(hVTK) 
            if ~isnan(hVTK.IndexCellData) 
                % Access a private external function to read the data 
                [data,normals,dataCnt,normalsCnt] = readData('cell data' ... 
                    , '%*s %d' ... 
                    , '%f' ... 
                    , hVTK.IndexCellData ... 
                    , hVTK.Filename ... 
                    , 2 ... 
                    , 1 ... 
                    , false ... 
                    , 0 ... 
                    ); 
                data = reshape(data, 1, dataCnt); 
                cellData = data.'; 
                % Assign the Cells to the instance variable 
                hVTK.CellData = cellData; 
            else 
                hVTK.CellData = [] 
            end 
        end 
         
        function hVTK = readAllData(hVTK) 
            readPoints(hVTK); 
            readCells(hVTK); 
            readPointData(hVTK); 
            readCellData(hVTK); 
        end 
         
    end 




function [data,normals,dataCnt,normalsCnt] = readData(dataName ... 
                                            , indexFormat ... 
                                            , dataFormat ... 
                                            , filePosition ... 
                                            , filename ... 
                                            , offset ... 
                                            , itemMultiplier ... 
                                            , readNormals ... 
                                            , indexNormals ... 
                                             ) 
%     ********************************************************************** 
%     * The contents of this package are copyright (c) King's College London 
%     * 
%     * They may not be reproduced, distributed, modified or sold for any  
%     * purpose 
%     * 
%     * Author:     Dr S. E. Williams 
%     * Address:    Division of Imaging Sciences and Biomedical Engineering, 
%     *             King's College London 
%     *             St Thomas' Hospital 
%     * 
%     * March 2014 
%     ********************************************************************** 
  
% @VTKREADER/READDATA is a helper method for objects of the class VTKReader 
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% which reads sections of data from a vtk file 
% 
% Usage: 
%   Accessed only by objects of class VTKReader 
% 
% Where: 
%   data - a column matrix of the read data 
%   normals - a column matrix of the normals data 
%   dataCnt - the number of entries in the column matrix of data 
%   normalsCnt - the number of entries in the column matrix of normals 
%   dataName - the name of the data that is being sought (only used for 
%       error writing purposes 
%   indexFormat - the format of the first line of the section (POINTS 28442  
%       float would be described as %*s %d %*s), permitting the length of  
%       the  
%       section to be read from the VTK file 
%   dataFormat - the format of the data in the section 
%   filePosition - the line number that the section starts at 
%   filename - the vtk file 
%   offset - the number of lines to skip between section header and data 
%   itemMultiplier - the number of data values per data item. For example a 
%       triangular polygon would have itemMultiplier = 3 whilst a scaler 
%       would have itemMultiplier = 1 
%   readNormals - boolean to identify whether or not to read a NORMALS data 
%   section immediately subsequent to the read data section 
  
% Author: Steven Williams (2011) 
% Modifications -  
  








    % Open the file 
    dataFileID = fopen(filename,'r'); 
     
    % Skip unwanted lines 
    for i = 1:filePosition - 1 
        fgetl(dataFileID); 
    end 
  
    % Get the section header and number of data items (nvert) 
    if (~strcmp(indexFormat,'skip')) 
        str = fgets(dataFileID); 
        nvert = sscanf(str, indexFormat, 1); 
    else 
        nvert = 1; 
    end 
     
    % If necessary, skip lines between the header and the data 
    while (offset~=0) 
        fgetl(dataFileID); 
        offset = offset - 1; 
    end 
     
    numDataItems = itemMultiplier * nvert; 
     
    % Read the data 
    [data,dataCnt] = fscanf(dataFileID, dataFormat, numDataItems); 
    if dataCnt~=itemMultiplier*nvert 
        warning(strcat('Problem reading :', dataName)); 
    end 
     
    % Read the normals 
         
    if (readNormals) 
         
        fseek(dataFileID,0,'bof'); 
         
        if numel(indexNormals) == 0 
            normals = 0; 
            normalsCnt = 0; 
             
        elseif numel(indexNormals) == 1 && strcmp(dataName, 'cells') 
            normOffset = indexNormals(1); 
            while (normOffset~=0) 
                fgetl(dataFileID); 
                normOffset = normOffset - 1; 
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            end 
            % read data 
            [normals,normalsCnt] = fscanf(dataFileID, '%f %f %f', numDataItems*3); 
            if normalsCnt~=itemMultiplier*nvert 
                warning(strcat('Problem reading :', dataName, ': NORMALS')); 
            end  
         
        elseif numel(indexNormals) == 1 && strcmp(dataName, 'points') 
            normals = 0; 
            normalsCnt = 0; 
             
        elseif numel(indexNormals) == 2 && strcmp(dataName, 'cells') 
            normOffset = indexNormals(1); 
            while (normOffset~=0) 
                fgetl(dataFileID); 
                normOffset = normOffset - 1; 
            end 
            % read data 
            [normals,normalsCnt] = fscanf(dataFileID, '%f %f %f', numDataItems*3); 
            if normalsCnt~=itemMultiplier*nvert 
                warning(strcat('Problem reading :', dataName, ': NORMALS')); 
            end  
             
        elseif numel(indexNormals) == 2 && strcmp(dataName, 'points') 
            normOffset = indexNormals(2); 
            while (normOffset~=0) 
                fgetl(dataFileID); 
                normOffset = normOffset - 1; 
            end 
            % read data       
            [normals,normalsCnt] = fscanf(dataFileID, '%f %f %f', numDataItems*3); 
            if normalsCnt~=itemMultiplier*nvert 
                warning(strcat('Problem reading :', dataName, ': NORMALS')); 
            end  
             
        end 
    else 
        normals = 0; 
        normalsCnt = 0; 
    end 
          
    % Close the file 
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Young Investigator Award (Shortlisted), Heart Rhythm Congress, Birmingham, 2014 
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Williams SE, et al. High Accuracy Unipolar Activation Time Assignment to Facilitate 
Dense Multipolar Electrode Mapping. Heart Rhythm Congress, Birmingham, 2013. 
Williams SE, et al. CMR Characterization of Linear Ablation Lesions with Varying 
Contact Force – a Chronic Porcine Model. Heart Rhythm Congress, Birmingham, 2014.  
Williams SE, et al. Optimized Local Activation Time Sampling Density for Left Atrial 
Electroanatomic Mapping. Heart Rhythm Congress, Birmingham, 2014. 
Williams SE, et al. Ripple Mapping to Assess Atrial Tachycardia. Heart Rhythm 
Society, Boston, 2012. 
Williams SE, et al. Low Force vs. High Force Atrial RF Ablation in a Chronic Porcine 
Model: Effective Lesion Assessment by Voltage, Pathology and Cardiac MR. Heart 
Rhythm Society, Boston, 2015. 
Poster presentations 
Williams SE, et al. Bipolar Voltage Cut-Offs For Identifying Post-Ablation Atrial scar 
are Different at Acute and Chronic Time-Points. Cardiostim, Nice 2014.  
Williams SE, et al. Cardiac Magnetic Resonance of Atrial Ablation Injury: Impact of 
Catheter-Myocardium Contact Force. SCMR, San Francisco, 2014. 
Williams SE, et al. Dot Mapping: A Novel Method to Display Multiple Parameters on a 
Single Electroanatomical Chamber Model. Heart Rhythm Congress, Birmingham, 2013. 
Williams SE, et al. In Vivo Method for Determining Patient-Specific Atrial Electrical 
Conductivities and Fiber Orientation. Heart Rhythm Congress, Birmingham, 2013. 
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Williams SE, et al. Abnormal Electrogram Populations are Revealed by Atrial 
Programmed Stimulation in Paroxysmal Atrial Fibrillation. Heart Rhythm Congress, 
Birmingham, 2014. 
Williams SE, et al. High Accuracy Unipolar Local Activation Time Assignment to 
Facilitate Accurate Dense Multipolar Electrode Mapping. Heart Rhythm Society, 
Denver, 2013 
Williams SE, et al. Dot Mapping: A Novel Method to Display Multiple Parameters on a 
Single Electroanatomical Chamber Model. Heart Rhythm Society, Denver, 2013 
Williams SE, et al. RealTime	Positional	Adjustment	of	Electroanatomical	Models	to	Improve	Spatial	Perception	and	Catheter	Localization.	Heart Rhythm Society, 
Denver, 2013 
Williams SE, et al. Optimized Atrial Local Activation Time Sampling Density and 
Technique. Heart Rhythm Society, San Francisco, 2014. 
Williams SE, et al. Pace-Capture Defined Bipolar Voltage Thresholds for Identifying 
Post-Ablation Scar. Heart Rhythm Society, San Francisco, 2014. 
Williams SE, et al. CMR Characterisation of Linear Ablation Lesions with Varying 
Contact Force – A Porcine Model. Heart Rhythm Society, San Francisco, 2014. 
Williams SE, et al. Voltage and Pace-Capture Mapping of Linear Ablation Lesions 
Overestimate Chronic Gap Size. Heart Rhythm Society, Boston, 2014. 
Publications 
Williams SE et al. The Effect of Contact Force in Atrial Radiofrequency Ablation: 
Electroanatomical, Cardiovascular Magnetic Resonance and Histological Assessment in 
a Chronic Porcine Model. JACC Clin Electrophysiol 2015; 1(5): 421-431. 
Williams SE et al. Quantitative Assessment of the Effects of Therapeutic Hypothermia 
on Early Repolarization in Idiopathic Ventricular Fibrillation Survivors: A 7-Year 
Cohort Study. Circ Arrhythmia Electrophysiol 2014; 7(1): 120-6. 
Williams SE et al. Ectopy and Supraventricular Tachycardia: Is There a Relationship. 
Pacing Clin Electrophysiol 2013; 36(4): 497-500. 
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